data_4a4h_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 4a4h _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.3 m . . . . . 0 N--CA 1.438 -1.072 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -113.54 151.48 31.53 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.136 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -129.25 159.74 35.15 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.99 133.38 30.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 123.078 0.551 . . . . 0.0 110.766 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.54 26.87 37.45 Favored Glycine 0 CA--C 1.499 -0.943 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.444 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.74 155.47 19.66 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -96.4 131.47 42.92 Favored 'General case' 0 C--N 1.274 -2.698 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.243 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 17.3 p -144.03 176.67 9.12 Favored 'General case' 0 C--N 1.263 -3.181 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.561 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 41.1 mtp -119.23 130.44 55.46 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 172.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.79 153.61 34.18 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -175.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.7 t -86.74 116.81 29.93 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.442 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -66.35 123.61 20.45 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.4 t -61.2 -23.36 65.54 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.219 0.533 . . . . 0.0 111.483 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -83.16 -42.63 17.09 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -106.71 -17.24 14.28 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.222 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.24 3.5 82.06 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 119.554 -1.307 . . . . 0.0 112.398 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -91.48 163.85 14.02 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 24.7 p -94.84 136.42 35.18 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.697 0.284 . . . . 0.0 110.7 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -136.71 157.56 46.47 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 123.535 0.734 . . . . 0.0 109.581 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -75.09 129.47 37.63 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -145.02 152.94 40.92 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.121 -177.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -112.53 134.96 53.79 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.346 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 73.9 mt -71.63 123.21 25.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 123.252 0.621 . . . . 0.0 111.491 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -98.66 -37.41 9.52 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.01 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -152.86 145.42 24.18 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 68.5 mt -121.68 140.06 46.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -121.73 97.13 5.35 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 172.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.08 -24.67 67.52 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -176.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -68.17 -45.78 72.53 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -87.32 -15.22 38.62 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.386 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.429 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 67.62 40.46 90.5 Favored Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -176.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 69.9 p -124.7 157.9 34.5 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -177.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.85 141.15 36.66 Favored 'General case' 0 C--N 1.29 -2.022 0 CA-C-O 121.308 0.575 . . . . 0.0 110.408 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.92 121.13 29.96 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.9 pp -124.92 153.47 32.06 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.756 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.973 -174.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.2 m -120.44 120.46 35.98 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.725 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -69.56 117.74 11.54 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.581 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.26 133.07 49.83 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.948 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.9 -42.95 2.01 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.869 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -87.63 -43.45 11.95 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.305 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.77 3.59 62.31 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.218 -0.992 . . . . 0.0 112.127 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -77.57 152.7 33.85 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -141.24 143.49 34.16 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -151.55 159.12 44.26 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 123.962 0.788 . . . . 0.0 109.026 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.0 t -97.66 113.92 33.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -128.49 141.32 41.07 Favored Pre-proline 0 C--N 1.288 -2.098 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -174.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.529 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 40.6 Cg_endo -62.6 147.7 94.41 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.447 2.098 . . . . 0.0 111.229 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 45.8 mt -54.44 -26.11 28.96 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.608 0.763 . . . . 0.0 111.592 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.7 pp -64.53 -26.0 68.23 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.342 0.591 . . . . 0.0 110.399 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -89.62 -14.26 35.32 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.955 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 81.7 mt -85.31 125.83 33.24 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.988 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -115.39 151.39 45.9 Favored Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.48 153.43 70.21 Favored 'Trans proline' 0 C--O 1.243 0.742 0 C-N-CA 121.597 1.531 . . . . 0.0 110.913 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 C--N 1.314 -0.953 0 CA-C-O 121.721 0.772 . . . . 0.0 109.003 179.74 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.1 m . . . . . 0 N--CA 1.435 -1.223 0 CA-C-O 120.999 0.428 . . . . 0.0 110.009 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -118.91 151.58 37.87 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.665 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -131.4 153.93 49.17 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.79 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 141.61 17.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 C-N-CA 123.908 0.883 . . . . 0.0 110.746 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.23 28.49 55.84 Favored Glycine 0 CA--C 1.498 -0.972 0 N-CA-C 112.122 -0.391 . . . . 0.0 112.122 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.38 153.28 35.41 Favored 'General case' 0 CA--C 1.483 -1.614 0 CA-C-O 120.814 0.34 . . . . 0.0 110.887 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -90.75 139.12 31.03 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.172 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 17.2 p -148.65 179.52 7.76 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-N 113.719 -1.582 . . . . 0.0 107.327 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 58.4 mtp -120.37 131.18 54.72 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 173.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.95 149.75 41.62 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.8 t -85.35 116.48 28.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -64.19 120.66 12.54 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.7 t -62.37 -21.04 65.02 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 123.578 0.549 . . . . 0.0 111.292 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -84.87 -42.35 15.14 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -112.5 -15.51 13.05 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 119.336 -0.946 . . . . 0.0 111.916 -174.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.1 0.36 89.58 Favored Glycine 0 C--N 1.313 -0.719 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.924 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -93.22 159.86 15.09 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 120.559 -0.456 . . . . 0.0 109.825 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 23.3 p -92.76 137.07 32.68 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.167 0.508 . . . . 0.0 110.945 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -136.46 158.33 44.68 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 123.846 0.858 . . . . 0.0 109.36 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.28 127.99 34.42 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.66 153.65 48.58 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.126 0.488 . . . . 0.0 111.25 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -115.03 132.93 56.44 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.997 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 62.5 mt -73.03 123.78 28.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.928 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -99.9 -38.2 8.72 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.858 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -149.58 143.72 25.75 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -176.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.4 mt -123.24 140.42 46.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -120.43 92.7 3.83 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 173.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -65.94 -23.49 66.62 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.82 -46.71 88.38 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.042 0.537 . . . . 0.0 109.805 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -95.46 -11.65 27.2 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.087 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.43 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 72.32 39.55 57.1 Favored Glycine 0 C--N 1.312 -0.804 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -177.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 35.5 p -124.36 156.96 36.14 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 122.793 0.437 . . . . 0.0 110.217 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.69 148.61 41.05 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.399 0.619 . . . . 0.0 111.089 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -97.52 121.75 39.79 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.9 pp -124.78 154.79 32.78 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.669 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.782 -174.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 91.3 m -120.76 120.3 35.23 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.448 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -67.71 121.58 16.25 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.186 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.24 130.72 46.67 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.552 -175.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.29 -49.94 2.99 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 121.131 -0.557 . . . . 0.0 111.868 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -72.63 -43.25 63.5 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 120.612 0.244 . . . . 0.0 111.235 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.84 8.57 65.07 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.27 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 107' ' ' THR . 3.9 m-20 -80.65 148.52 30.19 Favored 'General case' 0 CA--C 1.49 -1.364 0 O-C-N 122.352 -0.499 . . . . 0.0 110.222 178.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -137.64 133.32 34.19 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 -176.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -151.51 162.79 40.36 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.685 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.5 t -96.37 119.88 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.6 t -133.8 140.71 37.4 Favored Pre-proline 0 C--N 1.278 -2.503 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 42.6 Cg_endo -63.71 147.43 92.6 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 122.346 2.031 . . . . 0.0 110.941 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 49.8 mt -53.56 -27.12 24.43 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 123.677 0.791 . . . . 0.0 111.646 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.57 -23.41 66.2 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.249 0.619 . . . . 0.0 111.604 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -91.64 -12.59 33.77 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 121.185 0.517 . . . . 0.0 110.803 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 81.4 mt -84.49 128.21 34.46 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.066 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -111.36 157.59 38.61 Favored Pre-proline 0 C--N 1.294 -1.844 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.76 156.89 63.96 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 121.63 1.554 . . . . 0.0 109.628 170.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 89.8 t . . . . . 0 C--N 1.306 -1.316 0 CA-C-O 121.507 0.67 . . . . 0.0 110.536 -179.961 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.3 p . . . . . 0 N--CA 1.437 -1.111 0 CA-C-O 121.078 0.466 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -109.88 151.99 26.35 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.313 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -124.89 151.0 45.93 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.1 t -64.48 133.78 29.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.54 31.94 26.1 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.139 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 11.0 t0 -113.14 165.02 12.78 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.716 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -96.72 130.7 43.91 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 23.6 p -144.93 176.64 9.32 Favored 'General case' 0 C--N 1.265 -3.091 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 38.7 mtp -117.6 130.48 56.41 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 173.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.54 149.82 41.82 Favored 'General case' 0 C--N 1.279 -2.49 0 O-C-N 123.435 0.46 . . . . 0.0 109.865 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.3 t -85.3 117.54 30.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.453 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.6 t90 -66.25 124.86 23.82 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.2 t -61.38 -26.51 67.89 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.15 0.5 . . . . 0.0 111.229 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.453 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 16.2 mm-40 -80.26 -40.06 27.72 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -175.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.404 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 11.6 t70 -115.61 -15.46 11.4 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.77 -177.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.85 6.88 89.14 Favored Glycine 0 C--N 1.307 -1.074 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.142 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.404 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 27.0 mm-40 -95.82 161.29 14.07 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.137 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 25.1 p -90.8 136.77 32.85 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.46 0.648 . . . . 0.0 110.84 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -136.35 158.02 45.42 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.944 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -74.63 131.29 40.8 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.93 153.55 44.44 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.376 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 77' ' ' ASP . 38.3 tt0 -114.04 132.11 56.12 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.578 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.4 ' HA ' HG23 ' A' ' 106' ' ' ILE . 66.3 mt -73.44 125.08 31.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 122.977 0.511 . . . . 0.0 112.37 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -97.87 -40.39 8.53 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.37 1.068 . . . . 0.0 111.201 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -149.28 148.84 30.03 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.3 mt -121.5 131.6 72.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -114.99 90.87 3.44 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -66.5 -20.4 66.03 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.2 -46.26 74.4 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.143 0.497 . . . . 0.0 109.882 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -92.38 -6.3 50.37 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.798 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.85 38.74 94.6 Favored Glycine 0 C--O 1.241 0.55 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 67.4 p -130.29 155.57 46.09 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.45 149.56 48.29 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-O 120.914 0.387 . . . . 0.0 110.509 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.65 124.12 38.49 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.9 pp -127.73 155.56 39.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.196 -175.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 75.4 m -117.9 120.37 37.68 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -68.01 123.13 19.77 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.36 130.76 44.09 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.839 -175.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.89 -59.32 0.76 Allowed Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -69.57 -42.59 74.32 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.101 0.477 . . . . 0.0 110.543 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.31 16.26 62.85 Favored Glycine 0 N--CA 1.434 -1.442 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.919 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -86.76 154.61 20.81 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -142.19 136.24 29.73 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 123.099 0.249 . . . . 0.0 110.673 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.03 159.67 43.65 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.2 t -93.71 121.85 44.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 176.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.9 t -134.67 141.49 38.95 Favored Pre-proline 0 C--N 1.287 -2.136 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -176.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 36.9 Cg_endo -61.74 146.23 96.81 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 122.627 2.218 . . . . 0.0 111.415 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 48.4 mt -54.75 -26.08 31.91 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 123.702 0.801 . . . . 0.0 111.858 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.17 -27.98 69.08 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.116 0.484 . . . . 0.0 110.771 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -85.55 -15.06 43.93 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.564 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.1 mt -85.85 125.78 33.56 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -114.97 151.91 46.01 Favored Pre-proline 0 C--N 1.282 -2.355 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -71.0 146.96 53.87 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 121.5 1.467 . . . . 0.0 110.727 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 C--N 1.312 -1.048 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.325 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.0 m . . . . . 0 N--CA 1.436 -1.175 0 CA-C-O 121.252 0.549 . . . . 0.0 110.442 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -111.6 151.53 28.67 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.592 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -131.66 159.18 39.07 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.4 t -65.42 135.89 27.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.03 40.88 13.1 Favored Glycine 0 N--CA 1.431 -1.637 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.404 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.41 152.7 41.31 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -95.04 131.21 41.27 Favored 'General case' 0 N--CA 1.402 -2.836 0 O-C-N 123.892 0.745 . . . . 0.0 109.744 174.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 18.7 p -141.43 177.48 8.09 Favored 'General case' 0 C--N 1.261 -3.257 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 51.5 mtp -118.05 130.75 56.35 Favored 'General case' 0 N--CA 1.4 -2.935 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 173.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.76 150.01 40.5 Favored 'General case' 0 C--N 1.267 -3.001 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -176.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.4 t -84.64 120.76 35.82 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -69.57 127.26 32.35 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.7 m -59.3 -29.07 67.34 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -84.12 -42.01 16.5 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -175.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -105.8 -15.75 14.85 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.702 0.763 . . . . 0.0 110.516 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.29 13.29 73.46 Favored Glycine 0 C--N 1.312 -0.765 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.239 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -102.65 163.86 11.98 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 20.5 p -90.19 136.27 33.15 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.898 0.38 . . . . 0.0 110.604 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -134.38 158.26 44.3 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 124.199 1.0 . . . . 0.0 109.282 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -74.86 125.3 28.52 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -136.95 149.63 47.68 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.159 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -110.91 132.17 54.43 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.892 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.1 mt -72.51 123.43 27.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.124 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -98.02 -40.07 8.63 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.914 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -152.39 142.51 22.3 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -175.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 69.9 mt -119.21 131.99 70.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -123.92 90.55 3.29 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.17 -20.31 65.71 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.106 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -56.32 -42.86 78.33 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 123.991 0.807 . . . . 0.0 110.227 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -101.81 -1.55 32.04 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.201 0.524 . . . . 0.0 110.215 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.63 39.29 95.34 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 37.0 p -128.28 155.69 44.19 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 122.382 0.273 . . . . 0.0 110.427 -175.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.93 147.19 46.24 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.77 122.04 34.76 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.9 pp -126.01 153.35 34.09 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.497 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.5 m -120.14 120.41 36.11 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -67.8 118.3 10.85 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.32 130.66 41.94 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 114.623 -1.172 . . . . 0.0 110.489 -174.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.02 -41.86 2.09 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -87.37 -43.21 12.29 Favored 'General case' 0 C--N 1.313 -1.006 0 O-C-N 122.515 -0.403 . . . . 0.0 110.955 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.41 1.48 68.95 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.623 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -76.06 148.09 38.2 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -135.32 140.84 45.41 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -152.01 158.16 42.7 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.8 t -93.66 115.46 32.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 175.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.2 t -129.49 141.21 41.04 Favored Pre-proline 0 C--N 1.281 -2.387 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -175.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.5 Cg_endo -61.5 145.03 98.27 Favored 'Trans proline' 0 N--CA 1.437 -1.833 0 C-N-CA 122.165 1.91 . . . . 0.0 110.671 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 55.2 mt -53.94 -26.15 24.07 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 123.887 0.875 . . . . 0.0 111.472 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 pp -64.37 -25.48 68.05 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.093 0.473 . . . . 0.0 110.855 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -88.31 -12.84 42.34 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.86 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 81.3 mt -86.7 125.88 34.18 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.153 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -114.91 155.76 46.0 Favored Pre-proline 0 C--N 1.288 -2.089 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.62 157.22 59.34 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 121.526 1.484 . . . . 0.0 110.46 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 C--N 1.312 -1.045 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.332 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.9 t . . . . . 0 N--CA 1.427 -1.579 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -110.06 151.52 27.1 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.637 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -129.09 159.01 37.34 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.11 134.35 29.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 C-N-CA 123.385 0.674 . . . . 0.0 110.741 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.1 35.97 25.87 Favored Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -117.36 154.53 31.13 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -93.92 132.42 38.39 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-O 121.68 0.752 . . . . 0.0 110.355 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 19.4 p -142.89 178.88 7.36 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.1 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 33.5 mtp -118.99 130.54 55.74 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.13 149.96 43.87 Favored 'General case' 0 C--N 1.28 -2.455 0 O-C-N 123.517 0.51 . . . . 0.0 109.964 -175.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.0 t -85.3 119.07 33.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -67.16 123.49 20.42 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.2 m -60.31 -28.23 67.95 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.607 0.718 . . . . 0.0 112.087 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -79.59 -41.87 26.21 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.628 -174.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -112.73 -15.74 12.91 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.804 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.39 3.92 89.95 Favored Glycine 0 C--N 1.313 -0.715 0 C-N-CA 120.03 -1.081 . . . . 0.0 113.561 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.441 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 33.0 mm-40 -90.14 161.22 15.87 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 122.362 -0.493 . . . . 0.0 109.701 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 71.2 m -95.14 135.54 36.58 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.441 ' CE2' ' HB2' ' A' ' 88' ' ' GLN . 97.7 m-85 -135.96 158.03 45.4 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.067 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -75.34 131.31 40.18 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.81 152.52 43.79 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.583 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -111.45 134.34 53.1 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 70.0 mt -72.15 125.07 30.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 C-N-CA 123.432 0.693 . . . . 0.0 111.659 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -96.28 -41.73 8.51 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.085 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -150.78 152.03 33.21 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 72.2 mt -124.77 136.04 62.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.429 ' HB3' ' HG1' ' A' ' 103' ' ' THR . 12.2 t70 -112.67 91.61 3.72 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 174.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -65.64 -25.61 67.43 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.729 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -64.6 -44.11 91.67 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.936 -176.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -98.22 -5.53 33.11 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.97 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.418 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 68.19 40.94 87.68 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -175.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 40.3 p -125.41 155.93 39.62 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 122.641 -0.329 . . . . 0.0 110.143 -177.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -141.74 145.73 35.17 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.122 0.487 . . . . 0.0 111.105 176.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.99 125.03 35.67 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.9 pp -128.12 154.59 38.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.546 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 92.1 m -120.08 120.24 35.68 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.782 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -66.88 123.13 19.32 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 123.242 0.617 . . . . 0.0 110.38 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.75 137.9 55.81 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.275 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.28 -49.71 3.26 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.879 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -81.95 -35.48 29.01 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 120.758 0.313 . . . . 0.0 110.902 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 82.04 9.74 84.84 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.488 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -81.42 152.68 27.3 Favored 'General case' 0 CA--C 1.49 -1.332 0 O-C-N 122.634 -0.333 . . . . 0.0 110.109 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.09 138.79 40.74 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 120.645 0.26 . . . . 0.0 110.991 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -151.85 161.06 43.26 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.872 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.2 t -98.27 122.04 49.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.0 t -135.8 141.6 37.49 Favored Pre-proline 0 C--N 1.282 -2.348 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -174.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.525 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 36.8 Cg_endo -62.54 147.11 95.31 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 122.425 2.083 . . . . 0.0 111.207 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 55.6 mt -55.65 -26.05 42.49 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 123.668 0.787 . . . . 0.0 111.788 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 pp -63.92 -28.89 70.14 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.637 0.732 . . . . 0.0 110.511 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -85.13 -17.62 36.71 Favored 'General case' 0 CA--C 1.484 -1.58 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.661 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 81.1 mt -82.98 125.79 31.8 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-O 121.64 0.733 . . . . 0.0 109.355 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -114.45 154.81 46.49 Favored Pre-proline 0 C--N 1.275 -2.658 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.214 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.38 155.38 70.65 Favored 'Trans proline' 0 C--O 1.255 1.367 0 C-N-CA 121.506 1.47 . . . . 0.0 110.003 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.3 t . . . . . 0 N--CA 1.43 -1.458 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.383 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.43 -1.448 0 CA-C-O 120.87 0.367 . . . . 0.0 110.476 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -115.81 151.95 34.25 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.219 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -127.79 162.65 26.13 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 173.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.49 135.57 27.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 122.943 0.497 . . . . 0.0 110.419 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.56 18.46 48.51 Favored Glycine 0 C--O 1.239 0.449 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.323 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.01 151.18 26.17 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -91.41 140.82 29.4 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-O 121.604 0.716 . . . . 0.0 109.844 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.401 ' SG ' HD23 ' A' ' 122' ' ' LEU . 16.5 p -146.8 173.01 12.77 Favored 'General case' 0 C--N 1.261 -3.248 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.3 mtp -114.12 130.22 56.59 Favored 'General case' 0 C--N 1.274 -2.695 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -121.19 150.67 40.96 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.38 -175.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.1 t -85.31 117.22 30.0 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.422 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.3 t90 -64.76 123.08 18.44 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.4 m -61.19 -22.8 65.08 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.422 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 28.0 mm-40 -83.28 -42.04 17.62 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -116.21 -15.47 11.05 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 118.849 -1.14 . . . . 0.0 112.124 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.09 6.37 89.2 Favored Glycine 0 C--N 1.315 -0.612 0 C-N-CA 120.394 -0.908 . . . . 0.0 114.098 176.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.439 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 28.3 mm-40 -91.28 161.81 14.88 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 59.4 m -91.33 135.64 33.67 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.439 ' CE1' ' HB2' ' A' ' 88' ' ' GLN . 96.4 m-85 -136.71 157.63 46.31 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.202 0.601 . . . . 0.0 109.481 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -76.43 123.8 26.56 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.43 151.89 49.0 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.845 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -108.54 135.94 48.97 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.576 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.4 mt -73.46 118.51 18.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.819 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -94.71 -36.49 11.71 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.044 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -152.82 151.09 30.04 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.496 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 68.4 mt -127.15 141.43 46.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -120.77 98.3 5.95 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 173.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -65.75 -25.01 67.08 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -63.08 -46.54 86.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.931 0.396 . . . . 0.0 110.957 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -93.82 -13.6 27.1 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.408 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.496 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 68.87 40.8 84.46 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -175.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 40.6 p -122.93 155.59 36.42 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.02 145.0 43.55 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.216 0.531 . . . . 0.0 111.108 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.9 121.58 33.63 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.9 pp -124.4 152.84 30.55 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.818 -175.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.9 m -122.65 120.41 33.63 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.548 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -66.7 118.77 10.72 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.871 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.48 134.53 55.78 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.967 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.43 -54.61 2.41 Favored Glycine 0 N--CA 1.424 -2.136 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.554 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -74.77 -43.47 54.68 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.072 0.463 . . . . 0.0 111.059 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.79 4.81 69.26 Favored Glycine 0 N--CA 1.433 -1.525 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.142 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -76.98 151.27 35.73 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -138.44 140.19 39.18 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -177.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -151.75 161.53 42.51 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.8 t -98.71 120.57 48.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.5 t -135.06 141.14 37.08 Favored Pre-proline 0 C--N 1.289 -2.053 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -176.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.3 Cg_endo -62.51 147.88 94.16 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 122.552 2.168 . . . . 0.0 111.698 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 50.0 mt -55.51 -26.32 42.2 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 123.834 0.854 . . . . 0.0 111.515 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.2 -26.78 68.29 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.968 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -87.91 -17.42 31.41 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.784 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.401 HD23 ' SG ' ' A' ' 79' ' ' CYS . 83.8 mt -81.8 125.87 31.18 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.483 0.659 . . . . 0.0 109.276 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -114.75 151.19 45.14 Favored Pre-proline 0 C--N 1.284 -2.255 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.83 147.53 69.01 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.966 1.778 . . . . 0.0 111.378 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.5 t . . . . . 0 CA--C 1.498 -1.044 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.745 179.784 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.0 m . . . . . 0 N--CA 1.434 -1.227 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -107.72 150.81 26.5 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.199 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -129.9 151.88 49.98 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.4 t -64.4 134.93 28.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.49 30.85 23.44 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.364 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -120.87 157.65 29.36 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -91.81 141.94 28.11 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.285 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.402 ' SG ' HD23 ' A' ' 122' ' ' LEU . 22.5 p -148.26 177.37 9.47 Favored 'General case' 0 C--N 1.265 -3.089 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 36.6 mtp -118.51 130.66 56.05 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 173.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.23 150.17 41.1 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.1 t -86.0 113.91 24.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -64.46 122.64 17.22 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.5 t -65.23 -19.99 66.22 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 120.778 0.323 . . . . 0.0 111.285 -175.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -84.98 -42.65 14.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.448 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 9.2 t70 -108.33 -15.63 14.43 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.086 -175.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.72 2.27 89.84 Favored Glycine 0 C--N 1.316 -0.558 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.512 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.448 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 24.2 mm-40 -95.14 163.28 13.36 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 17.5 p -93.23 136.42 33.51 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.135 0.493 . . . . 0.0 110.74 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -134.07 158.68 42.96 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 124.145 0.978 . . . . 0.0 109.426 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -75.26 128.41 35.37 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.94 151.82 42.94 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.84 0.352 . . . . 0.0 110.905 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -113.75 135.29 54.11 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.433 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.408 ' HA ' HG23 ' A' ' 106' ' ' ILE . 64.3 mt -72.87 122.03 24.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.473 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -99.29 -33.5 10.7 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.462 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -153.66 150.78 28.95 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 77.1 mt -126.53 133.7 68.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -118.27 94.18 4.4 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.74 -20.69 66.01 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -61.4 -46.81 88.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -97.49 -13.88 21.45 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.047 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.479 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.05 36.59 51.29 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -177.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 43.9 p -124.52 155.35 39.14 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -176.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.36 147.88 50.6 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-O 121.011 0.434 . . . . 0.0 110.392 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.48 120.15 34.28 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.9 pp -124.76 149.9 29.43 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.989 -174.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 94.0 m -118.02 120.56 38.17 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.078 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -68.48 125.4 26.36 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.576 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.09 136.95 57.72 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.407 -176.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 86.28 -46.83 3.66 Favored Glycine 0 C--N 1.311 -0.813 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.567 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -79.87 -43.01 23.05 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.155 0.502 . . . . 0.0 110.739 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 88.34 1.33 81.46 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.878 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -70.44 148.71 48.02 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -136.64 133.96 36.81 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -146.86 156.32 43.01 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.0 t -91.1 122.05 42.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.7 t -135.84 141.19 35.86 Favored Pre-proline 0 C--N 1.283 -2.303 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 40.8 Cg_endo -62.38 146.6 95.67 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.423 2.082 . . . . 0.0 110.923 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 55.4 mt -54.66 -26.48 33.57 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 123.504 0.722 . . . . 0.0 111.497 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 pp -63.37 -27.87 69.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.897 0.38 . . . . 0.0 110.703 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -87.39 -14.71 39.89 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.518 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.402 HD23 ' SG ' ' A' ' 79' ' ' CYS . 82.1 mt -84.27 126.28 33.03 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.198 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -114.34 151.54 45.19 Favored Pre-proline 0 C--N 1.285 -2.218 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.78 150.98 68.83 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.747 1.631 . . . . 0.0 111.607 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 64.0 t . . . . . 0 C--N 1.3 -1.574 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.723 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.1 m . . . . . 0 N--CA 1.441 -0.885 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -111.25 151.88 27.79 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 122.754 0.421 . . . . 0.0 111.692 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.506 ' HB2' ' HZ3' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -129.1 152.16 49.0 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 175.386 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.4 t -63.98 139.84 20.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 123.325 0.65 . . . . 0.0 110.188 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.19 35.34 34.33 Favored Glycine 0 CA--C 1.497 -1.079 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.2 153.74 38.42 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -91.86 135.34 34.0 Favored 'General case' 0 N--CA 1.412 -2.375 0 O-C-N 123.872 0.732 . . . . 0.0 110.801 175.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 20.5 p -145.99 179.51 7.42 Favored 'General case' 0 C--N 1.27 -2.871 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 56.5 mtp -119.97 130.69 54.88 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.25 151.49 39.09 Favored 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.034 -174.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 88.6 t -85.28 115.8 27.57 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.3 t90 -64.15 121.39 14.1 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.1 t -63.19 -19.84 64.87 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 123.438 0.461 . . . . 0.0 111.431 -175.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -84.73 -43.2 14.5 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.982 -0.687 . . . . 0.0 112.417 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -111.87 -16.41 13.15 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.765 -174.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.59 6.0 89.48 Favored Glycine 0 C--N 1.308 -0.99 0 C-N-CA 119.798 -1.191 . . . . 0.0 113.855 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -93.78 163.07 13.67 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 13.0 p -92.12 136.59 33.06 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 120.544 0.212 . . . . 0.0 110.77 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -137.69 157.96 45.37 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 124.052 0.941 . . . . 0.0 109.449 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -75.2 127.29 32.86 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -139.93 153.07 46.85 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.072 0.463 . . . . 0.0 110.964 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -113.01 134.59 54.44 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.45 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.412 ' HA ' HG23 ' A' ' 106' ' ' ILE . 67.4 mt -73.29 123.01 27.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 123.314 0.646 . . . . 0.0 112.2 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -95.13 -43.06 8.28 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.952 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -148.11 149.98 33.02 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.8 mt -129.17 138.33 54.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 O-C-N 123.382 0.426 . . . . 0.0 109.873 177.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -122.96 94.86 4.4 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 174.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.87 -25.95 66.65 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -177.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -61.28 -46.48 90.17 Favored 'General case' 0 C--O 1.221 -0.443 0 O-C-N 123.433 0.458 . . . . 0.0 109.938 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -93.94 -12.6 28.43 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.29 0.567 . . . . 0.0 110.393 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.18 42.02 51.91 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 60.4 p -126.88 157.45 39.33 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 -177.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -141.56 144.61 34.36 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.887 175.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.27 125.06 36.78 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.412 HG23 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -126.81 154.35 36.69 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.629 0 O-C-N 123.41 0.444 . . . . 0.0 110.659 -175.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.4 m -121.26 120.57 35.54 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.769 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -66.78 120.76 14.08 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 123.735 0.814 . . . . 0.0 110.738 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.62 123.81 21.9 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.765 -175.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.93 -34.14 6.02 Favored Glycine 0 N--CA 1.425 -2.059 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.009 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -96.23 -40.45 9.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.815 0.341 . . . . 0.0 111.432 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.06 6.02 65.42 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.256 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -81.28 151.1 28.24 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -140.03 139.15 35.9 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.397 -176.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -147.35 160.55 42.4 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 123.716 0.635 . . . . 0.0 109.471 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.7 t -97.48 114.7 35.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 174.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.5 t -130.14 141.52 42.18 Favored Pre-proline 0 C--N 1.28 -2.455 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -175.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 38.3 Cg_endo -62.97 146.9 95.0 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.04 1.827 . . . . 0.0 111.164 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 60.7 mt -53.0 -26.65 16.01 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.019 0.928 . . . . 0.0 111.918 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 pp -66.28 -24.48 66.57 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.066 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -91.42 -9.82 43.27 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 121.331 0.586 . . . . 0.0 110.561 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.1 mt -88.71 127.29 35.59 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.991 175.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -113.86 156.53 43.68 Favored Pre-proline 0 C--N 1.282 -2.345 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -65.56 160.38 43.41 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.086 1.858 . . . . 0.0 109.135 172.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 89.2 t . . . . . 0 C--N 1.304 -1.384 0 CA-C-O 122.153 0.978 . . . . 0.0 109.918 177.511 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.438 -1.027 0 CA-C-O 121.087 0.47 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.405 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 91.4 m95 -115.92 151.19 35.84 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.584 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -126.59 152.75 46.21 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.6 t -64.12 131.24 29.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.84 32.23 18.71 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.381 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 2.9 t70 -113.55 158.69 20.45 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -97.53 131.58 44.01 Favored 'General case' 0 N--CA 1.409 -2.486 0 CA-C-O 121.913 0.863 . . . . 0.0 110.862 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.405 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 17.4 p -144.04 179.62 7.08 Favored 'General case' 0 C--N 1.265 -3.074 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.197 -178.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 40.0 mtp -118.37 130.27 55.9 Favored 'General case' 0 N--CA 1.41 -2.449 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 172.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.94 149.98 41.24 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -176.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.5 t -85.36 116.18 28.25 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.052 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.471 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.7 t90 -64.31 121.6 14.7 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.7 t -65.08 -18.76 65.57 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 120.926 0.393 . . . . 0.0 111.339 -176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.471 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 43.6 mt-10 -83.75 -41.84 17.19 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -176.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.513 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 15.9 t70 -114.79 -16.57 11.75 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 118.897 -1.121 . . . . 0.0 111.812 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.26 -0.89 86.0 Favored Glycine 0 C--N 1.3 -1.423 0 C-N-CA 119.832 -1.175 . . . . 0.0 113.47 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.513 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 28.0 mm-40 -85.89 159.13 19.76 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.077 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 8.9 p -93.01 136.2 33.48 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.44 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 88' ' ' GLN . 97.5 m-85 -137.39 158.81 43.6 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 124.36 1.064 . . . . 0.0 108.957 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -74.68 127.11 32.32 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.42 150.35 47.57 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.854 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 77' ' ' ASP . 42.9 tt0 -111.37 132.29 54.54 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.712 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.402 ' HA ' HG23 ' A' ' 106' ' ' ILE . 69.8 mt -71.99 124.39 28.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.079 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -96.14 -39.85 9.5 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.241 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -152.68 152.18 31.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -177.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 71.1 mt -125.55 140.48 48.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -123.87 91.35 3.45 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.92 -22.92 66.53 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -175.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -71.5 -34.59 70.25 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.848 -178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -98.51 -10.13 23.98 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.727 174.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.423 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 67.55 38.79 90.81 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -178.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 65.0 p -128.61 155.86 44.3 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -175.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.62 148.5 45.86 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 121.161 0.505 . . . . 0.0 110.566 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.68 122.02 38.01 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.9 pp -124.94 154.83 33.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.317 -174.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 94.6 m -118.76 121.07 39.22 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -66.79 118.35 10.19 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.69 117.1 8.37 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.253 -173.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 110.39 -45.92 1.25 Allowed Glycine 0 N--CA 1.423 -2.193 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.847 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -81.83 -36.58 28.18 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.218 0.532 . . . . 0.0 110.975 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.81 2.58 86.45 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 120.081 -1.056 . . . . 0.0 112.01 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -73.52 147.8 43.68 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.31 129.39 25.15 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.473 -176.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -145.91 155.98 43.23 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.8 t -92.04 120.86 41.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.4 t -135.02 140.76 35.9 Favored Pre-proline 0 C--N 1.284 -2.256 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.0 Cg_endo -62.84 148.45 93.42 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.42 2.08 . . . . 0.0 111.463 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 56.2 mt -55.69 -26.34 44.5 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 123.883 0.873 . . . . 0.0 111.839 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.6 -25.43 67.39 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.085 0.554 . . . . 0.0 110.957 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -89.61 -13.31 37.43 Favored 'General case' 0 CA--C 1.482 -1.638 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.448 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.6 mt -86.34 127.23 34.77 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.517 176.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -113.67 154.55 45.68 Favored Pre-proline 0 C--N 1.274 -2.69 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.58 160.43 46.09 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.045 1.83 . . . . 0.0 108.284 172.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 76.7 t . . . . . 0 C--N 1.298 -1.669 0 CA-C-O 122.438 1.113 . . . . 0.0 110.824 -179.764 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.5 t . . . . . 0 N--CA 1.44 -0.932 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -113.05 152.21 29.78 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -122.53 150.24 42.84 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.652 0.381 . . . . 0.0 110.136 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.3 138.53 22.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.36 25.71 53.74 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.708 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 13.0 t0 -105.57 165.43 11.16 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.609 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -94.34 130.87 40.47 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 24.2 p -144.44 174.24 11.1 Favored 'General case' 0 C--N 1.258 -3.404 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.9 mtp -117.22 130.72 56.76 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.46 148.35 42.67 Favored 'General case' 0 C--N 1.264 -3.115 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -175.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 72.3 t -85.33 115.12 26.47 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -63.17 121.48 13.75 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.2 t -62.89 -20.07 64.8 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 122.813 0.445 . . . . 0.0 111.208 -175.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -82.11 -43.08 18.29 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.486 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 14.1 t70 -115.6 -16.13 11.34 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 118.657 -1.217 . . . . 0.0 112.276 -174.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.3 5.18 89.08 Favored Glycine 0 C--N 1.307 -1.053 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.273 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.486 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 29.4 mm-40 -90.7 162.96 14.69 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 176.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 5.5 p -95.99 136.02 36.99 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.516 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -137.88 158.03 45.19 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 124.007 0.923 . . . . 0.0 109.422 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -74.8 132.1 41.31 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.27 155.92 44.6 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.627 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 77' ' ' ASP . 36.5 tt0 -114.61 132.67 56.28 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.542 176.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.452 ' HA ' HG23 ' A' ' 106' ' ' ILE . 71.6 mt -71.48 123.37 25.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 O-C-N 123.67 0.606 . . . . 0.0 112.081 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -96.97 -42.55 7.86 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.09 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 105' ' ' ALA . 26.3 tt0 -144.35 145.03 31.73 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.459 -174.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 80.1 mt -121.74 126.1 74.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -111.51 94.85 5.17 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 175.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -65.4 -25.32 67.5 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.401 -174.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -70.75 -44.59 66.45 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.436 0.636 . . . . 0.0 109.967 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -91.24 -7.77 50.31 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.987 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.515 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 64.63 39.26 96.6 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 53.7 p -123.01 155.93 35.85 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.411 ' HB1' HD12 ' A' ' 122' ' ' LEU . . . -138.58 138.8 38.26 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-O 121.279 0.562 . . . . 0.0 110.208 176.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.426 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . . . -87.74 128.36 35.31 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 175.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.452 HG23 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -130.37 157.75 42.81 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.53 0 CA-C-O 120.669 0.271 . . . . 0.0 110.721 -175.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 65.2 m -121.68 120.6 35.18 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -67.89 120.67 14.57 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.334 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.67 140.89 58.52 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.179 -176.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.65 -53.92 3.75 Favored Glycine 0 N--CA 1.43 -1.72 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -75.36 -43.16 51.97 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.924 0.392 . . . . 0.0 111.155 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.74 18.28 61.97 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.021 -1.085 . . . . 0.0 111.442 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -87.61 156.12 19.64 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.95 143.52 32.0 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -151.78 162.19 41.42 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 105' ' ' ALA . 57.5 t -100.91 113.83 38.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 174.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.1 t -126.44 141.13 39.1 Favored Pre-proline 0 C--N 1.278 -2.534 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -174.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 33.2 Cg_endo -62.38 149.99 88.84 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.255 1.97 . . . . 0.0 111.728 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 51.7 mt -56.62 -25.7 53.81 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 123.37 0.668 . . . . 0.0 110.71 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.7 pp -65.0 -23.94 67.36 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.536 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -93.71 -14.87 25.84 Favored 'General case' 0 CA--C 1.49 -1.35 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.571 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.411 HD12 ' HB1' ' A' ' 104' ' ' ALA . 71.6 mt -83.17 126.67 32.87 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -114.61 150.62 44.24 Favored Pre-proline 0 C--N 1.285 -2.228 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -71.59 148.02 52.67 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.436 1.424 . . . . 0.0 110.187 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 C--N 1.306 -1.296 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.553 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.4 p . . . . . 0 N--CA 1.422 -1.862 0 CA-C-O 121.404 0.621 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.464 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 94.2 m95 -99.28 150.89 21.64 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.392 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -134.58 161.59 34.66 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 120.639 -0.425 . . . . 0.0 110.009 176.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.0 t -65.09 131.95 30.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 123.583 0.753 . . . . 0.0 110.008 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.21 38.02 10.53 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.228 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.75 153.32 41.1 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -92.27 133.87 35.42 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-O 121.65 0.738 . . . . 0.0 110.433 174.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.464 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 23.7 p -145.68 179.4 7.46 Favored 'General case' 0 C--N 1.267 -3.004 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.447 ' HG3' ' HA ' ' A' ' 125' ' ' VAL . 61.1 mtp -118.08 131.4 56.44 Favored 'General case' 0 N--CA 1.404 -2.772 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 172.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.26 148.89 41.97 Favored 'General case' 0 C--N 1.264 -3.11 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -175.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.9 t -84.63 113.67 23.67 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.468 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 13.5 t90 -63.29 122.67 16.76 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -177.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.1 t -63.5 -19.66 64.95 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 123.535 0.522 . . . . 0.0 111.583 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.468 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 21.9 mm-40 -84.73 -42.48 15.21 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -111.31 -15.62 13.57 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 118.62 -1.232 . . . . 0.0 111.791 -175.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.29 8.77 87.28 Favored Glycine 0 C--N 1.311 -0.81 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.16 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -101.69 162.31 13.0 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 26.5 p -92.48 136.4 33.24 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.415 0.626 . . . . 0.0 111.828 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -135.8 158.4 44.5 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 124.284 1.033 . . . . 0.0 109.195 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -74.72 126.74 31.53 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -177.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.0 150.48 47.02 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.801 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -109.62 132.5 54.08 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.638 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.414 ' HA ' HG23 ' A' ' 106' ' ' ILE . 60.3 mt -72.52 123.2 26.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 123.165 0.586 . . . . 0.0 111.459 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -96.21 -40.3 9.25 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.982 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -154.71 152.64 30.16 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 57.1 mt -129.56 138.44 54.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.867 0.365 . . . . 0.0 110.076 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -122.34 91.29 3.47 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 173.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -66.9 -19.56 65.75 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -64.63 -46.31 83.12 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.556 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -90.45 -16.22 29.38 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.586 0.708 . . . . 0.0 109.834 176.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.85 37.91 37.76 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 61.4 p -123.92 155.42 38.17 Favored 'General case' 0 N--CA 1.413 -2.3 0 O-C-N 122.601 -0.352 . . . . 0.0 110.201 -176.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.31 140.53 39.59 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-O 121.178 0.514 . . . . 0.0 109.874 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.33 121.9 32.04 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 107.13 -1.434 . . . . 0.0 107.13 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.414 HG23 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -126.74 154.83 37.04 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.512 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.99 -175.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 97.6 m -121.86 120.75 35.43 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.521 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -66.86 119.09 11.29 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.554 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.44 130.28 40.31 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.841 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.49 -39.68 2.71 Favored Glycine 0 N--CA 1.427 -1.96 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -96.56 -39.97 9.27 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.244 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.31 -2.68 71.46 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.933 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -71.62 152.0 43.27 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-N 115.687 -0.256 . . . . 0.0 110.356 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -139.68 141.28 36.98 Favored 'General case' 0 C--N 1.285 -2.229 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.568 -176.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -151.25 159.18 44.5 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.4 t -98.35 113.52 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 175.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.8 t -125.13 141.41 38.47 Favored Pre-proline 0 C--N 1.274 -2.675 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 46.0 Cg_endo -63.7 146.94 92.76 Favored 'Trans proline' 0 N--CA 1.443 -1.455 0 C-N-CA 121.777 1.651 . . . . 0.0 110.763 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 42.3 mt -55.51 -26.27 41.94 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 123.537 0.735 . . . . 0.0 110.828 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 pp -63.86 -23.24 67.28 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.214 0.53 . . . . 0.0 110.849 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -93.54 -10.38 35.01 Favored 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.465 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.2 mt -84.44 127.43 34.01 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.856 0.836 . . . . 0.0 109.962 176.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -114.26 150.23 43.37 Favored Pre-proline 0 C--N 1.277 -2.574 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.135 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.82 153.79 70.47 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.597 1.531 . . . . 0.0 108.557 170.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.447 ' HA ' ' HG3' ' A' ' 80' ' ' MET . 45.1 t . . . . . 0 C--N 1.307 -1.261 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.246 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.435 -1.207 0 CA-C-O 121.451 0.643 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -105.69 152.11 23.57 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.647 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -127.14 158.9 35.84 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.911 175.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.7 t -65.14 138.0 23.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.863 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.35 38.64 28.53 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.55 154.14 37.08 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -95.22 135.44 36.8 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.97 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 18.7 p -147.17 176.86 9.63 Favored 'General case' 0 C--N 1.263 -3.173 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 34.2 mtp -115.67 130.53 56.89 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -119.74 151.67 38.41 Favored 'General case' 0 C--N 1.277 -2.553 0 O-C-N 123.44 0.462 . . . . 0.0 109.818 -175.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.4 t -85.19 114.27 25.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.494 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 12.4 t90 -67.03 125.52 26.25 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 58.6 m -57.75 -33.02 68.04 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.376 0.608 . . . . 0.0 111.844 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -79.07 -41.66 28.25 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -172.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.494 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 42.6 t0 -105.75 -16.3 14.71 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.681 0.753 . . . . 0.0 110.194 -176.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.88 8.13 77.08 Favored Glycine 0 C--N 1.316 -0.529 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.88 178.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -101.49 163.76 12.1 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 15.2 p -93.7 135.58 34.85 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.227 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -134.66 158.18 44.72 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 124.364 1.066 . . . . 0.0 109.185 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -75.26 125.64 29.38 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.26 0.552 . . . . 0.0 109.738 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.42 154.36 46.65 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.652 -177.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -112.09 133.87 53.98 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.286 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 70.7 mt -71.94 122.31 23.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 C-N-CA 123.528 0.731 . . . . 0.0 111.453 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -96.96 -40.54 8.83 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.284 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -151.02 146.97 26.57 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 72.5 mt -122.45 135.88 61.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -120.03 93.97 4.23 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 174.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.13 -19.87 65.97 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -63.87 -46.47 84.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -93.01 -15.39 26.24 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.136 0.493 . . . . 0.0 110.244 178.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.434 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.3 37.02 48.97 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -176.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 41.2 p -125.6 155.81 40.14 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.51 148.6 47.73 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-O 121.233 0.539 . . . . 0.0 110.28 177.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.07 124.79 39.3 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 176.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.9 pp -126.75 154.7 36.93 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.693 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.644 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 98.4 m -122.08 120.1 33.31 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -67.19 118.72 10.98 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 123.201 0.6 . . . . 0.0 110.494 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.78 129.41 39.69 Favored 'General case' 0 N--CA 1.436 -1.126 0 O-C-N 124.509 1.131 . . . . 0.0 110.883 -175.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.77 -44.99 1.76 Allowed Glycine 0 N--CA 1.425 -2.088 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.736 178.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -82.47 -43.14 17.6 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 120.729 0.299 . . . . 0.0 111.11 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.25 10.42 60.91 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.642 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -85.02 156.92 20.9 Favored 'General case' 0 CA--C 1.488 -1.41 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.03 140.73 32.71 Favored 'General case' 0 C--N 1.29 -2.015 0 O-C-N 123.033 0.208 . . . . 0.0 110.789 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -151.75 158.9 43.98 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 123.371 0.419 . . . . 0.0 109.985 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.1 t -95.79 116.34 37.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.0 t -130.28 141.61 42.52 Favored Pre-proline 0 C--N 1.288 -2.099 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -174.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 42.1 Cg_endo -63.92 146.52 91.55 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.212 1.941 . . . . 0.0 111.108 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 61.6 mt -55.04 -26.15 35.38 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 123.906 0.882 . . . . 0.0 111.952 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.65 -27.05 68.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.057 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -88.9 -12.88 40.49 Favored 'General case' 0 CA--C 1.484 -1.584 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.803 -177.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 84.3 mt -82.64 126.15 32.01 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -114.11 148.43 40.02 Favored Pre-proline 0 C--N 1.28 -2.414 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.35 146.66 57.15 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 C-N-CA 121.31 1.34 . . . . 0.0 111.16 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 65.8 t . . . . . 0 N--CA 1.438 -1.045 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 173.466 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.425 -1.69 0 CA-C-O 120.933 0.397 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -114.25 150.89 33.68 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.34 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -131.01 157.18 43.69 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.464 177.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.76 141.61 17.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 C-N-CA 123.225 0.61 . . . . 0.0 111.05 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.73 31.23 40.94 Favored Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 121.444 -0.407 . . . . 0.0 112.139 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.13 150.16 42.58 Favored 'General case' 0 CA--C 1.481 -1.678 0 CA-C-O 120.533 0.206 . . . . 0.0 111.04 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -90.84 138.64 31.43 Favored 'General case' 0 N--CA 1.406 -2.669 0 CA-C-O 121.858 0.837 . . . . 0.0 110.507 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 18.6 p -147.42 176.39 10.06 Favored 'General case' 0 C--N 1.271 -2.813 0 CA-C-N 113.952 -1.476 . . . . 0.0 107.5 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 41.1 mtp -116.4 130.85 56.98 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 173.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.99 151.9 38.28 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.529 -175.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 72.2 t -88.01 117.55 31.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -66.5 126.04 27.63 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.3 m -60.08 -30.85 69.5 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 121.232 0.539 . . . . 0.0 112.383 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.15 -42.55 23.25 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -173.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -109.27 -14.08 14.53 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.136 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.95 3.65 89.41 Favored Glycine 0 C--N 1.305 -1.19 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.604 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -93.28 162.72 13.89 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 117.559 0.68 . . . . 0.0 110.255 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 25.0 p -89.94 136.63 32.92 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.23 0.538 . . . . 0.0 110.367 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -137.79 158.05 45.16 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 123.725 0.81 . . . . 0.0 108.955 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -75.21 128.98 36.7 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -142.35 150.12 40.31 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.304 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -110.41 134.56 52.21 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.53 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.0 mt -73.03 120.84 22.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.258 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -96.03 -39.07 9.93 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.425 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -151.39 147.79 27.32 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -176.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.7 mt -123.07 143.19 36.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -116.67 91.23 3.52 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 171.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -65.69 -20.29 66.23 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.984 -1.007 . . . . 0.0 113.091 -174.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -65.97 -46.65 77.34 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -91.92 -13.27 31.48 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.688 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.493 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 70.43 41.09 67.82 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -175.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 41.3 p -123.58 155.75 37.06 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.33 146.72 42.72 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.267 0.556 . . . . 0.0 111.134 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.89 122.05 37.12 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.9 pp -124.7 152.12 30.61 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.218 -174.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 90.9 m -117.01 122.99 45.78 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.051 177.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -72.62 124.43 25.24 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.752 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.32 134.42 55.76 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.706 -1.133 . . . . 0.0 111.044 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.8 -48.25 3.26 Favored Glycine 0 N--CA 1.432 -1.591 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.249 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -78.51 -43.4 27.0 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.796 0.332 . . . . 0.0 111.003 -178.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 88.71 11.9 65.13 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.262 -0.97 . . . . 0.0 111.911 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 107' ' ' THR . 4.3 m-20 -81.58 155.98 25.42 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -141.06 138.75 33.83 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.44 162.79 40.32 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 123.358 0.411 . . . . 0.0 109.982 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.6 t -97.56 121.87 48.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.8 t -136.55 141.09 34.24 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -177.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.522 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.4 Cg_endo -63.02 147.46 94.45 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 122.432 2.088 . . . . 0.0 111.346 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 43.4 mt -54.24 -26.79 30.61 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 123.73 0.812 . . . . 0.0 111.501 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 pp -63.97 -27.26 69.01 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.953 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -83.89 -27.27 28.75 Favored 'General case' 0 CA--C 1.487 -1.45 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.661 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 81.5 mt -73.67 127.09 31.82 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.485 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.76 153.96 44.95 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.96 151.79 56.72 Favored 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 121.607 1.538 . . . . 0.0 111.048 175.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.9 t . . . . . 0 C--N 1.309 -1.169 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 176.923 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.43 -1.432 0 CA-C-O 120.999 0.428 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -111.45 151.39 28.62 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.636 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -128.38 158.93 36.91 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 69.8 t -65.35 133.04 31.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 123.076 0.55 . . . . 0.0 110.066 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.85 31.4 23.83 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.786 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 1.3 t0 -115.32 164.06 14.8 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.836 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -94.46 131.9 39.67 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 21.0 p -147.0 172.74 13.25 Favored 'General case' 0 C--N 1.267 -3.016 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.1 mtp -117.08 129.91 56.3 Favored 'General case' 0 N--CA 1.411 -2.377 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.0 154.82 37.95 Favored 'General case' 0 C--N 1.273 -2.72 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.451 -173.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.0 t -87.51 122.15 38.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.426 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 10.8 t90 -71.44 122.17 19.91 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.9 m -61.34 -25.23 67.01 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.426 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 13.8 mm-40 -78.4 -42.11 31.14 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.783 -177.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -114.61 -15.52 11.97 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.271 -174.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.76 0.58 89.54 Favored Glycine 0 C--N 1.31 -0.881 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.688 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -90.97 164.67 13.9 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.189 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 22.0 p -90.37 136.18 33.21 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.787 0.327 . . . . 0.0 110.445 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -136.59 157.75 46.03 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 123.131 0.573 . . . . 0.0 109.777 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -75.41 130.97 39.84 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.52 154.55 43.74 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.746 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 77' ' ' ASP . 36.0 tt0 -112.6 132.24 55.24 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.847 177.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 74.5 mt -69.54 124.4 25.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 O-C-N 123.673 0.608 . . . . 0.0 111.639 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -99.07 -40.65 7.91 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.265 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.463 ' HB3' ' HB2' ' A' ' 105' ' ' ALA . 27.7 tt0 -143.3 143.35 31.66 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -173.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 79.1 mt -125.76 129.65 72.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 175.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -119.01 93.62 4.16 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 174.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -66.16 -20.0 66.01 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.457 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -61.13 -46.95 88.48 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.273 0.558 . . . . 0.0 110.232 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -99.39 -8.92 24.12 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.012 0.434 . . . . 0.0 110.716 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.414 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 71.17 41.5 59.86 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -177.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 75.5 p -123.07 157.33 33.04 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.436 ' HB1' HD12 ' A' ' 122' ' ' LEU . . . -139.43 140.26 37.3 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-O 121.167 0.508 . . . . 0.0 109.937 175.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . . . -89.67 124.55 34.7 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 175.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.9 pp -125.1 156.03 33.9 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 CA-C-O 120.855 0.36 . . . . 0.0 110.884 -174.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 97.3 m -121.98 119.89 32.79 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.398 176.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -66.16 125.73 26.44 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.375 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.72 129.53 41.47 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.975 -174.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.28 -50.85 3.36 Favored Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 111.616 -0.593 . . . . 0.0 111.616 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -70.15 -41.69 73.52 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.078 0.466 . . . . 0.0 110.071 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.36 5.5 85.05 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.615 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 107' ' ' THR . 4.0 m-20 -77.17 150.38 35.52 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -139.56 138.86 36.61 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.806 -176.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -151.69 162.73 40.52 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.209 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.4 t -99.45 119.99 48.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.3 t -132.72 141.17 40.13 Favored Pre-proline 0 C--N 1.281 -2.374 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 30.4 Cg_endo -62.48 148.86 92.65 Favored 'Trans proline' 0 N--CA 1.441 -1.574 0 C-N-CA 122.217 1.944 . . . . 0.0 111.48 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 50.6 mt -54.93 -26.54 36.91 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.793 0.837 . . . . 0.0 111.168 178.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.9 pp -66.88 -24.2 66.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.957 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -89.96 -17.92 27.03 Favored 'General case' 0 CA--C 1.49 -1.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.416 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.436 HD12 ' HB1' ' A' ' 104' ' ' ALA . 82.5 mt -82.2 125.37 30.84 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.314 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -115.81 153.97 48.12 Favored Pre-proline 0 C--N 1.281 -2.386 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.648 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.18 145.4 39.02 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 121.347 1.365 . . . . 0.0 110.535 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.4 t . . . . . 0 C--N 1.299 -1.592 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -178.91 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.427 -1.604 0 CA-C-O 121.427 0.632 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -112.85 151.12 30.78 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.711 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -133.37 160.69 36.62 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 175.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.9 t -64.87 133.46 30.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.528 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.12 30.89 21.57 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.779 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.03 152.17 35.21 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -92.12 132.4 36.63 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.91 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 18.0 p -142.53 174.72 10.38 Favored 'General case' 0 C--N 1.259 -3.327 0 CA-C-N 114.403 -1.271 . . . . 0.0 107.78 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 38.4 mtp -115.52 130.19 56.79 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 173.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -121.27 149.55 42.72 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.488 -176.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.8 t -85.04 116.5 28.63 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -63.74 120.64 12.24 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.9 t -63.65 -18.6 64.12 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 122.854 0.462 . . . . 0.0 111.298 -175.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -85.1 -42.51 14.72 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -115.91 -15.82 11.19 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 119.123 -1.031 . . . . 0.0 112.118 -173.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.32 -5.78 83.55 Favored Glycine 0 C--N 1.31 -0.861 0 C-N-CA 119.853 -1.165 . . . . 0.0 114.293 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.465 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 25.8 mm-40 -83.61 158.4 21.91 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 22.2 p -90.37 136.04 33.31 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.936 0.398 . . . . 0.0 109.977 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.465 ' CE2' ' HB2' ' A' ' 88' ' ' GLN . 97.4 m-85 -136.91 158.53 44.24 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.612 0.765 . . . . 0.0 109.681 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -75.33 123.36 25.22 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -135.74 149.87 49.33 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.89 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -112.05 132.35 54.87 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.986 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 64.5 mt -71.52 123.08 25.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.948 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -96.77 -41.34 8.52 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.09 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -151.7 142.09 22.49 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.574 -176.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 69.0 mt -113.44 138.35 43.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -120.8 92.06 3.67 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -65.76 -18.05 65.05 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.65 -46.91 80.51 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 121.412 0.625 . . . . 0.0 109.659 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -93.8 -15.66 24.89 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.566 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.42 37.4 47.36 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -175.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 42.8 p -125.36 155.79 39.74 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -176.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.58 144.64 48.06 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-O 121.238 0.542 . . . . 0.0 110.412 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.62 121.79 32.85 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.9 pp -124.57 151.9 30.22 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.705 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.477 -175.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.8 m -119.71 121.26 38.82 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -67.73 118.24 10.72 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.46 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.28 126.27 29.16 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.171 -173.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.81 -37.69 3.66 Favored Glycine 0 N--CA 1.425 -2.065 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.097 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -89.9 -43.61 10.48 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.921 0.391 . . . . 0.0 110.172 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.43 4.91 62.17 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.044 -178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -79.84 156.64 27.28 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 117.039 0.42 . . . . 0.0 109.934 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -143.1 143.56 31.89 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 120.564 0.221 . . . . 0.0 110.622 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -151.67 162.48 40.93 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.8 t -103.73 115.37 45.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.9 t -128.72 141.5 41.81 Favored Pre-proline 0 C--N 1.279 -2.498 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.08 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.2 Cg_endo -62.18 146.46 95.99 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 122.456 2.104 . . . . 0.0 111.457 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 60.1 mt -55.15 -26.39 38.35 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 123.623 0.769 . . . . 0.0 111.469 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 pp -66.22 -24.37 66.6 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.958 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -90.26 -16.38 29.46 Favored 'General case' 0 CA--C 1.479 -1.763 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 84.7 mt -80.98 126.24 31.14 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.86 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -114.8 147.43 38.2 Favored Pre-proline 0 C--N 1.288 -2.084 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -67.36 150.64 81.02 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 122.006 1.804 . . . . 0.0 110.837 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.427 -1.59 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.993 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.44 -0.973 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -110.81 151.15 28.15 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.819 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -126.87 153.21 46.02 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.67 133.13 30.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 175.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.11 39.42 9.28 Favored Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.484 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -117.79 161.17 20.16 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -98.75 131.24 45.05 Favored 'General case' 0 N--CA 1.394 -3.258 0 CA-C-O 122.1 0.953 . . . . 0.0 110.818 175.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.5 p -143.63 168.09 20.71 Favored 'General case' 0 C--N 1.262 -3.227 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.129 -177.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 31.3 mtp -111.83 130.2 55.89 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 172.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -121.42 149.47 42.97 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.4 t -85.42 117.01 29.66 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.443 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.5 t90 -66.76 123.05 19.06 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.5 m -60.24 -26.36 66.36 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.443 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 45.4 mt-10 -82.09 -41.98 19.8 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.005 -174.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -110.99 -15.48 13.74 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.762 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.28 10.51 86.16 Favored Glycine 0 C--N 1.307 -1.056 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.643 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -98.94 160.09 14.5 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 23.0 p -90.34 136.33 33.12 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 120.879 0.371 . . . . 0.0 110.916 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -136.46 158.14 45.14 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 123.725 0.81 . . . . 0.0 110.085 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -76.66 125.89 30.03 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.415 0.626 . . . . 0.0 109.887 -177.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -139.25 155.06 48.02 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.688 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -114.49 132.47 56.28 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.138 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.408 ' HA ' HG23 ' A' ' 106' ' ' ILE . 69.4 mt -70.88 123.85 25.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.311 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -98.34 -40.53 8.27 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.545 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -148.43 146.35 28.4 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -174.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 72.1 mt -124.72 137.61 56.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -116.98 95.48 5.02 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 174.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -65.99 -22.1 66.44 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -67.86 -46.78 70.77 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 121.277 0.561 . . . . 0.0 110.354 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -92.39 -9.47 41.61 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.784 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.542 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 64.56 41.98 97.62 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -176.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 41.6 p -126.23 155.9 41.12 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.73 149.01 43.11 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.207 0.527 . . . . 0.0 111.313 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.41 124.05 39.24 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.408 HG23 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -126.41 155.07 36.53 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.046 -175.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.7 m -121.79 120.34 34.32 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -68.91 121.63 16.99 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.381 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.1 135.34 57.15 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.167 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.74 -46.13 3.29 Favored Glycine 0 C--N 1.309 -0.934 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.743 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -77.23 -40.24 45.58 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.985 0.421 . . . . 0.0 110.698 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.97 7.89 76.85 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.526 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -82.07 149.25 28.15 Favored 'General case' 0 CA--C 1.485 -1.519 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -144.05 137.57 27.71 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.803 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -151.83 160.55 43.51 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 123.521 0.513 . . . . 0.0 110.031 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.0 t -93.34 122.07 44.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.4 t -135.75 141.21 36.12 Favored Pre-proline 0 C--N 1.282 -2.328 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -177.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.2 Cg_endo -63.21 148.55 92.99 Favored 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 122.273 1.982 . . . . 0.0 111.497 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 50.6 mt -55.54 -26.32 42.6 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 123.858 0.863 . . . . 0.0 111.412 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 pp -63.97 -26.97 68.82 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 121.434 0.635 . . . . 0.0 110.497 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -84.17 -26.03 29.13 Favored 'General case' 0 CA--C 1.476 -1.902 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.576 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.2 mt -78.3 126.23 30.49 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.272 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -114.67 150.32 43.77 Favored Pre-proline 0 C--N 1.288 -2.086 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 175.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.85 146.91 48.93 Favored 'Trans proline' 0 C--N 1.325 -0.663 0 C-N-CA 121.493 1.462 . . . . 0.0 110.871 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.4 t . . . . . 0 N--CA 1.441 -0.911 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.276 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.434 -1.228 0 CA-C-O 121.139 0.495 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -112.79 151.25 30.56 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.252 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -133.71 155.24 50.09 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.355 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.9 t -63.5 141.42 18.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.15 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.13 27.92 51.1 Favored Glycine 0 CA--C 1.498 -0.975 0 C-N-CA 121.401 -0.428 . . . . 0.0 112.527 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.46 153.81 41.43 Favored 'General case' 0 CA--C 1.488 -1.438 0 CA-C-O 120.927 0.394 . . . . 0.0 111.774 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -90.71 141.28 28.95 Favored 'General case' 0 N--CA 1.413 -2.321 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.76 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.2 p -147.99 175.2 11.18 Favored 'General case' 0 C--N 1.265 -3.097 0 CA-C-N 113.573 -1.649 . . . . 0.0 107.158 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 82.0 mmm -112.13 129.38 56.25 Favored 'General case' 0 C--N 1.271 -2.811 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 175.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -122.39 147.52 46.19 Favored 'General case' 0 C--N 1.266 -3.063 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.089 -176.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.8 t -85.09 115.01 26.17 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.463 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 12.7 t90 -64.44 121.22 13.86 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.6 t -63.12 -20.25 65.2 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 123.434 0.459 . . . . 0.0 111.658 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.463 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 37.6 mm-40 -84.82 -42.22 15.34 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -177.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -109.74 -15.98 14.01 Favored 'General case' 0 CA--C 1.507 -0.708 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.239 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.59 9.33 86.97 Favored Glycine 0 C--O 1.221 -0.66 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.076 177.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -102.85 162.03 13.26 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 7.1 p -89.87 136.6 32.94 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.085 0.469 . . . . 0.0 111.91 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -136.06 158.52 44.21 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 124.866 1.266 . . . . 0.0 109.134 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -75.03 127.95 34.43 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.41 151.98 43.92 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.71 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -111.33 133.35 53.71 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.394 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.8 mt -72.67 123.94 28.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 123.745 0.818 . . . . 0.0 111.92 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -99.69 -38.21 8.8 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.989 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -151.79 143.91 23.92 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.879 -175.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 64.5 mt -124.29 140.23 48.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -124.39 94.39 4.19 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 171.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -66.28 -23.11 66.33 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -66.76 -44.14 82.22 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.397 0.617 . . . . 0.0 109.821 -179.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -92.67 -9.51 40.57 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.357 0.599 . . . . 0.0 110.367 177.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 68.13 39.19 88.61 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.527 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 73.8 p -125.28 155.42 40.19 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 122.265 -0.55 . . . . 0.0 110.405 -176.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.48 146.15 41.7 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 121.461 0.648 . . . . 0.0 110.601 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.62 121.59 36.34 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.9 pp -124.97 153.19 31.93 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.679 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.862 -175.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 87.8 m -120.38 120.37 35.78 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.779 177.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -67.33 124.85 24.29 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 123.543 0.737 . . . . 0.0 110.72 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.24 129.28 39.43 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.023 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.28 -39.59 2.83 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.919 178.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -87.06 -40.24 14.87 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.286 0.565 . . . . 0.0 110.157 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.21 11.29 72.87 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.823 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -80.51 154.07 27.76 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.91 139.1 30.62 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.729 -176.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -149.2 160.58 43.24 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 56.8 t -98.06 114.82 36.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 176.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.3 t -130.67 141.4 41.82 Favored Pre-proline 0 C--N 1.281 -2.408 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -175.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 40.9 Cg_endo -63.05 148.36 93.48 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.371 2.047 . . . . 0.0 111.682 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 54.3 mt -55.2 -26.78 41.39 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.595 0.758 . . . . 0.0 111.539 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.63 -23.5 66.82 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.248 0.547 . . . . 0.0 111.057 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -92.13 -13.24 31.01 Favored 'General case' 0 CA--C 1.485 -1.551 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.026 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 82.1 mt -85.28 125.95 33.32 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -114.75 153.19 46.89 Favored Pre-proline 0 C--N 1.284 -2.276 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.84 154.02 53.49 Favored 'Trans proline' 0 C--O 1.248 1.021 0 C-N-CA 121.475 1.45 . . . . 0.0 111.869 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 46.1 t . . . . . 0 C--N 1.311 -1.07 0 CA-C-O 121.962 0.887 . . . . 0.0 108.885 179.493 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 N--CA 1.44 -0.93 0 CA-C-O 121.649 0.737 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . 0.441 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 97.5 m95 -116.3 151.8 35.13 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.872 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -132.97 160.0 38.37 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.61 136.41 26.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 123.687 0.795 . . . . 0.0 111.362 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.21 21.99 46.74 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.33 177.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.66 153.55 28.73 Favored 'General case' 0 CA--C 1.482 -1.655 0 CA-C-O 120.598 0.237 . . . . 0.0 110.453 -177.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -91.81 135.29 34.03 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-O 121.93 0.872 . . . . 0.0 110.809 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.441 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 19.4 p -146.03 176.38 9.76 Favored 'General case' 0 C--N 1.265 -3.085 0 CA-C-N 114.023 -1.444 . . . . 0.0 107.181 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 59.9 mtp -115.82 130.84 57.0 Favored 'General case' 0 C--N 1.27 -2.891 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 173.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.79 150.54 39.62 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -175.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 82.7 t -85.39 115.29 26.77 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.473 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.509 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.0 t90 -63.74 123.25 18.4 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.1 t -62.36 -25.06 67.7 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.229 0.538 . . . . 0.0 110.997 -177.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.509 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 21.5 mm-40 -79.05 -41.73 28.13 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -176.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -115.33 -16.31 11.48 Favored 'General case' 0 CA--C 1.502 -0.891 0 C-N-CA 117.654 -1.618 . . . . 0.0 112.367 -178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.59 5.75 88.04 Favored Glycine 0 C--N 1.306 -1.116 0 C-N-CA 119.795 -1.193 . . . . 0.0 113.596 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -93.19 161.6 14.35 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 23.4 p -94.25 135.74 35.31 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 120.957 0.408 . . . . 0.0 110.56 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -137.9 157.6 46.08 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 123.741 0.817 . . . . 0.0 109.203 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -75.5 126.02 30.19 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -177.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.25 151.15 47.37 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -112.08 133.37 54.28 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.115 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.4 mt -71.72 123.34 25.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 123.558 0.743 . . . . 0.0 111.756 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -97.39 -38.61 9.56 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.513 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -154.97 151.57 28.65 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 71.6 mt -123.33 137.27 57.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -117.68 95.82 5.11 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -65.54 -22.6 66.73 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.768 -1.106 . . . . 0.0 113.022 -177.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -65.08 -46.3 81.7 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 120.603 0.24 . . . . 0.0 110.78 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -95.36 -5.86 42.37 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.84 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.411 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 64.75 43.15 96.67 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -176.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 39.9 p -127.27 156.0 42.61 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -175.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.32 141.7 43.8 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-O 121.09 0.471 . . . . 0.0 110.086 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.04 120.76 29.69 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.9 pp -124.89 154.22 32.57 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.679 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.082 -174.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.7 m -121.82 120.41 34.49 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.469 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -67.11 123.35 20.02 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 123.387 0.675 . . . . 0.0 110.359 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.48 135.67 55.48 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.266 -176.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.92 -55.81 3.7 Favored Glycine 0 N--CA 1.429 -1.784 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.948 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -72.99 -41.94 63.79 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.137 0.494 . . . . 0.0 110.806 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 89.95 2.03 75.54 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.836 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -72.81 158.05 36.29 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -145.14 135.86 24.48 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.591 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -146.97 157.9 43.76 Favored 'General case' 0 N--CA 1.432 -1.336 0 O-C-N 123.715 0.634 . . . . 0.0 109.67 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 69.4 t -91.96 114.32 28.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 174.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.1 t -128.0 141.67 41.97 Favored Pre-proline 0 C--N 1.29 -2.017 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -175.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 43.5 Cg_endo -64.28 147.13 91.0 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.126 1.884 . . . . 0.0 111.192 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 48.0 mt -55.38 -26.07 39.12 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 123.494 0.717 . . . . 0.0 111.138 178.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.39 -19.47 65.41 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.18 178.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -95.78 -13.27 24.24 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-O 120.951 0.405 . . . . 0.0 111.357 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.5 mt -81.94 126.29 31.76 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.257 177.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -114.09 154.3 46.16 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.42 153.11 70.93 Favored 'Trans proline' 0 C--O 1.243 0.763 0 C-N-CA 121.616 1.544 . . . . 0.0 110.428 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.6 t . . . . . 0 C--N 1.305 -1.365 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.765 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.2 t . . . . . 0 N--CA 1.426 -1.66 0 CA-C-O 121.605 0.717 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -112.06 152.21 28.47 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.469 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -131.19 160.95 33.32 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 175.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 99.0 t -66.0 139.31 21.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.771 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.8 32.82 48.63 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -110.49 159.18 17.74 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -95.26 131.19 41.59 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 17.9 p -144.65 173.94 11.39 Favored 'General case' 0 C--N 1.263 -3.181 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.8 mtp -117.28 130.55 56.62 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 173.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.04 149.97 40.76 Favored 'General case' 0 C--N 1.27 -2.883 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.9 t -87.41 113.54 24.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.429 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 12.7 t90 -63.46 120.45 11.69 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -179.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.7 t -67.06 -16.58 64.44 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.224 0.535 . . . . 0.0 110.946 -174.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.429 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 38.4 mt-10 -85.1 -42.29 14.93 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.468 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 13.9 t70 -110.31 -15.72 13.89 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.289 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.82 4.39 90.07 Favored Glycine 0 C--N 1.305 -1.17 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.374 176.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.468 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 28.1 mm-40 -94.68 161.26 14.26 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.913 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 7.9 p -92.65 136.08 33.54 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.311 0.577 . . . . 0.0 111.623 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -136.87 157.72 46.09 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 123.797 0.839 . . . . 0.0 109.441 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -75.34 132.98 41.33 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.47 158.09 43.92 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.896 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -120.6 134.08 55.31 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.819 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.409 ' HA ' HG23 ' A' ' 106' ' ' ILE . 70.9 mt -71.78 125.33 30.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 O-C-N 123.759 0.662 . . . . 0.0 112.733 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -98.43 -42.54 7.29 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.601 -1.182 . . . . 0.0 111.306 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -148.8 143.44 26.34 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -174.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.0 mt -121.81 138.46 52.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -123.05 92.6 3.74 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 171.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.49 -24.79 67.24 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -177.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -63.04 -45.32 92.8 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.537 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -95.2 -4.71 45.42 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.26 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.61 43.04 97.04 Favored Glycine 0 N--CA 1.438 -1.214 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 41.6 p -128.44 155.7 44.36 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 122.69 -0.3 . . . . 0.0 110.491 -177.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.39 144.52 36.26 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.058 0.456 . . . . 0.0 110.009 175.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.03 124.77 35.05 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.409 HG23 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -127.85 152.08 35.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.977 -175.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.3 m -116.23 120.47 39.07 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.988 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -69.12 125.93 28.2 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.915 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.45 128.4 35.86 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.44 -1.255 . . . . 0.0 111.57 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.13 -46.65 2.87 Favored Glycine 0 N--CA 1.437 -1.27 0 C-N-CA 121.293 -0.48 . . . . 0.0 112.798 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -78.75 -33.94 46.11 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.621 0.248 . . . . 0.0 110.981 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 83.88 -0.92 89.34 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.548 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -71.6 150.19 44.92 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.51 132.08 28.78 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.714 -176.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -144.48 160.76 40.56 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.564 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.8 t -96.09 116.21 37.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.2 t -130.69 141.42 41.89 Favored Pre-proline 0 C--N 1.278 -2.533 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -176.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 40.0 Cg_endo -62.92 146.36 94.85 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 122.057 1.838 . . . . 0.0 110.889 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 56.3 mt -54.27 -26.49 29.33 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 123.966 0.906 . . . . 0.0 111.672 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.65 -23.84 66.89 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.289 0.566 . . . . 0.0 110.92 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -90.0 -13.72 35.49 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.994 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.2 mt -85.58 126.34 33.81 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.193 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -114.61 152.75 46.54 Favored Pre-proline 0 C--N 1.281 -2.402 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.9 151.31 50.6 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.48 1.453 . . . . 0.0 110.31 176.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 C--N 1.306 -1.285 0 CA-C-O 121.302 0.572 . . . . 0.0 110.333 -177.753 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.435 -1.216 0 CA-C-O 120.805 0.336 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -121.54 152.23 39.43 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 123.028 0.531 . . . . 0.0 111.332 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -133.35 154.46 50.71 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.221 177.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.5 t -63.82 141.91 17.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 C-N-CA 123.914 0.886 . . . . 0.0 110.51 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.1 19.39 62.92 Favored Glycine 0 CA--C 1.499 -0.959 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.51 151.88 34.02 Favored 'General case' 0 CA--C 1.477 -1.858 0 CA-C-O 120.502 0.191 . . . . 0.0 110.754 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -90.97 142.03 28.21 Favored 'General case' 0 N--CA 1.399 -2.978 0 O-C-N 123.907 0.755 . . . . 0.0 110.25 176.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 21.0 p -148.99 176.59 10.31 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.207 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 47.5 mtp -116.67 131.23 57.0 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.91 149.05 42.24 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -176.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 88.9 t -85.87 118.77 33.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -67.03 120.58 13.89 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.3 m -57.63 -28.89 64.1 Favored 'General case' 0 C--N 1.288 -2.065 0 C-N-CA 123.205 0.602 . . . . 0.0 112.26 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -77.64 -41.98 36.46 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.953 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.449 ' OD1' ' HG2' ' A' ' 88' ' ' GLN . 9.0 t70 -113.49 -16.26 12.44 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.748 -175.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.83 3.18 90.61 Favored Glycine 0 C--N 1.31 -0.914 0 C-N-CA 120.27 -0.967 . . . . 0.0 113.021 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.449 ' HG2' ' OD1' ' A' ' 86' ' ' ASP . 30.0 mm-40 -94.01 160.85 14.53 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.619 -0.342 . . . . 0.0 110.08 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 11.1 p -90.43 136.8 32.83 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 120.991 0.424 . . . . 0.0 110.528 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -136.46 157.16 47.44 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -78.66 123.96 27.68 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.106 0.479 . . . . 0.0 110.012 -176.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.62 152.32 49.23 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.34 -176.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -108.41 134.25 51.46 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.165 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 63.6 mt -73.25 118.6 18.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.161 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -94.38 -38.72 10.83 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.442 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -153.81 150.4 28.41 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -176.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 68.4 mt -124.7 141.2 45.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -120.6 90.97 3.43 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -66.35 -21.71 66.25 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.427 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -60.09 -46.22 90.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.061 178.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -94.61 -15.61 23.89 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.393 0.616 . . . . 0.0 110.648 176.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.496 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 76.73 37.41 34.41 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -177.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 50.8 p -124.44 158.02 33.79 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.29 147.65 47.58 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.075 0.464 . . . . 0.0 110.501 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.66 121.8 37.76 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 176.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.9 pp -124.83 153.72 32.06 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.72 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.751 -174.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 95.1 m -121.45 121.29 37.21 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -68.7 119.71 13.53 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.995 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.38 130.65 43.75 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 124.262 0.976 . . . . 0.0 110.284 -175.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.09 -51.26 1.29 Allowed Glycine 0 N--CA 1.429 -1.819 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.456 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -76.79 -43.62 36.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.762 0.315 . . . . 0.0 110.76 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.22 2.27 66.19 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.339 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -75.99 154.53 35.74 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.23 138.79 31.69 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -152.34 162.81 40.64 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 123.178 0.299 . . . . 0.0 110.642 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.2 t -97.82 120.37 47.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.3 t -133.96 141.02 38.13 Favored Pre-proline 0 C--N 1.284 -2.256 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -176.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.4 Cg_endo -64.21 146.97 91.2 Favored 'Trans proline' 0 N--CA 1.438 -1.765 0 C-N-CA 122.071 1.847 . . . . 0.0 111.436 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 45.2 mt -53.93 -26.41 25.27 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 123.864 0.865 . . . . 0.0 111.317 178.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 pp -68.09 -21.61 64.95 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.119 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -93.09 -17.88 23.28 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.064 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 85.9 mt -77.74 126.83 31.47 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 121.435 0.636 . . . . 0.0 109.856 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -114.4 155.47 45.79 Favored Pre-proline 0 C--N 1.291 -1.965 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.55 148.7 48.26 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 121.735 1.623 . . . . 0.0 111.356 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 CA--C 1.509 -0.626 0 CA-C-O 121.226 0.536 . . . . 0.0 110.376 -178.373 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 101' ' ' ASN . 16.1 m -137.84 -74.82 0.4 Allowed 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 99.3 m -99.09 120.09 38.91 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -81.58 114.25 48.37 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -59.97 133.84 52.96 Favored 'Trans proline' 0 C--O 1.239 0.528 0 C-N-CA 122.525 2.15 . . . . 0.0 113.509 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.1 t -112.54 -3.42 14.39 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -141.31 143.6 34.14 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -176.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.3 m -95.42 114.45 26.22 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -113.54 151.48 31.53 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.136 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -129.25 159.74 35.15 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.99 133.38 30.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 123.078 0.551 . . . . 0.0 110.766 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.54 26.87 37.45 Favored Glycine 0 CA--C 1.499 -0.943 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.444 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.74 155.47 19.66 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -96.4 131.47 42.92 Favored 'General case' 0 C--N 1.274 -2.698 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.243 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 17.3 p -144.03 176.67 9.12 Favored 'General case' 0 C--N 1.263 -3.181 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.561 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 41.1 mtp -119.23 130.44 55.46 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 172.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.79 153.61 34.18 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -175.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.7 t -86.74 116.81 29.93 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.442 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -66.35 123.61 20.45 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.4 t -61.2 -23.36 65.54 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.219 0.533 . . . . 0.0 111.483 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -83.16 -42.63 17.09 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -106.71 -17.24 14.28 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.222 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.24 3.5 82.06 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 119.554 -1.307 . . . . 0.0 112.398 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -91.48 163.85 14.02 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 24.7 p -94.84 136.42 35.18 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.697 0.284 . . . . 0.0 110.7 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -136.71 157.56 46.47 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 123.535 0.734 . . . . 0.0 109.581 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -75.09 129.47 37.63 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -145.02 152.94 40.92 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.121 -177.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -112.53 134.96 53.79 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.346 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 73.9 mt -71.63 123.21 25.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 123.252 0.621 . . . . 0.0 111.491 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -98.66 -37.41 9.52 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.01 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -152.86 145.42 24.18 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 68.5 mt -121.68 140.06 46.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -121.73 97.13 5.35 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 172.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.08 -24.67 67.52 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -176.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -68.17 -45.78 72.53 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.431 ' O ' ' HB2' ' A' ' 66' ' ' SER . 28.4 m-80 -87.32 -15.22 38.62 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.386 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.429 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 67.62 40.46 90.5 Favored Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -176.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 69.9 p -124.7 157.9 34.5 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -177.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.85 141.15 36.66 Favored 'General case' 0 C--N 1.29 -2.022 0 CA-C-O 121.308 0.575 . . . . 0.0 110.408 175.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.92 121.13 29.96 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.9 pp -124.92 153.47 32.06 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.756 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.973 -174.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.2 m -120.44 120.46 35.98 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.725 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.549 ' CD1' HC11 ' A' 1129 ' ' DA2 . 98.5 m-85 -69.56 117.74 11.54 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.581 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.26 133.07 49.83 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.948 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.9 -42.95 2.01 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.869 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -87.63 -43.45 11.95 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.305 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.77 3.59 62.31 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.218 -0.992 . . . . 0.0 112.127 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -77.57 152.7 33.85 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -141.24 143.49 34.16 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -151.55 159.12 44.26 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 123.962 0.788 . . . . 0.0 109.026 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.0 t -97.66 113.92 33.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -128.49 141.32 41.07 Favored Pre-proline 0 C--N 1.288 -2.098 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -174.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.529 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 40.6 Cg_endo -62.6 147.7 94.41 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.447 2.098 . . . . 0.0 111.229 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 45.8 mt -54.44 -26.11 28.96 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.608 0.763 . . . . 0.0 111.592 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.7 pp -64.53 -26.0 68.23 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.342 0.591 . . . . 0.0 110.399 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -89.62 -14.26 35.32 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.955 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 81.7 mt -85.31 125.83 33.24 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.988 178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -115.39 151.39 45.9 Favored Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.48 153.43 70.21 Favored 'Trans proline' 0 C--O 1.243 0.742 0 C-N-CA 121.597 1.531 . . . . 0.0 110.913 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.5 t -80.5 93.57 2.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 121.721 0.772 . . . . 0.0 109.003 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.37 112.32 24.53 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -84.97 62.71 7.67 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 122.189 0.995 . . . . 0.0 111.045 -174.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.805 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.32 177.725 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1129 ' ' DA2 . . . . . 0.549 HC11 ' CD1' ' A' ' 108' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.735 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.8 p -66.96 -19.06 65.66 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.6 m -114.99 135.98 53.63 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -88.44 133.44 36.46 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 175.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -59.35 133.19 50.8 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 121.047 1.164 . . . . 0.0 109.908 174.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.8 t -82.59 -22.46 34.82 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -142.02 138.64 31.98 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.1 m -83.34 113.29 20.62 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 120.999 0.428 . . . . 0.0 110.009 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -118.91 151.58 37.87 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.665 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -131.4 153.93 49.17 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.79 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 141.61 17.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 C-N-CA 123.908 0.883 . . . . 0.0 110.746 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.23 28.49 55.84 Favored Glycine 0 CA--C 1.498 -0.972 0 N-CA-C 112.122 -0.391 . . . . 0.0 112.122 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.38 153.28 35.41 Favored 'General case' 0 CA--C 1.483 -1.614 0 CA-C-O 120.814 0.34 . . . . 0.0 110.887 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -90.75 139.12 31.03 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.172 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 17.2 p -148.65 179.52 7.76 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-N 113.719 -1.582 . . . . 0.0 107.327 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 58.4 mtp -120.37 131.18 54.72 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 173.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.95 149.75 41.62 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.8 t -85.35 116.48 28.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -64.19 120.66 12.54 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.7 t -62.37 -21.04 65.02 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 123.578 0.549 . . . . 0.0 111.292 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -84.87 -42.35 15.14 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -112.5 -15.51 13.05 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 119.336 -0.946 . . . . 0.0 111.916 -174.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.1 0.36 89.58 Favored Glycine 0 C--N 1.313 -0.719 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.924 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -93.22 159.86 15.09 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 120.559 -0.456 . . . . 0.0 109.825 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 23.3 p -92.76 137.07 32.68 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.167 0.508 . . . . 0.0 110.945 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -136.46 158.33 44.68 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 123.846 0.858 . . . . 0.0 109.36 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.28 127.99 34.42 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.66 153.65 48.58 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.126 0.488 . . . . 0.0 111.25 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -115.03 132.93 56.44 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.997 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 62.5 mt -73.03 123.78 28.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.928 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -99.9 -38.2 8.72 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.858 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -149.58 143.72 25.75 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -176.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.4 mt -123.24 140.42 46.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -120.43 92.7 3.83 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 173.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -65.94 -23.49 66.62 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.82 -46.71 88.38 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.042 0.537 . . . . 0.0 109.805 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -95.46 -11.65 27.2 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.087 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.43 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 72.32 39.55 57.1 Favored Glycine 0 C--N 1.312 -0.804 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -177.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 35.5 p -124.36 156.96 36.14 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 122.793 0.437 . . . . 0.0 110.217 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.69 148.61 41.05 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.399 0.619 . . . . 0.0 111.089 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -97.52 121.75 39.79 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.9 pp -124.78 154.79 32.78 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.669 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.782 -174.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 91.3 m -120.76 120.3 35.23 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.448 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.554 ' CD1' HC11 ' A' 1129 ' ' DA2 . 99.2 m-85 -67.71 121.58 16.25 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.186 -178.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.24 130.72 46.67 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.552 -175.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.29 -49.94 2.99 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 121.131 -0.557 . . . . 0.0 111.868 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -72.63 -43.25 63.5 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 120.612 0.244 . . . . 0.0 111.235 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.84 8.57 65.07 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.27 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 107' ' ' THR . 3.9 m-20 -80.65 148.52 30.19 Favored 'General case' 0 CA--C 1.49 -1.364 0 O-C-N 122.352 -0.499 . . . . 0.0 110.222 178.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -137.64 133.32 34.19 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 -176.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -151.51 162.79 40.36 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.685 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.5 t -96.37 119.88 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.6 t -133.8 140.71 37.4 Favored Pre-proline 0 C--N 1.278 -2.503 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 42.6 Cg_endo -63.71 147.43 92.6 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 122.346 2.031 . . . . 0.0 110.941 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 49.8 mt -53.56 -27.12 24.43 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 123.677 0.791 . . . . 0.0 111.646 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.57 -23.41 66.2 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.249 0.619 . . . . 0.0 111.604 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -91.64 -12.59 33.77 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 121.185 0.517 . . . . 0.0 110.803 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 81.4 mt -84.49 128.21 34.46 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.066 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -111.36 157.59 38.61 Favored Pre-proline 0 C--N 1.294 -1.844 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.76 156.89 63.96 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 121.63 1.554 . . . . 0.0 109.628 170.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 89.8 t -73.1 95.98 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-O 121.507 0.67 . . . . 0.0 110.536 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -78.17 116.04 18.33 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.333 177.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -95.26 3.12 54.88 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 122.488 1.137 . . . . 0.0 109.478 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.41 -3.1 0 N-CA-C 107.5 -2.24 . . . . 0.0 107.5 -178.07 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1129 ' ' DA2 . . . . . 0.554 HC11 ' CD1' ' A' ' 108' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.631 0 CA-C-O 120.866 0.365 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.9 m -71.65 -39.04 70.62 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 48.6 m -101.91 113.32 26.42 Favored 'General case' 0 N--CA 1.411 -2.404 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 171.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -71.99 119.12 72.63 Favored Pre-proline 0 C--N 1.309 -1.182 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -54.68 133.78 58.9 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.107 2.538 . . . . 0.0 112.352 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.5 t -91.77 -18.08 24.41 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.187 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -141.37 139.77 33.58 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 -176.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.3 p -87.84 110.96 20.9 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.078 0.466 . . . . 0.0 110.411 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -109.88 151.99 26.35 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.313 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -124.89 151.0 45.93 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.1 t -64.48 133.78 29.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.54 31.94 26.1 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.139 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 11.0 t0 -113.14 165.02 12.78 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.716 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -96.72 130.7 43.91 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 176.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 23.6 p -144.93 176.64 9.32 Favored 'General case' 0 C--N 1.265 -3.091 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 38.7 mtp -117.6 130.48 56.41 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 173.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.54 149.82 41.82 Favored 'General case' 0 C--N 1.279 -2.49 0 O-C-N 123.435 0.46 . . . . 0.0 109.865 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.3 t -85.3 117.54 30.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.453 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.6 t90 -66.25 124.86 23.82 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.2 t -61.38 -26.51 67.89 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.15 0.5 . . . . 0.0 111.229 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.453 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 16.2 mm-40 -80.26 -40.06 27.72 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -175.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.404 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 11.6 t70 -115.61 -15.46 11.4 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.77 -177.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.85 6.88 89.14 Favored Glycine 0 C--N 1.307 -1.074 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.142 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.404 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 27.0 mm-40 -95.82 161.29 14.07 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.137 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 25.1 p -90.8 136.77 32.85 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.46 0.648 . . . . 0.0 110.84 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -136.35 158.02 45.42 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.944 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -74.63 131.29 40.8 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.93 153.55 44.44 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.376 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 77' ' ' ASP . 38.3 tt0 -114.04 132.11 56.12 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.578 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.4 ' HA ' HG23 ' A' ' 106' ' ' ILE . 66.3 mt -73.44 125.08 31.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 122.977 0.511 . . . . 0.0 112.37 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -97.87 -40.39 8.53 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.37 1.068 . . . . 0.0 111.201 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -149.28 148.84 30.03 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.3 mt -121.5 131.6 72.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -114.99 90.87 3.44 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -66.5 -20.4 66.03 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.2 -46.26 74.4 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.143 0.497 . . . . 0.0 109.882 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -92.38 -6.3 50.37 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.798 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.85 38.74 94.6 Favored Glycine 0 C--O 1.241 0.55 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 67.4 p -130.29 155.57 46.09 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.45 149.56 48.29 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-O 120.914 0.387 . . . . 0.0 110.509 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.65 124.12 38.49 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.9 pp -127.73 155.56 39.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.196 -175.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 75.4 m -117.9 120.37 37.68 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.529 ' CD1' HC13 ' A' 1129 ' ' DA2 . 98.6 m-85 -68.01 123.13 19.77 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.36 130.76 44.09 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.839 -175.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.89 -59.32 0.76 Allowed Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -69.57 -42.59 74.32 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.101 0.477 . . . . 0.0 110.543 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.31 16.26 62.85 Favored Glycine 0 N--CA 1.434 -1.442 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.919 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -86.76 154.61 20.81 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -142.19 136.24 29.73 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 123.099 0.249 . . . . 0.0 110.673 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.03 159.67 43.65 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.2 t -93.71 121.85 44.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 176.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.9 t -134.67 141.49 38.95 Favored Pre-proline 0 C--N 1.287 -2.136 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -176.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 36.9 Cg_endo -61.74 146.23 96.81 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 122.627 2.218 . . . . 0.0 111.415 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 48.4 mt -54.75 -26.08 31.91 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 123.702 0.801 . . . . 0.0 111.858 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.17 -27.98 69.08 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.116 0.484 . . . . 0.0 110.771 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -85.55 -15.06 43.93 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.564 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.1 mt -85.85 125.78 33.56 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -114.97 151.91 46.01 Favored Pre-proline 0 C--N 1.282 -2.355 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -71.0 146.96 53.87 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 121.5 1.467 . . . . 0.0 110.727 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.1 t -75.87 90.89 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.77 109.81 7.57 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.678 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -121.76 14.78 10.92 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.56 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.329 0 N-CA-C 107.668 -2.173 . . . . 0.0 107.668 -178.56 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1129 ' ' DA2 . . . . . 0.529 HC13 ' CD1' ' A' ' 108' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.211 -0.952 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.9 p -85.29 149.08 25.72 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 117.861 0.3 . . . . 0.0 110.981 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 46.0 m -137.15 144.39 42.93 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -97.25 126.76 40.75 Favored Pre-proline 0 N--CA 1.428 -1.533 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -60.02 138.0 79.32 Favored 'Trans proline' 0 C--O 1.242 0.702 0 C-N-CA 123.016 2.477 . . . . 0.0 112.302 175.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.3 t -80.73 -22.81 39.93 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.11 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -141.25 147.84 38.92 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 -177.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.0 m -83.98 105.11 14.6 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.252 0.549 . . . . 0.0 110.442 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -111.6 151.53 28.67 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.592 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -131.66 159.18 39.07 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.4 t -65.42 135.89 27.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.03 40.88 13.1 Favored Glycine 0 N--CA 1.431 -1.637 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.404 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.41 152.7 41.31 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -95.04 131.21 41.27 Favored 'General case' 0 N--CA 1.402 -2.836 0 O-C-N 123.892 0.745 . . . . 0.0 109.744 174.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 18.7 p -141.43 177.48 8.09 Favored 'General case' 0 C--N 1.261 -3.257 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 51.5 mtp -118.05 130.75 56.35 Favored 'General case' 0 N--CA 1.4 -2.935 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 173.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.76 150.01 40.5 Favored 'General case' 0 C--N 1.267 -3.001 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -176.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.4 t -84.64 120.76 35.82 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -69.57 127.26 32.35 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.7 m -59.3 -29.07 67.34 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -84.12 -42.01 16.5 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -175.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -105.8 -15.75 14.85 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.702 0.763 . . . . 0.0 110.516 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.29 13.29 73.46 Favored Glycine 0 C--N 1.312 -0.765 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.239 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -102.65 163.86 11.98 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 20.5 p -90.19 136.27 33.15 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.898 0.38 . . . . 0.0 110.604 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -134.38 158.26 44.3 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 124.199 1.0 . . . . 0.0 109.282 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -74.86 125.3 28.52 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -136.95 149.63 47.68 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.159 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -110.91 132.17 54.43 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.892 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 68.1 mt -72.51 123.43 27.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.124 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -98.02 -40.07 8.63 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.914 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -152.39 142.51 22.3 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -175.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 69.9 mt -119.21 131.99 70.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -123.92 90.55 3.29 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.17 -20.31 65.71 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.106 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -56.32 -42.86 78.33 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 123.991 0.807 . . . . 0.0 110.227 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -101.81 -1.55 32.04 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.201 0.524 . . . . 0.0 110.215 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.63 39.29 95.34 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 37.0 p -128.28 155.69 44.19 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 122.382 0.273 . . . . 0.0 110.427 -175.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.93 147.19 46.24 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.77 122.04 34.76 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.9 pp -126.01 153.35 34.09 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.497 -175.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.5 m -120.14 120.41 36.11 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.448 ' CD1' HC13 ' A' 1129 ' ' DA2 . 98.3 m-85 -67.8 118.3 10.85 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.32 130.66 41.94 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 114.623 -1.172 . . . . 0.0 110.489 -174.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.02 -41.86 2.09 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -87.37 -43.21 12.29 Favored 'General case' 0 C--N 1.313 -1.006 0 O-C-N 122.515 -0.403 . . . . 0.0 110.955 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.41 1.48 68.95 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.623 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -76.06 148.09 38.2 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -135.32 140.84 45.41 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -152.01 158.16 42.7 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.8 t -93.66 115.46 32.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 175.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.2 t -129.49 141.21 41.04 Favored Pre-proline 0 C--N 1.281 -2.387 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -175.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.5 Cg_endo -61.5 145.03 98.27 Favored 'Trans proline' 0 N--CA 1.437 -1.833 0 C-N-CA 122.165 1.91 . . . . 0.0 110.671 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 55.2 mt -53.94 -26.15 24.07 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 123.887 0.875 . . . . 0.0 111.472 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 pp -64.37 -25.48 68.05 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.093 0.473 . . . . 0.0 110.855 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -88.31 -12.84 42.34 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.86 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 81.3 mt -86.7 125.88 34.18 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.153 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -114.91 155.76 46.0 Favored Pre-proline 0 C--N 1.288 -2.089 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.62 157.22 59.34 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 121.526 1.484 . . . . 0.0 110.46 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.5 t -80.13 79.45 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -98.74 100.17 11.35 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.783 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -92.06 59.74 3.64 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.423 -175.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.309 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.308 -179.724 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1129 ' ' DA2 . . . . . 0.448 HC13 ' CD1' ' A' ' 108' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.557 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.2 m -62.85 -37.48 86.98 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.691 0.758 . . . . 0.0 109.721 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 80.1 m -129.02 125.28 36.98 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.751 HE21 ' N ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -90.24 141.44 27.66 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -175.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -53.73 135.05 61.28 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 123.16 2.573 . . . . 0.0 113.283 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.3 t -88.03 -18.03 29.84 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -140.99 143.24 34.35 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.9 t -85.48 104.67 15.48 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -110.06 151.52 27.1 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.637 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -129.09 159.01 37.34 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.11 134.35 29.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 C-N-CA 123.385 0.674 . . . . 0.0 110.741 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.1 35.97 25.87 Favored Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -117.36 154.53 31.13 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -93.92 132.42 38.39 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-O 121.68 0.752 . . . . 0.0 110.355 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 19.4 p -142.89 178.88 7.36 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.1 -178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 33.5 mtp -118.99 130.54 55.74 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.13 149.96 43.87 Favored 'General case' 0 C--N 1.28 -2.455 0 O-C-N 123.517 0.51 . . . . 0.0 109.964 -175.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.0 t -85.3 119.07 33.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -67.16 123.49 20.42 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.2 m -60.31 -28.23 67.95 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.607 0.718 . . . . 0.0 112.087 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -79.59 -41.87 26.21 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.628 -174.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -112.73 -15.74 12.91 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.804 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.39 3.92 89.95 Favored Glycine 0 C--N 1.313 -0.715 0 C-N-CA 120.03 -1.081 . . . . 0.0 113.561 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.441 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 33.0 mm-40 -90.14 161.22 15.87 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 122.362 -0.493 . . . . 0.0 109.701 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 71.2 m -95.14 135.54 36.58 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.441 ' CE2' ' HB2' ' A' ' 88' ' ' GLN . 97.7 m-85 -135.96 158.03 45.4 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.067 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -75.34 131.31 40.18 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.81 152.52 43.79 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.583 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -111.45 134.34 53.1 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 70.0 mt -72.15 125.07 30.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 C-N-CA 123.432 0.693 . . . . 0.0 111.659 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -96.28 -41.73 8.51 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.085 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -150.78 152.03 33.21 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 72.2 mt -124.77 136.04 62.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.429 ' HB3' ' HG1' ' A' ' 103' ' ' THR . 12.2 t70 -112.67 91.61 3.72 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 174.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -65.64 -25.61 67.43 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.729 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -64.6 -44.11 91.67 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.936 -176.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -98.22 -5.53 33.11 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.97 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.418 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 68.19 40.94 87.68 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -175.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 40.3 p -125.41 155.93 39.62 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 122.641 -0.329 . . . . 0.0 110.143 -177.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -141.74 145.73 35.17 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.122 0.487 . . . . 0.0 111.105 176.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.99 125.03 35.67 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.9 pp -128.12 154.59 38.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.546 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 92.1 m -120.08 120.24 35.68 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.782 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.477 ' CD1' HC11 ' A' 1129 ' ' DA2 . 97.0 m-85 -66.88 123.13 19.32 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 123.242 0.617 . . . . 0.0 110.38 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.75 137.9 55.81 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.275 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.28 -49.71 3.26 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.879 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -81.95 -35.48 29.01 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 120.758 0.313 . . . . 0.0 110.902 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 82.04 9.74 84.84 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.488 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -81.42 152.68 27.3 Favored 'General case' 0 CA--C 1.49 -1.332 0 O-C-N 122.634 -0.333 . . . . 0.0 110.109 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.09 138.79 40.74 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 120.645 0.26 . . . . 0.0 110.991 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -151.85 161.06 43.26 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.872 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.2 t -98.27 122.04 49.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.0 t -135.8 141.6 37.49 Favored Pre-proline 0 C--N 1.282 -2.348 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -174.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.525 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 36.8 Cg_endo -62.54 147.11 95.31 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 122.425 2.083 . . . . 0.0 111.207 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 55.6 mt -55.65 -26.05 42.49 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 123.668 0.787 . . . . 0.0 111.788 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 pp -63.92 -28.89 70.14 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.637 0.732 . . . . 0.0 110.511 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -85.13 -17.62 36.71 Favored 'General case' 0 CA--C 1.484 -1.58 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.661 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 81.1 mt -82.98 125.79 31.8 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-O 121.64 0.733 . . . . 0.0 109.355 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -114.45 154.81 46.49 Favored Pre-proline 0 C--N 1.275 -2.658 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.214 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.38 155.38 70.65 Favored 'Trans proline' 0 C--O 1.255 1.367 0 C-N-CA 121.506 1.47 . . . . 0.0 110.003 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.3 t -74.33 95.67 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -86.65 115.39 24.07 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.322 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -96.86 13.81 27.45 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.498 0.666 . . . . 0.0 110.834 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.778 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 178.762 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1129 ' ' DA2 . . . . . 0.477 HC11 ' CD1' ' A' ' 108' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.492 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.6 m 64.21 18.98 11.59 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.091 0.957 . . . . 0.0 110.941 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.6 p -126.61 98.61 5.46 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.766 -174.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.581 ' OE1' ' HD2' ' A' ' 69' ' ' PRO . 6.2 tp-100 -112.15 126.15 28.93 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.581 ' HD2' ' OE1' ' A' ' 68' ' ' GLN . 34.8 Cg_exo -44.24 136.63 8.07 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 124.366 3.377 . . . . 0.0 113.8 175.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.6 t -97.4 -23.88 15.88 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.819 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -135.23 135.49 41.0 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 -175.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.9 p -82.51 108.62 16.05 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 123.474 0.484 . . . . 0.0 110.476 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -115.81 151.95 34.25 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.219 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.6 pttm -127.79 162.65 26.13 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 173.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.49 135.57 27.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 122.943 0.497 . . . . 0.0 110.419 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.56 18.46 48.51 Favored Glycine 0 C--O 1.239 0.449 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.323 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.01 151.18 26.17 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -91.41 140.82 29.4 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-O 121.604 0.716 . . . . 0.0 109.844 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.401 ' SG ' HD23 ' A' ' 122' ' ' LEU . 16.5 p -146.8 173.01 12.77 Favored 'General case' 0 C--N 1.261 -3.248 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.3 mtp -114.12 130.22 56.59 Favored 'General case' 0 C--N 1.274 -2.695 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -121.19 150.67 40.96 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.38 -175.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.1 t -85.31 117.22 30.0 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.422 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.3 t90 -64.76 123.08 18.44 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.4 m -61.19 -22.8 65.08 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.422 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 28.0 mm-40 -83.28 -42.04 17.62 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -116.21 -15.47 11.05 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 118.849 -1.14 . . . . 0.0 112.124 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.09 6.37 89.2 Favored Glycine 0 C--N 1.315 -0.612 0 C-N-CA 120.394 -0.908 . . . . 0.0 114.098 176.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.439 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 28.3 mm-40 -91.28 161.81 14.88 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 59.4 m -91.33 135.64 33.67 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.439 ' CE1' ' HB2' ' A' ' 88' ' ' GLN . 96.4 m-85 -136.71 157.63 46.31 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.202 0.601 . . . . 0.0 109.481 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -76.43 123.8 26.56 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.43 151.89 49.0 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.845 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -108.54 135.94 48.97 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.576 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.4 mt -73.46 118.51 18.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.819 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -94.71 -36.49 11.71 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.044 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -152.82 151.09 30.04 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.496 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 68.4 mt -127.15 141.43 46.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -120.77 98.3 5.95 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 173.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -65.75 -25.01 67.08 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -63.08 -46.54 86.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.931 0.396 . . . . 0.0 110.957 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -93.82 -13.6 27.1 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.408 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.496 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 68.87 40.8 84.46 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -175.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 40.6 p -122.93 155.59 36.42 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.02 145.0 43.55 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.216 0.531 . . . . 0.0 111.108 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.9 121.58 33.63 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.9 pp -124.4 152.84 30.55 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.818 -175.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.9 m -122.65 120.41 33.63 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.548 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.546 ' CD1' HC11 ' A' 1129 ' ' DA2 . 99.7 m-85 -66.7 118.77 10.72 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.871 -178.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.48 134.53 55.78 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.967 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.43 -54.61 2.41 Favored Glycine 0 N--CA 1.424 -2.136 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.554 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -74.77 -43.47 54.68 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.072 0.463 . . . . 0.0 111.059 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.79 4.81 69.26 Favored Glycine 0 N--CA 1.433 -1.525 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.142 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -76.98 151.27 35.73 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -138.44 140.19 39.18 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -177.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -151.75 161.53 42.51 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.8 t -98.71 120.57 48.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.5 t -135.06 141.14 37.08 Favored Pre-proline 0 C--N 1.289 -2.053 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -176.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.3 Cg_endo -62.51 147.88 94.16 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 122.552 2.168 . . . . 0.0 111.698 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 50.0 mt -55.51 -26.32 42.2 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 123.834 0.854 . . . . 0.0 111.515 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.2 -26.78 68.29 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.968 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -87.91 -17.42 31.41 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.784 -178.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.401 HD23 ' SG ' ' A' ' 79' ' ' CYS . 83.8 mt -81.8 125.87 31.18 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.483 0.659 . . . . 0.0 109.276 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -114.75 151.19 45.14 Favored Pre-proline 0 C--N 1.284 -2.255 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.83 147.53 69.01 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.966 1.778 . . . . 0.0 111.378 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.5 t -80.48 91.35 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.745 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -88.35 138.24 31.61 Favored 'General case' 0 N--CA 1.405 -2.719 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 72.6 30.4 1.87 Allowed 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 125.358 1.463 . . . . 0.0 110.686 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.187 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 177.808 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1129 ' ' DA2 . . . . . 0.546 HC11 ' CD1' ' A' ' 108' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.3 m -127.94 29.69 5.38 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -83.89 102.9 12.72 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 113.698 -1.592 . . . . 0.0 109.612 -174.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -101.06 107.85 51.89 Favored Pre-proline 0 C--N 1.301 -1.525 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -50.24 134.93 38.3 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 123.802 3.001 . . . . 0.0 113.206 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.7 t -78.54 -22.56 47.09 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.565 0.698 . . . . 0.0 110.284 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -141.05 140.43 34.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.0 m -83.36 105.04 13.99 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -107.72 150.81 26.5 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.199 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -129.9 151.88 49.98 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.4 t -64.4 134.93 28.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.49 30.85 23.44 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.364 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -120.87 157.65 29.36 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -91.81 141.94 28.11 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.285 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.402 ' SG ' HD23 ' A' ' 122' ' ' LEU . 22.5 p -148.26 177.37 9.47 Favored 'General case' 0 C--N 1.265 -3.089 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 36.6 mtp -118.51 130.66 56.05 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 173.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.23 150.17 41.1 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -176.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.1 t -86.0 113.91 24.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -64.46 122.64 17.22 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.5 t -65.23 -19.99 66.22 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 120.778 0.323 . . . . 0.0 111.285 -175.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -84.98 -42.65 14.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.448 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 9.2 t70 -108.33 -15.63 14.43 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.086 -175.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.72 2.27 89.84 Favored Glycine 0 C--N 1.316 -0.558 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.512 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.448 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 24.2 mm-40 -95.14 163.28 13.36 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 17.5 p -93.23 136.42 33.51 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.135 0.493 . . . . 0.0 110.74 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -134.07 158.68 42.96 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 124.145 0.978 . . . . 0.0 109.426 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -75.26 128.41 35.37 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.94 151.82 42.94 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.84 0.352 . . . . 0.0 110.905 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -113.75 135.29 54.11 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.433 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.408 ' HA ' HG23 ' A' ' 106' ' ' ILE . 64.3 mt -72.87 122.03 24.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.473 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -99.29 -33.5 10.7 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.462 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -153.66 150.78 28.95 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 77.1 mt -126.53 133.7 68.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -118.27 94.18 4.4 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.74 -20.69 66.01 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -61.4 -46.81 88.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -97.49 -13.88 21.45 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.047 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.479 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.05 36.59 51.29 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -177.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 43.9 p -124.52 155.35 39.14 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -176.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.36 147.88 50.6 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-O 121.011 0.434 . . . . 0.0 110.392 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.48 120.15 34.28 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.9 pp -124.76 149.9 29.43 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.989 -174.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 94.0 m -118.02 120.56 38.17 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.078 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.462 ' CD2' HC22 ' A' 1129 ' ' DA2 . 98.5 m-85 -68.48 125.4 26.36 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.576 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.09 136.95 57.72 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.407 -176.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 86.28 -46.83 3.66 Favored Glycine 0 C--N 1.311 -0.813 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.567 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -79.87 -43.01 23.05 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.155 0.502 . . . . 0.0 110.739 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 88.34 1.33 81.46 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.878 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -70.44 148.71 48.02 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -136.64 133.96 36.81 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -146.86 156.32 43.01 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.0 t -91.1 122.05 42.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.7 t -135.84 141.19 35.86 Favored Pre-proline 0 C--N 1.283 -2.303 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.521 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 40.8 Cg_endo -62.38 146.6 95.67 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.423 2.082 . . . . 0.0 110.923 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 55.4 mt -54.66 -26.48 33.57 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 123.504 0.722 . . . . 0.0 111.497 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 pp -63.37 -27.87 69.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.897 0.38 . . . . 0.0 110.703 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -87.39 -14.71 39.89 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.518 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.402 HD23 ' SG ' ' A' ' 79' ' ' CYS . 82.1 mt -84.27 126.28 33.03 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.198 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -114.34 151.54 45.19 Favored Pre-proline 0 C--N 1.285 -2.218 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.78 150.98 68.83 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.747 1.631 . . . . 0.0 111.607 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 64.0 t -79.74 96.26 2.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -85.2 109.51 18.36 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.263 0.554 . . . . 0.0 109.896 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -127.14 21.89 6.7 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.046 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.409 0 N-CA-C 107.644 -2.182 . . . . 0.0 107.644 179.287 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1129 ' ' DA2 . . . . . 0.462 HC22 ' CD2' ' A' ' 108' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.471 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.3 m -69.21 104.82 2.3 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 123.286 0.366 . . . . 0.0 111.146 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.2 t -175.42 -179.05 1.22 Allowed 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -115.56 151.39 46.06 Favored Pre-proline 0 C--N 1.286 -2.181 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.87 146.47 91.67 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 122.18 1.92 . . . . 0.0 111.537 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.8 t -74.45 -28.72 61.17 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.375 0.607 . . . . 0.0 110.027 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -141.84 144.95 34.14 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.1 m -87.95 105.62 17.57 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -111.25 151.88 27.79 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 122.754 0.421 . . . . 0.0 111.692 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.506 ' HB2' ' HZ3' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -129.1 152.16 49.0 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 175.386 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.4 t -63.98 139.84 20.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 123.325 0.65 . . . . 0.0 110.188 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.19 35.34 34.33 Favored Glycine 0 CA--C 1.497 -1.079 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.2 153.74 38.42 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -91.86 135.34 34.0 Favored 'General case' 0 N--CA 1.412 -2.375 0 O-C-N 123.872 0.732 . . . . 0.0 110.801 175.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 20.5 p -145.99 179.51 7.42 Favored 'General case' 0 C--N 1.27 -2.871 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 56.5 mtp -119.97 130.69 54.88 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 173.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.25 151.49 39.09 Favored 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.034 -174.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 88.6 t -85.28 115.8 27.57 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.3 t90 -64.15 121.39 14.1 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.1 t -63.19 -19.84 64.87 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 123.438 0.461 . . . . 0.0 111.431 -175.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -84.73 -43.2 14.5 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.982 -0.687 . . . . 0.0 112.417 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -111.87 -16.41 13.15 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.765 -174.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.59 6.0 89.48 Favored Glycine 0 C--N 1.308 -0.99 0 C-N-CA 119.798 -1.191 . . . . 0.0 113.855 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -93.78 163.07 13.67 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 13.0 p -92.12 136.59 33.06 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 120.544 0.212 . . . . 0.0 110.77 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -137.69 157.96 45.37 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 124.052 0.941 . . . . 0.0 109.449 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -75.2 127.29 32.86 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -139.93 153.07 46.85 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.072 0.463 . . . . 0.0 110.964 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -113.01 134.59 54.44 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.45 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.412 ' HA ' HG23 ' A' ' 106' ' ' ILE . 67.4 mt -73.29 123.01 27.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 123.314 0.646 . . . . 0.0 112.2 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -95.13 -43.06 8.28 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.952 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -148.11 149.98 33.02 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.8 mt -129.17 138.33 54.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 O-C-N 123.382 0.426 . . . . 0.0 109.873 177.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -122.96 94.86 4.4 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 174.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.87 -25.95 66.65 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -177.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -61.28 -46.48 90.17 Favored 'General case' 0 C--O 1.221 -0.443 0 O-C-N 123.433 0.458 . . . . 0.0 109.938 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -93.94 -12.6 28.43 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.29 0.567 . . . . 0.0 110.393 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.18 42.02 51.91 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 60.4 p -126.88 157.45 39.33 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 -177.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -141.56 144.61 34.36 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.887 175.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.27 125.06 36.78 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.412 HG23 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -126.81 154.35 36.69 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.629 0 O-C-N 123.41 0.444 . . . . 0.0 110.659 -175.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.4 m -121.26 120.57 35.54 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.769 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.545 ' CD1' HC12 ' A' 1129 ' ' DA2 . 98.4 m-85 -66.78 120.76 14.08 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 123.735 0.814 . . . . 0.0 110.738 -178.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.62 123.81 21.9 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.765 -175.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.93 -34.14 6.02 Favored Glycine 0 N--CA 1.425 -2.059 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.009 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -96.23 -40.45 9.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.815 0.341 . . . . 0.0 111.432 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.06 6.02 65.42 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.256 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -81.28 151.1 28.24 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -140.03 139.15 35.9 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.397 -176.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -147.35 160.55 42.4 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 123.716 0.635 . . . . 0.0 109.471 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.7 t -97.48 114.7 35.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 174.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.5 t -130.14 141.52 42.18 Favored Pre-proline 0 C--N 1.28 -2.455 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -175.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.524 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 38.3 Cg_endo -62.97 146.9 95.0 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.04 1.827 . . . . 0.0 111.164 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 60.7 mt -53.0 -26.65 16.01 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.019 0.928 . . . . 0.0 111.918 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 pp -66.28 -24.48 66.57 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.066 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -91.42 -9.82 43.27 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 121.331 0.586 . . . . 0.0 110.561 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.1 mt -88.71 127.29 35.59 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.991 175.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -113.86 156.53 43.68 Favored Pre-proline 0 C--N 1.282 -2.345 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -65.56 160.38 43.41 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.086 1.858 . . . . 0.0 109.135 172.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 89.2 t -70.43 89.01 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 122.153 0.978 . . . . 0.0 109.918 177.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -79.1 114.04 17.72 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 113.907 -1.497 . . . . 0.0 108.719 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -111.29 10.81 21.67 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.412 -2.937 0 N-CA-C 106.721 -2.551 . . . . 0.0 106.721 179.041 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1129 ' ' DA2 . . . . . 0.545 HC12 ' CD1' ' A' ' 108' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.483 ' H ' ' CD ' ' A' ' 100' ' ' GLU . . . . . . . . 0 C--O 1.233 0.201 0 CA-C-O 119.531 -0.271 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.7 m 61.38 84.96 0.12 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.753 0.787 . . . . 0.0 111.309 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 p -123.77 134.6 53.63 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.8 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -73.81 127.27 88.65 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.441 ' HB3' ' CD1' ' A' ' 119' ' ' LEU . 74.9 Cg_exo -48.5 153.22 3.43 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.099 3.2 . . . . 0.0 114.332 178.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.8 t -74.11 -25.53 59.84 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 121.328 0.585 . . . . 0.0 110.078 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -141.33 142.53 33.81 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.7 m -78.82 104.79 9.68 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.087 0.47 . . . . 0.0 110.398 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.405 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 91.4 m95 -115.92 151.19 35.84 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.584 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -126.59 152.75 46.21 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.6 t -64.12 131.24 29.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.84 32.23 18.71 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.381 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 2.9 t70 -113.55 158.69 20.45 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -97.53 131.58 44.01 Favored 'General case' 0 N--CA 1.409 -2.486 0 CA-C-O 121.913 0.863 . . . . 0.0 110.862 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.405 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 17.4 p -144.04 179.62 7.08 Favored 'General case' 0 C--N 1.265 -3.074 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.197 -178.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 40.0 mtp -118.37 130.27 55.9 Favored 'General case' 0 N--CA 1.41 -2.449 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 172.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.94 149.98 41.24 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -176.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.5 t -85.36 116.18 28.25 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.052 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.471 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.7 t90 -64.31 121.6 14.7 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.7 t -65.08 -18.76 65.57 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 120.926 0.393 . . . . 0.0 111.339 -176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.471 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 43.6 mt-10 -83.75 -41.84 17.19 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -176.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.513 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 15.9 t70 -114.79 -16.57 11.75 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 118.897 -1.121 . . . . 0.0 111.812 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.26 -0.89 86.0 Favored Glycine 0 C--N 1.3 -1.423 0 C-N-CA 119.832 -1.175 . . . . 0.0 113.47 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.513 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 28.0 mm-40 -85.89 159.13 19.76 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.077 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 8.9 p -93.01 136.2 33.48 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.44 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 88' ' ' GLN . 97.5 m-85 -137.39 158.81 43.6 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 124.36 1.064 . . . . 0.0 108.957 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -74.68 127.11 32.32 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.42 150.35 47.57 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.854 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 77' ' ' ASP . 42.9 tt0 -111.37 132.29 54.54 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.712 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.402 ' HA ' HG23 ' A' ' 106' ' ' ILE . 69.8 mt -71.99 124.39 28.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.079 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -96.14 -39.85 9.5 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.241 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -152.68 152.18 31.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -177.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 71.1 mt -125.55 140.48 48.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -123.87 91.35 3.45 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.92 -22.92 66.53 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -175.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' A' ' 65' ' ' ALA . 16.5 tp10 -71.5 -34.59 70.25 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.848 -178.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -98.51 -10.13 23.98 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.727 174.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.423 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 67.55 38.79 90.81 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -178.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 65.0 p -128.61 155.86 44.3 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -175.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.62 148.5 45.86 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 121.161 0.505 . . . . 0.0 110.566 177.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.68 122.02 38.01 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.9 pp -124.94 154.83 33.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.317 -174.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 94.6 m -118.76 121.07 39.22 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.521 ' CD1' HC12 ' A' 1129 ' ' DA2 . 97.8 m-85 -66.79 118.35 10.19 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.69 117.1 8.37 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.253 -173.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 110.39 -45.92 1.25 Allowed Glycine 0 N--CA 1.423 -2.193 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.847 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -81.83 -36.58 28.18 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.218 0.532 . . . . 0.0 110.975 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.81 2.58 86.45 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 120.081 -1.056 . . . . 0.0 112.01 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -73.52 147.8 43.68 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.31 129.39 25.15 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.473 -176.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -145.91 155.98 43.23 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.8 t -92.04 120.86 41.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.4 t -135.02 140.76 35.9 Favored Pre-proline 0 C--N 1.284 -2.256 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.538 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.0 Cg_endo -62.84 148.45 93.42 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.42 2.08 . . . . 0.0 111.463 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.441 ' CD1' ' HB3' ' A' ' 69' ' ' PRO . 56.2 mt -55.69 -26.34 44.5 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 123.883 0.873 . . . . 0.0 111.839 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.6 -25.43 67.39 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.085 0.554 . . . . 0.0 110.957 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -89.61 -13.31 37.43 Favored 'General case' 0 CA--C 1.482 -1.638 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.448 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.6 mt -86.34 127.23 34.77 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.517 176.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -113.67 154.55 45.68 Favored Pre-proline 0 C--N 1.274 -2.69 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.47 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 45.1 Cg_endo -66.58 160.43 46.09 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.045 1.83 . . . . 0.0 108.284 172.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 76.7 t -67.74 94.1 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 122.438 1.113 . . . . 0.0 110.824 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 124' ' ' PRO . 41.9 mt-10 -86.86 103.3 15.13 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.57 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -96.69 9.27 42.13 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.628 0.728 . . . . 0.0 110.701 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.411 -2.977 0 N-CA-C 108.691 -1.763 . . . . 0.0 108.691 -179.908 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1129 ' ' DA2 . . . . . 0.521 HC12 ' CD1' ' A' ' 108' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 120.78 0.324 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.7 t -68.91 -37.76 79.16 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.266 0.555 . . . . 0.0 109.941 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.9 m -129.23 123.38 31.82 Favored 'General case' 0 N--CA 1.416 -2.167 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -95.25 123.95 55.28 Favored Pre-proline 0 C--N 1.292 -1.926 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -48.06 134.1 23.92 Favored 'Trans proline' 0 CA--C 1.51 -0.719 0 C-N-CA 123.54 2.826 . . . . 0.0 113.081 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 t -87.4 -21.63 25.5 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -142.12 137.18 30.75 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.5 t -83.81 112.67 20.32 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -113.05 152.21 29.78 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -122.53 150.24 42.84 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.652 0.381 . . . . 0.0 110.136 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.3 138.53 22.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.36 25.71 53.74 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.708 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 13.0 t0 -105.57 165.43 11.16 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.609 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -94.34 130.87 40.47 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 24.2 p -144.44 174.24 11.1 Favored 'General case' 0 C--N 1.258 -3.404 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.9 mtp -117.22 130.72 56.76 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.46 148.35 42.67 Favored 'General case' 0 C--N 1.264 -3.115 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -175.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 72.3 t -85.33 115.12 26.47 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -63.17 121.48 13.75 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.2 t -62.89 -20.07 64.8 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 122.813 0.445 . . . . 0.0 111.208 -175.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -82.11 -43.08 18.29 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.486 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 14.1 t70 -115.6 -16.13 11.34 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 118.657 -1.217 . . . . 0.0 112.276 -174.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.3 5.18 89.08 Favored Glycine 0 C--N 1.307 -1.053 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.273 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.486 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 29.4 mm-40 -90.7 162.96 14.69 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 176.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 5.5 p -95.99 136.02 36.99 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.516 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.405 ' CD2' HC12 ' A' 1129 ' ' DA2 . 97.2 m-85 -137.88 158.03 45.19 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 124.007 0.923 . . . . 0.0 109.422 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -74.8 132.1 41.31 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.27 155.92 44.6 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.627 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 77' ' ' ASP . 36.5 tt0 -114.61 132.67 56.28 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.542 176.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.452 ' HA ' HG23 ' A' ' 106' ' ' ILE . 71.6 mt -71.48 123.37 25.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 O-C-N 123.67 0.606 . . . . 0.0 112.081 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -96.97 -42.55 7.86 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.09 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 105' ' ' ALA . 26.3 tt0 -144.35 145.03 31.73 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.459 -174.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 80.1 mt -121.74 126.1 74.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -111.51 94.85 5.17 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 175.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -65.4 -25.32 67.5 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.401 -174.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -70.75 -44.59 66.45 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.436 0.636 . . . . 0.0 109.967 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -91.24 -7.77 50.31 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.987 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.515 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 64.63 39.26 96.6 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 53.7 p -123.01 155.93 35.85 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.411 ' HB1' HD12 ' A' ' 122' ' ' LEU . . . -138.58 138.8 38.26 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-O 121.279 0.562 . . . . 0.0 110.208 176.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.426 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . . . -87.74 128.36 35.31 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 175.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.452 HG23 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -130.37 157.75 42.81 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.53 0 CA-C-O 120.669 0.271 . . . . 0.0 110.721 -175.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 65.2 m -121.68 120.6 35.18 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.534 ' CD2' HC21 ' A' 1129 ' ' DA2 . 98.5 m-85 -67.89 120.67 14.57 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.334 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.67 140.89 58.52 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.179 -176.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.65 -53.92 3.75 Favored Glycine 0 N--CA 1.43 -1.72 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -75.36 -43.16 51.97 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.924 0.392 . . . . 0.0 111.155 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.74 18.28 61.97 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.021 -1.085 . . . . 0.0 111.442 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -87.61 156.12 19.64 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.95 143.52 32.0 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -151.78 162.19 41.42 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 105' ' ' ALA . 57.5 t -100.91 113.83 38.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 174.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.1 t -126.44 141.13 39.1 Favored Pre-proline 0 C--N 1.278 -2.534 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -174.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 33.2 Cg_endo -62.38 149.99 88.84 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.255 1.97 . . . . 0.0 111.728 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 51.7 mt -56.62 -25.7 53.81 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 123.37 0.668 . . . . 0.0 110.71 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.7 pp -65.0 -23.94 67.36 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.536 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -93.71 -14.87 25.84 Favored 'General case' 0 CA--C 1.49 -1.35 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.571 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.411 HD12 ' HB1' ' A' ' 104' ' ' ALA . 71.6 mt -83.17 126.67 32.87 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -114.61 150.62 44.24 Favored Pre-proline 0 C--N 1.285 -2.228 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -71.59 148.02 52.67 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.436 1.424 . . . . 0.0 110.187 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.8 t -74.7 104.06 2.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.47 95.8 4.56 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.76 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -128.81 13.38 6.35 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.625 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.497 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 -176.351 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1129 ' ' DA2 . . . . . 0.534 HC21 ' CD2' ' A' ' 108' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 100' ' ' GLU . . . . . . . . 0 CA--C 1.513 -0.479 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.4 p -78.61 -19.79 51.89 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.163 0.506 . . . . 0.0 111.204 -178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.4 t -156.04 163.74 39.3 Favored 'General case' 0 N--CA 1.409 -2.497 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -102.3 135.21 19.64 Favored Pre-proline 0 C--N 1.281 -2.385 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -61.91 134.56 50.59 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.003 1.802 . . . . 0.0 111.409 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.2 t -95.27 -7.4 38.95 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -140.75 133.18 28.43 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.4 p -88.36 105.71 17.76 Favored 'General case' 0 N--CA 1.422 -1.862 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.456 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.464 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 94.2 m95 -99.28 150.89 21.64 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.392 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -134.58 161.59 34.66 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 120.639 -0.425 . . . . 0.0 110.009 176.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.0 t -65.09 131.95 30.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 123.583 0.753 . . . . 0.0 110.008 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.21 38.02 10.53 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.228 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.75 153.32 41.1 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -92.27 133.87 35.42 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-O 121.65 0.738 . . . . 0.0 110.433 174.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.464 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 23.7 p -145.68 179.4 7.46 Favored 'General case' 0 C--N 1.267 -3.004 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.447 ' HG3' ' HA ' ' A' ' 125' ' ' VAL . 61.1 mtp -118.08 131.4 56.44 Favored 'General case' 0 N--CA 1.404 -2.772 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 172.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.26 148.89 41.97 Favored 'General case' 0 C--N 1.264 -3.11 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -175.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.9 t -84.63 113.67 23.67 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.468 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 13.5 t90 -63.29 122.67 16.76 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -177.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.1 t -63.5 -19.66 64.95 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 123.535 0.522 . . . . 0.0 111.583 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.468 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 21.9 mm-40 -84.73 -42.48 15.21 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -111.31 -15.62 13.57 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 118.62 -1.232 . . . . 0.0 111.791 -175.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.29 8.77 87.28 Favored Glycine 0 C--N 1.311 -0.81 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.16 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -101.69 162.31 13.0 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 26.5 p -92.48 136.4 33.24 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.415 0.626 . . . . 0.0 111.828 -178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -135.8 158.4 44.5 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 124.284 1.033 . . . . 0.0 109.195 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -74.72 126.74 31.53 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -177.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.0 150.48 47.02 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.801 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -109.62 132.5 54.08 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.638 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.414 ' HA ' HG23 ' A' ' 106' ' ' ILE . 60.3 mt -72.52 123.2 26.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 123.165 0.586 . . . . 0.0 111.459 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -96.21 -40.3 9.25 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.982 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -154.71 152.64 30.16 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 57.1 mt -129.56 138.44 54.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.867 0.365 . . . . 0.0 110.076 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -122.34 91.29 3.47 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 173.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -66.9 -19.56 65.75 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.6 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 12.8 tp10 -64.63 -46.31 83.12 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.556 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -90.45 -16.22 29.38 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.586 0.708 . . . . 0.0 109.834 176.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.85 37.91 37.76 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 61.4 p -123.92 155.42 38.17 Favored 'General case' 0 N--CA 1.413 -2.3 0 O-C-N 122.601 -0.352 . . . . 0.0 110.201 -176.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.31 140.53 39.59 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-O 121.178 0.514 . . . . 0.0 109.874 176.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.33 121.9 32.04 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 107.13 -1.434 . . . . 0.0 107.13 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.414 HG23 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -126.74 154.83 37.04 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.512 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.99 -175.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 97.6 m -121.86 120.75 35.43 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.521 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.48 ' CD1' HC13 ' A' 1129 ' ' DA2 . 96.7 m-85 -66.86 119.09 11.29 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.554 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.44 130.28 40.31 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.841 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.49 -39.68 2.71 Favored Glycine 0 N--CA 1.427 -1.96 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -96.56 -39.97 9.27 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.244 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.31 -2.68 71.46 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.933 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -71.62 152.0 43.27 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-N 115.687 -0.256 . . . . 0.0 110.356 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -139.68 141.28 36.98 Favored 'General case' 0 C--N 1.285 -2.229 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.568 -176.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -151.25 159.18 44.5 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.4 t -98.35 113.52 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 175.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.8 t -125.13 141.41 38.47 Favored Pre-proline 0 C--N 1.274 -2.675 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 46.0 Cg_endo -63.7 146.94 92.76 Favored 'Trans proline' 0 N--CA 1.443 -1.455 0 C-N-CA 121.777 1.651 . . . . 0.0 110.763 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 42.3 mt -55.51 -26.27 41.94 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 123.537 0.735 . . . . 0.0 110.828 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 pp -63.86 -23.24 67.28 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.214 0.53 . . . . 0.0 110.849 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -93.54 -10.38 35.01 Favored 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.465 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.2 mt -84.44 127.43 34.01 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.856 0.836 . . . . 0.0 109.962 176.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -114.26 150.23 43.37 Favored Pre-proline 0 C--N 1.277 -2.574 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.135 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.82 153.79 70.47 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.597 1.531 . . . . 0.0 108.557 170.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.447 ' HA ' ' HG3' ' A' ' 80' ' ' MET . 45.1 t -73.44 97.77 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.246 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -77.28 73.56 3.86 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 122.197 0.999 . . . . 0.0 113.609 -176.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -122.79 14.67 10.07 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 122.928 1.347 . . . . 0.0 107.813 173.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.407 -3.299 0 N-CA-C 106.252 -2.739 . . . . 0.0 106.252 -179.412 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 1129 ' ' DA2 . . . . . 0.48 HC13 ' CD1' ' A' ' 108' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.295 0 N-CA-C 111.609 0.226 . . . . 0.0 111.609 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.2 m -91.72 -46.74 7.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.318 0.58 . . . . 0.0 111.179 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 t -106.46 102.39 11.79 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.572 0.701 . . . . 0.0 109.45 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -94.86 145.4 29.5 Favored Pre-proline 0 C--N 1.298 -1.666 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.369 -176.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -60.74 133.84 50.5 Favored 'Trans proline' 0 CA--C 1.515 -0.453 0 C-N-CA 122.596 2.197 . . . . 0.0 111.335 176.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.3 t -91.08 -16.54 27.67 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.05 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -142.22 139.16 31.91 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.2 p -85.78 104.85 15.84 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.451 0.643 . . . . 0.0 110.767 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -105.69 152.11 23.57 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.647 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -127.14 158.9 35.84 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.911 175.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.7 t -65.14 138.0 23.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.863 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.35 38.64 28.53 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.55 154.14 37.08 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -95.22 135.44 36.8 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.97 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 18.7 p -147.17 176.86 9.63 Favored 'General case' 0 C--N 1.263 -3.173 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 34.2 mtp -115.67 130.53 56.89 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -119.74 151.67 38.41 Favored 'General case' 0 C--N 1.277 -2.553 0 O-C-N 123.44 0.462 . . . . 0.0 109.818 -175.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.4 t -85.19 114.27 25.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.494 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 12.4 t90 -67.03 125.52 26.25 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 58.6 m -57.75 -33.02 68.04 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.376 0.608 . . . . 0.0 111.844 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -79.07 -41.66 28.25 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -172.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.494 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 42.6 t0 -105.75 -16.3 14.71 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.681 0.753 . . . . 0.0 110.194 -176.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.88 8.13 77.08 Favored Glycine 0 C--N 1.316 -0.529 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.88 178.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -101.49 163.76 12.1 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 15.2 p -93.7 135.58 34.85 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.227 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -134.66 158.18 44.72 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 124.364 1.066 . . . . 0.0 109.185 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -75.26 125.64 29.38 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.26 0.552 . . . . 0.0 109.738 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.42 154.36 46.65 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.652 -177.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -112.09 133.87 53.98 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.286 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 70.7 mt -71.94 122.31 23.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 C-N-CA 123.528 0.731 . . . . 0.0 111.453 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -96.96 -40.54 8.83 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.284 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -151.02 146.97 26.57 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 72.5 mt -122.45 135.88 61.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -120.03 93.97 4.23 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 174.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.13 -19.87 65.97 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -63.87 -46.47 84.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -93.01 -15.39 26.24 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.136 0.493 . . . . 0.0 110.244 178.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.434 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.3 37.02 48.97 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -176.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 41.2 p -125.6 155.81 40.14 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.51 148.6 47.73 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-O 121.233 0.539 . . . . 0.0 110.28 177.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.07 124.79 39.3 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 176.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.9 pp -126.75 154.7 36.93 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.693 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.644 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 98.4 m -122.08 120.1 33.31 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.501 ' CD2' HC21 ' A' 1129 ' ' DA2 . 98.0 m-85 -67.19 118.72 10.98 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 123.201 0.6 . . . . 0.0 110.494 -178.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.78 129.41 39.69 Favored 'General case' 0 N--CA 1.436 -1.126 0 O-C-N 124.509 1.131 . . . . 0.0 110.883 -175.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.77 -44.99 1.76 Allowed Glycine 0 N--CA 1.425 -2.088 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.736 178.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -82.47 -43.14 17.6 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 120.729 0.299 . . . . 0.0 111.11 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.25 10.42 60.91 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.642 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -85.02 156.92 20.9 Favored 'General case' 0 CA--C 1.488 -1.41 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.03 140.73 32.71 Favored 'General case' 0 C--N 1.29 -2.015 0 O-C-N 123.033 0.208 . . . . 0.0 110.789 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -151.75 158.9 43.98 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 123.371 0.419 . . . . 0.0 109.985 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.1 t -95.79 116.34 37.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.0 t -130.28 141.61 42.52 Favored Pre-proline 0 C--N 1.288 -2.099 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -174.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 42.1 Cg_endo -63.92 146.52 91.55 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.212 1.941 . . . . 0.0 111.108 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 61.6 mt -55.04 -26.15 35.38 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 123.906 0.882 . . . . 0.0 111.952 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.65 -27.05 68.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.057 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -88.9 -12.88 40.49 Favored 'General case' 0 CA--C 1.484 -1.584 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.803 -177.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 84.3 mt -82.64 126.15 32.01 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -114.11 148.43 40.02 Favored Pre-proline 0 C--N 1.28 -2.414 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.35 146.66 57.15 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 C-N-CA 121.31 1.34 . . . . 0.0 111.16 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 65.8 t -73.69 98.79 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 173.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -73.6 101.17 3.53 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -171.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -120.36 12.85 11.78 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 172.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.77 0 N-CA-C 106.988 -2.445 . . . . 0.0 106.988 -177.196 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 1129 ' ' DA2 . . . . . 0.501 HC21 ' CD2' ' A' ' 108' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.65 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.4 m -62.49 119.06 8.42 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 123.359 0.412 . . . . 0.0 110.521 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.0 m -80.08 124.47 28.77 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.21 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -116.46 124.65 29.25 Favored Pre-proline 0 C--N 1.298 -1.636 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 171.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -52.57 137.95 58.07 Favored 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 122.949 2.433 . . . . 0.0 113.076 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.9 t -74.0 -27.21 60.85 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 122.062 0.934 . . . . 0.0 108.541 175.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -140.55 130.63 24.8 Favored 'General case' 0 N--CA 1.408 -2.539 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 175.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.3 p -78.26 110.11 12.99 Favored 'General case' 0 C--N 1.289 -2.058 0 O-C-N 123.461 0.475 . . . . 0.0 111.112 -178.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -114.25 150.89 33.68 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.34 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -131.01 157.18 43.69 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.464 177.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.76 141.61 17.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 C-N-CA 123.225 0.61 . . . . 0.0 111.05 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.73 31.23 40.94 Favored Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 121.444 -0.407 . . . . 0.0 112.139 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.13 150.16 42.58 Favored 'General case' 0 CA--C 1.481 -1.678 0 CA-C-O 120.533 0.206 . . . . 0.0 111.04 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -90.84 138.64 31.43 Favored 'General case' 0 N--CA 1.406 -2.669 0 CA-C-O 121.858 0.837 . . . . 0.0 110.507 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 18.6 p -147.42 176.39 10.06 Favored 'General case' 0 C--N 1.271 -2.813 0 CA-C-N 113.952 -1.476 . . . . 0.0 107.5 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 41.1 mtp -116.4 130.85 56.98 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 173.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.99 151.9 38.28 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.529 -175.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 72.2 t -88.01 117.55 31.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -66.5 126.04 27.63 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.3 m -60.08 -30.85 69.5 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 121.232 0.539 . . . . 0.0 112.383 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.15 -42.55 23.25 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -173.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -109.27 -14.08 14.53 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.136 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.95 3.65 89.41 Favored Glycine 0 C--N 1.305 -1.19 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.604 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -93.28 162.72 13.89 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 117.559 0.68 . . . . 0.0 110.255 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 25.0 p -89.94 136.63 32.92 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.23 0.538 . . . . 0.0 110.367 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.439 ' CD2' HC12 ' A' 1129 ' ' DA2 . 96.9 m-85 -137.79 158.05 45.16 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 123.725 0.81 . . . . 0.0 108.955 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -75.21 128.98 36.7 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -142.35 150.12 40.31 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.304 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -110.41 134.56 52.21 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.53 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.0 mt -73.03 120.84 22.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.258 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -96.03 -39.07 9.93 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.425 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -151.39 147.79 27.32 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -176.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.7 mt -123.07 143.19 36.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -116.67 91.23 3.52 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 171.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -65.69 -20.29 66.23 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.984 -1.007 . . . . 0.0 113.091 -174.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -65.97 -46.65 77.34 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -91.92 -13.27 31.48 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.688 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.493 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 70.43 41.09 67.82 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -175.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 41.3 p -123.58 155.75 37.06 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.33 146.72 42.72 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.267 0.556 . . . . 0.0 111.134 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.89 122.05 37.12 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 114' ' ' ALA . 2.9 pp -124.7 152.12 30.61 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.218 -174.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 90.9 m -117.01 122.99 45.78 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.051 177.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.521 ' CD2' HC21 ' A' 1129 ' ' DA2 . 98.8 m-85 -72.62 124.43 25.24 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.752 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.32 134.42 55.76 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.706 -1.133 . . . . 0.0 111.044 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.8 -48.25 3.26 Favored Glycine 0 N--CA 1.432 -1.591 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.249 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -78.51 -43.4 27.0 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.796 0.332 . . . . 0.0 111.003 -178.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 88.71 11.9 65.13 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.262 -0.97 . . . . 0.0 111.911 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 107' ' ' THR . 4.3 m-20 -81.58 155.98 25.42 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -141.06 138.75 33.83 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.44 162.79 40.32 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 123.358 0.411 . . . . 0.0 109.982 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.6 t -97.56 121.87 48.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.8 t -136.55 141.09 34.24 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -177.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.522 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.4 Cg_endo -63.02 147.46 94.45 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 122.432 2.088 . . . . 0.0 111.346 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 43.4 mt -54.24 -26.79 30.61 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 123.73 0.812 . . . . 0.0 111.501 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 pp -63.97 -27.26 69.01 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.953 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -83.89 -27.27 28.75 Favored 'General case' 0 CA--C 1.487 -1.45 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.661 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 81.5 mt -73.67 127.09 31.82 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.485 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.76 153.96 44.95 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.96 151.79 56.72 Favored 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 121.607 1.538 . . . . 0.0 111.048 175.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.9 t -84.91 94.49 3.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 176.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -78.2 107.6 10.92 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.966 -174.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -125.7 13.26 8.03 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.824 0.821 . . . . 0.0 109.4 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.412 -2.912 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.803 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 1129 ' ' DA2 . . . . . 0.521 HC21 ' CD2' ' A' ' 108' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.473 0 CA-C-O 120.617 0.246 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.5 p -77.06 -45.54 26.76 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 95.9 m -88.15 119.93 29.01 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.92 117.92 63.87 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -57.58 134.4 62.95 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.141 1.894 . . . . 0.0 111.291 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.0 t -83.98 -23.27 31.11 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.102 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -141.28 136.44 31.61 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.8 m -82.52 105.6 13.7 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 123.391 0.432 . . . . 0.0 110.088 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -111.45 151.39 28.62 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.636 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -128.38 158.93 36.91 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 69.8 t -65.35 133.04 31.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 123.076 0.55 . . . . 0.0 110.066 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.85 31.4 23.83 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.786 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 1.3 t0 -115.32 164.06 14.8 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.836 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? -94.46 131.9 39.67 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 21.0 p -147.0 172.74 13.25 Favored 'General case' 0 C--N 1.267 -3.016 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.1 mtp -117.08 129.91 56.3 Favored 'General case' 0 N--CA 1.411 -2.377 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.0 154.82 37.95 Favored 'General case' 0 C--N 1.273 -2.72 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.451 -173.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.0 t -87.51 122.15 38.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.426 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 10.8 t90 -71.44 122.17 19.91 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.9 m -61.34 -25.23 67.01 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.426 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 13.8 mm-40 -78.4 -42.11 31.14 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.783 -177.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -114.61 -15.52 11.97 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.271 -174.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.76 0.58 89.54 Favored Glycine 0 C--N 1.31 -0.881 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.688 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -90.97 164.67 13.9 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.189 -179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 22.0 p -90.37 136.18 33.21 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.787 0.327 . . . . 0.0 110.445 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -136.59 157.75 46.03 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 123.131 0.573 . . . . 0.0 109.777 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -75.41 130.97 39.84 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.52 154.55 43.74 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.746 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 77' ' ' ASP . 36.0 tt0 -112.6 132.24 55.24 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.847 177.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 74.5 mt -69.54 124.4 25.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 O-C-N 123.673 0.608 . . . . 0.0 111.639 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -99.07 -40.65 7.91 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.265 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.463 ' HB3' ' HB2' ' A' ' 105' ' ' ALA . 27.7 tt0 -143.3 143.35 31.66 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -173.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 79.1 mt -125.76 129.65 72.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 175.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -119.01 93.62 4.16 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 174.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -66.16 -20.0 66.01 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.457 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -61.13 -46.95 88.48 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.273 0.558 . . . . 0.0 110.232 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -99.39 -8.92 24.12 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.012 0.434 . . . . 0.0 110.716 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.414 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 71.17 41.5 59.86 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -177.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 75.5 p -123.07 157.33 33.04 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.436 ' HB1' HD12 ' A' ' 122' ' ' LEU . . . -139.43 140.26 37.3 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-O 121.167 0.508 . . . . 0.0 109.937 175.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . . . -89.67 124.55 34.7 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 175.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.9 pp -125.1 156.03 33.9 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 CA-C-O 120.855 0.36 . . . . 0.0 110.884 -174.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 97.3 m -121.98 119.89 32.79 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.398 176.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.555 ' CD1' HC12 ' A' 1129 ' ' DA2 . 96.9 m-85 -66.16 125.73 26.44 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.375 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.72 129.53 41.47 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.975 -174.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.28 -50.85 3.36 Favored Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 111.616 -0.593 . . . . 0.0 111.616 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -70.15 -41.69 73.52 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.078 0.466 . . . . 0.0 110.071 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.36 5.5 85.05 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.615 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.41 ' O ' ' HA ' ' A' ' 107' ' ' THR . 4.0 m-20 -77.17 150.38 35.52 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -139.56 138.86 36.61 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.806 -176.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -151.69 162.73 40.52 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.209 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.4 t -99.45 119.99 48.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.3 t -132.72 141.17 40.13 Favored Pre-proline 0 C--N 1.281 -2.374 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.523 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 30.4 Cg_endo -62.48 148.86 92.65 Favored 'Trans proline' 0 N--CA 1.441 -1.574 0 C-N-CA 122.217 1.944 . . . . 0.0 111.48 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 50.6 mt -54.93 -26.54 36.91 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.793 0.837 . . . . 0.0 111.168 178.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.9 pp -66.88 -24.2 66.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.957 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -89.96 -17.92 27.03 Favored 'General case' 0 CA--C 1.49 -1.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.416 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.436 HD12 ' HB1' ' A' ' 104' ' ' ALA . 82.5 mt -82.2 125.37 30.84 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.314 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -115.81 153.97 48.12 Favored Pre-proline 0 C--N 1.281 -2.386 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.648 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.18 145.4 39.02 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 121.347 1.365 . . . . 0.0 110.535 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.4 t -77.45 105.56 6.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -67.16 94.26 0.34 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.46 0.648 . . . . 0.0 109.417 174.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -107.13 -6.64 17.24 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.756 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.279 -2.638 0 CA-C-N 113.887 -1.506 . . . . 0.0 109.47 -179.197 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 1129 ' ' DA2 . . . . . 0.555 HC12 ' CD1' ' A' ' 108' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.431 0 CA-C-O 121.062 0.458 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.7 m -76.42 -36.4 58.04 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 176.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.65 ' HB ' ' O ' ' A' ' 99' ' ' GLU . 24.5 m -97.36 108.61 21.38 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 176.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.449 ' HA ' ' OE1' ' A' ' 68' ' ' GLN . 13.6 mm-40 -86.75 119.45 71.25 Favored Pre-proline 0 C--N 1.288 -2.083 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.952 -176.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.32 134.8 31.72 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 124.069 3.179 . . . . 0.0 112.955 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.5 t -79.04 -19.5 51.26 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 122.153 0.978 . . . . 0.0 108.889 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -140.95 136.17 31.94 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.9 t -78.94 105.18 10.08 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.427 0.632 . . . . 0.0 109.489 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -112.85 151.12 30.78 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.711 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -133.37 160.69 36.62 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 175.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.9 t -64.87 133.46 30.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.528 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.12 30.89 21.57 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.779 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.03 152.17 35.21 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -92.12 132.4 36.63 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.91 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 18.0 p -142.53 174.72 10.38 Favored 'General case' 0 C--N 1.259 -3.327 0 CA-C-N 114.403 -1.271 . . . . 0.0 107.78 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 38.4 mtp -115.52 130.19 56.79 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 173.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -121.27 149.55 42.72 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.488 -176.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.8 t -85.04 116.5 28.63 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -63.74 120.64 12.24 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.9 t -63.65 -18.6 64.12 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 122.854 0.462 . . . . 0.0 111.298 -175.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -85.1 -42.51 14.72 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -115.91 -15.82 11.19 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 119.123 -1.031 . . . . 0.0 112.118 -173.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.32 -5.78 83.55 Favored Glycine 0 C--N 1.31 -0.861 0 C-N-CA 119.853 -1.165 . . . . 0.0 114.293 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.465 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 25.8 mm-40 -83.61 158.4 21.91 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 22.2 p -90.37 136.04 33.31 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.936 0.398 . . . . 0.0 109.977 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.465 ' CE2' ' HB2' ' A' ' 88' ' ' GLN . 97.4 m-85 -136.91 158.53 44.24 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.612 0.765 . . . . 0.0 109.681 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -75.33 123.36 25.22 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -135.74 149.87 49.33 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.89 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -112.05 132.35 54.87 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.986 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 64.5 mt -71.52 123.08 25.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.948 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -96.77 -41.34 8.52 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.09 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -151.7 142.09 22.49 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.574 -176.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 69.0 mt -113.44 138.35 43.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -120.8 92.06 3.67 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.65 ' O ' ' HB ' ' A' ' 67' ' ' THR . 8.9 pt-20 -65.76 -18.05 65.05 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.65 -46.91 80.51 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 121.412 0.625 . . . . 0.0 109.659 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -93.8 -15.66 24.89 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.566 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.42 37.4 47.36 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -175.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 42.8 p -125.36 155.79 39.74 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -176.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.58 144.64 48.06 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-O 121.238 0.542 . . . . 0.0 110.412 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.62 121.79 32.85 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.9 pp -124.57 151.9 30.22 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.705 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.477 -175.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.8 m -119.71 121.26 38.82 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.542 ' CD1' HC12 ' A' 1129 ' ' DA2 . 98.8 m-85 -67.73 118.24 10.72 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.46 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.28 126.27 29.16 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.171 -173.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.81 -37.69 3.66 Favored Glycine 0 N--CA 1.425 -2.065 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.097 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -89.9 -43.61 10.48 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.921 0.391 . . . . 0.0 110.172 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.43 4.91 62.17 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.044 -178.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -79.84 156.64 27.28 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 117.039 0.42 . . . . 0.0 109.934 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -143.1 143.56 31.89 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 120.564 0.221 . . . . 0.0 110.622 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -151.67 162.48 40.93 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.8 t -103.73 115.37 45.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.9 t -128.72 141.5 41.81 Favored Pre-proline 0 C--N 1.279 -2.498 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.08 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.2 Cg_endo -62.18 146.46 95.99 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 122.456 2.104 . . . . 0.0 111.457 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 60.1 mt -55.15 -26.39 38.35 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 123.623 0.769 . . . . 0.0 111.469 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 pp -66.22 -24.37 66.6 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.958 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -90.26 -16.38 29.46 Favored 'General case' 0 CA--C 1.479 -1.763 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 84.7 mt -80.98 126.24 31.14 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.86 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -114.8 147.43 38.2 Favored Pre-proline 0 C--N 1.288 -2.084 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -67.36 150.64 81.02 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 122.006 1.804 . . . . 0.0 110.837 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.1 t -82.92 83.48 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -90.94 76.7 6.23 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 61.82 20.55 11.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.777 -1.556 . . . . 0.0 113.606 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.042 0 CA-C-O 118.406 -1.219 . . . . 0.0 111.027 177.305 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 1129 ' ' DA2 . . . . . 0.542 HC12 ' CD1' ' A' ' 108' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.619 0 CA-C-O 120.731 0.301 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.4 m -74.24 -40.06 62.64 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 122.224 1.011 . . . . 0.0 108.353 176.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.5 m -138.8 148.42 43.78 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 174.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -105.82 133.15 20.33 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -58.02 134.01 59.43 Favored 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.637 2.224 . . . . 0.0 112.594 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.6 t -88.94 -18.95 26.44 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.345 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -141.54 149.03 40.3 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -177.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.4 m -88.79 104.8 17.25 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -110.81 151.15 28.15 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.819 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -126.87 153.21 46.02 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.67 133.13 30.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 175.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.11 39.42 9.28 Favored Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.484 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -117.79 161.17 20.16 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -98.75 131.24 45.05 Favored 'General case' 0 N--CA 1.394 -3.258 0 CA-C-O 122.1 0.953 . . . . 0.0 110.818 175.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.5 p -143.63 168.09 20.71 Favored 'General case' 0 C--N 1.262 -3.227 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.129 -177.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 31.3 mtp -111.83 130.2 55.89 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 172.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -121.42 149.47 42.97 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.4 t -85.42 117.01 29.66 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.443 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.5 t90 -66.76 123.05 19.06 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.5 m -60.24 -26.36 66.36 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.443 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 45.4 mt-10 -82.09 -41.98 19.8 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.005 -174.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -110.99 -15.48 13.74 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.762 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.28 10.51 86.16 Favored Glycine 0 C--N 1.307 -1.056 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.643 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -98.94 160.09 14.5 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 23.0 p -90.34 136.33 33.12 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 120.879 0.371 . . . . 0.0 110.916 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -136.46 158.14 45.14 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 123.725 0.81 . . . . 0.0 110.085 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -76.66 125.89 30.03 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.415 0.626 . . . . 0.0 109.887 -177.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -139.25 155.06 48.02 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.688 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -114.49 132.47 56.28 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.138 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.408 ' HA ' HG23 ' A' ' 106' ' ' ILE . 69.4 mt -70.88 123.85 25.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.311 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -98.34 -40.53 8.27 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.545 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -148.43 146.35 28.4 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -174.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 72.1 mt -124.72 137.61 56.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -116.98 95.48 5.02 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 174.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -65.99 -22.1 66.44 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -67.86 -46.78 70.77 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 121.277 0.561 . . . . 0.0 110.354 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -92.39 -9.47 41.61 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.784 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.542 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 64.56 41.98 97.62 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -176.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 41.6 p -126.23 155.9 41.12 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.73 149.01 43.11 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.207 0.527 . . . . 0.0 111.313 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.41 124.05 39.24 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 176.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.408 HG23 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -126.41 155.07 36.53 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.046 -175.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.7 m -121.79 120.34 34.32 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.452 ' CD2' HC23 ' A' 1129 ' ' DA2 . 99.5 m-85 -68.91 121.63 16.99 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.381 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.1 135.34 57.15 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.167 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.74 -46.13 3.29 Favored Glycine 0 C--N 1.309 -0.934 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.743 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -77.23 -40.24 45.58 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.985 0.421 . . . . 0.0 110.698 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.97 7.89 76.85 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.526 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -82.07 149.25 28.15 Favored 'General case' 0 CA--C 1.485 -1.519 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -144.05 137.57 27.71 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.803 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -151.83 160.55 43.51 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 123.521 0.513 . . . . 0.0 110.031 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.0 t -93.34 122.07 44.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.4 t -135.75 141.21 36.12 Favored Pre-proline 0 C--N 1.282 -2.328 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -177.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.2 Cg_endo -63.21 148.55 92.99 Favored 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 122.273 1.982 . . . . 0.0 111.497 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 50.6 mt -55.54 -26.32 42.6 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 123.858 0.863 . . . . 0.0 111.412 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 pp -63.97 -26.97 68.82 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 121.434 0.635 . . . . 0.0 110.497 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -84.17 -26.03 29.13 Favored 'General case' 0 CA--C 1.476 -1.902 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.576 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.2 mt -78.3 126.23 30.49 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.272 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -114.67 150.32 43.77 Favored Pre-proline 0 C--N 1.288 -2.086 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 175.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.85 146.91 48.93 Favored 'Trans proline' 0 C--N 1.325 -0.663 0 C-N-CA 121.493 1.462 . . . . 0.0 110.871 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.4 t -79.83 100.71 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -85.67 118.7 25.34 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -102.57 4.61 38.62 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.763 0.792 . . . . 0.0 110.338 -178.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.415 -2.738 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 -178.04 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 1129 ' ' DA2 . . . . . 0.452 HC23 ' CD2' ' A' ' 108' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.207 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.5 t -71.9 -30.65 65.59 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.1 m -119.95 134.85 55.12 Favored 'General case' 0 N--CA 1.4 -2.933 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 175.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -116.92 132.72 23.28 Favored Pre-proline 0 C--N 1.297 -1.698 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.8 136.49 42.03 Favored 'Trans proline' 0 C--O 1.25 1.081 0 C-N-CA 122.069 1.846 . . . . 0.0 110.804 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.8 t -74.14 -23.56 59.29 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.736 -176.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -140.95 140.18 34.39 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.7 m -81.24 104.93 12.05 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.139 0.495 . . . . 0.0 110.002 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -112.79 151.25 30.56 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.252 177.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -133.71 155.24 50.09 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.355 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.9 t -63.5 141.42 18.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.15 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.13 27.92 51.1 Favored Glycine 0 CA--C 1.498 -0.975 0 C-N-CA 121.401 -0.428 . . . . 0.0 112.527 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.46 153.81 41.43 Favored 'General case' 0 CA--C 1.488 -1.438 0 CA-C-O 120.927 0.394 . . . . 0.0 111.774 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -90.71 141.28 28.95 Favored 'General case' 0 N--CA 1.413 -2.321 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.76 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 14.2 p -147.99 175.2 11.18 Favored 'General case' 0 C--N 1.265 -3.097 0 CA-C-N 113.573 -1.649 . . . . 0.0 107.158 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 82.0 mmm -112.13 129.38 56.25 Favored 'General case' 0 C--N 1.271 -2.811 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 175.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -122.39 147.52 46.19 Favored 'General case' 0 C--N 1.266 -3.063 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.089 -176.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.8 t -85.09 115.01 26.17 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.463 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 12.7 t90 -64.44 121.22 13.86 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.6 t -63.12 -20.25 65.2 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 123.434 0.459 . . . . 0.0 111.658 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.463 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 37.6 mm-40 -84.82 -42.22 15.34 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -177.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -109.74 -15.98 14.01 Favored 'General case' 0 CA--C 1.507 -0.708 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.239 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.59 9.33 86.97 Favored Glycine 0 C--O 1.221 -0.66 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.076 177.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -102.85 162.03 13.26 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 7.1 p -89.87 136.6 32.94 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.085 0.469 . . . . 0.0 111.91 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -136.06 158.52 44.21 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 124.866 1.266 . . . . 0.0 109.134 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -75.03 127.95 34.43 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.41 151.98 43.92 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.71 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -111.33 133.35 53.71 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.394 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 67.8 mt -72.67 123.94 28.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 123.745 0.818 . . . . 0.0 111.92 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -99.69 -38.21 8.8 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.989 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -151.79 143.91 23.92 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.879 -175.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 64.5 mt -124.29 140.23 48.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -124.39 94.39 4.19 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 171.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -66.28 -23.11 66.33 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -66.76 -44.14 82.22 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.397 0.617 . . . . 0.0 109.821 -179.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -92.67 -9.51 40.57 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.357 0.599 . . . . 0.0 110.367 177.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 68.13 39.19 88.61 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.527 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 73.8 p -125.28 155.42 40.19 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 122.265 -0.55 . . . . 0.0 110.405 -176.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.48 146.15 41.7 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 121.461 0.648 . . . . 0.0 110.601 176.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.62 121.59 36.34 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.9 pp -124.97 153.19 31.93 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.679 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.862 -175.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 87.8 m -120.38 120.37 35.78 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.779 177.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.589 ' CD1' HC11 ' A' 1129 ' ' DA2 . 98.4 m-85 -67.33 124.85 24.29 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 123.543 0.737 . . . . 0.0 110.72 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.24 129.28 39.43 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.023 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.28 -39.59 2.83 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.919 178.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -87.06 -40.24 14.87 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.286 0.565 . . . . 0.0 110.157 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.21 11.29 72.87 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.823 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -80.51 154.07 27.76 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.91 139.1 30.62 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.729 -176.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -149.2 160.58 43.24 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 56.8 t -98.06 114.82 36.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 176.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.3 t -130.67 141.4 41.82 Favored Pre-proline 0 C--N 1.281 -2.408 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -175.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 40.9 Cg_endo -63.05 148.36 93.48 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.371 2.047 . . . . 0.0 111.682 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 54.3 mt -55.2 -26.78 41.39 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.595 0.758 . . . . 0.0 111.539 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.63 -23.5 66.82 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.248 0.547 . . . . 0.0 111.057 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -92.13 -13.24 31.01 Favored 'General case' 0 CA--C 1.485 -1.551 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.026 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 82.1 mt -85.28 125.95 33.32 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -114.75 153.19 46.89 Favored Pre-proline 0 C--N 1.284 -2.276 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.84 154.02 53.49 Favored 'Trans proline' 0 C--O 1.248 1.021 0 C-N-CA 121.475 1.45 . . . . 0.0 111.869 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 46.1 t -81.76 80.12 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.962 0.887 . . . . 0.0 108.885 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -97.56 99.26 10.65 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.511 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.86 10.8 9.59 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.155 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.415 -2.745 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 -178.675 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 1129 ' ' DA2 . . . . . 0.589 HC11 ' CD1' ' A' ' 108' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.605 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.8 t -154.79 145.11 22.02 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.6 m -129.52 118.12 21.56 Favored 'General case' 0 N--CA 1.412 -2.347 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -67.45 125.76 91.6 Favored Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.37 134.75 37.12 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.444 2.096 . . . . 0.0 112.233 -176.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.3 t -78.69 -24.49 45.02 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -141.2 137.42 32.62 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.1 m -83.72 112.01 19.68 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.649 0.737 . . . . 0.0 110.916 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . 0.441 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 97.5 m95 -116.3 151.8 35.13 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.872 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -132.97 160.0 38.37 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.61 136.41 26.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 123.687 0.795 . . . . 0.0 111.362 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.21 21.99 46.74 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.33 177.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.66 153.55 28.73 Favored 'General case' 0 CA--C 1.482 -1.655 0 CA-C-O 120.598 0.237 . . . . 0.0 110.453 -177.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -91.81 135.29 34.03 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-O 121.93 0.872 . . . . 0.0 110.809 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.441 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 19.4 p -146.03 176.38 9.76 Favored 'General case' 0 C--N 1.265 -3.085 0 CA-C-N 114.023 -1.444 . . . . 0.0 107.181 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 59.9 mtp -115.82 130.84 57.0 Favored 'General case' 0 C--N 1.27 -2.891 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 173.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.79 150.54 39.62 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -175.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 82.7 t -85.39 115.29 26.77 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.473 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.509 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.0 t90 -63.74 123.25 18.4 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.1 t -62.36 -25.06 67.7 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.229 0.538 . . . . 0.0 110.997 -177.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.509 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 21.5 mm-40 -79.05 -41.73 28.13 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -176.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -115.33 -16.31 11.48 Favored 'General case' 0 CA--C 1.502 -0.891 0 C-N-CA 117.654 -1.618 . . . . 0.0 112.367 -178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.59 5.75 88.04 Favored Glycine 0 C--N 1.306 -1.116 0 C-N-CA 119.795 -1.193 . . . . 0.0 113.596 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -93.19 161.6 14.35 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 23.4 p -94.25 135.74 35.31 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 120.957 0.408 . . . . 0.0 110.56 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -137.9 157.6 46.08 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 123.741 0.817 . . . . 0.0 109.203 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -75.5 126.02 30.19 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -177.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.25 151.15 47.37 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -112.08 133.37 54.28 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.115 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 66.4 mt -71.72 123.34 25.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 123.558 0.743 . . . . 0.0 111.756 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -97.39 -38.61 9.56 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.513 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -154.97 151.57 28.65 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 71.6 mt -123.33 137.27 57.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -117.68 95.82 5.11 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -65.54 -22.6 66.73 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.768 -1.106 . . . . 0.0 113.022 -177.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -65.08 -46.3 81.7 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 120.603 0.24 . . . . 0.0 110.78 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -95.36 -5.86 42.37 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.84 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.411 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 64.75 43.15 96.67 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -176.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 39.9 p -127.27 156.0 42.61 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -175.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.32 141.7 43.8 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-O 121.09 0.471 . . . . 0.0 110.086 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.04 120.76 29.69 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.9 pp -124.89 154.22 32.57 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.679 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.082 -174.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.7 m -121.82 120.41 34.49 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.469 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.483 ' CD1' HC11 ' A' 1129 ' ' DA2 . 98.1 m-85 -67.11 123.35 20.02 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 123.387 0.675 . . . . 0.0 110.359 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.48 135.67 55.48 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.266 -176.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.92 -55.81 3.7 Favored Glycine 0 N--CA 1.429 -1.784 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.948 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -72.99 -41.94 63.79 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.137 0.494 . . . . 0.0 110.806 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 89.95 2.03 75.54 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.836 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -72.81 158.05 36.29 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -145.14 135.86 24.48 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.591 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -146.97 157.9 43.76 Favored 'General case' 0 N--CA 1.432 -1.336 0 O-C-N 123.715 0.634 . . . . 0.0 109.67 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 69.4 t -91.96 114.32 28.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 174.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.1 t -128.0 141.67 41.97 Favored Pre-proline 0 C--N 1.29 -2.017 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -175.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 43.5 Cg_endo -64.28 147.13 91.0 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.126 1.884 . . . . 0.0 111.192 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 48.0 mt -55.38 -26.07 39.12 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 123.494 0.717 . . . . 0.0 111.138 178.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.39 -19.47 65.41 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.18 178.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -95.78 -13.27 24.24 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-O 120.951 0.405 . . . . 0.0 111.357 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 83.5 mt -81.94 126.29 31.76 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.257 177.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -114.09 154.3 46.16 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.42 153.11 70.93 Favored 'Trans proline' 0 C--O 1.243 0.763 0 C-N-CA 121.616 1.544 . . . . 0.0 110.428 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.6 t -84.54 98.34 5.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -87.05 116.47 25.13 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.011 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -88.94 1.34 55.6 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.513 0.673 . . . . 0.0 110.621 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.281 -2.494 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 -177.662 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 1129 ' ' DA2 . . . . . 0.483 HC11 ' CD1' ' A' ' 108' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.31 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.3 t -68.86 -43.45 75.36 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 174.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.6 m -120.97 141.94 50.23 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 22.4 tm0? -113.33 123.43 33.35 Favored Pre-proline 0 N--CA 1.428 -1.571 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 176.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -49.99 133.26 34.24 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.277 2.651 . . . . 0.0 114.538 -175.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 t -83.79 -22.01 31.97 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.49 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -141.0 140.45 34.33 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 105.769 -1.938 . . . . 0.0 105.769 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.2 t -87.51 109.92 19.95 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-O 121.605 0.717 . . . . 0.0 109.425 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -112.06 152.21 28.47 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.469 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -131.19 160.95 33.32 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 175.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 99.0 t -66.0 139.31 21.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.771 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.8 32.82 48.63 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -110.49 159.18 17.74 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -95.26 131.19 41.59 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 17.9 p -144.65 173.94 11.39 Favored 'General case' 0 C--N 1.263 -3.181 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.8 mtp -117.28 130.55 56.62 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 173.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.04 149.97 40.76 Favored 'General case' 0 C--N 1.27 -2.883 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.9 t -87.41 113.54 24.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.429 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 12.7 t90 -63.46 120.45 11.69 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -179.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.7 t -67.06 -16.58 64.44 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.224 0.535 . . . . 0.0 110.946 -174.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.429 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 38.4 mt-10 -85.1 -42.29 14.93 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.468 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 13.9 t70 -110.31 -15.72 13.89 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.289 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.82 4.39 90.07 Favored Glycine 0 C--N 1.305 -1.17 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.374 176.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.468 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 28.1 mm-40 -94.68 161.26 14.26 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.913 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 7.9 p -92.65 136.08 33.54 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.311 0.577 . . . . 0.0 111.623 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -136.87 157.72 46.09 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 123.797 0.839 . . . . 0.0 109.441 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -75.34 132.98 41.33 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.47 158.09 43.92 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.896 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -120.6 134.08 55.31 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.819 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.409 ' HA ' HG23 ' A' ' 106' ' ' ILE . 70.9 mt -71.78 125.33 30.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 O-C-N 123.759 0.662 . . . . 0.0 112.733 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -98.43 -42.54 7.29 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.601 -1.182 . . . . 0.0 111.306 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -148.8 143.44 26.34 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -174.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.0 mt -121.81 138.46 52.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -123.05 92.6 3.74 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 171.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.49 -24.79 67.24 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -177.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -63.04 -45.32 92.8 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.537 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -95.2 -4.71 45.42 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.26 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.61 43.04 97.04 Favored Glycine 0 N--CA 1.438 -1.214 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 41.6 p -128.44 155.7 44.36 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 122.69 -0.3 . . . . 0.0 110.491 -177.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.39 144.52 36.26 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.058 0.456 . . . . 0.0 110.009 175.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.03 124.77 35.05 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.409 HG23 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -127.85 152.08 35.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.977 -175.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.3 m -116.23 120.47 39.07 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.988 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.48 ' CD2' HC22 ' A' 1129 ' ' DA2 . 96.9 m-85 -69.12 125.93 28.2 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.915 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.45 128.4 35.86 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.44 -1.255 . . . . 0.0 111.57 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.13 -46.65 2.87 Favored Glycine 0 N--CA 1.437 -1.27 0 C-N-CA 121.293 -0.48 . . . . 0.0 112.798 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -78.75 -33.94 46.11 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.621 0.248 . . . . 0.0 110.981 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 83.88 -0.92 89.34 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.548 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -71.6 150.19 44.92 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.51 132.08 28.78 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.714 -176.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -144.48 160.76 40.56 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.564 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.8 t -96.09 116.21 37.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.2 t -130.69 141.42 41.89 Favored Pre-proline 0 C--N 1.278 -2.533 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -176.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 40.0 Cg_endo -62.92 146.36 94.85 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 122.057 1.838 . . . . 0.0 110.889 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 56.3 mt -54.27 -26.49 29.33 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 123.966 0.906 . . . . 0.0 111.672 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.65 -23.84 66.89 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.289 0.566 . . . . 0.0 110.92 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -90.0 -13.72 35.49 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.994 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.2 mt -85.58 126.34 33.81 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.193 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -114.61 152.75 46.54 Favored Pre-proline 0 C--N 1.281 -2.402 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.9 151.31 50.6 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.48 1.453 . . . . 0.0 110.31 176.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.2 t -76.53 101.53 2.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.302 0.572 . . . . 0.0 110.333 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -74.73 103.99 5.21 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.887 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -98.64 6.85 46.74 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.99 -174.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.282 -2.424 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -178.429 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 1129 ' ' DA2 . . . . . 0.48 HC22 ' CD2' ' A' ' 108' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.052 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.5 t -78.97 86.42 4.84 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.3 t -164.71 141.6 6.16 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -117.65 114.48 37.82 Favored Pre-proline 0 C--N 1.298 -1.66 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.748 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -58.89 148.31 84.93 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 123.029 2.486 . . . . 0.0 112.44 177.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.7 t -109.95 -15.28 14.1 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.196 0.522 . . . . 0.0 110.682 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -141.66 141.65 33.38 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 -177.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.2 m -93.35 119.85 32.96 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 122.69 0.396 . . . . 0.0 110.378 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -121.54 152.23 39.43 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 123.028 0.531 . . . . 0.0 111.332 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -133.35 154.46 50.71 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.221 177.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.5 t -63.82 141.91 17.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 C-N-CA 123.914 0.886 . . . . 0.0 110.51 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.1 19.39 62.92 Favored Glycine 0 CA--C 1.499 -0.959 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.51 151.88 34.02 Favored 'General case' 0 CA--C 1.477 -1.858 0 CA-C-O 120.502 0.191 . . . . 0.0 110.754 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -90.97 142.03 28.21 Favored 'General case' 0 N--CA 1.399 -2.978 0 O-C-N 123.907 0.755 . . . . 0.0 110.25 176.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 21.0 p -148.99 176.59 10.31 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.207 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 47.5 mtp -116.67 131.23 57.0 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.91 149.05 42.24 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -176.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 88.9 t -85.87 118.77 33.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -67.03 120.58 13.89 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.3 m -57.63 -28.89 64.1 Favored 'General case' 0 C--N 1.288 -2.065 0 C-N-CA 123.205 0.602 . . . . 0.0 112.26 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -77.64 -41.98 36.46 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.953 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.449 ' OD1' ' HG2' ' A' ' 88' ' ' GLN . 9.0 t70 -113.49 -16.26 12.44 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.748 -175.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.83 3.18 90.61 Favored Glycine 0 C--N 1.31 -0.914 0 C-N-CA 120.27 -0.967 . . . . 0.0 113.021 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.449 ' HG2' ' OD1' ' A' ' 86' ' ' ASP . 30.0 mm-40 -94.01 160.85 14.53 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.619 -0.342 . . . . 0.0 110.08 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 11.1 p -90.43 136.8 32.83 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 120.991 0.424 . . . . 0.0 110.528 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -136.46 157.16 47.44 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -78.66 123.96 27.68 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.106 0.479 . . . . 0.0 110.012 -176.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.62 152.32 49.23 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.34 -176.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -108.41 134.25 51.46 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.165 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 63.6 mt -73.25 118.6 18.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.161 178.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -94.38 -38.72 10.83 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.442 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -153.81 150.4 28.41 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -176.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 68.4 mt -124.7 141.2 45.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -120.6 90.97 3.43 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -66.35 -21.71 66.25 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.427 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -60.09 -46.22 90.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.061 178.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -94.61 -15.61 23.89 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.393 0.616 . . . . 0.0 110.648 176.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.496 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 76.73 37.41 34.41 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -177.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 50.8 p -124.44 158.02 33.79 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.29 147.65 47.58 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.075 0.464 . . . . 0.0 110.501 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.66 121.8 37.76 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 176.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 2.9 pp -124.83 153.72 32.06 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.72 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.751 -174.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 95.1 m -121.45 121.29 37.21 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.464 ' CD2' HC22 ' A' 1129 ' ' DA2 . 99.7 m-85 -68.7 119.71 13.53 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.995 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.38 130.65 43.75 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 124.262 0.976 . . . . 0.0 110.284 -175.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.09 -51.26 1.29 Allowed Glycine 0 N--CA 1.429 -1.819 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.456 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -76.79 -43.62 36.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.762 0.315 . . . . 0.0 110.76 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.22 2.27 66.19 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.339 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -75.99 154.53 35.74 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.23 138.79 31.69 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -152.34 162.81 40.64 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 123.178 0.299 . . . . 0.0 110.642 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.2 t -97.82 120.37 47.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.3 t -133.96 141.02 38.13 Favored Pre-proline 0 C--N 1.284 -2.256 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -176.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.4 Cg_endo -64.21 146.97 91.2 Favored 'Trans proline' 0 N--CA 1.438 -1.765 0 C-N-CA 122.071 1.847 . . . . 0.0 111.436 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 45.2 mt -53.93 -26.41 25.27 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 123.864 0.865 . . . . 0.0 111.317 178.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 pp -68.09 -21.61 64.95 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.119 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -93.09 -17.88 23.28 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.064 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 85.9 mt -77.74 126.83 31.47 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 121.435 0.636 . . . . 0.0 109.856 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -114.4 155.47 45.79 Favored Pre-proline 0 C--N 1.291 -1.965 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.55 148.7 48.26 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 121.735 1.623 . . . . 0.0 111.356 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.9 t -76.9 96.88 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 CA-C-O 121.226 0.536 . . . . 0.0 110.376 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -92.92 116.03 28.67 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.294 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -107.03 13.31 27.64 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.669 0.747 . . . . 0.0 110.256 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.272 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.628 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 1129 ' ' DA2 . . . . . 0.464 HC22 ' CD2' ' A' ' 108' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.3 m . . . . . 0 N--CA 1.438 -1.072 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.403 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 98.0 m95 -113.54 151.48 31.53 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.136 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -129.25 159.74 35.15 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.99 133.38 30.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 123.078 0.551 . . . . 0.0 110.766 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.54 26.87 37.45 Favored Glycine 0 CA--C 1.499 -0.943 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.444 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.74 155.47 19.66 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -96.4 131.47 42.92 Favored 'General case' 0 C--N 1.274 -2.698 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.243 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.403 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 17.3 p -144.03 176.67 9.12 Favored 'General case' 0 C--N 1.263 -3.181 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.561 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 41.1 mtp -119.23 130.44 55.46 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 172.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.79 153.61 34.18 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -175.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.7 t -86.74 116.81 29.93 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.442 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -66.35 123.61 20.45 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.4 t -61.2 -23.36 65.54 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.219 0.533 . . . . 0.0 111.483 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -83.16 -42.63 17.09 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -106.71 -17.24 14.28 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.222 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.24 3.5 82.06 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 119.554 -1.307 . . . . 0.0 112.398 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -91.48 163.85 14.02 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 24.7 p -94.84 136.42 35.18 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.697 0.284 . . . . 0.0 110.7 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -136.71 157.56 46.47 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 123.535 0.734 . . . . 0.0 109.581 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -75.09 129.47 37.63 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -145.02 152.94 40.92 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.121 -177.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -112.53 134.96 53.79 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.346 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.476 ' HA ' HG22 ' A' ' 106' ' ' ILE . 73.9 mt -71.63 123.21 25.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 123.252 0.621 . . . . 0.0 111.491 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -98.66 -37.41 9.52 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.01 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -152.86 145.42 24.18 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 68.5 mt -121.68 140.06 46.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -121.73 97.13 5.35 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 172.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.08 -24.67 67.52 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -176.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -68.17 -45.78 72.53 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -87.32 -15.22 38.62 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.386 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.436 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 67.62 40.46 90.5 Favored Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -176.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.615 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 69.9 p -124.7 157.9 34.5 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -177.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.456 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -139.85 141.15 36.66 Favored 'General case' 0 C--N 1.29 -2.022 0 CA-C-O 121.308 0.575 . . . . 0.0 110.408 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.92 121.13 29.96 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.476 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.92 153.47 32.06 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.756 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.973 -174.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.2 m -120.44 120.46 35.98 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.725 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -69.56 117.74 11.54 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.581 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.26 133.07 49.83 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.948 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.9 -42.95 2.01 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.869 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -87.63 -43.45 11.95 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.305 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.77 3.59 62.31 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.218 -0.992 . . . . 0.0 112.127 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -77.57 152.7 33.85 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -141.24 143.49 34.16 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -151.55 159.12 44.26 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 123.962 0.788 . . . . 0.0 109.026 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.0 t -97.66 113.92 33.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -128.49 141.32 41.07 Favored Pre-proline 0 C--N 1.288 -2.098 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -174.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.615 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 40.6 Cg_endo -62.6 147.7 94.41 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.447 2.098 . . . . 0.0 111.229 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 45.8 mt -54.44 -26.11 28.96 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.608 0.763 . . . . 0.0 111.592 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.7 pp -64.53 -26.0 68.23 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.342 0.591 . . . . 0.0 110.399 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -89.62 -14.26 35.32 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.955 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.456 HD11 ' HB3' ' A' ' 104' ' ' ALA . 81.7 mt -85.31 125.83 33.24 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.988 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -115.39 151.39 45.9 Favored Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.48 153.43 70.21 Favored 'Trans proline' 0 C--O 1.243 0.742 0 C-N-CA 121.597 1.531 . . . . 0.0 110.913 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 C--N 1.314 -0.953 0 CA-C-O 121.721 0.772 . . . . 0.0 109.003 179.74 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.1 m . . . . . 0 N--CA 1.435 -1.223 0 CA-C-O 120.999 0.428 . . . . 0.0 110.009 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -118.91 151.58 37.87 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.665 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -131.4 153.93 49.17 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.79 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 141.61 17.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 C-N-CA 123.908 0.883 . . . . 0.0 110.746 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.23 28.49 55.84 Favored Glycine 0 CA--C 1.498 -0.972 0 N-CA-C 112.122 -0.391 . . . . 0.0 112.122 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.38 153.28 35.41 Favored 'General case' 0 CA--C 1.483 -1.614 0 CA-C-O 120.814 0.34 . . . . 0.0 110.887 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -90.75 139.12 31.03 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.172 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 17.2 p -148.65 179.52 7.76 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-N 113.719 -1.582 . . . . 0.0 107.327 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 58.4 mtp -120.37 131.18 54.72 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 173.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.95 149.75 41.62 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.8 t -85.35 116.48 28.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -64.19 120.66 12.54 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.7 t -62.37 -21.04 65.02 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 123.578 0.549 . . . . 0.0 111.292 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -84.87 -42.35 15.14 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -112.5 -15.51 13.05 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 119.336 -0.946 . . . . 0.0 111.916 -174.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.1 0.36 89.58 Favored Glycine 0 C--N 1.313 -0.719 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.924 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -93.22 159.86 15.09 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 120.559 -0.456 . . . . 0.0 109.825 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 23.3 p -92.76 137.07 32.68 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.167 0.508 . . . . 0.0 110.945 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -136.46 158.33 44.68 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 123.846 0.858 . . . . 0.0 109.36 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.28 127.99 34.42 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.66 153.65 48.58 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.126 0.488 . . . . 0.0 111.25 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -115.03 132.93 56.44 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.997 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.468 ' HA ' HG22 ' A' ' 106' ' ' ILE . 62.5 mt -73.03 123.78 28.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.928 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -99.9 -38.2 8.72 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.858 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -149.58 143.72 25.75 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -176.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.4 mt -123.24 140.42 46.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -120.43 92.7 3.83 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 173.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -65.94 -23.49 66.62 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.82 -46.71 88.38 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.042 0.537 . . . . 0.0 109.805 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -95.46 -11.65 27.2 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.087 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.438 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 72.32 39.55 57.1 Favored Glycine 0 C--N 1.312 -0.804 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -177.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 35.5 p -124.36 156.96 36.14 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 122.793 0.437 . . . . 0.0 110.217 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.69 148.61 41.05 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.399 0.619 . . . . 0.0 111.089 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -97.52 121.75 39.79 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.468 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.78 154.79 32.78 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.669 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.782 -174.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 91.3 m -120.76 120.3 35.23 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.448 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -67.71 121.58 16.25 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.186 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.24 130.72 46.67 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.552 -175.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.29 -49.94 2.99 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 121.131 -0.557 . . . . 0.0 111.868 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -72.63 -43.25 63.5 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 120.612 0.244 . . . . 0.0 111.235 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.84 8.57 65.07 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.27 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.424 ' O ' ' HA ' ' A' ' 107' ' ' THR . 3.9 m-20 -80.65 148.52 30.19 Favored 'General case' 0 CA--C 1.49 -1.364 0 O-C-N 122.352 -0.499 . . . . 0.0 110.222 178.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -137.64 133.32 34.19 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 -176.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -151.51 162.79 40.36 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.685 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.5 t -96.37 119.88 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.6 t -133.8 140.71 37.4 Favored Pre-proline 0 C--N 1.278 -2.503 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 42.6 Cg_endo -63.71 147.43 92.6 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 122.346 2.031 . . . . 0.0 110.941 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 49.8 mt -53.56 -27.12 24.43 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 123.677 0.791 . . . . 0.0 111.646 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.57 -23.41 66.2 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.249 0.619 . . . . 0.0 111.604 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.4 HD22 ' HD2' ' A' ' 118' ' ' PRO . 72.2 m-20 -91.64 -12.59 33.77 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 121.185 0.517 . . . . 0.0 110.803 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 81.4 mt -84.49 128.21 34.46 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.066 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -111.36 157.59 38.61 Favored Pre-proline 0 C--N 1.294 -1.844 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.76 156.89 63.96 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 121.63 1.554 . . . . 0.0 109.628 170.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 89.8 t . . . . . 0 C--N 1.306 -1.316 0 CA-C-O 121.507 0.67 . . . . 0.0 110.536 -179.961 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.3 p . . . . . 0 N--CA 1.437 -1.111 0 CA-C-O 121.078 0.466 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -109.88 151.99 26.35 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.313 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -124.89 151.0 45.93 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.1 t -64.48 133.78 29.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.54 31.94 26.1 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.139 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 11.0 t0 -113.14 165.02 12.78 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.716 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.412 ' HB3' HG21 ' A' ' 125' ' ' VAL . 6.3 mmpt? -96.72 130.7 43.91 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 176.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 23.6 p -144.93 176.64 9.32 Favored 'General case' 0 C--N 1.265 -3.091 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 38.7 mtp -117.6 130.48 56.41 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 173.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.54 149.82 41.82 Favored 'General case' 0 C--N 1.279 -2.49 0 O-C-N 123.435 0.46 . . . . 0.0 109.865 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.3 t -85.3 117.54 30.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.464 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.6 t90 -66.25 124.86 23.82 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.2 t -61.38 -26.51 67.89 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.15 0.5 . . . . 0.0 111.229 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.464 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 16.2 mm-40 -80.26 -40.06 27.72 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -175.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.433 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 11.6 t70 -115.61 -15.46 11.4 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.77 -177.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.85 6.88 89.14 Favored Glycine 0 C--N 1.307 -1.074 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.142 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.433 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 27.0 mm-40 -95.82 161.29 14.07 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.137 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 25.1 p -90.8 136.77 32.85 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.46 0.648 . . . . 0.0 110.84 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -136.35 158.02 45.42 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.944 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -74.63 131.29 40.8 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.93 153.55 44.44 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.376 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 77' ' ' ASP . 38.3 tt0 -114.04 132.11 56.12 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.578 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.524 ' HA ' HG22 ' A' ' 106' ' ' ILE . 66.3 mt -73.44 125.08 31.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 122.977 0.511 . . . . 0.0 112.37 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -97.87 -40.39 8.53 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.37 1.068 . . . . 0.0 111.201 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -149.28 148.84 30.03 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.3 mt -121.5 131.6 72.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -114.99 90.87 3.44 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -66.5 -20.4 66.03 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.2 -46.26 74.4 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.143 0.497 . . . . 0.0 109.882 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -92.38 -6.3 50.37 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.798 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.85 38.74 94.6 Favored Glycine 0 C--O 1.241 0.55 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 67.4 p -130.29 155.57 46.09 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.45 149.56 48.29 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-O 120.914 0.387 . . . . 0.0 110.509 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.65 124.12 38.49 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.524 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -127.73 155.56 39.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.196 -175.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 75.4 m -117.9 120.37 37.68 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -68.01 123.13 19.77 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.36 130.76 44.09 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.839 -175.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.89 -59.32 0.76 Allowed Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -69.57 -42.59 74.32 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.101 0.477 . . . . 0.0 110.543 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.31 16.26 62.85 Favored Glycine 0 N--CA 1.434 -1.442 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.919 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -86.76 154.61 20.81 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -142.19 136.24 29.73 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 123.099 0.249 . . . . 0.0 110.673 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.03 159.67 43.65 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.2 t -93.71 121.85 44.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 176.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.9 t -134.67 141.49 38.95 Favored Pre-proline 0 C--N 1.287 -2.136 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -176.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 36.9 Cg_endo -61.74 146.23 96.81 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 122.627 2.218 . . . . 0.0 111.415 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 48.4 mt -54.75 -26.08 31.91 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 123.702 0.801 . . . . 0.0 111.858 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.17 -27.98 69.08 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.116 0.484 . . . . 0.0 110.771 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -85.55 -15.06 43.93 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.564 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.1 mt -85.85 125.78 33.56 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -114.97 151.91 46.01 Favored Pre-proline 0 C--N 1.282 -2.355 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -71.0 146.96 53.87 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 121.5 1.467 . . . . 0.0 110.727 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 78' ' ' LYS . 59.1 t . . . . . 0 C--N 1.312 -1.048 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.0 m . . . . . 0 N--CA 1.436 -1.175 0 CA-C-O 121.252 0.549 . . . . 0.0 110.442 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.418 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 93.2 m95 -111.6 151.53 28.67 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.592 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -131.66 159.18 39.07 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.4 t -65.42 135.89 27.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.03 40.88 13.1 Favored Glycine 0 N--CA 1.431 -1.637 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.404 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.41 152.7 41.31 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -95.04 131.21 41.27 Favored 'General case' 0 N--CA 1.402 -2.836 0 O-C-N 123.892 0.745 . . . . 0.0 109.744 174.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.418 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 18.7 p -141.43 177.48 8.09 Favored 'General case' 0 C--N 1.261 -3.257 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 51.5 mtp -118.05 130.75 56.35 Favored 'General case' 0 N--CA 1.4 -2.935 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 173.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.76 150.01 40.5 Favored 'General case' 0 C--N 1.267 -3.001 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -176.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.4 t -84.64 120.76 35.82 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -69.57 127.26 32.35 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.7 m -59.3 -29.07 67.34 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -84.12 -42.01 16.5 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -175.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -105.8 -15.75 14.85 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.702 0.763 . . . . 0.0 110.516 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.29 13.29 73.46 Favored Glycine 0 C--N 1.312 -0.765 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.239 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -102.65 163.86 11.98 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 20.5 p -90.19 136.27 33.15 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.898 0.38 . . . . 0.0 110.604 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -134.38 158.26 44.3 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 124.199 1.0 . . . . 0.0 109.282 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -74.86 125.3 28.52 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -136.95 149.63 47.68 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.159 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -110.91 132.17 54.43 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.892 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.51 ' HA ' HG22 ' A' ' 106' ' ' ILE . 68.1 mt -72.51 123.43 27.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.124 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -98.02 -40.07 8.63 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.914 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -152.39 142.51 22.3 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -175.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 69.9 mt -119.21 131.99 70.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -123.92 90.55 3.29 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.17 -20.31 65.71 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.106 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -56.32 -42.86 78.33 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 123.991 0.807 . . . . 0.0 110.227 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -101.81 -1.55 32.04 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.201 0.524 . . . . 0.0 110.215 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.63 39.29 95.34 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.597 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 37.0 p -128.28 155.69 44.19 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 122.382 0.273 . . . . 0.0 110.427 -175.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.93 147.19 46.24 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.77 122.04 34.76 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.51 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -126.01 153.35 34.09 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.497 -175.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.5 m -120.14 120.41 36.11 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -67.8 118.3 10.85 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.32 130.66 41.94 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 114.623 -1.172 . . . . 0.0 110.489 -174.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.02 -41.86 2.09 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -87.37 -43.21 12.29 Favored 'General case' 0 C--N 1.313 -1.006 0 O-C-N 122.515 -0.403 . . . . 0.0 110.955 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.41 1.48 68.95 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.623 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -76.06 148.09 38.2 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -135.32 140.84 45.41 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -152.01 158.16 42.7 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.8 t -93.66 115.46 32.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 175.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.2 t -129.49 141.21 41.04 Favored Pre-proline 0 C--N 1.281 -2.387 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -175.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.5 Cg_endo -61.5 145.03 98.27 Favored 'Trans proline' 0 N--CA 1.437 -1.833 0 C-N-CA 122.165 1.91 . . . . 0.0 110.671 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 55.2 mt -53.94 -26.15 24.07 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 123.887 0.875 . . . . 0.0 111.472 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 pp -64.37 -25.48 68.05 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.093 0.473 . . . . 0.0 110.855 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.425 HD22 ' HD2' ' A' ' 118' ' ' PRO . 73.5 m-20 -88.31 -12.84 42.34 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.86 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 81.3 mt -86.7 125.88 34.18 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.153 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -114.91 155.76 46.0 Favored Pre-proline 0 C--N 1.288 -2.089 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.62 157.22 59.34 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 121.526 1.484 . . . . 0.0 110.46 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 C--N 1.312 -1.045 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.332 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.9 t . . . . . 0 N--CA 1.427 -1.579 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.413 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 95.2 m95 -110.06 151.52 27.1 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.637 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -129.09 159.01 37.34 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.11 134.35 29.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 C-N-CA 123.385 0.674 . . . . 0.0 110.741 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.1 35.97 25.87 Favored Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -117.36 154.53 31.13 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -93.92 132.42 38.39 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-O 121.68 0.752 . . . . 0.0 110.355 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.413 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 19.4 p -142.89 178.88 7.36 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.1 -178.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 33.5 mtp -118.99 130.54 55.74 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.13 149.96 43.87 Favored 'General case' 0 C--N 1.28 -2.455 0 O-C-N 123.517 0.51 . . . . 0.0 109.964 -175.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.0 t -85.3 119.07 33.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -67.16 123.49 20.42 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.2 m -60.31 -28.23 67.95 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.607 0.718 . . . . 0.0 112.087 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -79.59 -41.87 26.21 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.628 -174.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -112.73 -15.74 12.91 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.804 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.39 3.92 89.95 Favored Glycine 0 C--N 1.313 -0.715 0 C-N-CA 120.03 -1.081 . . . . 0.0 113.561 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.451 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 33.0 mm-40 -90.14 161.22 15.87 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 122.362 -0.493 . . . . 0.0 109.701 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 71.2 m -95.14 135.54 36.58 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 88' ' ' GLN . 97.7 m-85 -135.96 158.03 45.4 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.067 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -75.34 131.31 40.18 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.81 152.52 43.79 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.583 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -111.45 134.34 53.1 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.526 ' HA ' HG22 ' A' ' 106' ' ' ILE . 70.0 mt -72.15 125.07 30.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 C-N-CA 123.432 0.693 . . . . 0.0 111.659 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -96.28 -41.73 8.51 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.085 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -150.78 152.03 33.21 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 72.2 mt -124.77 136.04 62.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -112.67 91.61 3.72 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 174.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -65.64 -25.61 67.43 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.729 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -64.6 -44.11 91.67 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.936 -176.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -98.22 -5.53 33.11 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.97 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.422 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 68.19 40.94 87.68 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -175.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 40.3 p -125.41 155.93 39.62 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 122.641 -0.329 . . . . 0.0 110.143 -177.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -141.74 145.73 35.17 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.122 0.487 . . . . 0.0 111.105 176.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.99 125.03 35.67 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.526 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -128.12 154.59 38.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.546 -175.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 92.1 m -120.08 120.24 35.68 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.782 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -66.88 123.13 19.32 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 123.242 0.617 . . . . 0.0 110.38 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.75 137.9 55.81 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.275 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.28 -49.71 3.26 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.879 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -81.95 -35.48 29.01 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 120.758 0.313 . . . . 0.0 110.902 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 82.04 9.74 84.84 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.488 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -81.42 152.68 27.3 Favored 'General case' 0 CA--C 1.49 -1.332 0 O-C-N 122.634 -0.333 . . . . 0.0 110.109 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.09 138.79 40.74 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 120.645 0.26 . . . . 0.0 110.991 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -151.85 161.06 43.26 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.872 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.2 t -98.27 122.04 49.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.0 t -135.8 141.6 37.49 Favored Pre-proline 0 C--N 1.282 -2.348 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -174.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 36.8 Cg_endo -62.54 147.11 95.31 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 122.425 2.083 . . . . 0.0 111.207 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 55.6 mt -55.65 -26.05 42.49 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 123.668 0.787 . . . . 0.0 111.788 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 pp -63.92 -28.89 70.14 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.637 0.732 . . . . 0.0 110.511 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -85.13 -17.62 36.71 Favored 'General case' 0 CA--C 1.484 -1.58 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.661 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 81.1 mt -82.98 125.79 31.8 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-O 121.64 0.733 . . . . 0.0 109.355 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -114.45 154.81 46.49 Favored Pre-proline 0 C--N 1.275 -2.658 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.214 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.38 155.38 70.65 Favored 'Trans proline' 0 C--O 1.255 1.367 0 C-N-CA 121.506 1.47 . . . . 0.0 110.003 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.3 t . . . . . 0 N--CA 1.43 -1.458 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.383 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.43 -1.448 0 CA-C-O 120.87 0.367 . . . . 0.0 110.476 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -115.81 151.95 34.25 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.219 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.409 ' HG2' ' OD2' ' A' ' 77' ' ' ASP . 21.6 pttm -127.79 162.65 26.13 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 173.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.49 135.57 27.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 122.943 0.497 . . . . 0.0 110.419 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.56 18.46 48.51 Favored Glycine 0 C--O 1.239 0.449 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.323 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.409 ' OD2' ' HG2' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -108.01 151.18 26.17 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -91.41 140.82 29.4 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-O 121.604 0.716 . . . . 0.0 109.844 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.42 ' SG ' HD22 ' A' ' 122' ' ' LEU . 16.5 p -146.8 173.01 12.77 Favored 'General case' 0 C--N 1.261 -3.248 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.3 mtp -114.12 130.22 56.59 Favored 'General case' 0 C--N 1.274 -2.695 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -121.19 150.67 40.96 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.38 -175.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.1 t -85.31 117.22 30.0 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.434 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.3 t90 -64.76 123.08 18.44 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.4 m -61.19 -22.8 65.08 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.434 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 28.0 mm-40 -83.28 -42.04 17.62 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -116.21 -15.47 11.05 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 118.849 -1.14 . . . . 0.0 112.124 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.09 6.37 89.2 Favored Glycine 0 C--N 1.315 -0.612 0 C-N-CA 120.394 -0.908 . . . . 0.0 114.098 176.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.453 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 28.3 mm-40 -91.28 161.81 14.88 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 59.4 m -91.33 135.64 33.67 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.453 ' CE1' ' HB2' ' A' ' 88' ' ' GLN . 96.4 m-85 -136.71 157.63 46.31 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.202 0.601 . . . . 0.0 109.481 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -76.43 123.8 26.56 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.43 151.89 49.0 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.845 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -108.54 135.94 48.97 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.576 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.493 ' HA ' HG22 ' A' ' 106' ' ' ILE . 67.4 mt -73.46 118.51 18.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.819 177.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -94.71 -36.49 11.71 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.044 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -152.82 151.09 30.04 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.496 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 68.4 mt -127.15 141.43 46.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -120.77 98.3 5.95 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 173.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -65.75 -25.01 67.08 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -63.08 -46.54 86.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.931 0.396 . . . . 0.0 110.957 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -93.82 -13.6 27.1 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.408 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.506 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 68.87 40.8 84.46 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -175.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.596 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 40.6 p -122.93 155.59 36.42 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.02 145.0 43.55 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.216 0.531 . . . . 0.0 111.108 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.9 121.58 33.63 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.493 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.4 152.84 30.55 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.818 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.9 m -122.65 120.41 33.63 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.548 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -66.7 118.77 10.72 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.871 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.48 134.53 55.78 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.967 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.43 -54.61 2.41 Favored Glycine 0 N--CA 1.424 -2.136 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.554 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -74.77 -43.47 54.68 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.072 0.463 . . . . 0.0 111.059 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.79 4.81 69.26 Favored Glycine 0 N--CA 1.433 -1.525 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.142 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -76.98 151.27 35.73 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -138.44 140.19 39.18 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -177.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -151.75 161.53 42.51 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.8 t -98.71 120.57 48.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.5 t -135.06 141.14 37.08 Favored Pre-proline 0 C--N 1.289 -2.053 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -176.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.596 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.3 Cg_endo -62.51 147.88 94.16 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 122.552 2.168 . . . . 0.0 111.698 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 50.0 mt -55.51 -26.32 42.2 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 123.834 0.854 . . . . 0.0 111.515 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.2 -26.78 68.29 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.968 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.426 HD22 ' HD2' ' A' ' 118' ' ' PRO . 75.4 m-20 -87.91 -17.42 31.41 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.784 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.42 HD22 ' SG ' ' A' ' 79' ' ' CYS . 83.8 mt -81.8 125.87 31.18 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.483 0.659 . . . . 0.0 109.276 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -114.75 151.19 45.14 Favored Pre-proline 0 C--N 1.284 -2.255 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.83 147.53 69.01 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.966 1.778 . . . . 0.0 111.378 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.5 t . . . . . 0 CA--C 1.498 -1.044 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.745 179.784 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.0 m . . . . . 0 N--CA 1.434 -1.227 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.401 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 91.9 m95 -107.72 150.81 26.5 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.199 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -129.9 151.88 49.98 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.4 t -64.4 134.93 28.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.49 30.85 23.44 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.364 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -120.87 157.65 29.36 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -91.81 141.94 28.11 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.285 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.42 ' SG ' HD22 ' A' ' 122' ' ' LEU . 22.5 p -148.26 177.37 9.47 Favored 'General case' 0 C--N 1.265 -3.089 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 36.6 mtp -118.51 130.66 56.05 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 173.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -120.23 150.17 41.1 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -176.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.1 t -86.0 113.91 24.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -64.46 122.64 17.22 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.5 t -65.23 -19.99 66.22 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 120.778 0.323 . . . . 0.0 111.285 -175.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -84.98 -42.65 14.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.497 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 9.2 t70 -108.33 -15.63 14.43 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.086 -175.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.72 2.27 89.84 Favored Glycine 0 C--N 1.316 -0.558 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.512 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.497 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 24.2 mm-40 -95.14 163.28 13.36 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 17.5 p -93.23 136.42 33.51 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.135 0.493 . . . . 0.0 110.74 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -134.07 158.68 42.96 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 124.145 0.978 . . . . 0.0 109.426 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -75.26 128.41 35.37 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.94 151.82 42.94 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.84 0.352 . . . . 0.0 110.905 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -113.75 135.29 54.11 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.433 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.521 ' HA ' HG22 ' A' ' 106' ' ' ILE . 64.3 mt -72.87 122.03 24.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.473 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -99.29 -33.5 10.7 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.462 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -153.66 150.78 28.95 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 77.1 mt -126.53 133.7 68.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -118.27 94.18 4.4 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.74 -20.69 66.01 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -61.4 -46.81 88.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -97.49 -13.88 21.45 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.047 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.485 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.05 36.59 51.29 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -177.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 43.9 p -124.52 155.35 39.14 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -176.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.36 147.88 50.6 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-O 121.011 0.434 . . . . 0.0 110.392 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.48 120.15 34.28 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.521 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.76 149.9 29.43 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.989 -174.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 94.0 m -118.02 120.56 38.17 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.078 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -68.48 125.4 26.36 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.576 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.09 136.95 57.72 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.407 -176.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 86.28 -46.83 3.66 Favored Glycine 0 C--N 1.311 -0.813 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.567 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -79.87 -43.01 23.05 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.155 0.502 . . . . 0.0 110.739 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 88.34 1.33 81.46 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.878 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -70.44 148.71 48.02 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -136.64 133.96 36.81 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -146.86 156.32 43.01 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.0 t -91.1 122.05 42.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.7 t -135.84 141.19 35.86 Favored Pre-proline 0 C--N 1.283 -2.303 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 40.8 Cg_endo -62.38 146.6 95.67 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.423 2.082 . . . . 0.0 110.923 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 55.4 mt -54.66 -26.48 33.57 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 123.504 0.722 . . . . 0.0 111.497 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 pp -63.37 -27.87 69.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.897 0.38 . . . . 0.0 110.703 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -87.39 -14.71 39.89 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.518 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.42 HD22 ' SG ' ' A' ' 79' ' ' CYS . 82.1 mt -84.27 126.28 33.03 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.198 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -114.34 151.54 45.19 Favored Pre-proline 0 C--N 1.285 -2.218 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.78 150.98 68.83 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.747 1.631 . . . . 0.0 111.607 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 64.0 t . . . . . 0 C--N 1.3 -1.574 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.723 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.1 m . . . . . 0 N--CA 1.441 -0.885 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -111.25 151.88 27.79 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 122.754 0.421 . . . . 0.0 111.692 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.412 ' NZ ' ' HB2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -129.1 152.16 49.0 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 175.386 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.4 t -63.98 139.84 20.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 123.325 0.65 . . . . 0.0 110.188 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.19 35.34 34.33 Favored Glycine 0 CA--C 1.497 -1.079 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.2 153.74 38.42 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -91.86 135.34 34.0 Favored 'General case' 0 N--CA 1.412 -2.375 0 O-C-N 123.872 0.732 . . . . 0.0 110.801 175.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 20.5 p -145.99 179.51 7.42 Favored 'General case' 0 C--N 1.27 -2.871 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.412 ' HG3' ' HA ' ' A' ' 125' ' ' VAL . 56.5 mtp -119.97 130.69 54.88 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 173.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.25 151.49 39.09 Favored 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.034 -174.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 88.6 t -85.28 115.8 27.57 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.3 t90 -64.15 121.39 14.1 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.1 t -63.19 -19.84 64.87 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 123.438 0.461 . . . . 0.0 111.431 -175.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -84.73 -43.2 14.5 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.982 -0.687 . . . . 0.0 112.417 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.421 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 11.2 t70 -111.87 -16.41 13.15 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.765 -174.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.59 6.0 89.48 Favored Glycine 0 C--N 1.308 -0.99 0 C-N-CA 119.798 -1.191 . . . . 0.0 113.855 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.421 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 28.9 mm-40 -93.78 163.07 13.67 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 13.0 p -92.12 136.59 33.06 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 120.544 0.212 . . . . 0.0 110.77 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -137.69 157.96 45.37 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 124.052 0.941 . . . . 0.0 109.449 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -75.2 127.29 32.86 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -139.93 153.07 46.85 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.072 0.463 . . . . 0.0 110.964 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -113.01 134.59 54.44 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.45 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.532 ' HA ' HG22 ' A' ' 106' ' ' ILE . 67.4 mt -73.29 123.01 27.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 123.314 0.646 . . . . 0.0 112.2 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -95.13 -43.06 8.28 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.952 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -148.11 149.98 33.02 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.8 mt -129.17 138.33 54.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 O-C-N 123.382 0.426 . . . . 0.0 109.873 177.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -122.96 94.86 4.4 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 174.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.87 -25.95 66.65 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -177.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -61.28 -46.48 90.17 Favored 'General case' 0 C--O 1.221 -0.443 0 O-C-N 123.433 0.458 . . . . 0.0 109.938 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -93.94 -12.6 28.43 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.29 0.567 . . . . 0.0 110.393 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.18 42.02 51.91 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 60.4 p -126.88 157.45 39.33 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 -177.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.44 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -141.56 144.61 34.36 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.887 175.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.27 125.06 36.78 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.532 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -126.81 154.35 36.69 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.629 0 O-C-N 123.41 0.444 . . . . 0.0 110.659 -175.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.4 m -121.26 120.57 35.54 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.769 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -66.78 120.76 14.08 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 123.735 0.814 . . . . 0.0 110.738 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.62 123.81 21.9 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.765 -175.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.93 -34.14 6.02 Favored Glycine 0 N--CA 1.425 -2.059 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.009 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -96.23 -40.45 9.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.815 0.341 . . . . 0.0 111.432 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.06 6.02 65.42 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.256 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -81.28 151.1 28.24 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -140.03 139.15 35.9 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.397 -176.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -147.35 160.55 42.4 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 123.716 0.635 . . . . 0.0 109.471 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.7 t -97.48 114.7 35.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 174.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.5 t -130.14 141.52 42.18 Favored Pre-proline 0 C--N 1.28 -2.455 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -175.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 38.3 Cg_endo -62.97 146.9 95.0 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.04 1.827 . . . . 0.0 111.164 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 60.7 mt -53.0 -26.65 16.01 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.019 0.928 . . . . 0.0 111.918 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 pp -66.28 -24.48 66.57 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.066 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -91.42 -9.82 43.27 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 121.331 0.586 . . . . 0.0 110.561 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.44 HD11 ' HB3' ' A' ' 104' ' ' ALA . 80.1 mt -88.71 127.29 35.59 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.991 175.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -113.86 156.53 43.68 Favored Pre-proline 0 C--N 1.282 -2.345 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -65.56 160.38 43.41 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.086 1.858 . . . . 0.0 109.135 172.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.412 ' HA ' ' HG3' ' A' ' 80' ' ' MET . 89.2 t . . . . . 0 C--N 1.304 -1.384 0 CA-C-O 122.153 0.978 . . . . 0.0 109.918 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.438 -1.027 0 CA-C-O 121.087 0.47 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.424 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 91.4 m95 -115.92 151.19 35.84 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.584 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -126.59 152.75 46.21 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.6 t -64.12 131.24 29.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.84 32.23 18.71 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.381 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 2.9 t70 -113.55 158.69 20.45 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -97.53 131.58 44.01 Favored 'General case' 0 N--CA 1.409 -2.486 0 CA-C-O 121.913 0.863 . . . . 0.0 110.862 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.424 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 17.4 p -144.04 179.62 7.08 Favored 'General case' 0 C--N 1.265 -3.074 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.197 -178.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.428 ' HG3' ' HA ' ' A' ' 125' ' ' VAL . 40.0 mtp -118.37 130.27 55.9 Favored 'General case' 0 N--CA 1.41 -2.449 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 172.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.94 149.98 41.24 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -176.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.5 t -85.36 116.18 28.25 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.052 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.492 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.7 t90 -64.31 121.6 14.7 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.7 t -65.08 -18.76 65.57 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 120.926 0.393 . . . . 0.0 111.339 -176.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.492 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 43.6 mt-10 -83.75 -41.84 17.19 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -176.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.53 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 15.9 t70 -114.79 -16.57 11.75 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 118.897 -1.121 . . . . 0.0 111.812 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.26 -0.89 86.0 Favored Glycine 0 C--N 1.3 -1.423 0 C-N-CA 119.832 -1.175 . . . . 0.0 113.47 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.53 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 28.0 mm-40 -85.89 159.13 19.76 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.077 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 8.9 p -93.01 136.2 33.48 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.44 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 88' ' ' GLN . 97.5 m-85 -137.39 158.81 43.6 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 124.36 1.064 . . . . 0.0 108.957 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -74.68 127.11 32.32 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.42 150.35 47.57 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.854 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 77' ' ' ASP . 42.9 tt0 -111.37 132.29 54.54 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.712 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.528 ' HA ' HG22 ' A' ' 106' ' ' ILE . 69.8 mt -71.99 124.39 28.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.079 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -96.14 -39.85 9.5 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.241 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -152.68 152.18 31.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -177.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 71.1 mt -125.55 140.48 48.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -123.87 91.35 3.45 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.92 -22.92 66.53 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -175.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -71.5 -34.59 70.25 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.848 -178.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -98.51 -10.13 23.98 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.727 174.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.432 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 67.55 38.79 90.81 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -178.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 65.0 p -128.61 155.86 44.3 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -175.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.406 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -137.62 148.5 45.86 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 121.161 0.505 . . . . 0.0 110.566 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.68 122.02 38.01 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.528 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.94 154.83 33.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.317 -174.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 94.6 m -118.76 121.07 39.22 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -66.79 118.35 10.19 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.69 117.1 8.37 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.253 -173.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 110.39 -45.92 1.25 Allowed Glycine 0 N--CA 1.423 -2.193 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.847 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -81.83 -36.58 28.18 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.218 0.532 . . . . 0.0 110.975 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.81 2.58 86.45 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 120.081 -1.056 . . . . 0.0 112.01 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -73.52 147.8 43.68 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.31 129.39 25.15 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.473 -176.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -145.91 155.98 43.23 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.8 t -92.04 120.86 41.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.4 t -135.02 140.76 35.9 Favored Pre-proline 0 C--N 1.284 -2.256 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.0 Cg_endo -62.84 148.45 93.42 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.42 2.08 . . . . 0.0 111.463 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 56.2 mt -55.69 -26.34 44.5 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 123.883 0.873 . . . . 0.0 111.839 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.6 -25.43 67.39 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.085 0.554 . . . . 0.0 110.957 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.413 HD22 ' HD2' ' A' ' 118' ' ' PRO . 73.9 m-20 -89.61 -13.31 37.43 Favored 'General case' 0 CA--C 1.482 -1.638 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.448 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 104' ' ' ALA . 80.6 mt -86.34 127.23 34.77 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.517 176.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -113.67 154.55 45.68 Favored Pre-proline 0 C--N 1.274 -2.69 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.58 160.43 46.09 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.045 1.83 . . . . 0.0 108.284 172.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.428 ' HA ' ' HG3' ' A' ' 80' ' ' MET . 76.7 t . . . . . 0 C--N 1.298 -1.669 0 CA-C-O 122.438 1.113 . . . . 0.0 110.824 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.5 t . . . . . 0 N--CA 1.44 -0.932 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -113.05 152.21 29.78 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -122.53 150.24 42.84 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.652 0.381 . . . . 0.0 110.136 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.3 138.53 22.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.36 25.71 53.74 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.708 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 13.0 t0 -105.57 165.43 11.16 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.609 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -94.34 130.87 40.47 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 24.2 p -144.44 174.24 11.1 Favored 'General case' 0 C--N 1.258 -3.404 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.9 mtp -117.22 130.72 56.76 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.46 148.35 42.67 Favored 'General case' 0 C--N 1.264 -3.115 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -175.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 72.3 t -85.33 115.12 26.47 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -63.17 121.48 13.75 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.2 t -62.89 -20.07 64.8 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 122.813 0.445 . . . . 0.0 111.208 -175.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -82.11 -43.08 18.29 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.514 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 14.1 t70 -115.6 -16.13 11.34 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 118.657 -1.217 . . . . 0.0 112.276 -174.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.3 5.18 89.08 Favored Glycine 0 C--N 1.307 -1.053 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.273 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.514 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 29.4 mm-40 -90.7 162.96 14.69 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 176.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 5.5 p -95.99 136.02 36.99 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.516 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -137.88 158.03 45.19 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 124.007 0.923 . . . . 0.0 109.422 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -74.8 132.1 41.31 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.27 155.92 44.6 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.627 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 77' ' ' ASP . 36.5 tt0 -114.61 132.67 56.28 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.542 176.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.593 ' HA ' HG22 ' A' ' 106' ' ' ILE . 71.6 mt -71.48 123.37 25.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 O-C-N 123.67 0.606 . . . . 0.0 112.081 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -96.97 -42.55 7.86 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.09 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 105' ' ' ALA . 26.3 tt0 -144.35 145.03 31.73 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.459 -174.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 80.1 mt -121.74 126.1 74.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -111.51 94.85 5.17 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 175.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -65.4 -25.32 67.5 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.401 -174.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -70.75 -44.59 66.45 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.436 0.636 . . . . 0.0 109.967 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -91.24 -7.77 50.31 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.987 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.525 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 64.63 39.26 96.6 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 53.7 p -123.01 155.93 35.85 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.529 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -138.58 138.8 38.26 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-O 121.279 0.562 . . . . 0.0 110.208 176.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.576 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . . . -87.74 128.36 35.31 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 175.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.593 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -130.37 157.75 42.81 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.53 0 CA-C-O 120.669 0.271 . . . . 0.0 110.721 -175.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 65.2 m -121.68 120.6 35.18 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -67.89 120.67 14.57 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.334 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.67 140.89 58.52 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.179 -176.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.65 -53.92 3.75 Favored Glycine 0 N--CA 1.43 -1.72 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -75.36 -43.16 51.97 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.924 0.392 . . . . 0.0 111.155 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.74 18.28 61.97 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.021 -1.085 . . . . 0.0 111.442 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -87.61 156.12 19.64 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.95 143.52 32.0 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -151.78 162.19 41.42 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 105' ' ' ALA . 57.5 t -100.91 113.83 38.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 174.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.1 t -126.44 141.13 39.1 Favored Pre-proline 0 C--N 1.278 -2.534 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -174.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.567 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 33.2 Cg_endo -62.38 149.99 88.84 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.255 1.97 . . . . 0.0 111.728 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 51.7 mt -56.62 -25.7 53.81 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 123.37 0.668 . . . . 0.0 110.71 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.7 pp -65.0 -23.94 67.36 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.536 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -93.71 -14.87 25.84 Favored 'General case' 0 CA--C 1.49 -1.35 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.571 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.529 HD11 ' HB3' ' A' ' 104' ' ' ALA . 71.6 mt -83.17 126.67 32.87 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -114.61 150.62 44.24 Favored Pre-proline 0 C--N 1.285 -2.228 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -71.59 148.02 52.67 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.436 1.424 . . . . 0.0 110.187 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 C--N 1.306 -1.296 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.553 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.4 p . . . . . 0 N--CA 1.422 -1.862 0 CA-C-O 121.404 0.621 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.489 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 94.2 m95 -99.28 150.89 21.64 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.392 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -134.58 161.59 34.66 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 120.639 -0.425 . . . . 0.0 110.009 176.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.0 t -65.09 131.95 30.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 123.583 0.753 . . . . 0.0 110.008 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.21 38.02 10.53 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.228 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.75 153.32 41.1 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -92.27 133.87 35.42 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-O 121.65 0.738 . . . . 0.0 110.433 174.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.489 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 23.7 p -145.68 179.4 7.46 Favored 'General case' 0 C--N 1.267 -3.004 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.502 ' HG3' ' HA ' ' A' ' 125' ' ' VAL . 61.1 mtp -118.08 131.4 56.44 Favored 'General case' 0 N--CA 1.404 -2.772 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 172.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.26 148.89 41.97 Favored 'General case' 0 C--N 1.264 -3.11 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -175.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.9 t -84.63 113.67 23.67 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.482 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 13.5 t90 -63.29 122.67 16.76 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -177.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.1 t -63.5 -19.66 64.95 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 123.535 0.522 . . . . 0.0 111.583 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.482 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 21.9 mm-40 -84.73 -42.48 15.21 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -111.31 -15.62 13.57 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 118.62 -1.232 . . . . 0.0 111.791 -175.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.29 8.77 87.28 Favored Glycine 0 C--N 1.311 -0.81 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.16 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -101.69 162.31 13.0 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 26.5 p -92.48 136.4 33.24 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.415 0.626 . . . . 0.0 111.828 -178.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -135.8 158.4 44.5 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 124.284 1.033 . . . . 0.0 109.195 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -74.72 126.74 31.53 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -177.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.0 150.48 47.02 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.801 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -109.62 132.5 54.08 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.638 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.551 ' HA ' HG22 ' A' ' 106' ' ' ILE . 60.3 mt -72.52 123.2 26.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 123.165 0.586 . . . . 0.0 111.459 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -96.21 -40.3 9.25 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.982 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -154.71 152.64 30.16 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 57.1 mt -129.56 138.44 54.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.867 0.365 . . . . 0.0 110.076 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -122.34 91.29 3.47 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 173.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -66.9 -19.56 65.75 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -64.63 -46.31 83.12 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.556 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -90.45 -16.22 29.38 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.586 0.708 . . . . 0.0 109.834 176.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.85 37.91 37.76 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 61.4 p -123.92 155.42 38.17 Favored 'General case' 0 N--CA 1.413 -2.3 0 O-C-N 122.601 -0.352 . . . . 0.0 110.201 -176.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.429 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -138.31 140.53 39.59 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-O 121.178 0.514 . . . . 0.0 109.874 176.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.33 121.9 32.04 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 107.13 -1.434 . . . . 0.0 107.13 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.551 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -126.74 154.83 37.04 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.512 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.99 -175.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 97.6 m -121.86 120.75 35.43 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.521 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -66.86 119.09 11.29 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.554 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.44 130.28 40.31 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.841 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.49 -39.68 2.71 Favored Glycine 0 N--CA 1.427 -1.96 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -96.56 -39.97 9.27 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.244 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.31 -2.68 71.46 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.933 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -71.62 152.0 43.27 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-N 115.687 -0.256 . . . . 0.0 110.356 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -139.68 141.28 36.98 Favored 'General case' 0 C--N 1.285 -2.229 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.568 -176.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -151.25 159.18 44.5 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.4 t -98.35 113.52 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 175.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.8 t -125.13 141.41 38.47 Favored Pre-proline 0 C--N 1.274 -2.675 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 46.0 Cg_endo -63.7 146.94 92.76 Favored 'Trans proline' 0 N--CA 1.443 -1.455 0 C-N-CA 121.777 1.651 . . . . 0.0 110.763 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 42.3 mt -55.51 -26.27 41.94 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 123.537 0.735 . . . . 0.0 110.828 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 pp -63.86 -23.24 67.28 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.214 0.53 . . . . 0.0 110.849 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -93.54 -10.38 35.01 Favored 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.465 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.429 HD11 ' HB3' ' A' ' 104' ' ' ALA . 80.2 mt -84.44 127.43 34.01 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.856 0.836 . . . . 0.0 109.962 176.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -114.26 150.23 43.37 Favored Pre-proline 0 C--N 1.277 -2.574 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.135 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.82 153.79 70.47 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.597 1.531 . . . . 0.0 108.557 170.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.502 ' HA ' ' HG3' ' A' ' 80' ' ' MET . 45.1 t . . . . . 0 C--N 1.307 -1.261 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.246 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.435 -1.207 0 CA-C-O 121.451 0.643 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -105.69 152.11 23.57 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.647 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -127.14 158.9 35.84 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.911 175.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.7 t -65.14 138.0 23.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.863 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.35 38.64 28.53 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.55 154.14 37.08 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -95.22 135.44 36.8 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.97 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 18.7 p -147.17 176.86 9.63 Favored 'General case' 0 C--N 1.263 -3.173 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 34.2 mtp -115.67 130.53 56.89 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -119.74 151.67 38.41 Favored 'General case' 0 C--N 1.277 -2.553 0 O-C-N 123.44 0.462 . . . . 0.0 109.818 -175.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.4 t -85.19 114.27 25.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.504 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 12.4 t90 -67.03 125.52 26.25 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 58.6 m -57.75 -33.02 68.04 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.376 0.608 . . . . 0.0 111.844 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.402 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 30.4 mt-10 -79.07 -41.66 28.25 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -172.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.504 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 42.6 t0 -105.75 -16.3 14.71 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.681 0.753 . . . . 0.0 110.194 -176.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.88 8.13 77.08 Favored Glycine 0 C--N 1.316 -0.529 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.88 178.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -101.49 163.76 12.1 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 15.2 p -93.7 135.58 34.85 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.227 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -134.66 158.18 44.72 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 124.364 1.066 . . . . 0.0 109.185 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -75.26 125.64 29.38 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.26 0.552 . . . . 0.0 109.738 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.42 154.36 46.65 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.652 -177.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -112.09 133.87 53.98 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.286 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.522 ' HA ' HG22 ' A' ' 106' ' ' ILE . 70.7 mt -71.94 122.31 23.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 C-N-CA 123.528 0.731 . . . . 0.0 111.453 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -96.96 -40.54 8.83 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.284 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -151.02 146.97 26.57 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 72.5 mt -122.45 135.88 61.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -120.03 93.97 4.23 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 174.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.13 -19.87 65.97 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -63.87 -46.47 84.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -93.01 -15.39 26.24 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.136 0.493 . . . . 0.0 110.244 178.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.441 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.3 37.02 48.97 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -176.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 41.2 p -125.6 155.81 40.14 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.51 148.6 47.73 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-O 121.233 0.539 . . . . 0.0 110.28 177.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.07 124.79 39.3 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 176.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.522 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -126.75 154.7 36.93 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.693 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.644 -175.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 98.4 m -122.08 120.1 33.31 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -67.19 118.72 10.98 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 123.201 0.6 . . . . 0.0 110.494 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.78 129.41 39.69 Favored 'General case' 0 N--CA 1.436 -1.126 0 O-C-N 124.509 1.131 . . . . 0.0 110.883 -175.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.77 -44.99 1.76 Allowed Glycine 0 N--CA 1.425 -2.088 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.736 178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -82.47 -43.14 17.6 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 120.729 0.299 . . . . 0.0 111.11 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.25 10.42 60.91 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.642 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -85.02 156.92 20.9 Favored 'General case' 0 CA--C 1.488 -1.41 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.03 140.73 32.71 Favored 'General case' 0 C--N 1.29 -2.015 0 O-C-N 123.033 0.208 . . . . 0.0 110.789 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -151.75 158.9 43.98 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 123.371 0.419 . . . . 0.0 109.985 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.1 t -95.79 116.34 37.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.0 t -130.28 141.61 42.52 Favored Pre-proline 0 C--N 1.288 -2.099 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -174.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 42.1 Cg_endo -63.92 146.52 91.55 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.212 1.941 . . . . 0.0 111.108 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 61.6 mt -55.04 -26.15 35.38 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 123.906 0.882 . . . . 0.0 111.952 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.65 -27.05 68.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.057 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -88.9 -12.88 40.49 Favored 'General case' 0 CA--C 1.484 -1.584 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.803 -177.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 84.3 mt -82.64 126.15 32.01 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -114.11 148.43 40.02 Favored Pre-proline 0 C--N 1.28 -2.414 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.35 146.66 57.15 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 C-N-CA 121.31 1.34 . . . . 0.0 111.16 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 65.8 t . . . . . 0 N--CA 1.438 -1.045 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 173.466 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.425 -1.69 0 CA-C-O 120.933 0.397 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -114.25 150.89 33.68 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.34 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -131.01 157.18 43.69 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.464 177.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.76 141.61 17.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 C-N-CA 123.225 0.61 . . . . 0.0 111.05 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.73 31.23 40.94 Favored Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 121.444 -0.407 . . . . 0.0 112.139 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.13 150.16 42.58 Favored 'General case' 0 CA--C 1.481 -1.678 0 CA-C-O 120.533 0.206 . . . . 0.0 111.04 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -90.84 138.64 31.43 Favored 'General case' 0 N--CA 1.406 -2.669 0 CA-C-O 121.858 0.837 . . . . 0.0 110.507 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 18.6 p -147.42 176.39 10.06 Favored 'General case' 0 C--N 1.271 -2.813 0 CA-C-N 113.952 -1.476 . . . . 0.0 107.5 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 41.1 mtp -116.4 130.85 56.98 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 173.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.99 151.9 38.28 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.529 -175.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 72.2 t -88.01 117.55 31.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.406 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.7 t90 -66.5 126.04 27.63 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.3 m -60.08 -30.85 69.5 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 121.232 0.539 . . . . 0.0 112.383 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.406 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 46.6 mt-10 -80.15 -42.55 23.25 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -173.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.436 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 10.0 t70 -109.27 -14.08 14.53 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.136 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.95 3.65 89.41 Favored Glycine 0 C--N 1.305 -1.19 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.604 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.436 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 28.4 mm-40 -93.28 162.72 13.89 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 117.559 0.68 . . . . 0.0 110.255 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 25.0 p -89.94 136.63 32.92 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.23 0.538 . . . . 0.0 110.367 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -137.79 158.05 45.16 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 123.725 0.81 . . . . 0.0 108.955 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -75.21 128.98 36.7 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -142.35 150.12 40.31 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.304 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -110.41 134.56 52.21 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.53 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.455 ' HA ' HG22 ' A' ' 106' ' ' ILE . 66.0 mt -73.03 120.84 22.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.258 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -96.03 -39.07 9.93 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.425 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -151.39 147.79 27.32 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -176.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.7 mt -123.07 143.19 36.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -116.67 91.23 3.52 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 171.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -65.69 -20.29 66.23 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.984 -1.007 . . . . 0.0 113.091 -174.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -65.97 -46.65 77.34 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -91.92 -13.27 31.48 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.688 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.504 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 70.43 41.09 67.82 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -175.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 41.3 p -123.58 155.75 37.06 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.33 146.72 42.72 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.267 0.556 . . . . 0.0 111.134 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.89 122.05 37.12 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.455 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.7 152.12 30.61 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.218 -174.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 90.9 m -117.01 122.99 45.78 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.051 177.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -72.62 124.43 25.24 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.752 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.32 134.42 55.76 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.706 -1.133 . . . . 0.0 111.044 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.8 -48.25 3.26 Favored Glycine 0 N--CA 1.432 -1.591 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.249 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -78.51 -43.4 27.0 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.796 0.332 . . . . 0.0 111.003 -178.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 88.71 11.9 65.13 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.262 -0.97 . . . . 0.0 111.911 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 107' ' ' THR . 4.3 m-20 -81.58 155.98 25.42 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -141.06 138.75 33.83 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.44 162.79 40.32 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 123.358 0.411 . . . . 0.0 109.982 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.6 t -97.56 121.87 48.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.8 t -136.55 141.09 34.24 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -177.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.585 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.4 Cg_endo -63.02 147.46 94.45 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 122.432 2.088 . . . . 0.0 111.346 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 43.4 mt -54.24 -26.79 30.61 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 123.73 0.812 . . . . 0.0 111.501 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 pp -63.97 -27.26 69.01 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.953 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.44 HD22 ' HD2' ' A' ' 118' ' ' PRO . 67.2 m-20 -83.89 -27.27 28.75 Favored 'General case' 0 CA--C 1.487 -1.45 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.661 -178.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 81.5 mt -73.67 127.09 31.82 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.485 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.424 ' HA ' ' HE3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -112.76 153.96 44.95 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.127 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.96 151.79 56.72 Favored 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 121.607 1.538 . . . . 0.0 111.048 175.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.9 t . . . . . 0 C--N 1.309 -1.169 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 176.923 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.43 -1.432 0 CA-C-O 120.999 0.428 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -111.45 151.39 28.62 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.636 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -128.38 158.93 36.91 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 69.8 t -65.35 133.04 31.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 123.076 0.55 . . . . 0.0 110.066 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.85 31.4 23.83 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.786 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 1.3 t0 -115.32 164.06 14.8 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.836 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.424 ' HB3' HG21 ' A' ' 125' ' ' VAL . 6.4 mmpt? -94.46 131.9 39.67 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.403 ' SG ' HD22 ' A' ' 122' ' ' LEU . 21.0 p -147.0 172.74 13.25 Favored 'General case' 0 C--N 1.267 -3.016 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.1 mtp -117.08 129.91 56.3 Favored 'General case' 0 N--CA 1.411 -2.377 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.0 154.82 37.95 Favored 'General case' 0 C--N 1.273 -2.72 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.451 -173.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.0 t -87.51 122.15 38.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.437 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 10.8 t90 -71.44 122.17 19.91 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.9 m -61.34 -25.23 67.01 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.437 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 13.8 mm-40 -78.4 -42.11 31.14 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.783 -177.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.414 ' OD1' ' HG2' ' A' ' 88' ' ' GLN . 8.2 t70 -114.61 -15.52 11.97 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.271 -174.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.76 0.58 89.54 Favored Glycine 0 C--N 1.31 -0.881 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.688 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.414 ' HG2' ' OD1' ' A' ' 86' ' ' ASP . 27.1 mm-40 -90.97 164.67 13.9 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.189 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 22.0 p -90.37 136.18 33.21 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.787 0.327 . . . . 0.0 110.445 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -136.59 157.75 46.03 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 123.131 0.573 . . . . 0.0 109.777 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -75.41 130.97 39.84 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.52 154.55 43.74 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.746 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 77' ' ' ASP . 36.0 tt0 -112.6 132.24 55.24 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.847 177.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.52 ' HA ' HG22 ' A' ' 106' ' ' ILE . 74.5 mt -69.54 124.4 25.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 O-C-N 123.673 0.608 . . . . 0.0 111.639 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -99.07 -40.65 7.91 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.265 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.667 ' HB3' ' HB3' ' A' ' 105' ' ' ALA . 27.7 tt0 -143.3 143.35 31.66 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -173.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 79.1 mt -125.76 129.65 72.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 175.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -119.01 93.62 4.16 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 174.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -66.16 -20.0 66.01 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.457 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -61.13 -46.95 88.48 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.273 0.558 . . . . 0.0 110.232 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -99.39 -8.92 24.12 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.012 0.434 . . . . 0.0 110.716 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.423 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 71.17 41.5 59.86 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -177.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 75.5 p -123.07 157.33 33.04 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.509 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -139.43 140.26 37.3 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-O 121.167 0.508 . . . . 0.0 109.937 175.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.667 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . . . -89.67 124.55 34.7 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 175.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.52 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -125.1 156.03 33.9 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 CA-C-O 120.855 0.36 . . . . 0.0 110.884 -174.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 97.3 m -121.98 119.89 32.79 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.398 176.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -66.16 125.73 26.44 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.375 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.72 129.53 41.47 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.975 -174.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.28 -50.85 3.36 Favored Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 111.616 -0.593 . . . . 0.0 111.616 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -70.15 -41.69 73.52 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.078 0.466 . . . . 0.0 110.071 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.36 5.5 85.05 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.615 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 107' ' ' THR . 4.0 m-20 -77.17 150.38 35.52 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.56 138.86 36.61 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.806 -176.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -151.69 162.73 40.52 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.209 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.4 t -99.45 119.99 48.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.3 t -132.72 141.17 40.13 Favored Pre-proline 0 C--N 1.281 -2.374 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 30.4 Cg_endo -62.48 148.86 92.65 Favored 'Trans proline' 0 N--CA 1.441 -1.574 0 C-N-CA 122.217 1.944 . . . . 0.0 111.48 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 50.6 mt -54.93 -26.54 36.91 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.793 0.837 . . . . 0.0 111.168 178.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.9 pp -66.88 -24.2 66.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.957 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -89.96 -17.92 27.03 Favored 'General case' 0 CA--C 1.49 -1.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.416 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 104' ' ' ALA . 82.5 mt -82.2 125.37 30.84 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.314 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -115.81 153.97 48.12 Favored Pre-proline 0 C--N 1.281 -2.386 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.648 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.18 145.4 39.02 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 121.347 1.365 . . . . 0.0 110.535 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.424 HG21 ' HB3' ' A' ' 78' ' ' LYS . 48.4 t . . . . . 0 C--N 1.299 -1.592 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -178.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.427 -1.604 0 CA-C-O 121.427 0.632 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -112.85 151.12 30.78 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.711 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -133.37 160.69 36.62 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 175.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.9 t -64.87 133.46 30.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.528 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.12 30.89 21.57 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.779 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.03 152.17 35.21 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -92.12 132.4 36.63 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.91 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 18.0 p -142.53 174.72 10.38 Favored 'General case' 0 C--N 1.259 -3.327 0 CA-C-N 114.403 -1.271 . . . . 0.0 107.78 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 38.4 mtp -115.52 130.19 56.79 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 173.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -121.27 149.55 42.72 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.488 -176.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.8 t -85.04 116.5 28.63 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -63.74 120.64 12.24 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.9 t -63.65 -18.6 64.12 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 122.854 0.462 . . . . 0.0 111.298 -175.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -85.1 -42.51 14.72 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.439 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 11.0 t70 -115.91 -15.82 11.19 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 119.123 -1.031 . . . . 0.0 112.118 -173.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.32 -5.78 83.55 Favored Glycine 0 C--N 1.31 -0.861 0 C-N-CA 119.853 -1.165 . . . . 0.0 114.293 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.476 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 25.8 mm-40 -83.61 158.4 21.91 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 22.2 p -90.37 136.04 33.31 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.936 0.398 . . . . 0.0 109.977 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.476 ' CE2' ' HB2' ' A' ' 88' ' ' GLN . 97.4 m-85 -136.91 158.53 44.24 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.612 0.765 . . . . 0.0 109.681 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -75.33 123.36 25.22 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -135.74 149.87 49.33 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.89 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -112.05 132.35 54.87 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.986 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.494 ' HA ' HG22 ' A' ' 106' ' ' ILE . 64.5 mt -71.52 123.08 25.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.948 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -96.77 -41.34 8.52 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.09 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -151.7 142.09 22.49 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.574 -176.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 69.0 mt -113.44 138.35 43.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -120.8 92.06 3.67 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -65.76 -18.05 65.05 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.65 -46.91 80.51 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 121.412 0.625 . . . . 0.0 109.659 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -93.8 -15.66 24.89 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.566 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.42 37.4 47.36 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -175.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 42.8 p -125.36 155.79 39.74 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -176.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.58 144.64 48.06 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-O 121.238 0.542 . . . . 0.0 110.412 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.62 121.79 32.85 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.494 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.57 151.9 30.22 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.705 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.477 -175.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.8 m -119.71 121.26 38.82 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -67.73 118.24 10.72 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.46 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.28 126.27 29.16 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.171 -173.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.81 -37.69 3.66 Favored Glycine 0 N--CA 1.425 -2.065 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.097 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -89.9 -43.61 10.48 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.921 0.391 . . . . 0.0 110.172 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.43 4.91 62.17 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.044 -178.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -79.84 156.64 27.28 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 117.039 0.42 . . . . 0.0 109.934 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -143.1 143.56 31.89 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 120.564 0.221 . . . . 0.0 110.622 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -151.67 162.48 40.93 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.8 t -103.73 115.37 45.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.9 t -128.72 141.5 41.81 Favored Pre-proline 0 C--N 1.279 -2.498 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.08 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.2 Cg_endo -62.18 146.46 95.99 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 122.456 2.104 . . . . 0.0 111.457 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 60.1 mt -55.15 -26.39 38.35 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 123.623 0.769 . . . . 0.0 111.469 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 pp -66.22 -24.37 66.6 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.958 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -90.26 -16.38 29.46 Favored 'General case' 0 CA--C 1.479 -1.763 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 84.7 mt -80.98 126.24 31.14 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.86 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -114.8 147.43 38.2 Favored Pre-proline 0 C--N 1.288 -2.084 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -67.36 150.64 81.02 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 122.006 1.804 . . . . 0.0 110.837 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.427 -1.59 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.993 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.44 -0.973 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -110.81 151.15 28.15 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.819 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -126.87 153.21 46.02 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.67 133.13 30.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 175.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.11 39.42 9.28 Favored Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.484 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -117.79 161.17 20.16 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -98.75 131.24 45.05 Favored 'General case' 0 N--CA 1.394 -3.258 0 CA-C-O 122.1 0.953 . . . . 0.0 110.818 175.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.5 p -143.63 168.09 20.71 Favored 'General case' 0 C--N 1.262 -3.227 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.129 -177.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 31.3 mtp -111.83 130.2 55.89 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 172.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -121.42 149.47 42.97 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.4 t -85.42 117.01 29.66 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.465 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.5 t90 -66.76 123.05 19.06 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.5 m -60.24 -26.36 66.36 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.465 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 45.4 mt-10 -82.09 -41.98 19.8 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.005 -174.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -110.99 -15.48 13.74 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.762 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.28 10.51 86.16 Favored Glycine 0 C--N 1.307 -1.056 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.643 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -98.94 160.09 14.5 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 23.0 p -90.34 136.33 33.12 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 120.879 0.371 . . . . 0.0 110.916 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -136.46 158.14 45.14 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 123.725 0.81 . . . . 0.0 110.085 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -76.66 125.89 30.03 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.415 0.626 . . . . 0.0 109.887 -177.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -139.25 155.06 48.02 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.688 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -114.49 132.47 56.28 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.138 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.545 ' HA ' HG22 ' A' ' 106' ' ' ILE . 69.4 mt -70.88 123.85 25.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.311 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -98.34 -40.53 8.27 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.545 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 105' ' ' ALA . 29.1 tt0 -148.43 146.35 28.4 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -174.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 72.1 mt -124.72 137.61 56.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -116.98 95.48 5.02 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 174.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -65.99 -22.1 66.44 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -67.86 -46.78 70.77 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 121.277 0.561 . . . . 0.0 110.354 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -92.39 -9.47 41.61 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.784 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.545 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 64.56 41.98 97.62 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -176.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 41.6 p -126.23 155.9 41.12 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.73 149.01 43.11 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.207 0.527 . . . . 0.0 111.313 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . . . -95.41 124.05 39.24 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 176.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.545 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -126.41 155.07 36.53 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.046 -175.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.7 m -121.79 120.34 34.32 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -68.91 121.63 16.99 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.381 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.1 135.34 57.15 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.167 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.74 -46.13 3.29 Favored Glycine 0 C--N 1.309 -0.934 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.743 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -77.23 -40.24 45.58 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.985 0.421 . . . . 0.0 110.698 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.97 7.89 76.85 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.526 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -82.07 149.25 28.15 Favored 'General case' 0 CA--C 1.485 -1.519 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -144.05 137.57 27.71 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.803 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -151.83 160.55 43.51 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 123.521 0.513 . . . . 0.0 110.031 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.0 t -93.34 122.07 44.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.4 t -135.75 141.21 36.12 Favored Pre-proline 0 C--N 1.282 -2.328 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -177.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.2 Cg_endo -63.21 148.55 92.99 Favored 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 122.273 1.982 . . . . 0.0 111.497 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 50.6 mt -55.54 -26.32 42.6 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 123.858 0.863 . . . . 0.0 111.412 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 pp -63.97 -26.97 68.82 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 121.434 0.635 . . . . 0.0 110.497 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.453 HD22 ' HD2' ' A' ' 118' ' ' PRO . 67.5 m-20 -84.17 -26.03 29.13 Favored 'General case' 0 CA--C 1.476 -1.902 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.576 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.2 mt -78.3 126.23 30.49 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.272 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -114.67 150.32 43.77 Favored Pre-proline 0 C--N 1.288 -2.086 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 175.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.85 146.91 48.93 Favored 'Trans proline' 0 C--N 1.325 -0.663 0 C-N-CA 121.493 1.462 . . . . 0.0 110.871 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.4 t . . . . . 0 N--CA 1.441 -0.911 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.276 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.434 -1.228 0 CA-C-O 121.139 0.495 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.419 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 92.0 m95 -112.79 151.25 30.56 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.252 177.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -133.71 155.24 50.09 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.355 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.9 t -63.5 141.42 18.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.15 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.13 27.92 51.1 Favored Glycine 0 CA--C 1.498 -0.975 0 C-N-CA 121.401 -0.428 . . . . 0.0 112.527 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.46 153.81 41.43 Favored 'General case' 0 CA--C 1.488 -1.438 0 CA-C-O 120.927 0.394 . . . . 0.0 111.774 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -90.71 141.28 28.95 Favored 'General case' 0 N--CA 1.413 -2.321 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.76 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.419 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 14.2 p -147.99 175.2 11.18 Favored 'General case' 0 C--N 1.265 -3.097 0 CA-C-N 113.573 -1.649 . . . . 0.0 107.158 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.404 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 82.0 mmm -112.13 129.38 56.25 Favored 'General case' 0 C--N 1.271 -2.811 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 175.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -122.39 147.52 46.19 Favored 'General case' 0 C--N 1.266 -3.063 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.089 -176.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.8 t -85.09 115.01 26.17 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.473 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 12.7 t90 -64.44 121.22 13.86 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.6 t -63.12 -20.25 65.2 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 123.434 0.459 . . . . 0.0 111.658 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.473 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 37.6 mm-40 -84.82 -42.22 15.34 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -177.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -109.74 -15.98 14.01 Favored 'General case' 0 CA--C 1.507 -0.708 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.239 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.59 9.33 86.97 Favored Glycine 0 C--O 1.221 -0.66 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.076 177.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -102.85 162.03 13.26 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 7.1 p -89.87 136.6 32.94 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.085 0.469 . . . . 0.0 111.91 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -136.06 158.52 44.21 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 124.866 1.266 . . . . 0.0 109.134 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -75.03 127.95 34.43 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.41 151.98 43.92 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.71 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -111.33 133.35 53.71 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.394 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.438 ' HA ' HG22 ' A' ' 106' ' ' ILE . 67.8 mt -72.67 123.94 28.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 123.745 0.818 . . . . 0.0 111.92 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -99.69 -38.21 8.8 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.989 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -151.79 143.91 23.92 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.879 -175.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 64.5 mt -124.29 140.23 48.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -124.39 94.39 4.19 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 171.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -66.28 -23.11 66.33 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -66.76 -44.14 82.22 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.397 0.617 . . . . 0.0 109.821 -179.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -92.67 -9.51 40.57 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.357 0.599 . . . . 0.0 110.367 177.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 68.13 39.19 88.61 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.527 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 73.8 p -125.28 155.42 40.19 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 122.265 -0.55 . . . . 0.0 110.405 -176.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.449 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -138.48 146.15 41.7 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 121.461 0.648 . . . . 0.0 110.601 176.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.62 121.59 36.34 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.438 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.97 153.19 31.93 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.679 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.862 -175.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 87.8 m -120.38 120.37 35.78 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.779 177.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -67.33 124.85 24.29 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 123.543 0.737 . . . . 0.0 110.72 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.24 129.28 39.43 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.023 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.28 -39.59 2.83 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.919 178.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -87.06 -40.24 14.87 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.286 0.565 . . . . 0.0 110.157 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.21 11.29 72.87 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.823 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -80.51 154.07 27.76 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.91 139.1 30.62 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.729 -176.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -149.2 160.58 43.24 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 56.8 t -98.06 114.82 36.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 176.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.3 t -130.67 141.4 41.82 Favored Pre-proline 0 C--N 1.281 -2.408 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -175.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.591 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 40.9 Cg_endo -63.05 148.36 93.48 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.371 2.047 . . . . 0.0 111.682 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 54.3 mt -55.2 -26.78 41.39 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.595 0.758 . . . . 0.0 111.539 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.63 -23.5 66.82 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.248 0.547 . . . . 0.0 111.057 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -92.13 -13.24 31.01 Favored 'General case' 0 CA--C 1.485 -1.551 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.026 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.449 HD11 ' HB3' ' A' ' 104' ' ' ALA . 82.1 mt -85.28 125.95 33.32 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 71.0 mmtt -114.75 153.19 46.89 Favored Pre-proline 0 C--N 1.284 -2.276 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.84 154.02 53.49 Favored 'Trans proline' 0 C--O 1.248 1.021 0 C-N-CA 121.475 1.45 . . . . 0.0 111.869 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 46.1 t . . . . . 0 C--N 1.311 -1.07 0 CA-C-O 121.962 0.887 . . . . 0.0 108.885 179.493 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 N--CA 1.44 -0.93 0 CA-C-O 121.649 0.737 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.462 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 97.5 m95 -116.3 151.8 35.13 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.872 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -132.97 160.0 38.37 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.61 136.41 26.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 123.687 0.795 . . . . 0.0 111.362 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.21 21.99 46.74 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.33 177.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.66 153.55 28.73 Favored 'General case' 0 CA--C 1.482 -1.655 0 CA-C-O 120.598 0.237 . . . . 0.0 110.453 -177.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -91.81 135.29 34.03 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-O 121.93 0.872 . . . . 0.0 110.809 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.462 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 19.4 p -146.03 176.38 9.76 Favored 'General case' 0 C--N 1.265 -3.085 0 CA-C-N 114.023 -1.444 . . . . 0.0 107.181 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 59.9 mtp -115.82 130.84 57.0 Favored 'General case' 0 C--N 1.27 -2.891 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 173.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.79 150.54 39.62 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -175.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 82.7 t -85.39 115.29 26.77 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.473 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.528 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.0 t90 -63.74 123.25 18.4 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.1 t -62.36 -25.06 67.7 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.229 0.538 . . . . 0.0 110.997 -177.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.528 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 21.5 mm-40 -79.05 -41.73 28.13 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -176.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -115.33 -16.31 11.48 Favored 'General case' 0 CA--C 1.502 -0.891 0 C-N-CA 117.654 -1.618 . . . . 0.0 112.367 -178.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.59 5.75 88.04 Favored Glycine 0 C--N 1.306 -1.116 0 C-N-CA 119.795 -1.193 . . . . 0.0 113.596 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -93.19 161.6 14.35 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 23.4 p -94.25 135.74 35.31 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 120.957 0.408 . . . . 0.0 110.56 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -137.9 157.6 46.08 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 123.741 0.817 . . . . 0.0 109.203 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -75.5 126.02 30.19 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -177.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.25 151.15 47.37 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -112.08 133.37 54.28 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.115 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.49 ' HA ' HG22 ' A' ' 106' ' ' ILE . 66.4 mt -71.72 123.34 25.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 123.558 0.743 . . . . 0.0 111.756 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -97.39 -38.61 9.56 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.513 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -154.97 151.57 28.65 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 71.6 mt -123.33 137.27 57.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -117.68 95.82 5.11 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -65.54 -22.6 66.73 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.768 -1.106 . . . . 0.0 113.022 -177.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -65.08 -46.3 81.7 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 120.603 0.24 . . . . 0.0 110.78 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -95.36 -5.86 42.37 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.84 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.422 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 64.75 43.15 96.67 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -176.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 39.9 p -127.27 156.0 42.61 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -175.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.32 141.7 43.8 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-O 121.09 0.471 . . . . 0.0 110.086 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.04 120.76 29.69 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.49 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.89 154.22 32.57 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.679 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.082 -174.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.7 m -121.82 120.41 34.49 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.469 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -67.11 123.35 20.02 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 123.387 0.675 . . . . 0.0 110.359 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.48 135.67 55.48 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.266 -176.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.92 -55.81 3.7 Favored Glycine 0 N--CA 1.429 -1.784 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.948 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -72.99 -41.94 63.79 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.137 0.494 . . . . 0.0 110.806 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 89.95 2.03 75.54 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.836 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -72.81 158.05 36.29 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -145.14 135.86 24.48 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.591 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -146.97 157.9 43.76 Favored 'General case' 0 N--CA 1.432 -1.336 0 O-C-N 123.715 0.634 . . . . 0.0 109.67 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 69.4 t -91.96 114.32 28.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 174.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.1 t -128.0 141.67 41.97 Favored Pre-proline 0 C--N 1.29 -2.017 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -175.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.57 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 43.5 Cg_endo -64.28 147.13 91.0 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.126 1.884 . . . . 0.0 111.192 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 48.0 mt -55.38 -26.07 39.12 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 123.494 0.717 . . . . 0.0 111.138 178.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.39 -19.47 65.41 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.18 178.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -95.78 -13.27 24.24 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-O 120.951 0.405 . . . . 0.0 111.357 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.414 HD22 ' SG ' ' A' ' 79' ' ' CYS . 83.5 mt -81.94 126.29 31.76 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.257 177.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -114.09 154.3 46.16 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.42 153.11 70.93 Favored 'Trans proline' 0 C--O 1.243 0.763 0 C-N-CA 121.616 1.544 . . . . 0.0 110.428 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.6 t . . . . . 0 C--N 1.305 -1.365 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.765 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.2 t . . . . . 0 N--CA 1.426 -1.66 0 CA-C-O 121.605 0.717 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -112.06 152.21 28.47 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.469 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -131.19 160.95 33.32 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 175.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 99.0 t -66.0 139.31 21.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.771 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.8 32.82 48.63 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 1.4 t70 -110.49 159.18 17.74 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -95.26 131.19 41.59 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 17.9 p -144.65 173.94 11.39 Favored 'General case' 0 C--N 1.263 -3.181 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.8 mtp -117.28 130.55 56.62 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 173.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.04 149.97 40.76 Favored 'General case' 0 C--N 1.27 -2.883 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.9 t -87.41 113.54 24.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.454 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 12.7 t90 -63.46 120.45 11.69 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -179.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.7 t -67.06 -16.58 64.44 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.224 0.535 . . . . 0.0 110.946 -174.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.454 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 38.4 mt-10 -85.1 -42.29 14.93 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.521 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 13.9 t70 -110.31 -15.72 13.89 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.289 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.82 4.39 90.07 Favored Glycine 0 C--N 1.305 -1.17 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.374 176.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.521 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 28.1 mm-40 -94.68 161.26 14.26 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.913 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 7.9 p -92.65 136.08 33.54 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.311 0.577 . . . . 0.0 111.623 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -136.87 157.72 46.09 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 123.797 0.839 . . . . 0.0 109.441 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -75.34 132.98 41.33 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.47 158.09 43.92 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.896 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 77' ' ' ASP . 43.9 tt0 -120.6 134.08 55.31 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.819 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.492 ' HA ' HG22 ' A' ' 106' ' ' ILE . 70.9 mt -71.78 125.33 30.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 O-C-N 123.759 0.662 . . . . 0.0 112.733 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -98.43 -42.54 7.29 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.601 -1.182 . . . . 0.0 111.306 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -148.8 143.44 26.34 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -174.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.0 mt -121.81 138.46 52.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -123.05 92.6 3.74 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 171.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.49 -24.79 67.24 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -177.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -63.04 -45.32 92.8 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.537 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -95.2 -4.71 45.42 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.26 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.61 43.04 97.04 Favored Glycine 0 N--CA 1.438 -1.214 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 41.6 p -128.44 155.7 44.36 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 122.69 -0.3 . . . . 0.0 110.491 -177.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.39 144.52 36.26 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.058 0.456 . . . . 0.0 110.009 175.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.03 124.77 35.05 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.492 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -127.85 152.08 35.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.977 -175.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.3 m -116.23 120.47 39.07 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.988 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -69.12 125.93 28.2 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.915 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.45 128.4 35.86 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.44 -1.255 . . . . 0.0 111.57 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.13 -46.65 2.87 Favored Glycine 0 N--CA 1.437 -1.27 0 C-N-CA 121.293 -0.48 . . . . 0.0 112.798 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -78.75 -33.94 46.11 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.621 0.248 . . . . 0.0 110.981 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 83.88 -0.92 89.34 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.548 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -71.6 150.19 44.92 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.51 132.08 28.78 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.714 -176.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -144.48 160.76 40.56 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.564 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.8 t -96.09 116.21 37.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.2 t -130.69 141.42 41.89 Favored Pre-proline 0 C--N 1.278 -2.533 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -176.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 40.0 Cg_endo -62.92 146.36 94.85 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 122.057 1.838 . . . . 0.0 110.889 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 56.3 mt -54.27 -26.49 29.33 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 123.966 0.906 . . . . 0.0 111.672 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.65 -23.84 66.89 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.289 0.566 . . . . 0.0 110.92 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -90.0 -13.72 35.49 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.994 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.2 mt -85.58 126.34 33.81 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.193 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -114.61 152.75 46.54 Favored Pre-proline 0 C--N 1.281 -2.402 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.9 151.31 50.6 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.48 1.453 . . . . 0.0 110.31 176.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 C--N 1.306 -1.285 0 CA-C-O 121.302 0.572 . . . . 0.0 110.333 -177.753 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.435 -1.216 0 CA-C-O 120.805 0.336 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -121.54 152.23 39.43 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 123.028 0.531 . . . . 0.0 111.332 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -133.35 154.46 50.71 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.221 177.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.5 t -63.82 141.91 17.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 C-N-CA 123.914 0.886 . . . . 0.0 110.51 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.1 19.39 62.92 Favored Glycine 0 CA--C 1.499 -0.959 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.51 151.88 34.02 Favored 'General case' 0 CA--C 1.477 -1.858 0 CA-C-O 120.502 0.191 . . . . 0.0 110.754 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -90.97 142.03 28.21 Favored 'General case' 0 N--CA 1.399 -2.978 0 O-C-N 123.907 0.755 . . . . 0.0 110.25 176.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 21.0 p -148.99 176.59 10.31 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.207 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 47.5 mtp -116.67 131.23 57.0 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.91 149.05 42.24 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -176.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 88.9 t -85.87 118.77 33.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -67.03 120.58 13.89 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.3 m -57.63 -28.89 64.1 Favored 'General case' 0 C--N 1.288 -2.065 0 C-N-CA 123.205 0.602 . . . . 0.0 112.26 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -77.64 -41.98 36.46 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.953 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.481 ' OD1' ' HG2' ' A' ' 88' ' ' GLN . 9.0 t70 -113.49 -16.26 12.44 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.748 -175.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.83 3.18 90.61 Favored Glycine 0 C--N 1.31 -0.914 0 C-N-CA 120.27 -0.967 . . . . 0.0 113.021 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.481 ' HG2' ' OD1' ' A' ' 86' ' ' ASP . 30.0 mm-40 -94.01 160.85 14.53 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.619 -0.342 . . . . 0.0 110.08 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 11.1 p -90.43 136.8 32.83 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 120.991 0.424 . . . . 0.0 110.528 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -136.46 157.16 47.44 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -78.66 123.96 27.68 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.106 0.479 . . . . 0.0 110.012 -176.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.62 152.32 49.23 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.34 -176.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -108.41 134.25 51.46 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.165 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.546 ' HA ' HG22 ' A' ' 106' ' ' ILE . 63.6 mt -73.25 118.6 18.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.161 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -94.38 -38.72 10.83 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.442 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -153.81 150.4 28.41 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -176.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 68.4 mt -124.7 141.2 45.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -120.6 90.97 3.43 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -66.35 -21.71 66.25 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.427 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -60.09 -46.22 90.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.061 178.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -94.61 -15.61 23.89 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.393 0.616 . . . . 0.0 110.648 176.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.504 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 76.73 37.41 34.41 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -177.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 50.8 p -124.44 158.02 33.79 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.29 147.65 47.58 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.075 0.464 . . . . 0.0 110.501 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.66 121.8 37.76 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 176.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.546 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.83 153.72 32.06 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.72 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.751 -174.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 95.1 m -121.45 121.29 37.21 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -68.7 119.71 13.53 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.995 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.38 130.65 43.75 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 124.262 0.976 . . . . 0.0 110.284 -175.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.09 -51.26 1.29 Allowed Glycine 0 N--CA 1.429 -1.819 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.456 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -76.79 -43.62 36.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.762 0.315 . . . . 0.0 110.76 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.22 2.27 66.19 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.339 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -75.99 154.53 35.74 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.23 138.79 31.69 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -152.34 162.81 40.64 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 123.178 0.299 . . . . 0.0 110.642 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.2 t -97.82 120.37 47.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.3 t -133.96 141.02 38.13 Favored Pre-proline 0 C--N 1.284 -2.256 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -176.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.4 Cg_endo -64.21 146.97 91.2 Favored 'Trans proline' 0 N--CA 1.438 -1.765 0 C-N-CA 122.071 1.847 . . . . 0.0 111.436 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 45.2 mt -53.93 -26.41 25.27 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 123.864 0.865 . . . . 0.0 111.317 178.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 pp -68.09 -21.61 64.95 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.119 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -93.09 -17.88 23.28 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.064 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 85.9 mt -77.74 126.83 31.47 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 121.435 0.636 . . . . 0.0 109.856 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -114.4 155.47 45.79 Favored Pre-proline 0 C--N 1.291 -1.965 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.55 148.7 48.26 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 121.735 1.623 . . . . 0.0 111.356 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 CA--C 1.509 -0.626 0 CA-C-O 121.226 0.536 . . . . 0.0 110.376 -178.373 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 101' ' ' ASN . 16.1 m -137.84 -74.82 0.4 Allowed 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 99.3 m -99.09 120.09 38.91 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -81.58 114.25 48.37 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -59.97 133.84 52.96 Favored 'Trans proline' 0 C--O 1.239 0.528 0 C-N-CA 122.525 2.15 . . . . 0.0 113.509 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.1 t -112.54 -3.42 14.39 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 -141.31 143.6 34.14 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -176.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.3 m -95.42 114.45 26.22 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.403 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 98.0 m95 -113.54 151.48 31.53 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.136 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -129.25 159.74 35.15 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.99 133.38 30.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 123.078 0.551 . . . . 0.0 110.766 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.54 26.87 37.45 Favored Glycine 0 CA--C 1.499 -0.943 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.444 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.74 155.47 19.66 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -96.4 131.47 42.92 Favored 'General case' 0 C--N 1.274 -2.698 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.243 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.403 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 17.3 p -144.03 176.67 9.12 Favored 'General case' 0 C--N 1.263 -3.181 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.561 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 41.1 mtp -119.23 130.44 55.46 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 172.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.79 153.61 34.18 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -175.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.7 t -86.74 116.81 29.93 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.442 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -66.35 123.61 20.45 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.4 t -61.2 -23.36 65.54 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.219 0.533 . . . . 0.0 111.483 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -83.16 -42.63 17.09 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -106.71 -17.24 14.28 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.222 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.24 3.5 82.06 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 119.554 -1.307 . . . . 0.0 112.398 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -91.48 163.85 14.02 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 24.7 p -94.84 136.42 35.18 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.697 0.284 . . . . 0.0 110.7 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -136.71 157.56 46.47 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 123.535 0.734 . . . . 0.0 109.581 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -75.09 129.47 37.63 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -145.02 152.94 40.92 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.121 -177.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -112.53 134.96 53.79 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.346 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.476 ' HA ' HG22 ' A' ' 106' ' ' ILE . 73.9 mt -71.63 123.21 25.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 123.252 0.621 . . . . 0.0 111.491 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -98.66 -37.41 9.52 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.01 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -152.86 145.42 24.18 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 68.5 mt -121.68 140.06 46.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -121.73 97.13 5.35 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 172.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.08 -24.67 67.52 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -176.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -68.17 -45.78 72.53 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 66' ' ' SER . 28.4 m-80 -87.32 -15.22 38.62 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.386 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.436 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 67.62 40.46 90.5 Favored Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -176.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.615 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 69.9 p -124.7 157.9 34.5 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -177.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.456 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -139.85 141.15 36.66 Favored 'General case' 0 C--N 1.29 -2.022 0 CA-C-O 121.308 0.575 . . . . 0.0 110.408 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.92 121.13 29.96 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.476 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.92 153.47 32.06 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.756 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.973 -174.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.2 m -120.44 120.46 35.98 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.725 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -69.56 117.74 11.54 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.581 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.26 133.07 49.83 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.948 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.9 -42.95 2.01 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.869 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -87.63 -43.45 11.95 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.305 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.77 3.59 62.31 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.218 -0.992 . . . . 0.0 112.127 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -77.57 152.7 33.85 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -141.24 143.49 34.16 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -151.55 159.12 44.26 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 123.962 0.788 . . . . 0.0 109.026 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.0 t -97.66 113.92 33.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -128.49 141.32 41.07 Favored Pre-proline 0 C--N 1.288 -2.098 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -174.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.615 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 40.6 Cg_endo -62.6 147.7 94.41 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.447 2.098 . . . . 0.0 111.229 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 45.8 mt -54.44 -26.11 28.96 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.608 0.763 . . . . 0.0 111.592 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.7 pp -64.53 -26.0 68.23 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.342 0.591 . . . . 0.0 110.399 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -89.62 -14.26 35.32 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.955 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.456 HD11 ' HB3' ' A' ' 104' ' ' ALA . 81.7 mt -85.31 125.83 33.24 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.988 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -115.39 151.39 45.9 Favored Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.48 153.43 70.21 Favored 'Trans proline' 0 C--O 1.243 0.742 0 C-N-CA 121.597 1.531 . . . . 0.0 110.913 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.5 t -80.5 93.57 2.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 121.721 0.772 . . . . 0.0 109.003 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.37 112.32 24.53 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -84.97 62.71 7.67 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 122.189 0.995 . . . . 0.0 111.045 -174.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.805 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.32 177.725 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1129 ' ' DA2 . . . . . 0.503 ' HNE' HC21 ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.735 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.8 p -66.96 -19.06 65.66 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.6 m -114.99 135.98 53.63 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -88.44 133.44 36.46 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 175.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -59.35 133.19 50.8 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 121.047 1.164 . . . . 0.0 109.908 174.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.8 t -82.59 -22.46 34.82 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -142.02 138.64 31.98 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.1 m -83.34 113.29 20.62 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 120.999 0.428 . . . . 0.0 110.009 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -118.91 151.58 37.87 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.665 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -131.4 153.93 49.17 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.79 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 141.61 17.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 C-N-CA 123.908 0.883 . . . . 0.0 110.746 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.23 28.49 55.84 Favored Glycine 0 CA--C 1.498 -0.972 0 N-CA-C 112.122 -0.391 . . . . 0.0 112.122 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.38 153.28 35.41 Favored 'General case' 0 CA--C 1.483 -1.614 0 CA-C-O 120.814 0.34 . . . . 0.0 110.887 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -90.75 139.12 31.03 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.172 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 17.2 p -148.65 179.52 7.76 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-N 113.719 -1.582 . . . . 0.0 107.327 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 58.4 mtp -120.37 131.18 54.72 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 173.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.95 149.75 41.62 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.8 t -85.35 116.48 28.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -64.19 120.66 12.54 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.7 t -62.37 -21.04 65.02 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 123.578 0.549 . . . . 0.0 111.292 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -84.87 -42.35 15.14 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -112.5 -15.51 13.05 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 119.336 -0.946 . . . . 0.0 111.916 -174.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.1 0.36 89.58 Favored Glycine 0 C--N 1.313 -0.719 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.924 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -93.22 159.86 15.09 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 120.559 -0.456 . . . . 0.0 109.825 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 23.3 p -92.76 137.07 32.68 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.167 0.508 . . . . 0.0 110.945 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.412 ' CD2' HC11 ' A' 1129 ' ' DA2 . 97.4 m-85 -136.46 158.33 44.68 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 123.846 0.858 . . . . 0.0 109.36 -178.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.28 127.99 34.42 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.66 153.65 48.58 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.126 0.488 . . . . 0.0 111.25 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -115.03 132.93 56.44 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.997 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.468 ' HA ' HG22 ' A' ' 106' ' ' ILE . 62.5 mt -73.03 123.78 28.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.928 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -99.9 -38.2 8.72 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.858 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -149.58 143.72 25.75 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -176.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.4 mt -123.24 140.42 46.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -120.43 92.7 3.83 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 173.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -65.94 -23.49 66.62 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.82 -46.71 88.38 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.042 0.537 . . . . 0.0 109.805 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -95.46 -11.65 27.2 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.087 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.438 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 72.32 39.55 57.1 Favored Glycine 0 C--N 1.312 -0.804 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -177.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 35.5 p -124.36 156.96 36.14 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 122.793 0.437 . . . . 0.0 110.217 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.69 148.61 41.05 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.399 0.619 . . . . 0.0 111.089 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -97.52 121.75 39.79 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.468 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.78 154.79 32.78 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.669 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.782 -174.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 91.3 m -120.76 120.3 35.23 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.448 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -67.71 121.58 16.25 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.186 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.24 130.72 46.67 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.552 -175.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.29 -49.94 2.99 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 121.131 -0.557 . . . . 0.0 111.868 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -72.63 -43.25 63.5 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 120.612 0.244 . . . . 0.0 111.235 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.84 8.57 65.07 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.27 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.424 ' O ' ' HA ' ' A' ' 107' ' ' THR . 3.9 m-20 -80.65 148.52 30.19 Favored 'General case' 0 CA--C 1.49 -1.364 0 O-C-N 122.352 -0.499 . . . . 0.0 110.222 178.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -137.64 133.32 34.19 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 -176.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -151.51 162.79 40.36 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.685 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.5 t -96.37 119.88 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.6 t -133.8 140.71 37.4 Favored Pre-proline 0 C--N 1.278 -2.503 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 42.6 Cg_endo -63.71 147.43 92.6 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 122.346 2.031 . . . . 0.0 110.941 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 49.8 mt -53.56 -27.12 24.43 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 123.677 0.791 . . . . 0.0 111.646 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.57 -23.41 66.2 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.249 0.619 . . . . 0.0 111.604 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.4 HD22 ' HD2' ' A' ' 118' ' ' PRO . 72.2 m-20 -91.64 -12.59 33.77 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 121.185 0.517 . . . . 0.0 110.803 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 81.4 mt -84.49 128.21 34.46 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.066 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -111.36 157.59 38.61 Favored Pre-proline 0 C--N 1.294 -1.844 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.76 156.89 63.96 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 121.63 1.554 . . . . 0.0 109.628 170.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 89.8 t -73.1 95.98 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-O 121.507 0.67 . . . . 0.0 110.536 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -78.17 116.04 18.33 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.333 177.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -95.26 3.12 54.88 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 122.488 1.137 . . . . 0.0 109.478 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.41 -3.1 0 N-CA-C 107.5 -2.24 . . . . 0.0 107.5 -178.07 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1129 ' ' DA2 . . . . . 0.518 ' HNE' HC21 ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.631 0 CA-C-O 120.866 0.365 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.9 m -71.65 -39.04 70.62 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 48.6 m -101.91 113.32 26.42 Favored 'General case' 0 N--CA 1.411 -2.404 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 171.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -71.99 119.12 72.63 Favored Pre-proline 0 C--N 1.309 -1.182 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -54.68 133.78 58.9 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.107 2.538 . . . . 0.0 112.352 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.5 t -91.77 -18.08 24.41 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.187 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -141.37 139.77 33.58 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 -176.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.3 p -87.84 110.96 20.9 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.078 0.466 . . . . 0.0 110.411 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -109.88 151.99 26.35 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.313 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -124.89 151.0 45.93 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.1 t -64.48 133.78 29.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.54 31.94 26.1 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.139 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 11.0 t0 -113.14 165.02 12.78 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.716 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.412 ' HB3' HG21 ' A' ' 125' ' ' VAL . 6.3 mmpt? -96.72 130.7 43.91 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 176.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 23.6 p -144.93 176.64 9.32 Favored 'General case' 0 C--N 1.265 -3.091 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 38.7 mtp -117.6 130.48 56.41 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 173.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.54 149.82 41.82 Favored 'General case' 0 C--N 1.279 -2.49 0 O-C-N 123.435 0.46 . . . . 0.0 109.865 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.3 t -85.3 117.54 30.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.464 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.6 t90 -66.25 124.86 23.82 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.2 t -61.38 -26.51 67.89 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.15 0.5 . . . . 0.0 111.229 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.464 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 16.2 mm-40 -80.26 -40.06 27.72 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -175.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.433 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 11.6 t70 -115.61 -15.46 11.4 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.77 -177.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.85 6.88 89.14 Favored Glycine 0 C--N 1.307 -1.074 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.142 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.433 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 27.0 mm-40 -95.82 161.29 14.07 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.137 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 25.1 p -90.8 136.77 32.85 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.46 0.648 . . . . 0.0 110.84 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.41 ' CD2' HC11 ' A' 1129 ' ' DA2 . 97.4 m-85 -136.35 158.02 45.42 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.944 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -74.63 131.29 40.8 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.93 153.55 44.44 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.376 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 77' ' ' ASP . 38.3 tt0 -114.04 132.11 56.12 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.578 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.524 ' HA ' HG22 ' A' ' 106' ' ' ILE . 66.3 mt -73.44 125.08 31.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 122.977 0.511 . . . . 0.0 112.37 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -97.87 -40.39 8.53 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.37 1.068 . . . . 0.0 111.201 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -149.28 148.84 30.03 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.3 mt -121.5 131.6 72.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -114.99 90.87 3.44 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -66.5 -20.4 66.03 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.2 -46.26 74.4 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.143 0.497 . . . . 0.0 109.882 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -92.38 -6.3 50.37 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.798 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.85 38.74 94.6 Favored Glycine 0 C--O 1.241 0.55 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 67.4 p -130.29 155.57 46.09 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.45 149.56 48.29 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-O 120.914 0.387 . . . . 0.0 110.509 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.65 124.12 38.49 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.524 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -127.73 155.56 39.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.196 -175.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 75.4 m -117.9 120.37 37.68 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -68.01 123.13 19.77 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.36 130.76 44.09 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.839 -175.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.89 -59.32 0.76 Allowed Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -69.57 -42.59 74.32 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.101 0.477 . . . . 0.0 110.543 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.31 16.26 62.85 Favored Glycine 0 N--CA 1.434 -1.442 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.919 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -86.76 154.61 20.81 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -142.19 136.24 29.73 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 123.099 0.249 . . . . 0.0 110.673 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.03 159.67 43.65 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.2 t -93.71 121.85 44.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 176.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.9 t -134.67 141.49 38.95 Favored Pre-proline 0 C--N 1.287 -2.136 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -176.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 36.9 Cg_endo -61.74 146.23 96.81 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 122.627 2.218 . . . . 0.0 111.415 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 48.4 mt -54.75 -26.08 31.91 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 123.702 0.801 . . . . 0.0 111.858 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.17 -27.98 69.08 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.116 0.484 . . . . 0.0 110.771 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -85.55 -15.06 43.93 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.564 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.1 mt -85.85 125.78 33.56 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -114.97 151.91 46.01 Favored Pre-proline 0 C--N 1.282 -2.355 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -71.0 146.96 53.87 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 121.5 1.467 . . . . 0.0 110.727 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 78' ' ' LYS . 59.1 t -75.87 90.89 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.77 109.81 7.57 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.678 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -121.76 14.78 10.92 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.56 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.329 0 N-CA-C 107.668 -2.173 . . . . 0.0 107.668 -178.56 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 1129 ' ' DA2 . . . . . 0.432 HC21 ' HNE' ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.211 -0.952 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.9 p -85.29 149.08 25.72 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 117.861 0.3 . . . . 0.0 110.981 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 99' ' ' GLU . 46.0 m -137.15 144.39 42.93 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -97.25 126.76 40.75 Favored Pre-proline 0 N--CA 1.428 -1.533 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -60.02 138.0 79.32 Favored 'Trans proline' 0 C--O 1.242 0.702 0 C-N-CA 123.016 2.477 . . . . 0.0 112.302 175.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.3 t -80.73 -22.81 39.93 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.11 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 21.0 t-80 -141.25 147.84 38.92 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 -177.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.0 m -83.98 105.11 14.6 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.252 0.549 . . . . 0.0 110.442 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.418 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 93.2 m95 -111.6 151.53 28.67 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.592 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -131.66 159.18 39.07 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.4 t -65.42 135.89 27.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.03 40.88 13.1 Favored Glycine 0 N--CA 1.431 -1.637 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.404 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.41 152.7 41.31 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -95.04 131.21 41.27 Favored 'General case' 0 N--CA 1.402 -2.836 0 O-C-N 123.892 0.745 . . . . 0.0 109.744 174.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.418 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 18.7 p -141.43 177.48 8.09 Favored 'General case' 0 C--N 1.261 -3.257 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 51.5 mtp -118.05 130.75 56.35 Favored 'General case' 0 N--CA 1.4 -2.935 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 173.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.76 150.01 40.5 Favored 'General case' 0 C--N 1.267 -3.001 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -176.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.4 t -84.64 120.76 35.82 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -69.57 127.26 32.35 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.7 m -59.3 -29.07 67.34 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -84.12 -42.01 16.5 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -175.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -105.8 -15.75 14.85 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.702 0.763 . . . . 0.0 110.516 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.29 13.29 73.46 Favored Glycine 0 C--N 1.312 -0.765 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.239 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -102.65 163.86 11.98 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 20.5 p -90.19 136.27 33.15 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.898 0.38 . . . . 0.0 110.604 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -134.38 158.26 44.3 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 124.199 1.0 . . . . 0.0 109.282 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -74.86 125.3 28.52 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -136.95 149.63 47.68 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.159 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -110.91 132.17 54.43 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.892 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.51 ' HA ' HG22 ' A' ' 106' ' ' ILE . 68.1 mt -72.51 123.43 27.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.124 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -98.02 -40.07 8.63 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.914 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -152.39 142.51 22.3 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -175.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 69.9 mt -119.21 131.99 70.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -123.92 90.55 3.29 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.41 ' O ' ' HB ' ' A' ' 67' ' ' THR . 10.5 pt-20 -67.17 -20.31 65.71 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.106 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -56.32 -42.86 78.33 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 123.991 0.807 . . . . 0.0 110.227 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -101.81 -1.55 32.04 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.201 0.524 . . . . 0.0 110.215 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.63 39.29 95.34 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.597 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 37.0 p -128.28 155.69 44.19 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 122.382 0.273 . . . . 0.0 110.427 -175.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.93 147.19 46.24 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.77 122.04 34.76 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.51 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -126.01 153.35 34.09 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.497 -175.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.5 m -120.14 120.41 36.11 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -67.8 118.3 10.85 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.32 130.66 41.94 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 114.623 -1.172 . . . . 0.0 110.489 -174.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.02 -41.86 2.09 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -87.37 -43.21 12.29 Favored 'General case' 0 C--N 1.313 -1.006 0 O-C-N 122.515 -0.403 . . . . 0.0 110.955 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.41 1.48 68.95 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.623 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -76.06 148.09 38.2 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -135.32 140.84 45.41 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -152.01 158.16 42.7 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.8 t -93.66 115.46 32.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 175.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.2 t -129.49 141.21 41.04 Favored Pre-proline 0 C--N 1.281 -2.387 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -175.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.5 Cg_endo -61.5 145.03 98.27 Favored 'Trans proline' 0 N--CA 1.437 -1.833 0 C-N-CA 122.165 1.91 . . . . 0.0 110.671 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 55.2 mt -53.94 -26.15 24.07 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 123.887 0.875 . . . . 0.0 111.472 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 pp -64.37 -25.48 68.05 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.093 0.473 . . . . 0.0 110.855 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.425 HD22 ' HD2' ' A' ' 118' ' ' PRO . 73.5 m-20 -88.31 -12.84 42.34 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.86 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 81.3 mt -86.7 125.88 34.18 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.153 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -114.91 155.76 46.0 Favored Pre-proline 0 C--N 1.288 -2.089 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.62 157.22 59.34 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 121.526 1.484 . . . . 0.0 110.46 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.5 t -80.13 79.45 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -98.74 100.17 11.35 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.783 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -92.06 59.74 3.64 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.423 -175.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.309 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.308 -179.724 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1129 ' ' DA2 . . . . . 0.465 ' HNE' HC21 ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.557 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.2 m -62.85 -37.48 86.98 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.691 0.758 . . . . 0.0 109.721 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 80.1 m -129.02 125.28 36.98 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.0 mp0 -90.24 141.44 27.66 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -175.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -53.73 135.05 61.28 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 123.16 2.573 . . . . 0.0 113.283 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.3 t -88.03 -18.03 29.84 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 20.5 t-80 -140.99 143.24 34.35 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.9 t -85.48 104.67 15.48 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.413 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 95.2 m95 -110.06 151.52 27.1 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.637 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -129.09 159.01 37.34 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.11 134.35 29.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 C-N-CA 123.385 0.674 . . . . 0.0 110.741 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.1 35.97 25.87 Favored Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -117.36 154.53 31.13 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -93.92 132.42 38.39 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-O 121.68 0.752 . . . . 0.0 110.355 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.413 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 19.4 p -142.89 178.88 7.36 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.1 -178.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 33.5 mtp -118.99 130.54 55.74 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.13 149.96 43.87 Favored 'General case' 0 C--N 1.28 -2.455 0 O-C-N 123.517 0.51 . . . . 0.0 109.964 -175.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.0 t -85.3 119.07 33.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -67.16 123.49 20.42 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.2 m -60.31 -28.23 67.95 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.607 0.718 . . . . 0.0 112.087 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -79.59 -41.87 26.21 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.628 -174.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -112.73 -15.74 12.91 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.804 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.39 3.92 89.95 Favored Glycine 0 C--N 1.313 -0.715 0 C-N-CA 120.03 -1.081 . . . . 0.0 113.561 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.451 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 33.0 mm-40 -90.14 161.22 15.87 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 122.362 -0.493 . . . . 0.0 109.701 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 71.2 m -95.14 135.54 36.58 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.461 ' CD2' HC11 ' A' 1129 ' ' DA2 . 97.7 m-85 -135.96 158.03 45.4 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.067 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -75.34 131.31 40.18 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.81 152.52 43.79 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.583 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -111.45 134.34 53.1 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.526 ' HA ' HG22 ' A' ' 106' ' ' ILE . 70.0 mt -72.15 125.07 30.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 C-N-CA 123.432 0.693 . . . . 0.0 111.659 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -96.28 -41.73 8.51 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.085 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -150.78 152.03 33.21 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 72.2 mt -124.77 136.04 62.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -112.67 91.61 3.72 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 174.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -65.64 -25.61 67.43 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.729 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -64.6 -44.11 91.67 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.936 -176.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -98.22 -5.53 33.11 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.97 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.422 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 68.19 40.94 87.68 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -175.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 40.3 p -125.41 155.93 39.62 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 122.641 -0.329 . . . . 0.0 110.143 -177.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -141.74 145.73 35.17 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.122 0.487 . . . . 0.0 111.105 176.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.99 125.03 35.67 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.526 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -128.12 154.59 38.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.546 -175.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 92.1 m -120.08 120.24 35.68 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.782 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -66.88 123.13 19.32 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 123.242 0.617 . . . . 0.0 110.38 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.75 137.9 55.81 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.275 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.28 -49.71 3.26 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.879 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -81.95 -35.48 29.01 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 120.758 0.313 . . . . 0.0 110.902 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 82.04 9.74 84.84 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.488 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -81.42 152.68 27.3 Favored 'General case' 0 CA--C 1.49 -1.332 0 O-C-N 122.634 -0.333 . . . . 0.0 110.109 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.09 138.79 40.74 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 120.645 0.26 . . . . 0.0 110.991 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -151.85 161.06 43.26 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.872 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.2 t -98.27 122.04 49.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.0 t -135.8 141.6 37.49 Favored Pre-proline 0 C--N 1.282 -2.348 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -174.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 36.8 Cg_endo -62.54 147.11 95.31 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 122.425 2.083 . . . . 0.0 111.207 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 55.6 mt -55.65 -26.05 42.49 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 123.668 0.787 . . . . 0.0 111.788 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 pp -63.92 -28.89 70.14 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.637 0.732 . . . . 0.0 110.511 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -85.13 -17.62 36.71 Favored 'General case' 0 CA--C 1.484 -1.58 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.661 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 81.1 mt -82.98 125.79 31.8 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-O 121.64 0.733 . . . . 0.0 109.355 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -114.45 154.81 46.49 Favored Pre-proline 0 C--N 1.275 -2.658 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.214 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.38 155.38 70.65 Favored 'Trans proline' 0 C--O 1.255 1.367 0 C-N-CA 121.506 1.47 . . . . 0.0 110.003 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.3 t -74.33 95.67 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -86.65 115.39 24.07 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.322 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -96.86 13.81 27.45 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.498 0.666 . . . . 0.0 110.834 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.778 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 178.762 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 1129 ' ' DA2 . . . . . 0.501 ' HNE' HC21 ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.492 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.6 m 64.21 18.98 11.59 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.091 0.957 . . . . 0.0 110.941 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.6 p -126.61 98.61 5.46 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.766 -174.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.582 ' OE1' ' HD2' ' A' ' 69' ' ' PRO . 6.2 tp-100 -112.15 126.15 28.93 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.582 ' HD2' ' OE1' ' A' ' 68' ' ' GLN . 34.8 Cg_exo -44.24 136.63 8.07 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 124.366 3.377 . . . . 0.0 113.8 175.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.6 t -97.4 -23.88 15.88 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.819 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -135.23 135.49 41.0 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 -175.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.9 p -82.51 108.62 16.05 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 123.474 0.484 . . . . 0.0 110.476 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -115.81 151.95 34.25 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.219 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.409 ' HG2' ' OD2' ' A' ' 77' ' ' ASP . 21.6 pttm -127.79 162.65 26.13 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 173.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.49 135.57 27.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 122.943 0.497 . . . . 0.0 110.419 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.56 18.46 48.51 Favored Glycine 0 C--O 1.239 0.449 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.323 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.409 ' OD2' ' HG2' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -108.01 151.18 26.17 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -91.41 140.82 29.4 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-O 121.604 0.716 . . . . 0.0 109.844 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.42 ' SG ' HD22 ' A' ' 122' ' ' LEU . 16.5 p -146.8 173.01 12.77 Favored 'General case' 0 C--N 1.261 -3.248 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.3 mtp -114.12 130.22 56.59 Favored 'General case' 0 C--N 1.274 -2.695 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -121.19 150.67 40.96 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.38 -175.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.1 t -85.31 117.22 30.0 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.434 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.3 t90 -64.76 123.08 18.44 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.4 m -61.19 -22.8 65.08 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.434 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 28.0 mm-40 -83.28 -42.04 17.62 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -116.21 -15.47 11.05 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 118.849 -1.14 . . . . 0.0 112.124 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.09 6.37 89.2 Favored Glycine 0 C--N 1.315 -0.612 0 C-N-CA 120.394 -0.908 . . . . 0.0 114.098 176.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.453 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 28.3 mm-40 -91.28 161.81 14.88 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 59.4 m -91.33 135.64 33.67 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.453 ' CE1' ' HB2' ' A' ' 88' ' ' GLN . 96.4 m-85 -136.71 157.63 46.31 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.202 0.601 . . . . 0.0 109.481 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -76.43 123.8 26.56 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.43 151.89 49.0 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.845 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -108.54 135.94 48.97 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.576 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.493 ' HA ' HG22 ' A' ' 106' ' ' ILE . 67.4 mt -73.46 118.51 18.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.819 177.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -94.71 -36.49 11.71 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.044 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -152.82 151.09 30.04 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.496 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 68.4 mt -127.15 141.43 46.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -120.77 98.3 5.95 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 173.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -65.75 -25.01 67.08 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -63.08 -46.54 86.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.931 0.396 . . . . 0.0 110.957 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -93.82 -13.6 27.1 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.408 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.506 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 68.87 40.8 84.46 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -175.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.596 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 40.6 p -122.93 155.59 36.42 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.02 145.0 43.55 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.216 0.531 . . . . 0.0 111.108 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.9 121.58 33.63 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.493 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.4 152.84 30.55 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.818 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.9 m -122.65 120.41 33.63 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.548 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -66.7 118.77 10.72 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.871 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.48 134.53 55.78 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.967 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.43 -54.61 2.41 Favored Glycine 0 N--CA 1.424 -2.136 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.554 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -74.77 -43.47 54.68 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.072 0.463 . . . . 0.0 111.059 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.79 4.81 69.26 Favored Glycine 0 N--CA 1.433 -1.525 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.142 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -76.98 151.27 35.73 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -138.44 140.19 39.18 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -177.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -151.75 161.53 42.51 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.8 t -98.71 120.57 48.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.5 t -135.06 141.14 37.08 Favored Pre-proline 0 C--N 1.289 -2.053 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -176.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.596 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.3 Cg_endo -62.51 147.88 94.16 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 122.552 2.168 . . . . 0.0 111.698 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 50.0 mt -55.51 -26.32 42.2 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 123.834 0.854 . . . . 0.0 111.515 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.2 -26.78 68.29 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.968 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.426 HD22 ' HD2' ' A' ' 118' ' ' PRO . 75.4 m-20 -87.91 -17.42 31.41 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.784 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.42 HD22 ' SG ' ' A' ' 79' ' ' CYS . 83.8 mt -81.8 125.87 31.18 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.483 0.659 . . . . 0.0 109.276 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -114.75 151.19 45.14 Favored Pre-proline 0 C--N 1.284 -2.255 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.83 147.53 69.01 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.966 1.778 . . . . 0.0 111.378 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.5 t -80.48 91.35 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.745 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -88.35 138.24 31.61 Favored 'General case' 0 N--CA 1.405 -2.719 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 72.6 30.4 1.87 Allowed 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 125.358 1.463 . . . . 0.0 110.686 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.187 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 177.808 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1129 ' ' DA2 . . . . . 0.515 ' HNE' HC21 ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.3 m -127.94 29.69 5.38 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -83.89 102.9 12.72 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 113.698 -1.592 . . . . 0.0 109.612 -174.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -101.06 107.85 51.89 Favored Pre-proline 0 C--N 1.301 -1.525 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -50.24 134.93 38.3 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 123.802 3.001 . . . . 0.0 113.206 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.7 t -78.54 -22.56 47.09 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.565 0.698 . . . . 0.0 110.284 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -141.05 140.43 34.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.0 m -83.36 105.04 13.99 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.401 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 91.9 m95 -107.72 150.81 26.5 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.199 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -129.9 151.88 49.98 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.4 t -64.4 134.93 28.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.49 30.85 23.44 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.364 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -120.87 157.65 29.36 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -91.81 141.94 28.11 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.285 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.42 ' SG ' HD22 ' A' ' 122' ' ' LEU . 22.5 p -148.26 177.37 9.47 Favored 'General case' 0 C--N 1.265 -3.089 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 36.6 mtp -118.51 130.66 56.05 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 173.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -120.23 150.17 41.1 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -176.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.1 t -86.0 113.91 24.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -64.46 122.64 17.22 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.5 t -65.23 -19.99 66.22 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 120.778 0.323 . . . . 0.0 111.285 -175.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -84.98 -42.65 14.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.497 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 9.2 t70 -108.33 -15.63 14.43 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.086 -175.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.72 2.27 89.84 Favored Glycine 0 C--N 1.316 -0.558 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.512 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.497 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 24.2 mm-40 -95.14 163.28 13.36 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 17.5 p -93.23 136.42 33.51 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.135 0.493 . . . . 0.0 110.74 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -134.07 158.68 42.96 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 124.145 0.978 . . . . 0.0 109.426 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -75.26 128.41 35.37 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.94 151.82 42.94 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.84 0.352 . . . . 0.0 110.905 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -113.75 135.29 54.11 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.433 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.521 ' HA ' HG22 ' A' ' 106' ' ' ILE . 64.3 mt -72.87 122.03 24.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.473 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -99.29 -33.5 10.7 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.462 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -153.66 150.78 28.95 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 77.1 mt -126.53 133.7 68.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -118.27 94.18 4.4 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.74 -20.69 66.01 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -61.4 -46.81 88.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -97.49 -13.88 21.45 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.047 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.485 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.05 36.59 51.29 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -177.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 43.9 p -124.52 155.35 39.14 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -176.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.36 147.88 50.6 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-O 121.011 0.434 . . . . 0.0 110.392 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.48 120.15 34.28 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.521 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.76 149.9 29.43 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.989 -174.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 94.0 m -118.02 120.56 38.17 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.078 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -68.48 125.4 26.36 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.576 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.09 136.95 57.72 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.407 -176.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 86.28 -46.83 3.66 Favored Glycine 0 C--N 1.311 -0.813 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.567 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -79.87 -43.01 23.05 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.155 0.502 . . . . 0.0 110.739 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 88.34 1.33 81.46 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.878 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -70.44 148.71 48.02 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -136.64 133.96 36.81 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -146.86 156.32 43.01 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.0 t -91.1 122.05 42.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.7 t -135.84 141.19 35.86 Favored Pre-proline 0 C--N 1.283 -2.303 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 40.8 Cg_endo -62.38 146.6 95.67 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.423 2.082 . . . . 0.0 110.923 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 55.4 mt -54.66 -26.48 33.57 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 123.504 0.722 . . . . 0.0 111.497 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 pp -63.37 -27.87 69.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.897 0.38 . . . . 0.0 110.703 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -87.39 -14.71 39.89 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.518 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.42 HD22 ' SG ' ' A' ' 79' ' ' CYS . 82.1 mt -84.27 126.28 33.03 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.198 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -114.34 151.54 45.19 Favored Pre-proline 0 C--N 1.285 -2.218 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.78 150.98 68.83 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.747 1.631 . . . . 0.0 111.607 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 64.0 t -79.74 96.26 2.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -85.2 109.51 18.36 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.263 0.554 . . . . 0.0 109.896 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -127.14 21.89 6.7 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.046 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.409 0 N-CA-C 107.644 -2.182 . . . . 0.0 107.644 179.287 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 1129 ' ' DA2 . . . . . 0.54 ' HNE' HC21 ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.471 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.3 m -69.21 104.82 2.3 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 123.286 0.366 . . . . 0.0 111.146 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.2 t -175.42 -179.05 1.22 Allowed 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -115.56 151.39 46.06 Favored Pre-proline 0 C--N 1.286 -2.181 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.87 146.47 91.67 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 122.18 1.92 . . . . 0.0 111.537 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.8 t -74.45 -28.72 61.17 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.375 0.607 . . . . 0.0 110.027 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -141.84 144.95 34.14 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.1 m -87.95 105.62 17.57 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -111.25 151.88 27.79 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 122.754 0.421 . . . . 0.0 111.692 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.412 ' NZ ' ' HB2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -129.1 152.16 49.0 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 175.386 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.4 t -63.98 139.84 20.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 123.325 0.65 . . . . 0.0 110.188 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.19 35.34 34.33 Favored Glycine 0 CA--C 1.497 -1.079 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.2 153.74 38.42 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -91.86 135.34 34.0 Favored 'General case' 0 N--CA 1.412 -2.375 0 O-C-N 123.872 0.732 . . . . 0.0 110.801 175.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 20.5 p -145.99 179.51 7.42 Favored 'General case' 0 C--N 1.27 -2.871 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.412 ' HG3' ' HA ' ' A' ' 125' ' ' VAL . 56.5 mtp -119.97 130.69 54.88 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 173.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.25 151.49 39.09 Favored 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.034 -174.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 88.6 t -85.28 115.8 27.57 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.3 t90 -64.15 121.39 14.1 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.1 t -63.19 -19.84 64.87 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 123.438 0.461 . . . . 0.0 111.431 -175.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -84.73 -43.2 14.5 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.982 -0.687 . . . . 0.0 112.417 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.421 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 11.2 t70 -111.87 -16.41 13.15 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.765 -174.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.59 6.0 89.48 Favored Glycine 0 C--N 1.308 -0.99 0 C-N-CA 119.798 -1.191 . . . . 0.0 113.855 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.421 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 28.9 mm-40 -93.78 163.07 13.67 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 13.0 p -92.12 136.59 33.06 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 120.544 0.212 . . . . 0.0 110.77 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -137.69 157.96 45.37 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 124.052 0.941 . . . . 0.0 109.449 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -75.2 127.29 32.86 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -139.93 153.07 46.85 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.072 0.463 . . . . 0.0 110.964 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -113.01 134.59 54.44 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.45 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.532 ' HA ' HG22 ' A' ' 106' ' ' ILE . 67.4 mt -73.29 123.01 27.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 123.314 0.646 . . . . 0.0 112.2 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -95.13 -43.06 8.28 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.952 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -148.11 149.98 33.02 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.8 mt -129.17 138.33 54.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 O-C-N 123.382 0.426 . . . . 0.0 109.873 177.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -122.96 94.86 4.4 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 174.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.87 -25.95 66.65 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -177.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -61.28 -46.48 90.17 Favored 'General case' 0 C--O 1.221 -0.443 0 O-C-N 123.433 0.458 . . . . 0.0 109.938 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -93.94 -12.6 28.43 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.29 0.567 . . . . 0.0 110.393 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.18 42.02 51.91 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 60.4 p -126.88 157.45 39.33 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 -177.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.44 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -141.56 144.61 34.36 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.887 175.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.27 125.06 36.78 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.532 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -126.81 154.35 36.69 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.629 0 O-C-N 123.41 0.444 . . . . 0.0 110.659 -175.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.4 m -121.26 120.57 35.54 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.769 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -66.78 120.76 14.08 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 123.735 0.814 . . . . 0.0 110.738 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.62 123.81 21.9 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.765 -175.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.93 -34.14 6.02 Favored Glycine 0 N--CA 1.425 -2.059 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.009 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -96.23 -40.45 9.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.815 0.341 . . . . 0.0 111.432 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.06 6.02 65.42 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.256 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -81.28 151.1 28.24 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -140.03 139.15 35.9 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.397 -176.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -147.35 160.55 42.4 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 123.716 0.635 . . . . 0.0 109.471 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.7 t -97.48 114.7 35.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 174.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.5 t -130.14 141.52 42.18 Favored Pre-proline 0 C--N 1.28 -2.455 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -175.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 38.3 Cg_endo -62.97 146.9 95.0 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.04 1.827 . . . . 0.0 111.164 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 60.7 mt -53.0 -26.65 16.01 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.019 0.928 . . . . 0.0 111.918 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 pp -66.28 -24.48 66.57 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.066 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -91.42 -9.82 43.27 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 121.331 0.586 . . . . 0.0 110.561 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.44 HD11 ' HB3' ' A' ' 104' ' ' ALA . 80.1 mt -88.71 127.29 35.59 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.991 175.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -113.86 156.53 43.68 Favored Pre-proline 0 C--N 1.282 -2.345 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -65.56 160.38 43.41 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.086 1.858 . . . . 0.0 109.135 172.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.412 ' HA ' ' HG3' ' A' ' 80' ' ' MET . 89.2 t -70.43 89.01 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 122.153 0.978 . . . . 0.0 109.918 177.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -79.1 114.04 17.72 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 113.907 -1.497 . . . . 0.0 108.719 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -111.29 10.81 21.67 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.412 -2.937 0 N-CA-C 106.721 -2.551 . . . . 0.0 106.721 179.041 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1129 ' ' DA2 . . . . . 0.405 HC21 ' HNE' ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.201 0 CA-C-O 119.531 -0.271 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.7 m 61.38 84.96 0.12 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.753 0.787 . . . . 0.0 111.309 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 p -123.77 134.6 53.63 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.8 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -73.81 127.27 88.65 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.446 ' HB3' ' CD1' ' A' ' 119' ' ' LEU . 74.9 Cg_exo -48.5 153.22 3.43 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.099 3.2 . . . . 0.0 114.332 178.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.8 t -74.11 -25.53 59.84 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 121.328 0.585 . . . . 0.0 110.078 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -141.33 142.53 33.81 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.7 m -78.82 104.79 9.68 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.087 0.47 . . . . 0.0 110.398 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.424 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 91.4 m95 -115.92 151.19 35.84 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.584 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -126.59 152.75 46.21 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.6 t -64.12 131.24 29.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.84 32.23 18.71 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.381 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 2.9 t70 -113.55 158.69 20.45 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -97.53 131.58 44.01 Favored 'General case' 0 N--CA 1.409 -2.486 0 CA-C-O 121.913 0.863 . . . . 0.0 110.862 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.424 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 17.4 p -144.04 179.62 7.08 Favored 'General case' 0 C--N 1.265 -3.074 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.197 -178.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.428 ' HG3' ' HA ' ' A' ' 125' ' ' VAL . 40.0 mtp -118.37 130.27 55.9 Favored 'General case' 0 N--CA 1.41 -2.449 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 172.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.94 149.98 41.24 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -176.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.5 t -85.36 116.18 28.25 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.052 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.492 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.7 t90 -64.31 121.6 14.7 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.7 t -65.08 -18.76 65.57 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 120.926 0.393 . . . . 0.0 111.339 -176.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.492 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 43.6 mt-10 -83.75 -41.84 17.19 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -176.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.53 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 15.9 t70 -114.79 -16.57 11.75 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 118.897 -1.121 . . . . 0.0 111.812 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.26 -0.89 86.0 Favored Glycine 0 C--N 1.3 -1.423 0 C-N-CA 119.832 -1.175 . . . . 0.0 113.47 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.53 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 28.0 mm-40 -85.89 159.13 19.76 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.077 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 8.9 p -93.01 136.2 33.48 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.44 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 88' ' ' GLN . 97.5 m-85 -137.39 158.81 43.6 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 124.36 1.064 . . . . 0.0 108.957 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -74.68 127.11 32.32 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.42 150.35 47.57 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.854 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 77' ' ' ASP . 42.9 tt0 -111.37 132.29 54.54 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.712 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.528 ' HA ' HG22 ' A' ' 106' ' ' ILE . 69.8 mt -71.99 124.39 28.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.079 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -96.14 -39.85 9.5 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.241 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -152.68 152.18 31.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -177.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 71.1 mt -125.55 140.48 48.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -123.87 91.35 3.45 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.92 -22.92 66.53 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -175.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -71.5 -34.59 70.25 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.848 -178.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -98.51 -10.13 23.98 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.727 174.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.432 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 67.55 38.79 90.81 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -178.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 65.0 p -128.61 155.86 44.3 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -175.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.406 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -137.62 148.5 45.86 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 121.161 0.505 . . . . 0.0 110.566 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.68 122.02 38.01 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.528 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.94 154.83 33.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.317 -174.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 94.6 m -118.76 121.07 39.22 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -66.79 118.35 10.19 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.69 117.1 8.37 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.253 -173.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 110.39 -45.92 1.25 Allowed Glycine 0 N--CA 1.423 -2.193 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.847 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -81.83 -36.58 28.18 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.218 0.532 . . . . 0.0 110.975 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.81 2.58 86.45 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 120.081 -1.056 . . . . 0.0 112.01 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -73.52 147.8 43.68 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.31 129.39 25.15 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.473 -176.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -145.91 155.98 43.23 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.8 t -92.04 120.86 41.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.4 t -135.02 140.76 35.9 Favored Pre-proline 0 C--N 1.284 -2.256 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.0 Cg_endo -62.84 148.45 93.42 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.42 2.08 . . . . 0.0 111.463 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.446 ' CD1' ' HB3' ' A' ' 69' ' ' PRO . 56.2 mt -55.69 -26.34 44.5 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 123.883 0.873 . . . . 0.0 111.839 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.6 -25.43 67.39 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.085 0.554 . . . . 0.0 110.957 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.413 HD22 ' HD2' ' A' ' 118' ' ' PRO . 73.9 m-20 -89.61 -13.31 37.43 Favored 'General case' 0 CA--C 1.482 -1.638 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.448 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 104' ' ' ALA . 80.6 mt -86.34 127.23 34.77 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.517 176.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -113.67 154.55 45.68 Favored Pre-proline 0 C--N 1.274 -2.69 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.48 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 45.1 Cg_endo -66.58 160.43 46.09 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.045 1.83 . . . . 0.0 108.284 172.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.428 ' HA ' ' HG3' ' A' ' 80' ' ' MET . 76.7 t -67.74 94.1 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 122.438 1.113 . . . . 0.0 110.824 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 124' ' ' PRO . 41.9 mt-10 -86.86 103.3 15.13 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.57 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -96.69 9.27 42.13 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.628 0.728 . . . . 0.0 110.701 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.411 -2.977 0 N-CA-C 108.691 -1.763 . . . . 0.0 108.691 -179.908 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1129 ' ' DA2 . . . . . 0.417 ' HNE' HC21 ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 120.78 0.324 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.7 t -68.91 -37.76 79.16 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.266 0.555 . . . . 0.0 109.941 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.9 m -129.23 123.38 31.82 Favored 'General case' 0 N--CA 1.416 -2.167 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -95.25 123.95 55.28 Favored Pre-proline 0 C--N 1.292 -1.926 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -48.06 134.1 23.92 Favored 'Trans proline' 0 CA--C 1.51 -0.719 0 C-N-CA 123.54 2.826 . . . . 0.0 113.081 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 t -87.4 -21.63 25.5 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -142.12 137.18 30.75 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.5 t -83.81 112.67 20.32 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -113.05 152.21 29.78 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -122.53 150.24 42.84 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.652 0.381 . . . . 0.0 110.136 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.3 138.53 22.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.36 25.71 53.74 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.708 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 13.0 t0 -105.57 165.43 11.16 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.609 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -94.34 130.87 40.47 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 24.2 p -144.44 174.24 11.1 Favored 'General case' 0 C--N 1.258 -3.404 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.9 mtp -117.22 130.72 56.76 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.46 148.35 42.67 Favored 'General case' 0 C--N 1.264 -3.115 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -175.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 72.3 t -85.33 115.12 26.47 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -63.17 121.48 13.75 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.2 t -62.89 -20.07 64.8 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 122.813 0.445 . . . . 0.0 111.208 -175.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -82.11 -43.08 18.29 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.514 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 14.1 t70 -115.6 -16.13 11.34 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 118.657 -1.217 . . . . 0.0 112.276 -174.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.3 5.18 89.08 Favored Glycine 0 C--N 1.307 -1.053 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.273 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.514 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 29.4 mm-40 -90.7 162.96 14.69 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 176.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 5.5 p -95.99 136.02 36.99 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.516 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.421 ' CD2' HC11 ' A' 1129 ' ' DA2 . 97.2 m-85 -137.88 158.03 45.19 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 124.007 0.923 . . . . 0.0 109.422 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -74.8 132.1 41.31 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.27 155.92 44.6 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.627 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 77' ' ' ASP . 36.5 tt0 -114.61 132.67 56.28 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.542 176.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.593 ' HA ' HG22 ' A' ' 106' ' ' ILE . 71.6 mt -71.48 123.37 25.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 O-C-N 123.67 0.606 . . . . 0.0 112.081 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -96.97 -42.55 7.86 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.09 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 105' ' ' ALA . 26.3 tt0 -144.35 145.03 31.73 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.459 -174.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 80.1 mt -121.74 126.1 74.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -111.51 94.85 5.17 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 175.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -65.4 -25.32 67.5 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.401 -174.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -70.75 -44.59 66.45 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.436 0.636 . . . . 0.0 109.967 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -91.24 -7.77 50.31 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.987 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.525 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 64.63 39.26 96.6 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 53.7 p -123.01 155.93 35.85 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.529 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -138.58 138.8 38.26 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-O 121.279 0.562 . . . . 0.0 110.208 176.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.576 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . . . -87.74 128.36 35.31 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 175.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.593 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -130.37 157.75 42.81 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.53 0 CA-C-O 120.669 0.271 . . . . 0.0 110.721 -175.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 65.2 m -121.68 120.6 35.18 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -67.89 120.67 14.57 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.334 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.67 140.89 58.52 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.179 -176.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.65 -53.92 3.75 Favored Glycine 0 N--CA 1.43 -1.72 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -75.36 -43.16 51.97 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.924 0.392 . . . . 0.0 111.155 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.74 18.28 61.97 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.021 -1.085 . . . . 0.0 111.442 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -87.61 156.12 19.64 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.95 143.52 32.0 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -151.78 162.19 41.42 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 105' ' ' ALA . 57.5 t -100.91 113.83 38.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 174.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.1 t -126.44 141.13 39.1 Favored Pre-proline 0 C--N 1.278 -2.534 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -174.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.567 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 33.2 Cg_endo -62.38 149.99 88.84 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.255 1.97 . . . . 0.0 111.728 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 51.7 mt -56.62 -25.7 53.81 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 123.37 0.668 . . . . 0.0 110.71 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.7 pp -65.0 -23.94 67.36 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.536 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -93.71 -14.87 25.84 Favored 'General case' 0 CA--C 1.49 -1.35 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.571 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.529 HD11 ' HB3' ' A' ' 104' ' ' ALA . 71.6 mt -83.17 126.67 32.87 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -114.61 150.62 44.24 Favored Pre-proline 0 C--N 1.285 -2.228 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -71.59 148.02 52.67 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.436 1.424 . . . . 0.0 110.187 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.8 t -74.7 104.06 2.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.47 95.8 4.56 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.76 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -128.81 13.38 6.35 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.625 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.497 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 -176.351 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 1129 ' ' DA2 . . . . . 0.519 ' HNE' HC21 ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.609 ' HA ' ' O ' ' A' ' 100' ' ' GLU . . . . . . . . 0 CA--C 1.513 -0.479 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.4 p -78.61 -19.79 51.89 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.163 0.506 . . . . 0.0 111.204 -178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.4 t -156.04 163.74 39.3 Favored 'General case' 0 N--CA 1.409 -2.497 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -102.3 135.21 19.64 Favored Pre-proline 0 C--N 1.281 -2.385 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -61.91 134.56 50.59 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.003 1.802 . . . . 0.0 111.409 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.2 t -95.27 -7.4 38.95 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -140.75 133.18 28.43 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.4 p -88.36 105.71 17.76 Favored 'General case' 0 N--CA 1.422 -1.862 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.456 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.489 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 94.2 m95 -99.28 150.89 21.64 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.392 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -134.58 161.59 34.66 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 120.639 -0.425 . . . . 0.0 110.009 176.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.0 t -65.09 131.95 30.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 123.583 0.753 . . . . 0.0 110.008 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.21 38.02 10.53 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.228 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.75 153.32 41.1 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -92.27 133.87 35.42 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-O 121.65 0.738 . . . . 0.0 110.433 174.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.489 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 23.7 p -145.68 179.4 7.46 Favored 'General case' 0 C--N 1.267 -3.004 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.502 ' HG3' ' HA ' ' A' ' 125' ' ' VAL . 61.1 mtp -118.08 131.4 56.44 Favored 'General case' 0 N--CA 1.404 -2.772 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 172.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.26 148.89 41.97 Favored 'General case' 0 C--N 1.264 -3.11 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -175.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.9 t -84.63 113.67 23.67 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.482 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 13.5 t90 -63.29 122.67 16.76 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -177.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.1 t -63.5 -19.66 64.95 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 123.535 0.522 . . . . 0.0 111.583 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.482 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 21.9 mm-40 -84.73 -42.48 15.21 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -111.31 -15.62 13.57 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 118.62 -1.232 . . . . 0.0 111.791 -175.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.29 8.77 87.28 Favored Glycine 0 C--N 1.311 -0.81 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.16 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -101.69 162.31 13.0 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 26.5 p -92.48 136.4 33.24 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.415 0.626 . . . . 0.0 111.828 -178.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -135.8 158.4 44.5 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 124.284 1.033 . . . . 0.0 109.195 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -74.72 126.74 31.53 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -177.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.0 150.48 47.02 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.801 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -109.62 132.5 54.08 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.638 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.551 ' HA ' HG22 ' A' ' 106' ' ' ILE . 60.3 mt -72.52 123.2 26.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 123.165 0.586 . . . . 0.0 111.459 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -96.21 -40.3 9.25 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.982 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -154.71 152.64 30.16 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 57.1 mt -129.56 138.44 54.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.867 0.365 . . . . 0.0 110.076 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -122.34 91.29 3.47 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 173.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -66.9 -19.56 65.75 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.609 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 12.8 tp10 -64.63 -46.31 83.12 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.556 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -90.45 -16.22 29.38 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.586 0.708 . . . . 0.0 109.834 176.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.85 37.91 37.76 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 61.4 p -123.92 155.42 38.17 Favored 'General case' 0 N--CA 1.413 -2.3 0 O-C-N 122.601 -0.352 . . . . 0.0 110.201 -176.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.429 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -138.31 140.53 39.59 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-O 121.178 0.514 . . . . 0.0 109.874 176.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.33 121.9 32.04 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 107.13 -1.434 . . . . 0.0 107.13 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.551 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -126.74 154.83 37.04 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.512 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.99 -175.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 97.6 m -121.86 120.75 35.43 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.521 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -66.86 119.09 11.29 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.554 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.44 130.28 40.31 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.841 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.49 -39.68 2.71 Favored Glycine 0 N--CA 1.427 -1.96 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -96.56 -39.97 9.27 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.244 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.31 -2.68 71.46 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.933 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -71.62 152.0 43.27 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-N 115.687 -0.256 . . . . 0.0 110.356 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -139.68 141.28 36.98 Favored 'General case' 0 C--N 1.285 -2.229 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.568 -176.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -151.25 159.18 44.5 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.4 t -98.35 113.52 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 175.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.8 t -125.13 141.41 38.47 Favored Pre-proline 0 C--N 1.274 -2.675 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 46.0 Cg_endo -63.7 146.94 92.76 Favored 'Trans proline' 0 N--CA 1.443 -1.455 0 C-N-CA 121.777 1.651 . . . . 0.0 110.763 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 42.3 mt -55.51 -26.27 41.94 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 123.537 0.735 . . . . 0.0 110.828 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 pp -63.86 -23.24 67.28 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.214 0.53 . . . . 0.0 110.849 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -93.54 -10.38 35.01 Favored 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.465 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.429 HD11 ' HB3' ' A' ' 104' ' ' ALA . 80.2 mt -84.44 127.43 34.01 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.856 0.836 . . . . 0.0 109.962 176.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -114.26 150.23 43.37 Favored Pre-proline 0 C--N 1.277 -2.574 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.135 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.82 153.79 70.47 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.597 1.531 . . . . 0.0 108.557 170.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.502 ' HA ' ' HG3' ' A' ' 80' ' ' MET . 45.1 t -73.44 97.77 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.246 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -77.28 73.56 3.86 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 122.197 0.999 . . . . 0.0 113.609 -176.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.411 ' HG2' HG12 ' A' ' 125' ' ' VAL . 9.6 pt-20 -122.79 14.67 10.07 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 122.928 1.347 . . . . 0.0 107.813 173.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.407 -3.299 0 N-CA-C 106.252 -2.739 . . . . 0.0 106.252 -179.412 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 1129 ' ' DA2 . . . . . 0.407 ' HNE' HC21 ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.295 0 N-CA-C 111.609 0.226 . . . . 0.0 111.609 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.2 m -91.72 -46.74 7.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.318 0.58 . . . . 0.0 111.179 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 t -106.46 102.39 11.79 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.572 0.701 . . . . 0.0 109.45 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -94.86 145.4 29.5 Favored Pre-proline 0 C--N 1.298 -1.666 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.369 -176.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -60.74 133.84 50.5 Favored 'Trans proline' 0 CA--C 1.515 -0.453 0 C-N-CA 122.596 2.197 . . . . 0.0 111.335 176.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.3 t -91.08 -16.54 27.67 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.05 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -142.22 139.16 31.91 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.2 p -85.78 104.85 15.84 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.451 0.643 . . . . 0.0 110.767 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -105.69 152.11 23.57 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.647 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -127.14 158.9 35.84 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.911 175.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.7 t -65.14 138.0 23.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.863 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.35 38.64 28.53 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.55 154.14 37.08 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -95.22 135.44 36.8 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.97 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 18.7 p -147.17 176.86 9.63 Favored 'General case' 0 C--N 1.263 -3.173 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 34.2 mtp -115.67 130.53 56.89 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -119.74 151.67 38.41 Favored 'General case' 0 C--N 1.277 -2.553 0 O-C-N 123.44 0.462 . . . . 0.0 109.818 -175.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.4 t -85.19 114.27 25.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.504 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 12.4 t90 -67.03 125.52 26.25 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 58.6 m -57.75 -33.02 68.04 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.376 0.608 . . . . 0.0 111.844 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.402 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 30.4 mt-10 -79.07 -41.66 28.25 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -172.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.504 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 42.6 t0 -105.75 -16.3 14.71 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.681 0.753 . . . . 0.0 110.194 -176.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.88 8.13 77.08 Favored Glycine 0 C--N 1.316 -0.529 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.88 178.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -101.49 163.76 12.1 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 15.2 p -93.7 135.58 34.85 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.227 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -134.66 158.18 44.72 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 124.364 1.066 . . . . 0.0 109.185 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -75.26 125.64 29.38 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.26 0.552 . . . . 0.0 109.738 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.42 154.36 46.65 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.652 -177.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -112.09 133.87 53.98 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.286 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.522 ' HA ' HG22 ' A' ' 106' ' ' ILE . 70.7 mt -71.94 122.31 23.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 C-N-CA 123.528 0.731 . . . . 0.0 111.453 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -96.96 -40.54 8.83 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.284 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -151.02 146.97 26.57 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 72.5 mt -122.45 135.88 61.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -120.03 93.97 4.23 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 174.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.13 -19.87 65.97 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -63.87 -46.47 84.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -93.01 -15.39 26.24 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.136 0.493 . . . . 0.0 110.244 178.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.441 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.3 37.02 48.97 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -176.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 41.2 p -125.6 155.81 40.14 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.51 148.6 47.73 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-O 121.233 0.539 . . . . 0.0 110.28 177.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.07 124.79 39.3 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 176.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.522 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -126.75 154.7 36.93 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.693 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.644 -175.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 98.4 m -122.08 120.1 33.31 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -67.19 118.72 10.98 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 123.201 0.6 . . . . 0.0 110.494 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.78 129.41 39.69 Favored 'General case' 0 N--CA 1.436 -1.126 0 O-C-N 124.509 1.131 . . . . 0.0 110.883 -175.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.77 -44.99 1.76 Allowed Glycine 0 N--CA 1.425 -2.088 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.736 178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -82.47 -43.14 17.6 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 120.729 0.299 . . . . 0.0 111.11 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.25 10.42 60.91 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.642 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -85.02 156.92 20.9 Favored 'General case' 0 CA--C 1.488 -1.41 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.03 140.73 32.71 Favored 'General case' 0 C--N 1.29 -2.015 0 O-C-N 123.033 0.208 . . . . 0.0 110.789 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -151.75 158.9 43.98 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 123.371 0.419 . . . . 0.0 109.985 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.1 t -95.79 116.34 37.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.0 t -130.28 141.61 42.52 Favored Pre-proline 0 C--N 1.288 -2.099 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -174.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 42.1 Cg_endo -63.92 146.52 91.55 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.212 1.941 . . . . 0.0 111.108 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 61.6 mt -55.04 -26.15 35.38 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 123.906 0.882 . . . . 0.0 111.952 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.65 -27.05 68.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.057 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -88.9 -12.88 40.49 Favored 'General case' 0 CA--C 1.484 -1.584 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.803 -177.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 84.3 mt -82.64 126.15 32.01 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -114.11 148.43 40.02 Favored Pre-proline 0 C--N 1.28 -2.414 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.35 146.66 57.15 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 C-N-CA 121.31 1.34 . . . . 0.0 111.16 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 65.8 t -73.69 98.79 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 173.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -73.6 101.17 3.53 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -171.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -120.36 12.85 11.78 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 172.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.77 0 N-CA-C 106.988 -2.445 . . . . 0.0 106.988 -177.196 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 1129 ' ' DA2 . . . . . 0.507 ' HNE' HC21 ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.65 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.4 m -62.49 119.06 8.42 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 123.359 0.412 . . . . 0.0 110.521 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.0 m -80.08 124.47 28.77 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.21 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -116.46 124.65 29.25 Favored Pre-proline 0 C--N 1.298 -1.636 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 171.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -52.57 137.95 58.07 Favored 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 122.949 2.433 . . . . 0.0 113.076 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.9 t -74.0 -27.21 60.85 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 122.062 0.934 . . . . 0.0 108.541 175.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -140.55 130.63 24.8 Favored 'General case' 0 N--CA 1.408 -2.539 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 175.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.3 p -78.26 110.11 12.99 Favored 'General case' 0 C--N 1.289 -2.058 0 O-C-N 123.461 0.475 . . . . 0.0 111.112 -178.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -114.25 150.89 33.68 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.34 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -131.01 157.18 43.69 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.464 177.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.76 141.61 17.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 C-N-CA 123.225 0.61 . . . . 0.0 111.05 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.73 31.23 40.94 Favored Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 121.444 -0.407 . . . . 0.0 112.139 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.13 150.16 42.58 Favored 'General case' 0 CA--C 1.481 -1.678 0 CA-C-O 120.533 0.206 . . . . 0.0 111.04 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -90.84 138.64 31.43 Favored 'General case' 0 N--CA 1.406 -2.669 0 CA-C-O 121.858 0.837 . . . . 0.0 110.507 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 18.6 p -147.42 176.39 10.06 Favored 'General case' 0 C--N 1.271 -2.813 0 CA-C-N 113.952 -1.476 . . . . 0.0 107.5 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 41.1 mtp -116.4 130.85 56.98 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 173.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.99 151.9 38.28 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.529 -175.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 72.2 t -88.01 117.55 31.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.406 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.7 t90 -66.5 126.04 27.63 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.3 m -60.08 -30.85 69.5 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 121.232 0.539 . . . . 0.0 112.383 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.406 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 46.6 mt-10 -80.15 -42.55 23.25 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -173.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.436 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 10.0 t70 -109.27 -14.08 14.53 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.136 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.95 3.65 89.41 Favored Glycine 0 C--N 1.305 -1.19 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.604 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.436 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 28.4 mm-40 -93.28 162.72 13.89 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 117.559 0.68 . . . . 0.0 110.255 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 25.0 p -89.94 136.63 32.92 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.23 0.538 . . . . 0.0 110.367 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.412 ' CD2' HC11 ' A' 1129 ' ' DA2 . 96.9 m-85 -137.79 158.05 45.16 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 123.725 0.81 . . . . 0.0 108.955 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -75.21 128.98 36.7 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -142.35 150.12 40.31 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.304 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -110.41 134.56 52.21 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.53 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.455 ' HA ' HG22 ' A' ' 106' ' ' ILE . 66.0 mt -73.03 120.84 22.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.258 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -96.03 -39.07 9.93 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.425 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -151.39 147.79 27.32 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -176.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.7 mt -123.07 143.19 36.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -116.67 91.23 3.52 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 171.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -65.69 -20.29 66.23 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.984 -1.007 . . . . 0.0 113.091 -174.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -65.97 -46.65 77.34 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -91.92 -13.27 31.48 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.688 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.504 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 70.43 41.09 67.82 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -175.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 41.3 p -123.58 155.75 37.06 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.33 146.72 42.72 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.267 0.556 . . . . 0.0 111.134 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.89 122.05 37.12 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.455 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.7 152.12 30.61 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.218 -174.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 90.9 m -117.01 122.99 45.78 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.051 177.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -72.62 124.43 25.24 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.752 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.32 134.42 55.76 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.706 -1.133 . . . . 0.0 111.044 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.8 -48.25 3.26 Favored Glycine 0 N--CA 1.432 -1.591 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.249 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -78.51 -43.4 27.0 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.796 0.332 . . . . 0.0 111.003 -178.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 88.71 11.9 65.13 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.262 -0.97 . . . . 0.0 111.911 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 107' ' ' THR . 4.3 m-20 -81.58 155.98 25.42 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -141.06 138.75 33.83 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.44 162.79 40.32 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 123.358 0.411 . . . . 0.0 109.982 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.6 t -97.56 121.87 48.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.8 t -136.55 141.09 34.24 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -177.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.585 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.4 Cg_endo -63.02 147.46 94.45 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 122.432 2.088 . . . . 0.0 111.346 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 43.4 mt -54.24 -26.79 30.61 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 123.73 0.812 . . . . 0.0 111.501 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 pp -63.97 -27.26 69.01 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.953 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.44 HD22 ' HD2' ' A' ' 118' ' ' PRO . 67.2 m-20 -83.89 -27.27 28.75 Favored 'General case' 0 CA--C 1.487 -1.45 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.661 -178.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 81.5 mt -73.67 127.09 31.82 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.485 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.424 ' HA ' ' HE3' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -112.76 153.96 44.95 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.127 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.96 151.79 56.72 Favored 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 121.607 1.538 . . . . 0.0 111.048 175.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.9 t -84.91 94.49 3.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 176.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -78.2 107.6 10.92 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.966 -174.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -125.7 13.26 8.03 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.824 0.821 . . . . 0.0 109.4 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.412 -2.912 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.803 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 1129 ' ' DA2 . . . . . 0.477 ' HNE' HC21 ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.473 0 CA-C-O 120.617 0.246 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.5 p -77.06 -45.54 26.76 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 95.9 m -88.15 119.93 29.01 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -72.92 117.92 63.87 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -57.58 134.4 62.95 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.141 1.894 . . . . 0.0 111.291 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.0 t -83.98 -23.27 31.11 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.102 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -141.28 136.44 31.61 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.8 m -82.52 105.6 13.7 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 123.391 0.432 . . . . 0.0 110.088 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -111.45 151.39 28.62 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.636 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -128.38 158.93 36.91 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 69.8 t -65.35 133.04 31.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 123.076 0.55 . . . . 0.0 110.066 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.85 31.4 23.83 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.786 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 1.3 t0 -115.32 164.06 14.8 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.836 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.424 ' HB3' HG21 ' A' ' 125' ' ' VAL . 6.4 mmpt? -94.46 131.9 39.67 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.403 ' SG ' HD22 ' A' ' 122' ' ' LEU . 21.0 p -147.0 172.74 13.25 Favored 'General case' 0 C--N 1.267 -3.016 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.1 mtp -117.08 129.91 56.3 Favored 'General case' 0 N--CA 1.411 -2.377 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.0 154.82 37.95 Favored 'General case' 0 C--N 1.273 -2.72 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.451 -173.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.0 t -87.51 122.15 38.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.437 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 10.8 t90 -71.44 122.17 19.91 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.9 m -61.34 -25.23 67.01 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.437 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 13.8 mm-40 -78.4 -42.11 31.14 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.783 -177.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.414 ' OD1' ' HG2' ' A' ' 88' ' ' GLN . 8.2 t70 -114.61 -15.52 11.97 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.271 -174.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.76 0.58 89.54 Favored Glycine 0 C--N 1.31 -0.881 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.688 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.414 ' HG2' ' OD1' ' A' ' 86' ' ' ASP . 27.1 mm-40 -90.97 164.67 13.9 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.189 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 22.0 p -90.37 136.18 33.21 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.787 0.327 . . . . 0.0 110.445 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -136.59 157.75 46.03 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 123.131 0.573 . . . . 0.0 109.777 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -75.41 130.97 39.84 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.52 154.55 43.74 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.746 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 77' ' ' ASP . 36.0 tt0 -112.6 132.24 55.24 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.847 177.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.52 ' HA ' HG22 ' A' ' 106' ' ' ILE . 74.5 mt -69.54 124.4 25.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 O-C-N 123.673 0.608 . . . . 0.0 111.639 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -99.07 -40.65 7.91 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.265 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.667 ' HB3' ' HB3' ' A' ' 105' ' ' ALA . 27.7 tt0 -143.3 143.35 31.66 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -173.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 79.1 mt -125.76 129.65 72.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 175.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -119.01 93.62 4.16 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 174.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -66.16 -20.0 66.01 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.457 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -61.13 -46.95 88.48 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.273 0.558 . . . . 0.0 110.232 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -99.39 -8.92 24.12 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.012 0.434 . . . . 0.0 110.716 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.423 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 71.17 41.5 59.86 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -177.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 75.5 p -123.07 157.33 33.04 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.509 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -139.43 140.26 37.3 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-O 121.167 0.508 . . . . 0.0 109.937 175.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.667 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . . . -89.67 124.55 34.7 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 175.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.52 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -125.1 156.03 33.9 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 CA-C-O 120.855 0.36 . . . . 0.0 110.884 -174.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 97.3 m -121.98 119.89 32.79 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.398 176.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -66.16 125.73 26.44 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.375 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.72 129.53 41.47 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.975 -174.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.28 -50.85 3.36 Favored Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 111.616 -0.593 . . . . 0.0 111.616 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -70.15 -41.69 73.52 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.078 0.466 . . . . 0.0 110.071 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.36 5.5 85.05 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.615 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 107' ' ' THR . 4.0 m-20 -77.17 150.38 35.52 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.56 138.86 36.61 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.806 -176.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -151.69 162.73 40.52 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.209 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.4 t -99.45 119.99 48.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.3 t -132.72 141.17 40.13 Favored Pre-proline 0 C--N 1.281 -2.374 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 30.4 Cg_endo -62.48 148.86 92.65 Favored 'Trans proline' 0 N--CA 1.441 -1.574 0 C-N-CA 122.217 1.944 . . . . 0.0 111.48 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 50.6 mt -54.93 -26.54 36.91 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.793 0.837 . . . . 0.0 111.168 178.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.9 pp -66.88 -24.2 66.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.957 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -89.96 -17.92 27.03 Favored 'General case' 0 CA--C 1.49 -1.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.416 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 104' ' ' ALA . 82.5 mt -82.2 125.37 30.84 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.314 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -115.81 153.97 48.12 Favored Pre-proline 0 C--N 1.281 -2.386 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.648 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.18 145.4 39.02 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 121.347 1.365 . . . . 0.0 110.535 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.424 HG21 ' HB3' ' A' ' 78' ' ' LYS . 48.4 t -77.45 105.56 6.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -67.16 94.26 0.34 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.46 0.648 . . . . 0.0 109.417 174.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -107.13 -6.64 17.24 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.756 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.279 -2.638 0 CA-C-N 113.887 -1.506 . . . . 0.0 109.47 -179.197 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 1129 ' ' DA2 . . . . . 0.472 ' HNE' HC21 ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.431 0 CA-C-O 121.062 0.458 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.7 m -76.42 -36.4 58.04 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 176.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.654 ' HB ' ' O ' ' A' ' 99' ' ' GLU . 24.5 m -97.36 108.61 21.38 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 176.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.442 ' OE1' ' HA ' ' A' ' 68' ' ' GLN . 13.6 mm-40 -86.75 119.45 71.25 Favored Pre-proline 0 C--N 1.288 -2.083 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.952 -176.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.32 134.8 31.72 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 124.069 3.179 . . . . 0.0 112.955 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.5 t -79.04 -19.5 51.26 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 122.153 0.978 . . . . 0.0 108.889 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -140.95 136.17 31.94 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.9 t -78.94 105.18 10.08 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.427 0.632 . . . . 0.0 109.489 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -112.85 151.12 30.78 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.711 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -133.37 160.69 36.62 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 175.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.9 t -64.87 133.46 30.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.528 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.12 30.89 21.57 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.779 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.03 152.17 35.21 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -92.12 132.4 36.63 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.91 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 18.0 p -142.53 174.72 10.38 Favored 'General case' 0 C--N 1.259 -3.327 0 CA-C-N 114.403 -1.271 . . . . 0.0 107.78 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 38.4 mtp -115.52 130.19 56.79 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 173.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -121.27 149.55 42.72 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.488 -176.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.8 t -85.04 116.5 28.63 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -63.74 120.64 12.24 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.9 t -63.65 -18.6 64.12 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 122.854 0.462 . . . . 0.0 111.298 -175.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -85.1 -42.51 14.72 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.439 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 11.0 t70 -115.91 -15.82 11.19 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 119.123 -1.031 . . . . 0.0 112.118 -173.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.32 -5.78 83.55 Favored Glycine 0 C--N 1.31 -0.861 0 C-N-CA 119.853 -1.165 . . . . 0.0 114.293 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.476 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 25.8 mm-40 -83.61 158.4 21.91 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 22.2 p -90.37 136.04 33.31 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.936 0.398 . . . . 0.0 109.977 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.476 ' CE2' ' HB2' ' A' ' 88' ' ' GLN . 97.4 m-85 -136.91 158.53 44.24 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.612 0.765 . . . . 0.0 109.681 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -75.33 123.36 25.22 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -135.74 149.87 49.33 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.89 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -112.05 132.35 54.87 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.986 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.494 ' HA ' HG22 ' A' ' 106' ' ' ILE . 64.5 mt -71.52 123.08 25.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.948 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -96.77 -41.34 8.52 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.09 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -151.7 142.09 22.49 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.574 -176.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 69.0 mt -113.44 138.35 43.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -120.8 92.06 3.67 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.654 ' O ' ' HB ' ' A' ' 67' ' ' THR . 8.9 pt-20 -65.76 -18.05 65.05 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.65 -46.91 80.51 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 121.412 0.625 . . . . 0.0 109.659 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -93.8 -15.66 24.89 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.566 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.42 37.4 47.36 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -175.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 42.8 p -125.36 155.79 39.74 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -176.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.58 144.64 48.06 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-O 121.238 0.542 . . . . 0.0 110.412 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.62 121.79 32.85 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.494 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.57 151.9 30.22 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.705 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.477 -175.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.8 m -119.71 121.26 38.82 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -67.73 118.24 10.72 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.46 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.28 126.27 29.16 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.171 -173.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.81 -37.69 3.66 Favored Glycine 0 N--CA 1.425 -2.065 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.097 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -89.9 -43.61 10.48 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.921 0.391 . . . . 0.0 110.172 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.43 4.91 62.17 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.044 -178.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -79.84 156.64 27.28 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 117.039 0.42 . . . . 0.0 109.934 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -143.1 143.56 31.89 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 120.564 0.221 . . . . 0.0 110.622 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -151.67 162.48 40.93 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.8 t -103.73 115.37 45.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.9 t -128.72 141.5 41.81 Favored Pre-proline 0 C--N 1.279 -2.498 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.08 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.2 Cg_endo -62.18 146.46 95.99 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 122.456 2.104 . . . . 0.0 111.457 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 60.1 mt -55.15 -26.39 38.35 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 123.623 0.769 . . . . 0.0 111.469 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 pp -66.22 -24.37 66.6 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.958 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -90.26 -16.38 29.46 Favored 'General case' 0 CA--C 1.479 -1.763 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 84.7 mt -80.98 126.24 31.14 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.86 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -114.8 147.43 38.2 Favored Pre-proline 0 C--N 1.288 -2.084 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -67.36 150.64 81.02 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 122.006 1.804 . . . . 0.0 110.837 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.1 t -82.92 83.48 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -90.94 76.7 6.23 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 61.82 20.55 11.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.777 -1.556 . . . . 0.0 113.606 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.042 0 CA-C-O 118.406 -1.219 . . . . 0.0 111.027 177.305 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A 1129 ' ' DA2 . . . . . 0.502 ' HNE' HC21 ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.619 0 CA-C-O 120.731 0.301 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.4 m -74.24 -40.06 62.64 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 122.224 1.011 . . . . 0.0 108.353 176.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.5 m -138.8 148.42 43.78 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 174.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -105.82 133.15 20.33 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -58.02 134.01 59.43 Favored 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.637 2.224 . . . . 0.0 112.594 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.6 t -88.94 -18.95 26.44 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.345 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 24.5 t-80 -141.54 149.03 40.3 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -177.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.4 m -88.79 104.8 17.25 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -110.81 151.15 28.15 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.819 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -126.87 153.21 46.02 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.67 133.13 30.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 175.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.11 39.42 9.28 Favored Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.484 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -117.79 161.17 20.16 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -98.75 131.24 45.05 Favored 'General case' 0 N--CA 1.394 -3.258 0 CA-C-O 122.1 0.953 . . . . 0.0 110.818 175.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.5 p -143.63 168.09 20.71 Favored 'General case' 0 C--N 1.262 -3.227 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.129 -177.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 31.3 mtp -111.83 130.2 55.89 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 172.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -121.42 149.47 42.97 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.4 t -85.42 117.01 29.66 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.465 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.5 t90 -66.76 123.05 19.06 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.5 m -60.24 -26.36 66.36 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.465 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 45.4 mt-10 -82.09 -41.98 19.8 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.005 -174.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -110.99 -15.48 13.74 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.762 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.28 10.51 86.16 Favored Glycine 0 C--N 1.307 -1.056 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.643 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -98.94 160.09 14.5 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 23.0 p -90.34 136.33 33.12 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 120.879 0.371 . . . . 0.0 110.916 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.4 ' CD2' HC11 ' A' 1129 ' ' DA2 . 96.7 m-85 -136.46 158.14 45.14 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 123.725 0.81 . . . . 0.0 110.085 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -76.66 125.89 30.03 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.415 0.626 . . . . 0.0 109.887 -177.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -139.25 155.06 48.02 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.688 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -114.49 132.47 56.28 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.138 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.545 ' HA ' HG22 ' A' ' 106' ' ' ILE . 69.4 mt -70.88 123.85 25.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.311 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -98.34 -40.53 8.27 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.545 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 105' ' ' ALA . 29.1 tt0 -148.43 146.35 28.4 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -174.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 72.1 mt -124.72 137.61 56.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -116.98 95.48 5.02 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 174.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -65.99 -22.1 66.44 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -67.86 -46.78 70.77 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 121.277 0.561 . . . . 0.0 110.354 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -92.39 -9.47 41.61 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.784 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.545 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 64.56 41.98 97.62 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -176.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 41.6 p -126.23 155.9 41.12 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.73 149.01 43.11 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.207 0.527 . . . . 0.0 111.313 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . . . -95.41 124.05 39.24 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 176.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.545 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -126.41 155.07 36.53 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.046 -175.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.7 m -121.79 120.34 34.32 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -68.91 121.63 16.99 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.381 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.1 135.34 57.15 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.167 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.74 -46.13 3.29 Favored Glycine 0 C--N 1.309 -0.934 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.743 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -77.23 -40.24 45.58 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.985 0.421 . . . . 0.0 110.698 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.97 7.89 76.85 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.526 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -82.07 149.25 28.15 Favored 'General case' 0 CA--C 1.485 -1.519 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -144.05 137.57 27.71 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.803 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -151.83 160.55 43.51 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 123.521 0.513 . . . . 0.0 110.031 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.0 t -93.34 122.07 44.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.4 t -135.75 141.21 36.12 Favored Pre-proline 0 C--N 1.282 -2.328 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -177.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.2 Cg_endo -63.21 148.55 92.99 Favored 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 122.273 1.982 . . . . 0.0 111.497 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 50.6 mt -55.54 -26.32 42.6 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 123.858 0.863 . . . . 0.0 111.412 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 pp -63.97 -26.97 68.82 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 121.434 0.635 . . . . 0.0 110.497 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.453 HD22 ' HD2' ' A' ' 118' ' ' PRO . 67.5 m-20 -84.17 -26.03 29.13 Favored 'General case' 0 CA--C 1.476 -1.902 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.576 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.2 mt -78.3 126.23 30.49 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.272 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -114.67 150.32 43.77 Favored Pre-proline 0 C--N 1.288 -2.086 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 175.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.85 146.91 48.93 Favored 'Trans proline' 0 C--N 1.325 -0.663 0 C-N-CA 121.493 1.462 . . . . 0.0 110.871 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.4 t -79.83 100.71 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -85.67 118.7 25.34 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -102.57 4.61 38.62 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.763 0.792 . . . . 0.0 110.338 -178.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.415 -2.738 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 -178.04 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 1129 ' ' DA2 . . . . . 0.406 ' HNE' HC21 ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.207 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.5 t -71.9 -30.65 65.59 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.1 m -119.95 134.85 55.12 Favored 'General case' 0 N--CA 1.4 -2.933 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 175.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -116.92 132.72 23.28 Favored Pre-proline 0 C--N 1.297 -1.698 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.8 136.49 42.03 Favored 'Trans proline' 0 C--O 1.25 1.081 0 C-N-CA 122.069 1.846 . . . . 0.0 110.804 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.8 t -74.14 -23.56 59.29 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.736 -176.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -140.95 140.18 34.39 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.7 m -81.24 104.93 12.05 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.139 0.495 . . . . 0.0 110.002 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.419 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 92.0 m95 -112.79 151.25 30.56 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.252 177.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -133.71 155.24 50.09 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.355 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.9 t -63.5 141.42 18.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.15 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.13 27.92 51.1 Favored Glycine 0 CA--C 1.498 -0.975 0 C-N-CA 121.401 -0.428 . . . . 0.0 112.527 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.46 153.81 41.43 Favored 'General case' 0 CA--C 1.488 -1.438 0 CA-C-O 120.927 0.394 . . . . 0.0 111.774 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -90.71 141.28 28.95 Favored 'General case' 0 N--CA 1.413 -2.321 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.76 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.419 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 14.2 p -147.99 175.2 11.18 Favored 'General case' 0 C--N 1.265 -3.097 0 CA-C-N 113.573 -1.649 . . . . 0.0 107.158 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.404 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 82.0 mmm -112.13 129.38 56.25 Favored 'General case' 0 C--N 1.271 -2.811 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 175.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -122.39 147.52 46.19 Favored 'General case' 0 C--N 1.266 -3.063 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.089 -176.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.8 t -85.09 115.01 26.17 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.473 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 12.7 t90 -64.44 121.22 13.86 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.6 t -63.12 -20.25 65.2 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 123.434 0.459 . . . . 0.0 111.658 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.473 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 37.6 mm-40 -84.82 -42.22 15.34 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -177.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -109.74 -15.98 14.01 Favored 'General case' 0 CA--C 1.507 -0.708 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.239 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.59 9.33 86.97 Favored Glycine 0 C--O 1.221 -0.66 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.076 177.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -102.85 162.03 13.26 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 7.1 p -89.87 136.6 32.94 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.085 0.469 . . . . 0.0 111.91 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -136.06 158.52 44.21 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 124.866 1.266 . . . . 0.0 109.134 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -75.03 127.95 34.43 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.41 151.98 43.92 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.71 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -111.33 133.35 53.71 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.394 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.438 ' HA ' HG22 ' A' ' 106' ' ' ILE . 67.8 mt -72.67 123.94 28.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 123.745 0.818 . . . . 0.0 111.92 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -99.69 -38.21 8.8 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.989 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -151.79 143.91 23.92 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.879 -175.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 64.5 mt -124.29 140.23 48.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -124.39 94.39 4.19 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 171.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -66.28 -23.11 66.33 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -66.76 -44.14 82.22 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.397 0.617 . . . . 0.0 109.821 -179.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -92.67 -9.51 40.57 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.357 0.599 . . . . 0.0 110.367 177.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 68.13 39.19 88.61 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.527 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 73.8 p -125.28 155.42 40.19 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 122.265 -0.55 . . . . 0.0 110.405 -176.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.449 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -138.48 146.15 41.7 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 121.461 0.648 . . . . 0.0 110.601 176.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.62 121.59 36.34 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.438 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.97 153.19 31.93 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.679 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.862 -175.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 87.8 m -120.38 120.37 35.78 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.779 177.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -67.33 124.85 24.29 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 123.543 0.737 . . . . 0.0 110.72 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.24 129.28 39.43 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.023 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.28 -39.59 2.83 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.919 178.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -87.06 -40.24 14.87 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.286 0.565 . . . . 0.0 110.157 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.21 11.29 72.87 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.823 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -80.51 154.07 27.76 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.91 139.1 30.62 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.729 -176.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -149.2 160.58 43.24 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 56.8 t -98.06 114.82 36.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 176.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.3 t -130.67 141.4 41.82 Favored Pre-proline 0 C--N 1.281 -2.408 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -175.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.591 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 40.9 Cg_endo -63.05 148.36 93.48 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.371 2.047 . . . . 0.0 111.682 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 54.3 mt -55.2 -26.78 41.39 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.595 0.758 . . . . 0.0 111.539 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.63 -23.5 66.82 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.248 0.547 . . . . 0.0 111.057 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -92.13 -13.24 31.01 Favored 'General case' 0 CA--C 1.485 -1.551 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.026 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.449 HD11 ' HB3' ' A' ' 104' ' ' ALA . 82.1 mt -85.28 125.95 33.32 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 71.0 mmtt -114.75 153.19 46.89 Favored Pre-proline 0 C--N 1.284 -2.276 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.84 154.02 53.49 Favored 'Trans proline' 0 C--O 1.248 1.021 0 C-N-CA 121.475 1.45 . . . . 0.0 111.869 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 46.1 t -81.76 80.12 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.962 0.887 . . . . 0.0 108.885 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -97.56 99.26 10.65 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.511 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.86 10.8 9.59 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.155 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.415 -2.745 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 -178.675 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 1129 ' ' DA2 . . . . . 0.493 ' HNE' HC21 ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.605 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.8 t -154.79 145.11 22.02 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.6 m -129.52 118.12 21.56 Favored 'General case' 0 N--CA 1.412 -2.347 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -67.45 125.76 91.6 Favored Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.37 134.75 37.12 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.444 2.096 . . . . 0.0 112.233 -176.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.3 t -78.69 -24.49 45.02 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -141.2 137.42 32.62 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.1 m -83.72 112.01 19.68 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.649 0.737 . . . . 0.0 110.916 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.462 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 97.5 m95 -116.3 151.8 35.13 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.872 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -132.97 160.0 38.37 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.61 136.41 26.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 123.687 0.795 . . . . 0.0 111.362 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.21 21.99 46.74 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.33 177.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.66 153.55 28.73 Favored 'General case' 0 CA--C 1.482 -1.655 0 CA-C-O 120.598 0.237 . . . . 0.0 110.453 -177.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -91.81 135.29 34.03 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-O 121.93 0.872 . . . . 0.0 110.809 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.462 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 19.4 p -146.03 176.38 9.76 Favored 'General case' 0 C--N 1.265 -3.085 0 CA-C-N 114.023 -1.444 . . . . 0.0 107.181 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 59.9 mtp -115.82 130.84 57.0 Favored 'General case' 0 C--N 1.27 -2.891 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 173.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.79 150.54 39.62 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -175.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 82.7 t -85.39 115.29 26.77 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.473 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.528 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.0 t90 -63.74 123.25 18.4 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.1 t -62.36 -25.06 67.7 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.229 0.538 . . . . 0.0 110.997 -177.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.528 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 21.5 mm-40 -79.05 -41.73 28.13 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -176.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -115.33 -16.31 11.48 Favored 'General case' 0 CA--C 1.502 -0.891 0 C-N-CA 117.654 -1.618 . . . . 0.0 112.367 -178.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.59 5.75 88.04 Favored Glycine 0 C--N 1.306 -1.116 0 C-N-CA 119.795 -1.193 . . . . 0.0 113.596 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -93.19 161.6 14.35 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 23.4 p -94.25 135.74 35.31 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 120.957 0.408 . . . . 0.0 110.56 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.432 ' CD2' HC11 ' A' 1129 ' ' DA2 . 97.5 m-85 -137.9 157.6 46.08 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 123.741 0.817 . . . . 0.0 109.203 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -75.5 126.02 30.19 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -177.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.25 151.15 47.37 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -112.08 133.37 54.28 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.115 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.49 ' HA ' HG22 ' A' ' 106' ' ' ILE . 66.4 mt -71.72 123.34 25.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 123.558 0.743 . . . . 0.0 111.756 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -97.39 -38.61 9.56 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.513 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -154.97 151.57 28.65 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 71.6 mt -123.33 137.27 57.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -117.68 95.82 5.11 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -65.54 -22.6 66.73 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.768 -1.106 . . . . 0.0 113.022 -177.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -65.08 -46.3 81.7 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 120.603 0.24 . . . . 0.0 110.78 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -95.36 -5.86 42.37 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.84 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.422 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 64.75 43.15 96.67 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -176.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 39.9 p -127.27 156.0 42.61 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -175.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.32 141.7 43.8 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-O 121.09 0.471 . . . . 0.0 110.086 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.04 120.76 29.69 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.49 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.89 154.22 32.57 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.679 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.082 -174.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.7 m -121.82 120.41 34.49 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.469 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -67.11 123.35 20.02 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 123.387 0.675 . . . . 0.0 110.359 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.48 135.67 55.48 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.266 -176.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.92 -55.81 3.7 Favored Glycine 0 N--CA 1.429 -1.784 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.948 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -72.99 -41.94 63.79 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.137 0.494 . . . . 0.0 110.806 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 89.95 2.03 75.54 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.836 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -72.81 158.05 36.29 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -145.14 135.86 24.48 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.591 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -146.97 157.9 43.76 Favored 'General case' 0 N--CA 1.432 -1.336 0 O-C-N 123.715 0.634 . . . . 0.0 109.67 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 69.4 t -91.96 114.32 28.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 174.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.1 t -128.0 141.67 41.97 Favored Pre-proline 0 C--N 1.29 -2.017 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -175.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.57 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 43.5 Cg_endo -64.28 147.13 91.0 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.126 1.884 . . . . 0.0 111.192 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 48.0 mt -55.38 -26.07 39.12 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 123.494 0.717 . . . . 0.0 111.138 178.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.39 -19.47 65.41 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.18 178.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -95.78 -13.27 24.24 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-O 120.951 0.405 . . . . 0.0 111.357 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.414 HD22 ' SG ' ' A' ' 79' ' ' CYS . 83.5 mt -81.94 126.29 31.76 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.257 177.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -114.09 154.3 46.16 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.42 153.11 70.93 Favored 'Trans proline' 0 C--O 1.243 0.763 0 C-N-CA 121.616 1.544 . . . . 0.0 110.428 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.6 t -84.54 98.34 5.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -87.05 116.47 25.13 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.011 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -88.94 1.34 55.6 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.513 0.673 . . . . 0.0 110.621 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.281 -2.494 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 -177.662 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 1129 ' ' DA2 . . . . . 0.432 HC11 ' CD2' ' A' ' 90' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.31 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.3 t -68.86 -43.45 75.36 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 174.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.6 m -120.97 141.94 50.23 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 22.4 tm0? -113.33 123.43 33.35 Favored Pre-proline 0 N--CA 1.428 -1.571 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 176.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -49.99 133.26 34.24 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.277 2.651 . . . . 0.0 114.538 -175.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 t -83.79 -22.01 31.97 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.49 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -141.0 140.45 34.33 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 105.769 -1.938 . . . . 0.0 105.769 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.2 t -87.51 109.92 19.95 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-O 121.605 0.717 . . . . 0.0 109.425 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -112.06 152.21 28.47 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.469 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -131.19 160.95 33.32 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 175.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 99.0 t -66.0 139.31 21.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.771 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.8 32.82 48.63 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 1.4 t70 -110.49 159.18 17.74 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -95.26 131.19 41.59 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 17.9 p -144.65 173.94 11.39 Favored 'General case' 0 C--N 1.263 -3.181 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.8 mtp -117.28 130.55 56.62 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 173.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.04 149.97 40.76 Favored 'General case' 0 C--N 1.27 -2.883 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.9 t -87.41 113.54 24.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.454 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 12.7 t90 -63.46 120.45 11.69 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -179.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.7 t -67.06 -16.58 64.44 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.224 0.535 . . . . 0.0 110.946 -174.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.454 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 38.4 mt-10 -85.1 -42.29 14.93 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.521 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 13.9 t70 -110.31 -15.72 13.89 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.289 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.82 4.39 90.07 Favored Glycine 0 C--N 1.305 -1.17 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.374 176.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.521 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 28.1 mm-40 -94.68 161.26 14.26 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.913 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 7.9 p -92.65 136.08 33.54 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.311 0.577 . . . . 0.0 111.623 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -136.87 157.72 46.09 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 123.797 0.839 . . . . 0.0 109.441 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -75.34 132.98 41.33 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.47 158.09 43.92 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.896 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 77' ' ' ASP . 43.9 tt0 -120.6 134.08 55.31 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.819 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.492 ' HA ' HG22 ' A' ' 106' ' ' ILE . 70.9 mt -71.78 125.33 30.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 O-C-N 123.759 0.662 . . . . 0.0 112.733 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -98.43 -42.54 7.29 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.601 -1.182 . . . . 0.0 111.306 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -148.8 143.44 26.34 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -174.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.0 mt -121.81 138.46 52.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -123.05 92.6 3.74 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 171.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.49 -24.79 67.24 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -177.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -63.04 -45.32 92.8 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.537 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -95.2 -4.71 45.42 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.26 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.61 43.04 97.04 Favored Glycine 0 N--CA 1.438 -1.214 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 41.6 p -128.44 155.7 44.36 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 122.69 -0.3 . . . . 0.0 110.491 -177.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.39 144.52 36.26 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.058 0.456 . . . . 0.0 110.009 175.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.03 124.77 35.05 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.492 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -127.85 152.08 35.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.977 -175.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.3 m -116.23 120.47 39.07 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.988 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -69.12 125.93 28.2 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.915 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.45 128.4 35.86 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.44 -1.255 . . . . 0.0 111.57 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.13 -46.65 2.87 Favored Glycine 0 N--CA 1.437 -1.27 0 C-N-CA 121.293 -0.48 . . . . 0.0 112.798 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -78.75 -33.94 46.11 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.621 0.248 . . . . 0.0 110.981 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 83.88 -0.92 89.34 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.548 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -71.6 150.19 44.92 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.51 132.08 28.78 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.714 -176.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -144.48 160.76 40.56 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.564 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.8 t -96.09 116.21 37.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.2 t -130.69 141.42 41.89 Favored Pre-proline 0 C--N 1.278 -2.533 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -176.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 40.0 Cg_endo -62.92 146.36 94.85 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 122.057 1.838 . . . . 0.0 110.889 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 56.3 mt -54.27 -26.49 29.33 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 123.966 0.906 . . . . 0.0 111.672 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.65 -23.84 66.89 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.289 0.566 . . . . 0.0 110.92 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -90.0 -13.72 35.49 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.994 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.2 mt -85.58 126.34 33.81 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.193 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -114.61 152.75 46.54 Favored Pre-proline 0 C--N 1.281 -2.402 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.9 151.31 50.6 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.48 1.453 . . . . 0.0 110.31 176.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.2 t -76.53 101.53 2.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.302 0.572 . . . . 0.0 110.333 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -74.73 103.99 5.21 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.887 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -98.64 6.85 46.74 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.99 -174.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.282 -2.424 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -178.429 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 1129 ' ' DA2 . . . . . 0.503 ' HNE' HC21 ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.052 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.5 t -78.97 86.42 4.84 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.3 t -164.71 141.6 6.16 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -117.65 114.48 37.82 Favored Pre-proline 0 C--N 1.298 -1.66 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.748 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -58.89 148.31 84.93 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 123.029 2.486 . . . . 0.0 112.44 177.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.7 t -109.95 -15.28 14.1 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.196 0.522 . . . . 0.0 110.682 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -141.66 141.65 33.38 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 -177.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.2 m -93.35 119.85 32.96 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 122.69 0.396 . . . . 0.0 110.378 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -121.54 152.23 39.43 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 123.028 0.531 . . . . 0.0 111.332 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -133.35 154.46 50.71 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.221 177.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.5 t -63.82 141.91 17.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 C-N-CA 123.914 0.886 . . . . 0.0 110.51 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.1 19.39 62.92 Favored Glycine 0 CA--C 1.499 -0.959 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.51 151.88 34.02 Favored 'General case' 0 CA--C 1.477 -1.858 0 CA-C-O 120.502 0.191 . . . . 0.0 110.754 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -90.97 142.03 28.21 Favored 'General case' 0 N--CA 1.399 -2.978 0 O-C-N 123.907 0.755 . . . . 0.0 110.25 176.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 21.0 p -148.99 176.59 10.31 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.207 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 47.5 mtp -116.67 131.23 57.0 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.91 149.05 42.24 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -176.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 88.9 t -85.87 118.77 33.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -67.03 120.58 13.89 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.3 m -57.63 -28.89 64.1 Favored 'General case' 0 C--N 1.288 -2.065 0 C-N-CA 123.205 0.602 . . . . 0.0 112.26 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -77.64 -41.98 36.46 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.953 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.481 ' OD1' ' HG2' ' A' ' 88' ' ' GLN . 9.0 t70 -113.49 -16.26 12.44 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.748 -175.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.83 3.18 90.61 Favored Glycine 0 C--N 1.31 -0.914 0 C-N-CA 120.27 -0.967 . . . . 0.0 113.021 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.481 ' HG2' ' OD1' ' A' ' 86' ' ' ASP . 30.0 mm-40 -94.01 160.85 14.53 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.619 -0.342 . . . . 0.0 110.08 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 11.1 p -90.43 136.8 32.83 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 120.991 0.424 . . . . 0.0 110.528 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.431 ' CD2' HC11 ' A' 1129 ' ' DA2 . 96.8 m-85 -136.46 157.16 47.44 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -78.66 123.96 27.68 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.106 0.479 . . . . 0.0 110.012 -176.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.62 152.32 49.23 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.34 -176.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -108.41 134.25 51.46 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.165 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.546 ' HA ' HG22 ' A' ' 106' ' ' ILE . 63.6 mt -73.25 118.6 18.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.161 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -94.38 -38.72 10.83 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.442 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -153.81 150.4 28.41 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -176.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 68.4 mt -124.7 141.2 45.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -120.6 90.97 3.43 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -66.35 -21.71 66.25 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.427 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -60.09 -46.22 90.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.061 178.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -94.61 -15.61 23.89 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.393 0.616 . . . . 0.0 110.648 176.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.504 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 76.73 37.41 34.41 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -177.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 50.8 p -124.44 158.02 33.79 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.29 147.65 47.58 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.075 0.464 . . . . 0.0 110.501 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.66 121.8 37.76 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 176.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.546 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.83 153.72 32.06 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.72 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.751 -174.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 95.1 m -121.45 121.29 37.21 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -68.7 119.71 13.53 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.995 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.38 130.65 43.75 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 124.262 0.976 . . . . 0.0 110.284 -175.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.09 -51.26 1.29 Allowed Glycine 0 N--CA 1.429 -1.819 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.456 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -76.79 -43.62 36.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.762 0.315 . . . . 0.0 110.76 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.22 2.27 66.19 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.339 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -75.99 154.53 35.74 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.23 138.79 31.69 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -152.34 162.81 40.64 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 123.178 0.299 . . . . 0.0 110.642 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.2 t -97.82 120.37 47.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.3 t -133.96 141.02 38.13 Favored Pre-proline 0 C--N 1.284 -2.256 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -176.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.4 Cg_endo -64.21 146.97 91.2 Favored 'Trans proline' 0 N--CA 1.438 -1.765 0 C-N-CA 122.071 1.847 . . . . 0.0 111.436 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 45.2 mt -53.93 -26.41 25.27 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 123.864 0.865 . . . . 0.0 111.317 178.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 pp -68.09 -21.61 64.95 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.119 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -93.09 -17.88 23.28 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.064 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 85.9 mt -77.74 126.83 31.47 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 121.435 0.636 . . . . 0.0 109.856 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -114.4 155.47 45.79 Favored Pre-proline 0 C--N 1.291 -1.965 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.55 148.7 48.26 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 121.735 1.623 . . . . 0.0 111.356 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.9 t -76.9 96.88 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 CA-C-O 121.226 0.536 . . . . 0.0 110.376 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -92.92 116.03 28.67 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.294 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -107.03 13.31 27.64 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.669 0.747 . . . . 0.0 110.256 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.272 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.628 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A 1129 ' ' DA2 . . . . . 0.487 ' HNE' HC21 ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.3 m . . . . . 0 N--CA 1.438 -1.072 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.403 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 98.0 m95 -113.54 151.48 31.53 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.136 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -129.25 159.74 35.15 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.99 133.38 30.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 123.078 0.551 . . . . 0.0 110.766 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.54 26.87 37.45 Favored Glycine 0 CA--C 1.499 -0.943 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.444 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.74 155.47 19.66 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -96.4 131.47 42.92 Favored 'General case' 0 C--N 1.274 -2.698 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.243 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.403 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 17.3 p -144.03 176.67 9.12 Favored 'General case' 0 C--N 1.263 -3.181 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.561 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 41.1 mtp -119.23 130.44 55.46 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 172.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.79 153.61 34.18 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -175.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.7 t -86.74 116.81 29.93 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.442 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -66.35 123.61 20.45 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.4 t -61.2 -23.36 65.54 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.219 0.533 . . . . 0.0 111.483 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -83.16 -42.63 17.09 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -106.71 -17.24 14.28 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.222 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.24 3.5 82.06 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 119.554 -1.307 . . . . 0.0 112.398 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -91.48 163.85 14.02 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 24.7 p -94.84 136.42 35.18 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.697 0.284 . . . . 0.0 110.7 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -136.71 157.56 46.47 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 123.535 0.734 . . . . 0.0 109.581 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -75.09 129.47 37.63 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -145.02 152.94 40.92 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.121 -177.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -112.53 134.96 53.79 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.346 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.476 ' HA ' HG22 ' A' ' 106' ' ' ILE . 73.9 mt -71.63 123.21 25.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 123.252 0.621 . . . . 0.0 111.491 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -98.66 -37.41 9.52 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.01 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -152.86 145.42 24.18 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 68.5 mt -121.68 140.06 46.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -121.73 97.13 5.35 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 172.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.08 -24.67 67.52 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -176.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -68.17 -45.78 72.53 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.4 m-80 -87.32 -15.22 38.62 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.386 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.436 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 67.62 40.46 90.5 Favored Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -176.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.615 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 69.9 p -124.7 157.9 34.5 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -177.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.456 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -139.85 141.15 36.66 Favored 'General case' 0 C--N 1.29 -2.022 0 CA-C-O 121.308 0.575 . . . . 0.0 110.408 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.92 121.13 29.96 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.476 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.92 153.47 32.06 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.756 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.973 -174.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.2 m -120.44 120.46 35.98 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.725 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -69.56 117.74 11.54 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.581 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.26 133.07 49.83 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.948 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.9 -42.95 2.01 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.869 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -87.63 -43.45 11.95 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.305 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.77 3.59 62.31 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.218 -0.992 . . . . 0.0 112.127 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -77.57 152.7 33.85 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -141.24 143.49 34.16 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -151.55 159.12 44.26 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 123.962 0.788 . . . . 0.0 109.026 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.0 t -97.66 113.92 33.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -128.49 141.32 41.07 Favored Pre-proline 0 C--N 1.288 -2.098 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -174.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.615 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 40.6 Cg_endo -62.6 147.7 94.41 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.447 2.098 . . . . 0.0 111.229 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 45.8 mt -54.44 -26.11 28.96 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.608 0.763 . . . . 0.0 111.592 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.7 pp -64.53 -26.0 68.23 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.342 0.591 . . . . 0.0 110.399 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -89.62 -14.26 35.32 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.955 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.456 HD11 ' HB3' ' A' ' 104' ' ' ALA . 81.7 mt -85.31 125.83 33.24 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.988 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -115.39 151.39 45.9 Favored Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.48 153.43 70.21 Favored 'Trans proline' 0 C--O 1.243 0.742 0 C-N-CA 121.597 1.531 . . . . 0.0 110.913 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 C--N 1.314 -0.953 0 CA-C-O 121.721 0.772 . . . . 0.0 109.003 179.74 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.1 m . . . . . 0 N--CA 1.435 -1.223 0 CA-C-O 120.999 0.428 . . . . 0.0 110.009 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -118.91 151.58 37.87 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.665 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -131.4 153.93 49.17 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.79 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 141.61 17.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 C-N-CA 123.908 0.883 . . . . 0.0 110.746 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.23 28.49 55.84 Favored Glycine 0 CA--C 1.498 -0.972 0 N-CA-C 112.122 -0.391 . . . . 0.0 112.122 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.38 153.28 35.41 Favored 'General case' 0 CA--C 1.483 -1.614 0 CA-C-O 120.814 0.34 . . . . 0.0 110.887 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -90.75 139.12 31.03 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.172 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 17.2 p -148.65 179.52 7.76 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-N 113.719 -1.582 . . . . 0.0 107.327 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 58.4 mtp -120.37 131.18 54.72 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 173.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.95 149.75 41.62 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.8 t -85.35 116.48 28.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -64.19 120.66 12.54 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.7 t -62.37 -21.04 65.02 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 123.578 0.549 . . . . 0.0 111.292 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -84.87 -42.35 15.14 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -112.5 -15.51 13.05 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 119.336 -0.946 . . . . 0.0 111.916 -174.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.1 0.36 89.58 Favored Glycine 0 C--N 1.313 -0.719 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.924 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -93.22 159.86 15.09 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 120.559 -0.456 . . . . 0.0 109.825 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 23.3 p -92.76 137.07 32.68 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.167 0.508 . . . . 0.0 110.945 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -136.46 158.33 44.68 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 123.846 0.858 . . . . 0.0 109.36 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.28 127.99 34.42 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.66 153.65 48.58 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.126 0.488 . . . . 0.0 111.25 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -115.03 132.93 56.44 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.997 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.468 ' HA ' HG22 ' A' ' 106' ' ' ILE . 62.5 mt -73.03 123.78 28.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.928 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -99.9 -38.2 8.72 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.858 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -149.58 143.72 25.75 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -176.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.4 mt -123.24 140.42 46.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -120.43 92.7 3.83 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 173.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -65.94 -23.49 66.62 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.82 -46.71 88.38 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.042 0.537 . . . . 0.0 109.805 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -95.46 -11.65 27.2 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.087 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.438 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 72.32 39.55 57.1 Favored Glycine 0 C--N 1.312 -0.804 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -177.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 35.5 p -124.36 156.96 36.14 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 122.793 0.437 . . . . 0.0 110.217 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.69 148.61 41.05 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.399 0.619 . . . . 0.0 111.089 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -97.52 121.75 39.79 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.468 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.78 154.79 32.78 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.669 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.782 -174.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 91.3 m -120.76 120.3 35.23 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.448 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -67.71 121.58 16.25 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.186 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.24 130.72 46.67 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.552 -175.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.29 -49.94 2.99 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 121.131 -0.557 . . . . 0.0 111.868 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -72.63 -43.25 63.5 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 120.612 0.244 . . . . 0.0 111.235 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.84 8.57 65.07 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.27 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.424 ' O ' ' HA ' ' A' ' 107' ' ' THR . 3.9 m-20 -80.65 148.52 30.19 Favored 'General case' 0 CA--C 1.49 -1.364 0 O-C-N 122.352 -0.499 . . . . 0.0 110.222 178.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -137.64 133.32 34.19 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 -176.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -151.51 162.79 40.36 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.685 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.5 t -96.37 119.88 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.6 t -133.8 140.71 37.4 Favored Pre-proline 0 C--N 1.278 -2.503 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 42.6 Cg_endo -63.71 147.43 92.6 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 122.346 2.031 . . . . 0.0 110.941 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 49.8 mt -53.56 -27.12 24.43 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 123.677 0.791 . . . . 0.0 111.646 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.57 -23.41 66.2 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.249 0.619 . . . . 0.0 111.604 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.4 HD22 ' HD2' ' A' ' 118' ' ' PRO . 72.2 m-20 -91.64 -12.59 33.77 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 121.185 0.517 . . . . 0.0 110.803 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 81.4 mt -84.49 128.21 34.46 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.066 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -111.36 157.59 38.61 Favored Pre-proline 0 C--N 1.294 -1.844 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.76 156.89 63.96 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 121.63 1.554 . . . . 0.0 109.628 170.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 89.8 t . . . . . 0 C--N 1.306 -1.316 0 CA-C-O 121.507 0.67 . . . . 0.0 110.536 -179.961 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.3 p . . . . . 0 N--CA 1.437 -1.111 0 CA-C-O 121.078 0.466 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -109.88 151.99 26.35 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.313 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -124.89 151.0 45.93 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.1 t -64.48 133.78 29.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.54 31.94 26.1 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.139 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 11.0 t0 -113.14 165.02 12.78 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.716 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.412 ' HB3' HG21 ' A' ' 125' ' ' VAL . 6.3 mmpt? -96.72 130.7 43.91 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 176.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 23.6 p -144.93 176.64 9.32 Favored 'General case' 0 C--N 1.265 -3.091 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 38.7 mtp -117.6 130.48 56.41 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 173.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.54 149.82 41.82 Favored 'General case' 0 C--N 1.279 -2.49 0 O-C-N 123.435 0.46 . . . . 0.0 109.865 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.3 t -85.3 117.54 30.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.464 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.6 t90 -66.25 124.86 23.82 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.2 t -61.38 -26.51 67.89 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.15 0.5 . . . . 0.0 111.229 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.464 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 16.2 mm-40 -80.26 -40.06 27.72 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -175.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.433 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 11.6 t70 -115.61 -15.46 11.4 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.77 -177.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.85 6.88 89.14 Favored Glycine 0 C--N 1.307 -1.074 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.142 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.433 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 27.0 mm-40 -95.82 161.29 14.07 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.137 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 25.1 p -90.8 136.77 32.85 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.46 0.648 . . . . 0.0 110.84 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -136.35 158.02 45.42 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.944 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -74.63 131.29 40.8 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.93 153.55 44.44 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.376 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 77' ' ' ASP . 38.3 tt0 -114.04 132.11 56.12 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.578 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.524 ' HA ' HG22 ' A' ' 106' ' ' ILE . 66.3 mt -73.44 125.08 31.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 122.977 0.511 . . . . 0.0 112.37 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -97.87 -40.39 8.53 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.37 1.068 . . . . 0.0 111.201 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -149.28 148.84 30.03 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.3 mt -121.5 131.6 72.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -114.99 90.87 3.44 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -66.5 -20.4 66.03 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.2 -46.26 74.4 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.143 0.497 . . . . 0.0 109.882 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -92.38 -6.3 50.37 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.798 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.85 38.74 94.6 Favored Glycine 0 C--O 1.241 0.55 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 67.4 p -130.29 155.57 46.09 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.45 149.56 48.29 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-O 120.914 0.387 . . . . 0.0 110.509 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.65 124.12 38.49 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.524 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -127.73 155.56 39.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.196 -175.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 75.4 m -117.9 120.37 37.68 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -68.01 123.13 19.77 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.36 130.76 44.09 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.839 -175.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.89 -59.32 0.76 Allowed Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -69.57 -42.59 74.32 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.101 0.477 . . . . 0.0 110.543 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.31 16.26 62.85 Favored Glycine 0 N--CA 1.434 -1.442 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.919 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -86.76 154.61 20.81 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -142.19 136.24 29.73 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 123.099 0.249 . . . . 0.0 110.673 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.03 159.67 43.65 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.2 t -93.71 121.85 44.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 176.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.9 t -134.67 141.49 38.95 Favored Pre-proline 0 C--N 1.287 -2.136 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -176.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 36.9 Cg_endo -61.74 146.23 96.81 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 122.627 2.218 . . . . 0.0 111.415 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 48.4 mt -54.75 -26.08 31.91 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 123.702 0.801 . . . . 0.0 111.858 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.17 -27.98 69.08 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.116 0.484 . . . . 0.0 110.771 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.425 HD22 ' HD2' ' A' ' 118' ' ' PRO . 70.1 m-20 -85.55 -15.06 43.93 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.564 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.1 mt -85.85 125.78 33.56 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -114.97 151.91 46.01 Favored Pre-proline 0 C--N 1.282 -2.355 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -71.0 146.96 53.87 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 121.5 1.467 . . . . 0.0 110.727 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 78' ' ' LYS . 59.1 t . . . . . 0 C--N 1.312 -1.048 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.0 m . . . . . 0 N--CA 1.436 -1.175 0 CA-C-O 121.252 0.549 . . . . 0.0 110.442 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.418 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 93.2 m95 -111.6 151.53 28.67 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.592 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -131.66 159.18 39.07 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.4 t -65.42 135.89 27.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.03 40.88 13.1 Favored Glycine 0 N--CA 1.431 -1.637 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.404 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.41 152.7 41.31 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -95.04 131.21 41.27 Favored 'General case' 0 N--CA 1.402 -2.836 0 O-C-N 123.892 0.745 . . . . 0.0 109.744 174.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.418 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 18.7 p -141.43 177.48 8.09 Favored 'General case' 0 C--N 1.261 -3.257 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 51.5 mtp -118.05 130.75 56.35 Favored 'General case' 0 N--CA 1.4 -2.935 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 173.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.76 150.01 40.5 Favored 'General case' 0 C--N 1.267 -3.001 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -176.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.4 t -84.64 120.76 35.82 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -69.57 127.26 32.35 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.7 m -59.3 -29.07 67.34 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -84.12 -42.01 16.5 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -175.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -105.8 -15.75 14.85 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.702 0.763 . . . . 0.0 110.516 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.29 13.29 73.46 Favored Glycine 0 C--N 1.312 -0.765 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.239 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -102.65 163.86 11.98 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 20.5 p -90.19 136.27 33.15 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.898 0.38 . . . . 0.0 110.604 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -134.38 158.26 44.3 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 124.199 1.0 . . . . 0.0 109.282 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -74.86 125.3 28.52 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -136.95 149.63 47.68 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.159 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -110.91 132.17 54.43 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.892 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.51 ' HA ' HG22 ' A' ' 106' ' ' ILE . 68.1 mt -72.51 123.43 27.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.124 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -98.02 -40.07 8.63 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.914 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -152.39 142.51 22.3 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -175.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 69.9 mt -119.21 131.99 70.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -123.92 90.55 3.29 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -67.17 -20.31 65.71 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.106 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -56.32 -42.86 78.33 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 123.991 0.807 . . . . 0.0 110.227 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -101.81 -1.55 32.04 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.201 0.524 . . . . 0.0 110.215 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.63 39.29 95.34 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.597 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 37.0 p -128.28 155.69 44.19 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 122.382 0.273 . . . . 0.0 110.427 -175.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.93 147.19 46.24 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.77 122.04 34.76 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.51 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -126.01 153.35 34.09 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.497 -175.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.5 m -120.14 120.41 36.11 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -67.8 118.3 10.85 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.32 130.66 41.94 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 114.623 -1.172 . . . . 0.0 110.489 -174.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.02 -41.86 2.09 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -87.37 -43.21 12.29 Favored 'General case' 0 C--N 1.313 -1.006 0 O-C-N 122.515 -0.403 . . . . 0.0 110.955 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.41 1.48 68.95 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.623 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -76.06 148.09 38.2 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -135.32 140.84 45.41 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -152.01 158.16 42.7 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.8 t -93.66 115.46 32.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 175.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.2 t -129.49 141.21 41.04 Favored Pre-proline 0 C--N 1.281 -2.387 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -175.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.5 Cg_endo -61.5 145.03 98.27 Favored 'Trans proline' 0 N--CA 1.437 -1.833 0 C-N-CA 122.165 1.91 . . . . 0.0 110.671 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 55.2 mt -53.94 -26.15 24.07 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 123.887 0.875 . . . . 0.0 111.472 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 pp -64.37 -25.48 68.05 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.093 0.473 . . . . 0.0 110.855 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.425 HD22 ' HD2' ' A' ' 118' ' ' PRO . 73.5 m-20 -88.31 -12.84 42.34 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.86 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 81.3 mt -86.7 125.88 34.18 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.153 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -114.91 155.76 46.0 Favored Pre-proline 0 C--N 1.288 -2.089 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.62 157.22 59.34 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 121.526 1.484 . . . . 0.0 110.46 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 C--N 1.312 -1.045 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.332 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.9 t . . . . . 0 N--CA 1.427 -1.579 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.413 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 95.2 m95 -110.06 151.52 27.1 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.637 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -129.09 159.01 37.34 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.11 134.35 29.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 C-N-CA 123.385 0.674 . . . . 0.0 110.741 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.1 35.97 25.87 Favored Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -117.36 154.53 31.13 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -93.92 132.42 38.39 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-O 121.68 0.752 . . . . 0.0 110.355 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.413 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 19.4 p -142.89 178.88 7.36 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.1 -178.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 33.5 mtp -118.99 130.54 55.74 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.13 149.96 43.87 Favored 'General case' 0 C--N 1.28 -2.455 0 O-C-N 123.517 0.51 . . . . 0.0 109.964 -175.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.0 t -85.3 119.07 33.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -67.16 123.49 20.42 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.2 m -60.31 -28.23 67.95 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.607 0.718 . . . . 0.0 112.087 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -79.59 -41.87 26.21 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.628 -174.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -112.73 -15.74 12.91 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.804 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.39 3.92 89.95 Favored Glycine 0 C--N 1.313 -0.715 0 C-N-CA 120.03 -1.081 . . . . 0.0 113.561 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.451 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 33.0 mm-40 -90.14 161.22 15.87 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 122.362 -0.493 . . . . 0.0 109.701 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 71.2 m -95.14 135.54 36.58 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.451 ' CE2' ' HB2' ' A' ' 88' ' ' GLN . 97.7 m-85 -135.96 158.03 45.4 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.067 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -75.34 131.31 40.18 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.81 152.52 43.79 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.583 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -111.45 134.34 53.1 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.526 ' HA ' HG22 ' A' ' 106' ' ' ILE . 70.0 mt -72.15 125.07 30.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 C-N-CA 123.432 0.693 . . . . 0.0 111.659 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -96.28 -41.73 8.51 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.085 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -150.78 152.03 33.21 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 72.2 mt -124.77 136.04 62.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -112.67 91.61 3.72 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 174.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -65.64 -25.61 67.43 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.729 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -64.6 -44.11 91.67 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.936 -176.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -98.22 -5.53 33.11 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.97 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.422 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 68.19 40.94 87.68 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -175.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 40.3 p -125.41 155.93 39.62 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 122.641 -0.329 . . . . 0.0 110.143 -177.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -141.74 145.73 35.17 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.122 0.487 . . . . 0.0 111.105 176.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.99 125.03 35.67 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.526 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -128.12 154.59 38.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.546 -175.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 92.1 m -120.08 120.24 35.68 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.782 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -66.88 123.13 19.32 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 123.242 0.617 . . . . 0.0 110.38 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.75 137.9 55.81 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.275 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.28 -49.71 3.26 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.879 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -81.95 -35.48 29.01 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 120.758 0.313 . . . . 0.0 110.902 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 82.04 9.74 84.84 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.488 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -81.42 152.68 27.3 Favored 'General case' 0 CA--C 1.49 -1.332 0 O-C-N 122.634 -0.333 . . . . 0.0 110.109 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.09 138.79 40.74 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 120.645 0.26 . . . . 0.0 110.991 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -151.85 161.06 43.26 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.872 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.2 t -98.27 122.04 49.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.0 t -135.8 141.6 37.49 Favored Pre-proline 0 C--N 1.282 -2.348 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -174.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 36.8 Cg_endo -62.54 147.11 95.31 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 122.425 2.083 . . . . 0.0 111.207 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 55.6 mt -55.65 -26.05 42.49 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 123.668 0.787 . . . . 0.0 111.788 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 pp -63.92 -28.89 70.14 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.637 0.732 . . . . 0.0 110.511 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -85.13 -17.62 36.71 Favored 'General case' 0 CA--C 1.484 -1.58 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.661 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 81.1 mt -82.98 125.79 31.8 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-O 121.64 0.733 . . . . 0.0 109.355 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -114.45 154.81 46.49 Favored Pre-proline 0 C--N 1.275 -2.658 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.214 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.38 155.38 70.65 Favored 'Trans proline' 0 C--O 1.255 1.367 0 C-N-CA 121.506 1.47 . . . . 0.0 110.003 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.3 t . . . . . 0 N--CA 1.43 -1.458 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.383 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.9 p . . . . . 0 N--CA 1.43 -1.448 0 CA-C-O 120.87 0.367 . . . . 0.0 110.476 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -115.81 151.95 34.25 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.219 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.409 ' HG2' ' OD2' ' A' ' 77' ' ' ASP . 21.6 pttm -127.79 162.65 26.13 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 173.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.49 135.57 27.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 122.943 0.497 . . . . 0.0 110.419 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.56 18.46 48.51 Favored Glycine 0 C--O 1.239 0.449 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.323 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.409 ' OD2' ' HG2' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -108.01 151.18 26.17 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -91.41 140.82 29.4 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-O 121.604 0.716 . . . . 0.0 109.844 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.42 ' SG ' HD22 ' A' ' 122' ' ' LEU . 16.5 p -146.8 173.01 12.77 Favored 'General case' 0 C--N 1.261 -3.248 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.3 mtp -114.12 130.22 56.59 Favored 'General case' 0 C--N 1.274 -2.695 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -121.19 150.67 40.96 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.38 -175.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.1 t -85.31 117.22 30.0 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.434 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.3 t90 -64.76 123.08 18.44 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.4 m -61.19 -22.8 65.08 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.434 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 28.0 mm-40 -83.28 -42.04 17.62 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -116.21 -15.47 11.05 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 118.849 -1.14 . . . . 0.0 112.124 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.09 6.37 89.2 Favored Glycine 0 C--N 1.315 -0.612 0 C-N-CA 120.394 -0.908 . . . . 0.0 114.098 176.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.453 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 28.3 mm-40 -91.28 161.81 14.88 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 59.4 m -91.33 135.64 33.67 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.453 ' CE1' ' HB2' ' A' ' 88' ' ' GLN . 96.4 m-85 -136.71 157.63 46.31 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.202 0.601 . . . . 0.0 109.481 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -76.43 123.8 26.56 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.43 151.89 49.0 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.845 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -108.54 135.94 48.97 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.576 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.493 ' HA ' HG22 ' A' ' 106' ' ' ILE . 67.4 mt -73.46 118.51 18.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.819 177.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -94.71 -36.49 11.71 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.044 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -152.82 151.09 30.04 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.496 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 68.4 mt -127.15 141.43 46.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -120.77 98.3 5.95 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 173.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -65.75 -25.01 67.08 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -63.08 -46.54 86.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.931 0.396 . . . . 0.0 110.957 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -93.82 -13.6 27.1 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.408 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.506 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 68.87 40.8 84.46 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -175.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.596 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 40.6 p -122.93 155.59 36.42 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.02 145.0 43.55 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.216 0.531 . . . . 0.0 111.108 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.9 121.58 33.63 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.493 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.4 152.84 30.55 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.818 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.9 m -122.65 120.41 33.63 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.548 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -66.7 118.77 10.72 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.871 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.48 134.53 55.78 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.967 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.43 -54.61 2.41 Favored Glycine 0 N--CA 1.424 -2.136 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.554 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -74.77 -43.47 54.68 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.072 0.463 . . . . 0.0 111.059 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.79 4.81 69.26 Favored Glycine 0 N--CA 1.433 -1.525 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.142 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -76.98 151.27 35.73 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -138.44 140.19 39.18 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -177.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -151.75 161.53 42.51 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.8 t -98.71 120.57 48.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.5 t -135.06 141.14 37.08 Favored Pre-proline 0 C--N 1.289 -2.053 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -176.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.596 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.3 Cg_endo -62.51 147.88 94.16 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 122.552 2.168 . . . . 0.0 111.698 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 50.0 mt -55.51 -26.32 42.2 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 123.834 0.854 . . . . 0.0 111.515 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.2 -26.78 68.29 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.968 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.426 HD22 ' HD2' ' A' ' 118' ' ' PRO . 75.4 m-20 -87.91 -17.42 31.41 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.784 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.42 HD22 ' SG ' ' A' ' 79' ' ' CYS . 83.8 mt -81.8 125.87 31.18 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.483 0.659 . . . . 0.0 109.276 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -114.75 151.19 45.14 Favored Pre-proline 0 C--N 1.284 -2.255 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.83 147.53 69.01 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.966 1.778 . . . . 0.0 111.378 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.5 t . . . . . 0 CA--C 1.498 -1.044 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.745 179.784 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.0 m . . . . . 0 N--CA 1.434 -1.227 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.401 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 91.9 m95 -107.72 150.81 26.5 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.199 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -129.9 151.88 49.98 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.4 t -64.4 134.93 28.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.49 30.85 23.44 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.364 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -120.87 157.65 29.36 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -91.81 141.94 28.11 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.285 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.42 ' SG ' HD22 ' A' ' 122' ' ' LEU . 22.5 p -148.26 177.37 9.47 Favored 'General case' 0 C--N 1.265 -3.089 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 36.6 mtp -118.51 130.66 56.05 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 173.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -120.23 150.17 41.1 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -176.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.1 t -86.0 113.91 24.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -64.46 122.64 17.22 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.5 t -65.23 -19.99 66.22 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 120.778 0.323 . . . . 0.0 111.285 -175.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -84.98 -42.65 14.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.497 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 9.2 t70 -108.33 -15.63 14.43 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.086 -175.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.72 2.27 89.84 Favored Glycine 0 C--N 1.316 -0.558 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.512 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.497 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 24.2 mm-40 -95.14 163.28 13.36 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 17.5 p -93.23 136.42 33.51 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.135 0.493 . . . . 0.0 110.74 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -134.07 158.68 42.96 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 124.145 0.978 . . . . 0.0 109.426 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -75.26 128.41 35.37 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.94 151.82 42.94 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.84 0.352 . . . . 0.0 110.905 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -113.75 135.29 54.11 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.433 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.521 ' HA ' HG22 ' A' ' 106' ' ' ILE . 64.3 mt -72.87 122.03 24.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.473 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -99.29 -33.5 10.7 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.462 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -153.66 150.78 28.95 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 77.1 mt -126.53 133.7 68.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -118.27 94.18 4.4 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.74 -20.69 66.01 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -61.4 -46.81 88.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -97.49 -13.88 21.45 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.047 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.485 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.05 36.59 51.29 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -177.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 43.9 p -124.52 155.35 39.14 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -176.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.36 147.88 50.6 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-O 121.011 0.434 . . . . 0.0 110.392 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.48 120.15 34.28 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.521 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.76 149.9 29.43 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.989 -174.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 94.0 m -118.02 120.56 38.17 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.078 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -68.48 125.4 26.36 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.576 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.09 136.95 57.72 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.407 -176.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 86.28 -46.83 3.66 Favored Glycine 0 C--N 1.311 -0.813 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.567 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -79.87 -43.01 23.05 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.155 0.502 . . . . 0.0 110.739 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 88.34 1.33 81.46 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.878 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -70.44 148.71 48.02 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -136.64 133.96 36.81 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -146.86 156.32 43.01 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.0 t -91.1 122.05 42.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.7 t -135.84 141.19 35.86 Favored Pre-proline 0 C--N 1.283 -2.303 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 40.8 Cg_endo -62.38 146.6 95.67 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.423 2.082 . . . . 0.0 110.923 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 55.4 mt -54.66 -26.48 33.57 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 123.504 0.722 . . . . 0.0 111.497 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 pp -63.37 -27.87 69.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.897 0.38 . . . . 0.0 110.703 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -87.39 -14.71 39.89 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.518 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.42 HD22 ' SG ' ' A' ' 79' ' ' CYS . 82.1 mt -84.27 126.28 33.03 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.198 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -114.34 151.54 45.19 Favored Pre-proline 0 C--N 1.285 -2.218 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.78 150.98 68.83 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.747 1.631 . . . . 0.0 111.607 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 64.0 t . . . . . 0 C--N 1.3 -1.574 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.723 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.1 m . . . . . 0 N--CA 1.441 -0.885 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -111.25 151.88 27.79 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 122.754 0.421 . . . . 0.0 111.692 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.412 ' HB2' ' NZ ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -129.1 152.16 49.0 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 175.386 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.4 t -63.98 139.84 20.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 123.325 0.65 . . . . 0.0 110.188 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.19 35.34 34.33 Favored Glycine 0 CA--C 1.497 -1.079 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.2 153.74 38.42 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -91.86 135.34 34.0 Favored 'General case' 0 N--CA 1.412 -2.375 0 O-C-N 123.872 0.732 . . . . 0.0 110.801 175.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 20.5 p -145.99 179.51 7.42 Favored 'General case' 0 C--N 1.27 -2.871 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.412 ' HG3' ' HA ' ' A' ' 125' ' ' VAL . 56.5 mtp -119.97 130.69 54.88 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 173.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.25 151.49 39.09 Favored 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.034 -174.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 88.6 t -85.28 115.8 27.57 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.3 t90 -64.15 121.39 14.1 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.1 t -63.19 -19.84 64.87 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 123.438 0.461 . . . . 0.0 111.431 -175.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -84.73 -43.2 14.5 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.982 -0.687 . . . . 0.0 112.417 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.421 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 11.2 t70 -111.87 -16.41 13.15 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.765 -174.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.59 6.0 89.48 Favored Glycine 0 C--N 1.308 -0.99 0 C-N-CA 119.798 -1.191 . . . . 0.0 113.855 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.421 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 28.9 mm-40 -93.78 163.07 13.67 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 13.0 p -92.12 136.59 33.06 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 120.544 0.212 . . . . 0.0 110.77 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -137.69 157.96 45.37 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 124.052 0.941 . . . . 0.0 109.449 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -75.2 127.29 32.86 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -139.93 153.07 46.85 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.072 0.463 . . . . 0.0 110.964 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -113.01 134.59 54.44 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.45 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.532 ' HA ' HG22 ' A' ' 106' ' ' ILE . 67.4 mt -73.29 123.01 27.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 123.314 0.646 . . . . 0.0 112.2 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -95.13 -43.06 8.28 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.952 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -148.11 149.98 33.02 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.8 mt -129.17 138.33 54.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 O-C-N 123.382 0.426 . . . . 0.0 109.873 177.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -122.96 94.86 4.4 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 174.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.87 -25.95 66.65 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -177.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -61.28 -46.48 90.17 Favored 'General case' 0 C--O 1.221 -0.443 0 O-C-N 123.433 0.458 . . . . 0.0 109.938 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -93.94 -12.6 28.43 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.29 0.567 . . . . 0.0 110.393 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.18 42.02 51.91 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 60.4 p -126.88 157.45 39.33 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 -177.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.44 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -141.56 144.61 34.36 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.887 175.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.27 125.06 36.78 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.532 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -126.81 154.35 36.69 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.629 0 O-C-N 123.41 0.444 . . . . 0.0 110.659 -175.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.4 m -121.26 120.57 35.54 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.769 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -66.78 120.76 14.08 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 123.735 0.814 . . . . 0.0 110.738 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.62 123.81 21.9 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.765 -175.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.93 -34.14 6.02 Favored Glycine 0 N--CA 1.425 -2.059 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.009 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -96.23 -40.45 9.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.815 0.341 . . . . 0.0 111.432 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.06 6.02 65.42 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.256 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -81.28 151.1 28.24 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -140.03 139.15 35.9 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.397 -176.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -147.35 160.55 42.4 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 123.716 0.635 . . . . 0.0 109.471 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.7 t -97.48 114.7 35.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 174.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.5 t -130.14 141.52 42.18 Favored Pre-proline 0 C--N 1.28 -2.455 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -175.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 38.3 Cg_endo -62.97 146.9 95.0 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.04 1.827 . . . . 0.0 111.164 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 60.7 mt -53.0 -26.65 16.01 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.019 0.928 . . . . 0.0 111.918 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 pp -66.28 -24.48 66.57 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.066 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -91.42 -9.82 43.27 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 121.331 0.586 . . . . 0.0 110.561 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.44 HD11 ' HB3' ' A' ' 104' ' ' ALA . 80.1 mt -88.71 127.29 35.59 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.991 175.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -113.86 156.53 43.68 Favored Pre-proline 0 C--N 1.282 -2.345 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -65.56 160.38 43.41 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.086 1.858 . . . . 0.0 109.135 172.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.412 ' HA ' ' HG3' ' A' ' 80' ' ' MET . 89.2 t . . . . . 0 C--N 1.304 -1.384 0 CA-C-O 122.153 0.978 . . . . 0.0 109.918 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 N--CA 1.438 -1.027 0 CA-C-O 121.087 0.47 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.424 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 91.4 m95 -115.92 151.19 35.84 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.584 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -126.59 152.75 46.21 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.6 t -64.12 131.24 29.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.84 32.23 18.71 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.381 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 2.9 t70 -113.55 158.69 20.45 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -97.53 131.58 44.01 Favored 'General case' 0 N--CA 1.409 -2.486 0 CA-C-O 121.913 0.863 . . . . 0.0 110.862 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.424 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 17.4 p -144.04 179.62 7.08 Favored 'General case' 0 C--N 1.265 -3.074 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.197 -178.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.428 ' HG3' ' HA ' ' A' ' 125' ' ' VAL . 40.0 mtp -118.37 130.27 55.9 Favored 'General case' 0 N--CA 1.41 -2.449 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 172.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.94 149.98 41.24 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -176.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.5 t -85.36 116.18 28.25 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.052 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.492 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.7 t90 -64.31 121.6 14.7 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.7 t -65.08 -18.76 65.57 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 120.926 0.393 . . . . 0.0 111.339 -176.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.492 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 43.6 mt-10 -83.75 -41.84 17.19 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -176.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.53 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 15.9 t70 -114.79 -16.57 11.75 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 118.897 -1.121 . . . . 0.0 111.812 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.26 -0.89 86.0 Favored Glycine 0 C--N 1.3 -1.423 0 C-N-CA 119.832 -1.175 . . . . 0.0 113.47 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.53 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 28.0 mm-40 -85.89 159.13 19.76 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.077 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 8.9 p -93.01 136.2 33.48 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.44 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 88' ' ' GLN . 97.5 m-85 -137.39 158.81 43.6 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 124.36 1.064 . . . . 0.0 108.957 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -74.68 127.11 32.32 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.42 150.35 47.57 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.854 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 77' ' ' ASP . 42.9 tt0 -111.37 132.29 54.54 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.712 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.528 ' HA ' HG22 ' A' ' 106' ' ' ILE . 69.8 mt -71.99 124.39 28.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.079 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -96.14 -39.85 9.5 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.241 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -152.68 152.18 31.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -177.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 71.1 mt -125.55 140.48 48.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -123.87 91.35 3.45 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.92 -22.92 66.53 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -175.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -71.5 -34.59 70.25 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.848 -178.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -98.51 -10.13 23.98 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.727 174.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.432 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 67.55 38.79 90.81 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -178.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 65.0 p -128.61 155.86 44.3 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -175.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.406 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -137.62 148.5 45.86 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 121.161 0.505 . . . . 0.0 110.566 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.68 122.02 38.01 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.528 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.94 154.83 33.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.317 -174.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 94.6 m -118.76 121.07 39.22 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -66.79 118.35 10.19 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.69 117.1 8.37 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.253 -173.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 110.39 -45.92 1.25 Allowed Glycine 0 N--CA 1.423 -2.193 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.847 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -81.83 -36.58 28.18 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.218 0.532 . . . . 0.0 110.975 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.81 2.58 86.45 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 120.081 -1.056 . . . . 0.0 112.01 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -73.52 147.8 43.68 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.31 129.39 25.15 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.473 -176.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -145.91 155.98 43.23 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.8 t -92.04 120.86 41.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.4 t -135.02 140.76 35.9 Favored Pre-proline 0 C--N 1.284 -2.256 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.0 Cg_endo -62.84 148.45 93.42 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.42 2.08 . . . . 0.0 111.463 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 56.2 mt -55.69 -26.34 44.5 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 123.883 0.873 . . . . 0.0 111.839 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.6 -25.43 67.39 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.085 0.554 . . . . 0.0 110.957 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.413 HD22 ' HD2' ' A' ' 118' ' ' PRO . 73.9 m-20 -89.61 -13.31 37.43 Favored 'General case' 0 CA--C 1.482 -1.638 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.448 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 104' ' ' ALA . 80.6 mt -86.34 127.23 34.77 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.517 176.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -113.67 154.55 45.68 Favored Pre-proline 0 C--N 1.274 -2.69 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -66.58 160.43 46.09 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.045 1.83 . . . . 0.0 108.284 172.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.428 ' HA ' ' HG3' ' A' ' 80' ' ' MET . 76.7 t . . . . . 0 C--N 1.298 -1.669 0 CA-C-O 122.438 1.113 . . . . 0.0 110.824 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.5 t . . . . . 0 N--CA 1.44 -0.932 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -113.05 152.21 29.78 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -122.53 150.24 42.84 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.652 0.381 . . . . 0.0 110.136 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.3 138.53 22.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.36 25.71 53.74 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.708 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 13.0 t0 -105.57 165.43 11.16 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.609 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -94.34 130.87 40.47 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 24.2 p -144.44 174.24 11.1 Favored 'General case' 0 C--N 1.258 -3.404 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.9 mtp -117.22 130.72 56.76 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.46 148.35 42.67 Favored 'General case' 0 C--N 1.264 -3.115 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -175.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 72.3 t -85.33 115.12 26.47 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -63.17 121.48 13.75 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.2 t -62.89 -20.07 64.8 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 122.813 0.445 . . . . 0.0 111.208 -175.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -82.11 -43.08 18.29 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.514 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 14.1 t70 -115.6 -16.13 11.34 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 118.657 -1.217 . . . . 0.0 112.276 -174.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.3 5.18 89.08 Favored Glycine 0 C--N 1.307 -1.053 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.273 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.514 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 29.4 mm-40 -90.7 162.96 14.69 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 176.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 5.5 p -95.99 136.02 36.99 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.516 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -137.88 158.03 45.19 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 124.007 0.923 . . . . 0.0 109.422 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -74.8 132.1 41.31 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.27 155.92 44.6 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.627 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 77' ' ' ASP . 36.5 tt0 -114.61 132.67 56.28 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.542 176.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.593 ' HA ' HG22 ' A' ' 106' ' ' ILE . 71.6 mt -71.48 123.37 25.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 O-C-N 123.67 0.606 . . . . 0.0 112.081 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -96.97 -42.55 7.86 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.09 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 105' ' ' ALA . 26.3 tt0 -144.35 145.03 31.73 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.459 -174.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 80.1 mt -121.74 126.1 74.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -111.51 94.85 5.17 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 175.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -65.4 -25.32 67.5 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.401 -174.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -70.75 -44.59 66.45 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.436 0.636 . . . . 0.0 109.967 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -91.24 -7.77 50.31 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.987 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.525 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 64.63 39.26 96.6 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 53.7 p -123.01 155.93 35.85 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.529 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -138.58 138.8 38.26 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-O 121.279 0.562 . . . . 0.0 110.208 176.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.576 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . . . -87.74 128.36 35.31 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 175.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.593 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -130.37 157.75 42.81 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.53 0 CA-C-O 120.669 0.271 . . . . 0.0 110.721 -175.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 65.2 m -121.68 120.6 35.18 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -67.89 120.67 14.57 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.334 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.67 140.89 58.52 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.179 -176.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.65 -53.92 3.75 Favored Glycine 0 N--CA 1.43 -1.72 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -75.36 -43.16 51.97 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.924 0.392 . . . . 0.0 111.155 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.74 18.28 61.97 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.021 -1.085 . . . . 0.0 111.442 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -87.61 156.12 19.64 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.95 143.52 32.0 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -151.78 162.19 41.42 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 105' ' ' ALA . 57.5 t -100.91 113.83 38.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 174.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.1 t -126.44 141.13 39.1 Favored Pre-proline 0 C--N 1.278 -2.534 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -174.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.567 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 33.2 Cg_endo -62.38 149.99 88.84 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.255 1.97 . . . . 0.0 111.728 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 51.7 mt -56.62 -25.7 53.81 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 123.37 0.668 . . . . 0.0 110.71 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.7 pp -65.0 -23.94 67.36 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.536 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -93.71 -14.87 25.84 Favored 'General case' 0 CA--C 1.49 -1.35 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.571 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.529 HD11 ' HB3' ' A' ' 104' ' ' ALA . 71.6 mt -83.17 126.67 32.87 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -114.61 150.62 44.24 Favored Pre-proline 0 C--N 1.285 -2.228 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -71.59 148.02 52.67 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.436 1.424 . . . . 0.0 110.187 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.8 t . . . . . 0 C--N 1.306 -1.296 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.553 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.4 p . . . . . 0 N--CA 1.422 -1.862 0 CA-C-O 121.404 0.621 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.489 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 94.2 m95 -99.28 150.89 21.64 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.392 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -134.58 161.59 34.66 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 120.639 -0.425 . . . . 0.0 110.009 176.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.0 t -65.09 131.95 30.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 123.583 0.753 . . . . 0.0 110.008 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.21 38.02 10.53 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.228 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.75 153.32 41.1 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -92.27 133.87 35.42 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-O 121.65 0.738 . . . . 0.0 110.433 174.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.489 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 23.7 p -145.68 179.4 7.46 Favored 'General case' 0 C--N 1.267 -3.004 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.502 ' HG3' ' HA ' ' A' ' 125' ' ' VAL . 61.1 mtp -118.08 131.4 56.44 Favored 'General case' 0 N--CA 1.404 -2.772 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 172.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.26 148.89 41.97 Favored 'General case' 0 C--N 1.264 -3.11 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -175.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.9 t -84.63 113.67 23.67 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.482 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 13.5 t90 -63.29 122.67 16.76 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -177.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.1 t -63.5 -19.66 64.95 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 123.535 0.522 . . . . 0.0 111.583 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.482 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 21.9 mm-40 -84.73 -42.48 15.21 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -111.31 -15.62 13.57 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 118.62 -1.232 . . . . 0.0 111.791 -175.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.29 8.77 87.28 Favored Glycine 0 C--N 1.311 -0.81 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.16 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -101.69 162.31 13.0 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 26.5 p -92.48 136.4 33.24 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.415 0.626 . . . . 0.0 111.828 -178.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -135.8 158.4 44.5 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 124.284 1.033 . . . . 0.0 109.195 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -74.72 126.74 31.53 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -177.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.0 150.48 47.02 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.801 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -109.62 132.5 54.08 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.638 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.551 ' HA ' HG22 ' A' ' 106' ' ' ILE . 60.3 mt -72.52 123.2 26.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 123.165 0.586 . . . . 0.0 111.459 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -96.21 -40.3 9.25 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.982 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -154.71 152.64 30.16 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 57.1 mt -129.56 138.44 54.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.867 0.365 . . . . 0.0 110.076 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -122.34 91.29 3.47 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 173.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -66.9 -19.56 65.75 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -64.63 -46.31 83.12 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.556 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -90.45 -16.22 29.38 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.586 0.708 . . . . 0.0 109.834 176.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.85 37.91 37.76 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 61.4 p -123.92 155.42 38.17 Favored 'General case' 0 N--CA 1.413 -2.3 0 O-C-N 122.601 -0.352 . . . . 0.0 110.201 -176.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.429 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -138.31 140.53 39.59 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-O 121.178 0.514 . . . . 0.0 109.874 176.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.33 121.9 32.04 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 107.13 -1.434 . . . . 0.0 107.13 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.551 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -126.74 154.83 37.04 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.512 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.99 -175.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 97.6 m -121.86 120.75 35.43 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.521 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -66.86 119.09 11.29 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.554 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.44 130.28 40.31 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.841 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.49 -39.68 2.71 Favored Glycine 0 N--CA 1.427 -1.96 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -96.56 -39.97 9.27 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.244 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.31 -2.68 71.46 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.933 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -71.62 152.0 43.27 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-N 115.687 -0.256 . . . . 0.0 110.356 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -139.68 141.28 36.98 Favored 'General case' 0 C--N 1.285 -2.229 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.568 -176.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -151.25 159.18 44.5 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.4 t -98.35 113.52 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 175.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.8 t -125.13 141.41 38.47 Favored Pre-proline 0 C--N 1.274 -2.675 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 46.0 Cg_endo -63.7 146.94 92.76 Favored 'Trans proline' 0 N--CA 1.443 -1.455 0 C-N-CA 121.777 1.651 . . . . 0.0 110.763 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 42.3 mt -55.51 -26.27 41.94 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 123.537 0.735 . . . . 0.0 110.828 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 pp -63.86 -23.24 67.28 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.214 0.53 . . . . 0.0 110.849 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -93.54 -10.38 35.01 Favored 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.465 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.429 HD11 ' HB3' ' A' ' 104' ' ' ALA . 80.2 mt -84.44 127.43 34.01 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.856 0.836 . . . . 0.0 109.962 176.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -114.26 150.23 43.37 Favored Pre-proline 0 C--N 1.277 -2.574 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.135 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.82 153.79 70.47 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.597 1.531 . . . . 0.0 108.557 170.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.502 ' HA ' ' HG3' ' A' ' 80' ' ' MET . 45.1 t . . . . . 0 C--N 1.307 -1.261 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.246 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.435 -1.207 0 CA-C-O 121.451 0.643 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -105.69 152.11 23.57 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.647 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -127.14 158.9 35.84 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.911 175.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.7 t -65.14 138.0 23.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.863 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.35 38.64 28.53 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.55 154.14 37.08 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -95.22 135.44 36.8 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.97 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 18.7 p -147.17 176.86 9.63 Favored 'General case' 0 C--N 1.263 -3.173 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 34.2 mtp -115.67 130.53 56.89 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -119.74 151.67 38.41 Favored 'General case' 0 C--N 1.277 -2.553 0 O-C-N 123.44 0.462 . . . . 0.0 109.818 -175.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.4 t -85.19 114.27 25.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.504 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 12.4 t90 -67.03 125.52 26.25 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 58.6 m -57.75 -33.02 68.04 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.376 0.608 . . . . 0.0 111.844 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.402 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 30.4 mt-10 -79.07 -41.66 28.25 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -172.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.504 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 42.6 t0 -105.75 -16.3 14.71 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.681 0.753 . . . . 0.0 110.194 -176.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.88 8.13 77.08 Favored Glycine 0 C--N 1.316 -0.529 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.88 178.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -101.49 163.76 12.1 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 15.2 p -93.7 135.58 34.85 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.227 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -134.66 158.18 44.72 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 124.364 1.066 . . . . 0.0 109.185 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -75.26 125.64 29.38 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.26 0.552 . . . . 0.0 109.738 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.42 154.36 46.65 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.652 -177.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -112.09 133.87 53.98 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.286 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.522 ' HA ' HG22 ' A' ' 106' ' ' ILE . 70.7 mt -71.94 122.31 23.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 C-N-CA 123.528 0.731 . . . . 0.0 111.453 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -96.96 -40.54 8.83 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.284 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -151.02 146.97 26.57 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 72.5 mt -122.45 135.88 61.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -120.03 93.97 4.23 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 174.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.13 -19.87 65.97 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -63.87 -46.47 84.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -93.01 -15.39 26.24 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.136 0.493 . . . . 0.0 110.244 178.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.441 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.3 37.02 48.97 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -176.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 41.2 p -125.6 155.81 40.14 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.51 148.6 47.73 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-O 121.233 0.539 . . . . 0.0 110.28 177.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.07 124.79 39.3 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 176.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.522 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -126.75 154.7 36.93 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.693 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.644 -175.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 98.4 m -122.08 120.1 33.31 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -67.19 118.72 10.98 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 123.201 0.6 . . . . 0.0 110.494 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.78 129.41 39.69 Favored 'General case' 0 N--CA 1.436 -1.126 0 O-C-N 124.509 1.131 . . . . 0.0 110.883 -175.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.77 -44.99 1.76 Allowed Glycine 0 N--CA 1.425 -2.088 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.736 178.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -82.47 -43.14 17.6 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 120.729 0.299 . . . . 0.0 111.11 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.25 10.42 60.91 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.642 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -85.02 156.92 20.9 Favored 'General case' 0 CA--C 1.488 -1.41 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.03 140.73 32.71 Favored 'General case' 0 C--N 1.29 -2.015 0 O-C-N 123.033 0.208 . . . . 0.0 110.789 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -151.75 158.9 43.98 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 123.371 0.419 . . . . 0.0 109.985 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.1 t -95.79 116.34 37.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.0 t -130.28 141.61 42.52 Favored Pre-proline 0 C--N 1.288 -2.099 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -174.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 42.1 Cg_endo -63.92 146.52 91.55 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.212 1.941 . . . . 0.0 111.108 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 61.6 mt -55.04 -26.15 35.38 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 123.906 0.882 . . . . 0.0 111.952 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.65 -27.05 68.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.057 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -88.9 -12.88 40.49 Favored 'General case' 0 CA--C 1.484 -1.584 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.803 -177.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 84.3 mt -82.64 126.15 32.01 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -114.11 148.43 40.02 Favored Pre-proline 0 C--N 1.28 -2.414 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.35 146.66 57.15 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 C-N-CA 121.31 1.34 . . . . 0.0 111.16 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 65.8 t . . . . . 0 N--CA 1.438 -1.045 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 173.466 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.3 p . . . . . 0 N--CA 1.425 -1.69 0 CA-C-O 120.933 0.397 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -114.25 150.89 33.68 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.34 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -131.01 157.18 43.69 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.464 177.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.76 141.61 17.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 C-N-CA 123.225 0.61 . . . . 0.0 111.05 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.73 31.23 40.94 Favored Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 121.444 -0.407 . . . . 0.0 112.139 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.13 150.16 42.58 Favored 'General case' 0 CA--C 1.481 -1.678 0 CA-C-O 120.533 0.206 . . . . 0.0 111.04 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -90.84 138.64 31.43 Favored 'General case' 0 N--CA 1.406 -2.669 0 CA-C-O 121.858 0.837 . . . . 0.0 110.507 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 18.6 p -147.42 176.39 10.06 Favored 'General case' 0 C--N 1.271 -2.813 0 CA-C-N 113.952 -1.476 . . . . 0.0 107.5 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 41.1 mtp -116.4 130.85 56.98 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 173.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.99 151.9 38.28 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.529 -175.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 72.2 t -88.01 117.55 31.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.406 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.7 t90 -66.5 126.04 27.63 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.3 m -60.08 -30.85 69.5 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 121.232 0.539 . . . . 0.0 112.383 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.406 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 46.6 mt-10 -80.15 -42.55 23.25 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -173.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.436 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 10.0 t70 -109.27 -14.08 14.53 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.136 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.95 3.65 89.41 Favored Glycine 0 C--N 1.305 -1.19 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.604 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.436 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 28.4 mm-40 -93.28 162.72 13.89 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 117.559 0.68 . . . . 0.0 110.255 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 25.0 p -89.94 136.63 32.92 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.23 0.538 . . . . 0.0 110.367 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -137.79 158.05 45.16 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 123.725 0.81 . . . . 0.0 108.955 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -75.21 128.98 36.7 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -142.35 150.12 40.31 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.304 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -110.41 134.56 52.21 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.53 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.455 ' HA ' HG22 ' A' ' 106' ' ' ILE . 66.0 mt -73.03 120.84 22.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.258 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -96.03 -39.07 9.93 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.425 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -151.39 147.79 27.32 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -176.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.7 mt -123.07 143.19 36.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -116.67 91.23 3.52 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 171.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -65.69 -20.29 66.23 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.984 -1.007 . . . . 0.0 113.091 -174.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -65.97 -46.65 77.34 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -91.92 -13.27 31.48 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.688 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.504 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 70.43 41.09 67.82 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -175.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 41.3 p -123.58 155.75 37.06 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.33 146.72 42.72 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.267 0.556 . . . . 0.0 111.134 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.89 122.05 37.12 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.455 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.7 152.12 30.61 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.218 -174.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 90.9 m -117.01 122.99 45.78 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.051 177.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -72.62 124.43 25.24 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.752 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.32 134.42 55.76 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.706 -1.133 . . . . 0.0 111.044 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.8 -48.25 3.26 Favored Glycine 0 N--CA 1.432 -1.591 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.249 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -78.51 -43.4 27.0 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.796 0.332 . . . . 0.0 111.003 -178.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 88.71 11.9 65.13 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.262 -0.97 . . . . 0.0 111.911 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 107' ' ' THR . 4.3 m-20 -81.58 155.98 25.42 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -141.06 138.75 33.83 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.44 162.79 40.32 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 123.358 0.411 . . . . 0.0 109.982 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.6 t -97.56 121.87 48.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.8 t -136.55 141.09 34.24 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -177.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.585 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.4 Cg_endo -63.02 147.46 94.45 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 122.432 2.088 . . . . 0.0 111.346 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 43.4 mt -54.24 -26.79 30.61 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 123.73 0.812 . . . . 0.0 111.501 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 pp -63.97 -27.26 69.01 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.953 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.44 HD22 ' HD2' ' A' ' 118' ' ' PRO . 67.2 m-20 -83.89 -27.27 28.75 Favored 'General case' 0 CA--C 1.487 -1.45 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.661 -178.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 81.5 mt -73.67 127.09 31.82 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.485 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.424 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -112.76 153.96 44.95 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.127 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.96 151.79 56.72 Favored 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 121.607 1.538 . . . . 0.0 111.048 175.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.9 t . . . . . 0 C--N 1.309 -1.169 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 176.923 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.8 m . . . . . 0 N--CA 1.43 -1.432 0 CA-C-O 120.999 0.428 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -111.45 151.39 28.62 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.636 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -128.38 158.93 36.91 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 69.8 t -65.35 133.04 31.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 123.076 0.55 . . . . 0.0 110.066 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.85 31.4 23.83 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.786 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 1.3 t0 -115.32 164.06 14.8 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.836 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.424 ' HB3' HG21 ' A' ' 125' ' ' VAL . 6.4 mmpt? -94.46 131.9 39.67 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.403 ' SG ' HD22 ' A' ' 122' ' ' LEU . 21.0 p -147.0 172.74 13.25 Favored 'General case' 0 C--N 1.267 -3.016 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.1 mtp -117.08 129.91 56.3 Favored 'General case' 0 N--CA 1.411 -2.377 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.0 154.82 37.95 Favored 'General case' 0 C--N 1.273 -2.72 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.451 -173.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.0 t -87.51 122.15 38.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.437 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 10.8 t90 -71.44 122.17 19.91 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.9 m -61.34 -25.23 67.01 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.437 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 13.8 mm-40 -78.4 -42.11 31.14 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.783 -177.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.414 ' OD1' ' HG2' ' A' ' 88' ' ' GLN . 8.2 t70 -114.61 -15.52 11.97 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.271 -174.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.76 0.58 89.54 Favored Glycine 0 C--N 1.31 -0.881 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.688 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.414 ' HG2' ' OD1' ' A' ' 86' ' ' ASP . 27.1 mm-40 -90.97 164.67 13.9 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.189 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 22.0 p -90.37 136.18 33.21 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.787 0.327 . . . . 0.0 110.445 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -136.59 157.75 46.03 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 123.131 0.573 . . . . 0.0 109.777 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -75.41 130.97 39.84 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.52 154.55 43.74 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.746 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 77' ' ' ASP . 36.0 tt0 -112.6 132.24 55.24 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.847 177.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.52 ' HA ' HG22 ' A' ' 106' ' ' ILE . 74.5 mt -69.54 124.4 25.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 O-C-N 123.673 0.608 . . . . 0.0 111.639 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -99.07 -40.65 7.91 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.265 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.667 ' HB3' ' HB3' ' A' ' 105' ' ' ALA . 27.7 tt0 -143.3 143.35 31.66 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -173.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 79.1 mt -125.76 129.65 72.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 175.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -119.01 93.62 4.16 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 174.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -66.16 -20.0 66.01 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.457 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -61.13 -46.95 88.48 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.273 0.558 . . . . 0.0 110.232 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -99.39 -8.92 24.12 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.012 0.434 . . . . 0.0 110.716 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.423 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 71.17 41.5 59.86 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -177.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 75.5 p -123.07 157.33 33.04 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.509 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -139.43 140.26 37.3 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-O 121.167 0.508 . . . . 0.0 109.937 175.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.667 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . . . -89.67 124.55 34.7 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 175.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.52 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -125.1 156.03 33.9 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 CA-C-O 120.855 0.36 . . . . 0.0 110.884 -174.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 97.3 m -121.98 119.89 32.79 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.398 176.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -66.16 125.73 26.44 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.375 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.72 129.53 41.47 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.975 -174.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.28 -50.85 3.36 Favored Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 111.616 -0.593 . . . . 0.0 111.616 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -70.15 -41.69 73.52 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.078 0.466 . . . . 0.0 110.071 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.36 5.5 85.05 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.615 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 107' ' ' THR . 4.0 m-20 -77.17 150.38 35.52 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.56 138.86 36.61 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.806 -176.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -151.69 162.73 40.52 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.209 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.4 t -99.45 119.99 48.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.3 t -132.72 141.17 40.13 Favored Pre-proline 0 C--N 1.281 -2.374 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 30.4 Cg_endo -62.48 148.86 92.65 Favored 'Trans proline' 0 N--CA 1.441 -1.574 0 C-N-CA 122.217 1.944 . . . . 0.0 111.48 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 50.6 mt -54.93 -26.54 36.91 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.793 0.837 . . . . 0.0 111.168 178.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.9 pp -66.88 -24.2 66.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.957 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.426 HD22 ' HD2' ' A' ' 118' ' ' PRO . 74.4 m-20 -89.96 -17.92 27.03 Favored 'General case' 0 CA--C 1.49 -1.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.416 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 104' ' ' ALA . 82.5 mt -82.2 125.37 30.84 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.314 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -115.81 153.97 48.12 Favored Pre-proline 0 C--N 1.281 -2.386 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.648 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.18 145.4 39.02 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 121.347 1.365 . . . . 0.0 110.535 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.424 HG21 ' HB3' ' A' ' 78' ' ' LYS . 48.4 t . . . . . 0 C--N 1.299 -1.592 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -178.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.427 -1.604 0 CA-C-O 121.427 0.632 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -112.85 151.12 30.78 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.711 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -133.37 160.69 36.62 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 175.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.9 t -64.87 133.46 30.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.528 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.12 30.89 21.57 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.779 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.03 152.17 35.21 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -92.12 132.4 36.63 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.91 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 18.0 p -142.53 174.72 10.38 Favored 'General case' 0 C--N 1.259 -3.327 0 CA-C-N 114.403 -1.271 . . . . 0.0 107.78 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 38.4 mtp -115.52 130.19 56.79 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 173.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -121.27 149.55 42.72 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.488 -176.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.8 t -85.04 116.5 28.63 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -63.74 120.64 12.24 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.9 t -63.65 -18.6 64.12 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 122.854 0.462 . . . . 0.0 111.298 -175.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -85.1 -42.51 14.72 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.439 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 11.0 t70 -115.91 -15.82 11.19 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 119.123 -1.031 . . . . 0.0 112.118 -173.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.32 -5.78 83.55 Favored Glycine 0 C--N 1.31 -0.861 0 C-N-CA 119.853 -1.165 . . . . 0.0 114.293 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.476 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 25.8 mm-40 -83.61 158.4 21.91 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 22.2 p -90.37 136.04 33.31 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.936 0.398 . . . . 0.0 109.977 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.476 ' CE2' ' HB2' ' A' ' 88' ' ' GLN . 97.4 m-85 -136.91 158.53 44.24 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.612 0.765 . . . . 0.0 109.681 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -75.33 123.36 25.22 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -135.74 149.87 49.33 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.89 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -112.05 132.35 54.87 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.986 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.494 ' HA ' HG22 ' A' ' 106' ' ' ILE . 64.5 mt -71.52 123.08 25.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.948 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -96.77 -41.34 8.52 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.09 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -151.7 142.09 22.49 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.574 -176.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 69.0 mt -113.44 138.35 43.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -120.8 92.06 3.67 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -65.76 -18.05 65.05 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.65 -46.91 80.51 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 121.412 0.625 . . . . 0.0 109.659 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -93.8 -15.66 24.89 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.566 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.42 37.4 47.36 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -175.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 42.8 p -125.36 155.79 39.74 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -176.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.58 144.64 48.06 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-O 121.238 0.542 . . . . 0.0 110.412 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.62 121.79 32.85 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.494 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.57 151.9 30.22 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.705 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.477 -175.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.8 m -119.71 121.26 38.82 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -67.73 118.24 10.72 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.46 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.28 126.27 29.16 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.171 -173.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.81 -37.69 3.66 Favored Glycine 0 N--CA 1.425 -2.065 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.097 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -89.9 -43.61 10.48 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.921 0.391 . . . . 0.0 110.172 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.43 4.91 62.17 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.044 -178.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -79.84 156.64 27.28 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 117.039 0.42 . . . . 0.0 109.934 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -143.1 143.56 31.89 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 120.564 0.221 . . . . 0.0 110.622 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -151.67 162.48 40.93 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.8 t -103.73 115.37 45.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.9 t -128.72 141.5 41.81 Favored Pre-proline 0 C--N 1.279 -2.498 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.08 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.2 Cg_endo -62.18 146.46 95.99 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 122.456 2.104 . . . . 0.0 111.457 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 60.1 mt -55.15 -26.39 38.35 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 123.623 0.769 . . . . 0.0 111.469 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 pp -66.22 -24.37 66.6 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.958 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -90.26 -16.38 29.46 Favored 'General case' 0 CA--C 1.479 -1.763 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 84.7 mt -80.98 126.24 31.14 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.86 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -114.8 147.43 38.2 Favored Pre-proline 0 C--N 1.288 -2.084 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -67.36 150.64 81.02 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 122.006 1.804 . . . . 0.0 110.837 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.427 -1.59 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.993 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.44 -0.973 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -110.81 151.15 28.15 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.819 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -126.87 153.21 46.02 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.67 133.13 30.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 175.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.11 39.42 9.28 Favored Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.484 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -117.79 161.17 20.16 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -98.75 131.24 45.05 Favored 'General case' 0 N--CA 1.394 -3.258 0 CA-C-O 122.1 0.953 . . . . 0.0 110.818 175.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.5 p -143.63 168.09 20.71 Favored 'General case' 0 C--N 1.262 -3.227 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.129 -177.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 31.3 mtp -111.83 130.2 55.89 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 172.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -121.42 149.47 42.97 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.4 t -85.42 117.01 29.66 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.465 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.5 t90 -66.76 123.05 19.06 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.5 m -60.24 -26.36 66.36 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.465 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 45.4 mt-10 -82.09 -41.98 19.8 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.005 -174.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -110.99 -15.48 13.74 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.762 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.28 10.51 86.16 Favored Glycine 0 C--N 1.307 -1.056 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.643 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -98.94 160.09 14.5 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 23.0 p -90.34 136.33 33.12 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 120.879 0.371 . . . . 0.0 110.916 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -136.46 158.14 45.14 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 123.725 0.81 . . . . 0.0 110.085 -179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -76.66 125.89 30.03 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.415 0.626 . . . . 0.0 109.887 -177.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -139.25 155.06 48.02 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.688 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -114.49 132.47 56.28 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.138 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.545 ' HA ' HG22 ' A' ' 106' ' ' ILE . 69.4 mt -70.88 123.85 25.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.311 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -98.34 -40.53 8.27 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.545 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 105' ' ' ALA . 29.1 tt0 -148.43 146.35 28.4 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -174.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 72.1 mt -124.72 137.61 56.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -116.98 95.48 5.02 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 174.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -65.99 -22.1 66.44 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -67.86 -46.78 70.77 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 121.277 0.561 . . . . 0.0 110.354 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -92.39 -9.47 41.61 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.784 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.545 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 64.56 41.98 97.62 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -176.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 41.6 p -126.23 155.9 41.12 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.73 149.01 43.11 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.207 0.527 . . . . 0.0 111.313 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . . . -95.41 124.05 39.24 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 176.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.545 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -126.41 155.07 36.53 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.046 -175.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.7 m -121.79 120.34 34.32 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -68.91 121.63 16.99 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.381 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.1 135.34 57.15 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.167 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.74 -46.13 3.29 Favored Glycine 0 C--N 1.309 -0.934 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.743 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -77.23 -40.24 45.58 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.985 0.421 . . . . 0.0 110.698 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.97 7.89 76.85 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.526 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -82.07 149.25 28.15 Favored 'General case' 0 CA--C 1.485 -1.519 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -144.05 137.57 27.71 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.803 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -151.83 160.55 43.51 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 123.521 0.513 . . . . 0.0 110.031 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.0 t -93.34 122.07 44.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.4 t -135.75 141.21 36.12 Favored Pre-proline 0 C--N 1.282 -2.328 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -177.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.2 Cg_endo -63.21 148.55 92.99 Favored 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 122.273 1.982 . . . . 0.0 111.497 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 50.6 mt -55.54 -26.32 42.6 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 123.858 0.863 . . . . 0.0 111.412 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 pp -63.97 -26.97 68.82 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 121.434 0.635 . . . . 0.0 110.497 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.453 HD22 ' HD2' ' A' ' 118' ' ' PRO . 67.5 m-20 -84.17 -26.03 29.13 Favored 'General case' 0 CA--C 1.476 -1.902 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.576 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.2 mt -78.3 126.23 30.49 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.272 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -114.67 150.32 43.77 Favored Pre-proline 0 C--N 1.288 -2.086 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 175.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.85 146.91 48.93 Favored 'Trans proline' 0 C--N 1.325 -0.663 0 C-N-CA 121.493 1.462 . . . . 0.0 110.871 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.4 t . . . . . 0 N--CA 1.441 -0.911 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.276 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.434 -1.228 0 CA-C-O 121.139 0.495 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.419 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 92.0 m95 -112.79 151.25 30.56 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.252 177.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -133.71 155.24 50.09 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.355 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.9 t -63.5 141.42 18.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.15 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.13 27.92 51.1 Favored Glycine 0 CA--C 1.498 -0.975 0 C-N-CA 121.401 -0.428 . . . . 0.0 112.527 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.46 153.81 41.43 Favored 'General case' 0 CA--C 1.488 -1.438 0 CA-C-O 120.927 0.394 . . . . 0.0 111.774 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -90.71 141.28 28.95 Favored 'General case' 0 N--CA 1.413 -2.321 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.76 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.419 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 14.2 p -147.99 175.2 11.18 Favored 'General case' 0 C--N 1.265 -3.097 0 CA-C-N 113.573 -1.649 . . . . 0.0 107.158 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.404 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 82.0 mmm -112.13 129.38 56.25 Favored 'General case' 0 C--N 1.271 -2.811 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 175.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -122.39 147.52 46.19 Favored 'General case' 0 C--N 1.266 -3.063 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.089 -176.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.8 t -85.09 115.01 26.17 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.473 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 12.7 t90 -64.44 121.22 13.86 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.6 t -63.12 -20.25 65.2 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 123.434 0.459 . . . . 0.0 111.658 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.473 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 37.6 mm-40 -84.82 -42.22 15.34 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -177.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -109.74 -15.98 14.01 Favored 'General case' 0 CA--C 1.507 -0.708 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.239 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.59 9.33 86.97 Favored Glycine 0 C--O 1.221 -0.66 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.076 177.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -102.85 162.03 13.26 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 7.1 p -89.87 136.6 32.94 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.085 0.469 . . . . 0.0 111.91 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -136.06 158.52 44.21 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 124.866 1.266 . . . . 0.0 109.134 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -75.03 127.95 34.43 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.41 151.98 43.92 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.71 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -111.33 133.35 53.71 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.394 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.438 ' HA ' HG22 ' A' ' 106' ' ' ILE . 67.8 mt -72.67 123.94 28.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 123.745 0.818 . . . . 0.0 111.92 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -99.69 -38.21 8.8 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.989 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -151.79 143.91 23.92 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.879 -175.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 64.5 mt -124.29 140.23 48.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -124.39 94.39 4.19 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 171.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -66.28 -23.11 66.33 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -66.76 -44.14 82.22 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.397 0.617 . . . . 0.0 109.821 -179.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -92.67 -9.51 40.57 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.357 0.599 . . . . 0.0 110.367 177.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 68.13 39.19 88.61 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.527 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 73.8 p -125.28 155.42 40.19 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 122.265 -0.55 . . . . 0.0 110.405 -176.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.449 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -138.48 146.15 41.7 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 121.461 0.648 . . . . 0.0 110.601 176.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.62 121.59 36.34 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.438 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.97 153.19 31.93 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.679 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.862 -175.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 87.8 m -120.38 120.37 35.78 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.779 177.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -67.33 124.85 24.29 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 123.543 0.737 . . . . 0.0 110.72 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.24 129.28 39.43 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.023 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.28 -39.59 2.83 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.919 178.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -87.06 -40.24 14.87 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.286 0.565 . . . . 0.0 110.157 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.21 11.29 72.87 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.823 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -80.51 154.07 27.76 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.91 139.1 30.62 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.729 -176.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -149.2 160.58 43.24 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 56.8 t -98.06 114.82 36.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 176.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.3 t -130.67 141.4 41.82 Favored Pre-proline 0 C--N 1.281 -2.408 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -175.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.591 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 40.9 Cg_endo -63.05 148.36 93.48 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.371 2.047 . . . . 0.0 111.682 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 54.3 mt -55.2 -26.78 41.39 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.595 0.758 . . . . 0.0 111.539 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.63 -23.5 66.82 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.248 0.547 . . . . 0.0 111.057 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -92.13 -13.24 31.01 Favored 'General case' 0 CA--C 1.485 -1.551 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.026 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.449 HD11 ' HB3' ' A' ' 104' ' ' ALA . 82.1 mt -85.28 125.95 33.32 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 71.0 mmtt -114.75 153.19 46.89 Favored Pre-proline 0 C--N 1.284 -2.276 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.84 154.02 53.49 Favored 'Trans proline' 0 C--O 1.248 1.021 0 C-N-CA 121.475 1.45 . . . . 0.0 111.869 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 46.1 t . . . . . 0 C--N 1.311 -1.07 0 CA-C-O 121.962 0.887 . . . . 0.0 108.885 179.493 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 N--CA 1.44 -0.93 0 CA-C-O 121.649 0.737 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.462 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 97.5 m95 -116.3 151.8 35.13 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.872 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -132.97 160.0 38.37 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.61 136.41 26.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 123.687 0.795 . . . . 0.0 111.362 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.21 21.99 46.74 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.33 177.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.66 153.55 28.73 Favored 'General case' 0 CA--C 1.482 -1.655 0 CA-C-O 120.598 0.237 . . . . 0.0 110.453 -177.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -91.81 135.29 34.03 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-O 121.93 0.872 . . . . 0.0 110.809 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.462 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 19.4 p -146.03 176.38 9.76 Favored 'General case' 0 C--N 1.265 -3.085 0 CA-C-N 114.023 -1.444 . . . . 0.0 107.181 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 59.9 mtp -115.82 130.84 57.0 Favored 'General case' 0 C--N 1.27 -2.891 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 173.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.79 150.54 39.62 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -175.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 82.7 t -85.39 115.29 26.77 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.473 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.528 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.0 t90 -63.74 123.25 18.4 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.1 t -62.36 -25.06 67.7 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.229 0.538 . . . . 0.0 110.997 -177.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.528 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 21.5 mm-40 -79.05 -41.73 28.13 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -176.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -115.33 -16.31 11.48 Favored 'General case' 0 CA--C 1.502 -0.891 0 C-N-CA 117.654 -1.618 . . . . 0.0 112.367 -178.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.59 5.75 88.04 Favored Glycine 0 C--N 1.306 -1.116 0 C-N-CA 119.795 -1.193 . . . . 0.0 113.596 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -93.19 161.6 14.35 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 23.4 p -94.25 135.74 35.31 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 120.957 0.408 . . . . 0.0 110.56 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -137.9 157.6 46.08 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 123.741 0.817 . . . . 0.0 109.203 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -75.5 126.02 30.19 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -177.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.25 151.15 47.37 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -112.08 133.37 54.28 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.115 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.49 ' HA ' HG22 ' A' ' 106' ' ' ILE . 66.4 mt -71.72 123.34 25.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 123.558 0.743 . . . . 0.0 111.756 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -97.39 -38.61 9.56 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.513 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -154.97 151.57 28.65 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 71.6 mt -123.33 137.27 57.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -117.68 95.82 5.11 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -65.54 -22.6 66.73 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.768 -1.106 . . . . 0.0 113.022 -177.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -65.08 -46.3 81.7 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 120.603 0.24 . . . . 0.0 110.78 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -95.36 -5.86 42.37 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.84 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.422 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 64.75 43.15 96.67 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -176.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 39.9 p -127.27 156.0 42.61 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -175.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.32 141.7 43.8 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-O 121.09 0.471 . . . . 0.0 110.086 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.04 120.76 29.69 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.49 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.89 154.22 32.57 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.679 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.082 -174.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.7 m -121.82 120.41 34.49 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.469 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -67.11 123.35 20.02 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 123.387 0.675 . . . . 0.0 110.359 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.48 135.67 55.48 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.266 -176.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.92 -55.81 3.7 Favored Glycine 0 N--CA 1.429 -1.784 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.948 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -72.99 -41.94 63.79 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.137 0.494 . . . . 0.0 110.806 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 89.95 2.03 75.54 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.836 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -72.81 158.05 36.29 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -145.14 135.86 24.48 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.591 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -146.97 157.9 43.76 Favored 'General case' 0 N--CA 1.432 -1.336 0 O-C-N 123.715 0.634 . . . . 0.0 109.67 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 69.4 t -91.96 114.32 28.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 174.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.1 t -128.0 141.67 41.97 Favored Pre-proline 0 C--N 1.29 -2.017 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -175.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.57 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 43.5 Cg_endo -64.28 147.13 91.0 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.126 1.884 . . . . 0.0 111.192 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 48.0 mt -55.38 -26.07 39.12 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 123.494 0.717 . . . . 0.0 111.138 178.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.39 -19.47 65.41 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.18 178.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -95.78 -13.27 24.24 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-O 120.951 0.405 . . . . 0.0 111.357 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.414 HD22 ' SG ' ' A' ' 79' ' ' CYS . 83.5 mt -81.94 126.29 31.76 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.257 177.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -114.09 154.3 46.16 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.42 153.11 70.93 Favored 'Trans proline' 0 C--O 1.243 0.763 0 C-N-CA 121.616 1.544 . . . . 0.0 110.428 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.6 t . . . . . 0 C--N 1.305 -1.365 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.765 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.2 t . . . . . 0 N--CA 1.426 -1.66 0 CA-C-O 121.605 0.717 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -112.06 152.21 28.47 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.469 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -131.19 160.95 33.32 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 175.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 99.0 t -66.0 139.31 21.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.771 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.8 32.82 48.63 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 1.4 t70 -110.49 159.18 17.74 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -95.26 131.19 41.59 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 17.9 p -144.65 173.94 11.39 Favored 'General case' 0 C--N 1.263 -3.181 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.8 mtp -117.28 130.55 56.62 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 173.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.04 149.97 40.76 Favored 'General case' 0 C--N 1.27 -2.883 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.9 t -87.41 113.54 24.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.454 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 12.7 t90 -63.46 120.45 11.69 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -179.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.7 t -67.06 -16.58 64.44 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.224 0.535 . . . . 0.0 110.946 -174.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.454 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 38.4 mt-10 -85.1 -42.29 14.93 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.521 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 13.9 t70 -110.31 -15.72 13.89 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.289 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.82 4.39 90.07 Favored Glycine 0 C--N 1.305 -1.17 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.374 176.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.521 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 28.1 mm-40 -94.68 161.26 14.26 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.913 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 7.9 p -92.65 136.08 33.54 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.311 0.577 . . . . 0.0 111.623 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -136.87 157.72 46.09 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 123.797 0.839 . . . . 0.0 109.441 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -75.34 132.98 41.33 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.47 158.09 43.92 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.896 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 77' ' ' ASP . 43.9 tt0 -120.6 134.08 55.31 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.819 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.492 ' HA ' HG22 ' A' ' 106' ' ' ILE . 70.9 mt -71.78 125.33 30.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 O-C-N 123.759 0.662 . . . . 0.0 112.733 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -98.43 -42.54 7.29 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.601 -1.182 . . . . 0.0 111.306 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -148.8 143.44 26.34 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -174.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.0 mt -121.81 138.46 52.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -123.05 92.6 3.74 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 171.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.49 -24.79 67.24 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -177.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -63.04 -45.32 92.8 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.537 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -95.2 -4.71 45.42 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.26 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.61 43.04 97.04 Favored Glycine 0 N--CA 1.438 -1.214 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 41.6 p -128.44 155.7 44.36 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 122.69 -0.3 . . . . 0.0 110.491 -177.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.39 144.52 36.26 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.058 0.456 . . . . 0.0 110.009 175.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.03 124.77 35.05 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.492 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -127.85 152.08 35.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.977 -175.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.3 m -116.23 120.47 39.07 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.988 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -69.12 125.93 28.2 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.915 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.45 128.4 35.86 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.44 -1.255 . . . . 0.0 111.57 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.13 -46.65 2.87 Favored Glycine 0 N--CA 1.437 -1.27 0 C-N-CA 121.293 -0.48 . . . . 0.0 112.798 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -78.75 -33.94 46.11 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.621 0.248 . . . . 0.0 110.981 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 83.88 -0.92 89.34 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.548 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -71.6 150.19 44.92 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.51 132.08 28.78 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.714 -176.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -144.48 160.76 40.56 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.564 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.8 t -96.09 116.21 37.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.2 t -130.69 141.42 41.89 Favored Pre-proline 0 C--N 1.278 -2.533 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -176.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 40.0 Cg_endo -62.92 146.36 94.85 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 122.057 1.838 . . . . 0.0 110.889 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 56.3 mt -54.27 -26.49 29.33 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 123.966 0.906 . . . . 0.0 111.672 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.65 -23.84 66.89 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.289 0.566 . . . . 0.0 110.92 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -90.0 -13.72 35.49 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.994 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.2 mt -85.58 126.34 33.81 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.193 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -114.61 152.75 46.54 Favored Pre-proline 0 C--N 1.281 -2.402 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.9 151.31 50.6 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.48 1.453 . . . . 0.0 110.31 176.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 C--N 1.306 -1.285 0 CA-C-O 121.302 0.572 . . . . 0.0 110.333 -177.753 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.435 -1.216 0 CA-C-O 120.805 0.336 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -121.54 152.23 39.43 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 123.028 0.531 . . . . 0.0 111.332 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -133.35 154.46 50.71 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.221 177.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.5 t -63.82 141.91 17.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 C-N-CA 123.914 0.886 . . . . 0.0 110.51 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.1 19.39 62.92 Favored Glycine 0 CA--C 1.499 -0.959 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.51 151.88 34.02 Favored 'General case' 0 CA--C 1.477 -1.858 0 CA-C-O 120.502 0.191 . . . . 0.0 110.754 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -90.97 142.03 28.21 Favored 'General case' 0 N--CA 1.399 -2.978 0 O-C-N 123.907 0.755 . . . . 0.0 110.25 176.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 21.0 p -148.99 176.59 10.31 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.207 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 47.5 mtp -116.67 131.23 57.0 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.91 149.05 42.24 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -176.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 88.9 t -85.87 118.77 33.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -67.03 120.58 13.89 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.3 m -57.63 -28.89 64.1 Favored 'General case' 0 C--N 1.288 -2.065 0 C-N-CA 123.205 0.602 . . . . 0.0 112.26 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -77.64 -41.98 36.46 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.953 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.481 ' OD1' ' HG2' ' A' ' 88' ' ' GLN . 9.0 t70 -113.49 -16.26 12.44 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.748 -175.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.83 3.18 90.61 Favored Glycine 0 C--N 1.31 -0.914 0 C-N-CA 120.27 -0.967 . . . . 0.0 113.021 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.481 ' HG2' ' OD1' ' A' ' 86' ' ' ASP . 30.0 mm-40 -94.01 160.85 14.53 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.619 -0.342 . . . . 0.0 110.08 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 11.1 p -90.43 136.8 32.83 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 120.991 0.424 . . . . 0.0 110.528 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -136.46 157.16 47.44 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -78.66 123.96 27.68 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.106 0.479 . . . . 0.0 110.012 -176.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.62 152.32 49.23 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.34 -176.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -108.41 134.25 51.46 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.165 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.546 ' HA ' HG22 ' A' ' 106' ' ' ILE . 63.6 mt -73.25 118.6 18.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.161 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -94.38 -38.72 10.83 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.442 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -153.81 150.4 28.41 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -176.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 68.4 mt -124.7 141.2 45.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -120.6 90.97 3.43 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -66.35 -21.71 66.25 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.427 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -60.09 -46.22 90.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.061 178.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -94.61 -15.61 23.89 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.393 0.616 . . . . 0.0 110.648 176.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.504 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 76.73 37.41 34.41 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -177.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 50.8 p -124.44 158.02 33.79 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.29 147.65 47.58 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.075 0.464 . . . . 0.0 110.501 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.66 121.8 37.76 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 176.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.546 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.83 153.72 32.06 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.72 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.751 -174.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 95.1 m -121.45 121.29 37.21 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -68.7 119.71 13.53 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.995 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.38 130.65 43.75 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 124.262 0.976 . . . . 0.0 110.284 -175.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.09 -51.26 1.29 Allowed Glycine 0 N--CA 1.429 -1.819 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.456 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -76.79 -43.62 36.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.762 0.315 . . . . 0.0 110.76 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.22 2.27 66.19 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.339 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -75.99 154.53 35.74 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.23 138.79 31.69 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -152.34 162.81 40.64 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 123.178 0.299 . . . . 0.0 110.642 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.2 t -97.82 120.37 47.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.3 t -133.96 141.02 38.13 Favored Pre-proline 0 C--N 1.284 -2.256 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -176.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.4 Cg_endo -64.21 146.97 91.2 Favored 'Trans proline' 0 N--CA 1.438 -1.765 0 C-N-CA 122.071 1.847 . . . . 0.0 111.436 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 45.2 mt -53.93 -26.41 25.27 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 123.864 0.865 . . . . 0.0 111.317 178.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 pp -68.09 -21.61 64.95 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.119 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.419 HD22 ' HD2' ' A' ' 118' ' ' PRO . 73.4 m-20 -93.09 -17.88 23.28 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.064 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 85.9 mt -77.74 126.83 31.47 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 121.435 0.636 . . . . 0.0 109.856 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -114.4 155.47 45.79 Favored Pre-proline 0 C--N 1.291 -1.965 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.55 148.7 48.26 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 121.735 1.623 . . . . 0.0 111.356 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.9 t . . . . . 0 CA--C 1.509 -0.626 0 CA-C-O 121.226 0.536 . . . . 0.0 110.376 -178.373 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 101' ' ' ASN . 16.1 m -137.84 -74.82 0.4 Allowed 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 99.3 m -99.09 120.09 38.91 Favored 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.412 HE21 ' HD2' ' A' ' 69' ' ' PRO . 25.5 tp60 -81.58 114.25 48.37 Favored Pre-proline 0 C--N 1.306 -1.285 0 N-CA-C 106.557 -1.645 . . . . 0.0 106.557 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.412 ' HD2' HE21 ' A' ' 68' ' ' GLN . 50.8 Cg_exo -59.97 133.84 52.96 Favored 'Trans proline' 0 C--O 1.239 0.528 0 C-N-CA 122.525 2.15 . . . . 0.0 113.509 -177.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.1 t -112.54 -3.42 14.39 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -141.31 143.6 34.14 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -176.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.3 m -95.42 114.45 26.22 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.403 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 98.0 m95 -113.54 151.48 31.53 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.136 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -129.25 159.74 35.15 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.2 t -64.99 133.38 30.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.936 0 C-N-CA 123.078 0.551 . . . . 0.0 110.766 178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.54 26.87 37.45 Favored Glycine 0 CA--C 1.499 -0.943 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.444 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -106.74 155.47 19.66 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -96.4 131.47 42.92 Favored 'General case' 0 C--N 1.274 -2.698 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.243 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.403 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 17.3 p -144.03 176.67 9.12 Favored 'General case' 0 C--N 1.263 -3.181 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.561 -178.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 41.1 mtp -119.23 130.44 55.46 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 172.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.79 153.61 34.18 Favored 'General case' 0 C--N 1.278 -2.541 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 -175.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.7 t -86.74 116.81 29.93 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.442 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.8 t90 -66.35 123.61 20.45 Favored 'General case' 0 CA--C 1.5 -0.959 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.4 t -61.2 -23.36 65.54 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-O 121.219 0.533 . . . . 0.0 111.483 -177.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -83.16 -42.63 17.09 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -176.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -106.71 -17.24 14.28 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.222 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.24 3.5 82.06 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 119.554 -1.307 . . . . 0.0 112.398 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -91.48 163.85 14.02 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 24.7 p -94.84 136.42 35.18 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 120.697 0.284 . . . . 0.0 110.7 -179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -136.71 157.56 46.47 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 123.535 0.734 . . . . 0.0 109.581 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -75.09 129.47 37.63 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -177.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -145.02 152.94 40.92 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.121 -177.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -112.53 134.96 53.79 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.346 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.476 ' HA ' HG22 ' A' ' 106' ' ' ILE . 73.9 mt -71.63 123.21 25.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 C-N-CA 123.252 0.621 . . . . 0.0 111.491 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -98.66 -37.41 9.52 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.01 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -152.86 145.42 24.18 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 -177.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 68.5 mt -121.68 140.06 46.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -121.73 97.13 5.35 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 172.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -65.08 -24.67 67.52 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -176.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -68.17 -45.78 72.53 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 66' ' ' SER . 28.4 m-80 -87.32 -15.22 38.62 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.386 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.436 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 67.62 40.46 90.5 Favored Glycine 0 N--CA 1.44 -1.088 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 -176.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.615 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 69.9 p -124.7 157.9 34.5 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -177.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.456 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -139.85 141.15 36.66 Favored 'General case' 0 C--N 1.29 -2.022 0 CA-C-O 121.308 0.575 . . . . 0.0 110.408 175.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -87.92 121.13 29.96 Favored 'General case' 0 N--CA 1.417 -2.1 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.476 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.92 153.47 32.06 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.756 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.973 -174.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 91.2 m -120.44 120.46 35.98 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.725 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -69.56 117.74 11.54 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.581 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.26 133.07 49.83 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.948 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.9 -42.95 2.01 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 120.879 -0.676 . . . . 0.0 111.869 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -87.63 -43.45 11.95 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.305 179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.77 3.59 62.31 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.218 -0.992 . . . . 0.0 112.127 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -77.57 152.7 33.85 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.402 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -141.24 143.49 34.16 Favored 'General case' 0 C--N 1.279 -2.476 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -177.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -151.55 159.12 44.26 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 123.962 0.788 . . . . 0.0 109.026 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 59.0 t -97.66 113.92 33.48 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.0 t -128.49 141.32 41.07 Favored Pre-proline 0 C--N 1.288 -2.098 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -174.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.615 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 40.6 Cg_endo -62.6 147.7 94.41 Favored 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 122.447 2.098 . . . . 0.0 111.229 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 45.8 mt -54.44 -26.11 28.96 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.608 0.763 . . . . 0.0 111.592 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.7 pp -64.53 -26.0 68.23 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.342 0.591 . . . . 0.0 110.399 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -89.62 -14.26 35.32 Favored 'General case' 0 CA--C 1.492 -1.276 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.955 -178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.456 HD11 ' HB3' ' A' ' 104' ' ' ALA . 81.7 mt -85.31 125.83 33.24 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.988 178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -115.39 151.39 45.9 Favored Pre-proline 0 C--N 1.288 -2.085 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -69.48 153.43 70.21 Favored 'Trans proline' 0 C--O 1.243 0.742 0 C-N-CA 121.597 1.531 . . . . 0.0 110.913 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.5 t -80.5 93.57 2.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 121.721 0.772 . . . . 0.0 109.003 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -99.37 112.32 24.53 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -84.97 62.71 7.67 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 122.189 0.995 . . . . 0.0 111.045 -174.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.805 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.32 177.725 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1129 ' ' DA2 . . . . . 0.503 HC21 ' HNE' ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.735 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.8 p -66.96 -19.06 65.66 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 20.6 m -114.99 135.98 53.63 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -88.44 133.44 36.46 Favored Pre-proline 0 C--N 1.298 -1.644 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 175.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -59.35 133.19 50.8 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 121.047 1.164 . . . . 0.0 109.908 174.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.8 t -82.59 -22.46 34.82 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -142.02 138.64 31.98 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 176.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.1 m -83.34 113.29 20.62 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 120.999 0.428 . . . . 0.0 110.009 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -118.91 151.58 37.87 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.665 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -131.4 153.93 49.17 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.79 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.13 141.61 17.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 C-N-CA 123.908 0.883 . . . . 0.0 110.746 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.23 28.49 55.84 Favored Glycine 0 CA--C 1.498 -0.972 0 N-CA-C 112.122 -0.391 . . . . 0.0 112.122 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.38 153.28 35.41 Favored 'General case' 0 CA--C 1.483 -1.614 0 CA-C-O 120.814 0.34 . . . . 0.0 110.887 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -90.75 139.12 31.03 Favored 'General case' 0 N--CA 1.412 -2.358 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.172 177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 17.2 p -148.65 179.52 7.76 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-N 113.719 -1.582 . . . . 0.0 107.327 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 58.4 mtp -120.37 131.18 54.72 Favored 'General case' 0 C--N 1.28 -2.419 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 173.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.95 149.75 41.62 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -175.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.8 t -85.35 116.48 28.76 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 176.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -64.19 120.66 12.54 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.7 t -62.37 -21.04 65.02 Favored 'General case' 0 C--N 1.307 -1.254 0 O-C-N 123.578 0.549 . . . . 0.0 111.292 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -84.87 -42.35 15.14 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -176.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -112.5 -15.51 13.05 Favored 'General case' 0 CA--C 1.508 -0.644 0 C-N-CA 119.336 -0.946 . . . . 0.0 111.916 -174.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 84.1 0.36 89.58 Favored Glycine 0 C--N 1.313 -0.719 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.924 176.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -93.22 159.86 15.09 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 120.559 -0.456 . . . . 0.0 109.825 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 23.3 p -92.76 137.07 32.68 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.167 0.508 . . . . 0.0 110.945 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.412 ' CD2' HC11 ' A' 1129 ' ' DA2 . 97.4 m-85 -136.46 158.33 44.68 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 123.846 0.858 . . . . 0.0 109.36 -178.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -75.28 127.99 34.42 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.66 153.65 48.58 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.126 0.488 . . . . 0.0 111.25 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -115.03 132.93 56.44 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.997 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.468 ' HA ' HG22 ' A' ' 106' ' ' ILE . 62.5 mt -73.03 123.78 28.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.928 -179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -99.9 -38.2 8.72 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.858 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -149.58 143.72 25.75 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -176.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.4 mt -123.24 140.42 46.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -120.43 92.7 3.83 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 173.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -65.94 -23.49 66.62 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -59.82 -46.71 88.38 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.042 0.537 . . . . 0.0 109.805 -178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -95.46 -11.65 27.2 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.087 178.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.438 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 72.32 39.55 57.1 Favored Glycine 0 C--N 1.312 -0.804 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -177.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 35.5 p -124.36 156.96 36.14 Favored 'General case' 0 N--CA 1.424 -1.772 0 C-N-CA 122.793 0.437 . . . . 0.0 110.217 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.69 148.61 41.05 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-O 121.399 0.619 . . . . 0.0 111.089 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -97.52 121.75 39.79 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.468 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.78 154.79 32.78 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.669 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.782 -174.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 91.3 m -120.76 120.3 35.23 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.448 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -67.71 121.58 16.25 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.186 -178.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.24 130.72 46.67 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.552 -175.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.29 -49.94 2.99 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 121.131 -0.557 . . . . 0.0 111.868 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -72.63 -43.25 63.5 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 120.612 0.244 . . . . 0.0 111.235 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.84 8.57 65.07 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.27 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.424 ' O ' ' HA ' ' A' ' 107' ' ' THR . 3.9 m-20 -80.65 148.52 30.19 Favored 'General case' 0 CA--C 1.49 -1.364 0 O-C-N 122.352 -0.499 . . . . 0.0 110.222 178.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -137.64 133.32 34.19 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 -176.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -151.51 162.79 40.36 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.685 -0.234 . . . . 0.0 110.685 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.5 t -96.37 119.88 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.6 t -133.8 140.71 37.4 Favored Pre-proline 0 C--N 1.278 -2.503 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 42.6 Cg_endo -63.71 147.43 92.6 Favored 'Trans proline' 0 N--CA 1.442 -1.528 0 C-N-CA 122.346 2.031 . . . . 0.0 110.941 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 49.8 mt -53.56 -27.12 24.43 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 123.677 0.791 . . . . 0.0 111.646 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.57 -23.41 66.2 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.249 0.619 . . . . 0.0 111.604 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.4 HD22 ' HD2' ' A' ' 118' ' ' PRO . 72.2 m-20 -91.64 -12.59 33.77 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 121.185 0.517 . . . . 0.0 110.803 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 81.4 mt -84.49 128.21 34.46 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.066 176.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -111.36 157.59 38.61 Favored Pre-proline 0 C--N 1.294 -1.844 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 175.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -68.76 156.89 63.96 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 121.63 1.554 . . . . 0.0 109.628 170.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 89.8 t -73.1 95.98 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-O 121.507 0.67 . . . . 0.0 110.536 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -78.17 116.04 18.33 Favored 'General case' 0 N--CA 1.423 -1.781 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.333 177.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -95.26 3.12 54.88 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-O 122.488 1.137 . . . . 0.0 109.478 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.41 -3.1 0 N-CA-C 107.5 -2.24 . . . . 0.0 107.5 -178.07 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1129 ' ' DA2 . . . . . 0.518 ' HNE' HC21 ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.631 0 CA-C-O 120.866 0.365 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.9 m -71.65 -39.04 70.62 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 177.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 48.6 m -101.91 113.32 26.42 Favored 'General case' 0 N--CA 1.411 -2.404 0 N-CA-C 106.034 -1.839 . . . . 0.0 106.034 171.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -71.99 119.12 72.63 Favored Pre-proline 0 C--N 1.309 -1.182 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -54.68 133.78 58.9 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.107 2.538 . . . . 0.0 112.352 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.5 t -91.77 -18.08 24.41 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.187 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -141.37 139.77 33.58 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 -176.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.3 p -87.84 110.96 20.9 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-O 121.078 0.466 . . . . 0.0 110.411 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -109.88 151.99 26.35 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.313 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -124.89 151.0 45.93 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.1 t -64.48 133.78 29.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 175.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.54 31.94 26.1 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 121.383 -0.437 . . . . 0.0 112.139 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 11.0 t0 -113.14 165.02 12.78 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.716 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.412 ' HB3' HG21 ' A' ' 125' ' ' VAL . 6.3 mmpt? -96.72 130.7 43.91 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 176.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 23.6 p -144.93 176.64 9.32 Favored 'General case' 0 C--N 1.265 -3.091 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 38.7 mtp -117.6 130.48 56.41 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 173.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.54 149.82 41.82 Favored 'General case' 0 C--N 1.279 -2.49 0 O-C-N 123.435 0.46 . . . . 0.0 109.865 -175.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 94.3 t -85.3 117.54 30.57 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.191 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 177.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.464 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.6 t90 -66.25 124.86 23.82 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.2 t -61.38 -26.51 67.89 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.15 0.5 . . . . 0.0 111.229 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.464 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 16.2 mm-40 -80.26 -40.06 27.72 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -175.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.433 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 11.6 t70 -115.61 -15.46 11.4 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 118.76 -1.176 . . . . 0.0 111.77 -177.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.85 6.88 89.14 Favored Glycine 0 C--N 1.307 -1.074 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.142 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.433 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 27.0 mm-40 -95.82 161.29 14.07 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.137 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 25.1 p -90.8 136.77 32.85 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 121.46 0.648 . . . . 0.0 110.84 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.41 ' CD2' HC11 ' A' 1129 ' ' DA2 . 97.4 m-85 -136.35 158.02 45.42 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.944 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -74.63 131.29 40.8 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.93 153.55 44.44 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.376 -177.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 77' ' ' ASP . 38.3 tt0 -114.04 132.11 56.12 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.578 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.524 ' HA ' HG22 ' A' ' 106' ' ' ILE . 66.3 mt -73.44 125.08 31.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 C-N-CA 122.977 0.511 . . . . 0.0 112.37 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -97.87 -40.39 8.53 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 124.37 1.068 . . . . 0.0 111.201 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -149.28 148.84 30.03 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.3 mt -121.5 131.6 72.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -114.99 90.87 3.44 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 175.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -66.5 -20.4 66.03 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -178.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.2 -46.26 74.4 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.143 0.497 . . . . 0.0 109.882 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -92.38 -6.3 50.37 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.798 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.85 38.74 94.6 Favored Glycine 0 C--O 1.241 0.55 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 67.4 p -130.29 155.57 46.09 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.45 149.56 48.29 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-O 120.914 0.387 . . . . 0.0 110.509 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.65 124.12 38.49 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 177.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.524 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -127.73 155.56 39.15 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.196 -175.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 75.4 m -117.9 120.37 37.68 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -68.01 123.13 19.77 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.36 130.76 44.09 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.021 -0.99 . . . . 0.0 110.839 -175.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 99.89 -59.32 0.76 Allowed Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -69.57 -42.59 74.32 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.101 0.477 . . . . 0.0 110.543 -178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.31 16.26 62.85 Favored Glycine 0 N--CA 1.434 -1.442 0 C-N-CA 120.283 -0.96 . . . . 0.0 111.919 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -86.76 154.61 20.81 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 176.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -142.19 136.24 29.73 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 123.099 0.249 . . . . 0.0 110.673 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.03 159.67 43.65 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 63.2 t -93.71 121.85 44.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 176.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.9 t -134.67 141.49 38.95 Favored Pre-proline 0 C--N 1.287 -2.136 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -176.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 36.9 Cg_endo -61.74 146.23 96.81 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 122.627 2.218 . . . . 0.0 111.415 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 48.4 mt -54.75 -26.08 31.91 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 123.702 0.801 . . . . 0.0 111.858 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.17 -27.98 69.08 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.116 0.484 . . . . 0.0 110.771 177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.425 HD22 ' HD2' ' A' ' 118' ' ' PRO . 70.1 m-20 -85.55 -15.06 43.93 Favored 'General case' 0 CA--C 1.487 -1.469 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.564 -178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.1 mt -85.85 125.78 33.56 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -114.97 151.91 46.01 Favored Pre-proline 0 C--N 1.282 -2.355 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -71.0 146.96 53.87 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 121.5 1.467 . . . . 0.0 110.727 176.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.412 HG21 ' HB3' ' A' ' 78' ' ' LYS . 59.1 t -75.87 90.89 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -73.77 109.81 7.57 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.678 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -121.76 14.78 10.92 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.56 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.421 -2.329 0 N-CA-C 107.668 -2.173 . . . . 0.0 107.668 -178.56 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 1129 ' ' DA2 . . . . . 0.432 HC21 ' HNE' ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.211 -0.952 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.9 p -85.29 149.08 25.72 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 117.861 0.3 . . . . 0.0 110.981 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 99' ' ' GLU . 46.0 m -137.15 144.39 42.93 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -97.25 126.76 40.75 Favored Pre-proline 0 N--CA 1.428 -1.533 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -60.02 138.0 79.32 Favored 'Trans proline' 0 C--O 1.242 0.702 0 C-N-CA 123.016 2.477 . . . . 0.0 112.302 175.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.3 t -80.73 -22.81 39.93 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.11 178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -141.25 147.84 38.92 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 106.244 -1.761 . . . . 0.0 106.244 -177.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 46.0 m -83.98 105.11 14.6 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.252 0.549 . . . . 0.0 110.442 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.418 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 93.2 m95 -111.6 151.53 28.67 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.592 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.1 pttm -131.66 159.18 39.07 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.4 t -65.42 135.89 27.58 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.03 40.88 13.1 Favored Glycine 0 N--CA 1.431 -1.637 0 C-N-CA 120.526 -0.845 . . . . 0.0 111.404 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.41 152.7 41.31 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -95.04 131.21 41.27 Favored 'General case' 0 N--CA 1.402 -2.836 0 O-C-N 123.892 0.745 . . . . 0.0 109.744 174.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.418 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 18.7 p -141.43 177.48 8.09 Favored 'General case' 0 C--N 1.261 -3.257 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 51.5 mtp -118.05 130.75 56.35 Favored 'General case' 0 N--CA 1.4 -2.935 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 173.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.76 150.01 40.5 Favored 'General case' 0 C--N 1.267 -3.001 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -176.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 93.4 t -84.64 120.76 35.82 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.5 t90 -69.57 127.26 32.35 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 55.7 m -59.3 -29.07 67.34 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -84.12 -42.01 16.5 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 114.166 1.172 . . . . 0.0 114.166 -175.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -105.8 -15.75 14.85 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.702 0.763 . . . . 0.0 110.516 -176.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.29 13.29 73.46 Favored Glycine 0 C--N 1.312 -0.765 0 CA-C-N 115.321 -0.854 . . . . 0.0 113.239 178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.6 mm-40 -102.65 163.86 11.98 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 20.5 p -90.19 136.27 33.15 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 120.898 0.38 . . . . 0.0 110.604 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -134.38 158.26 44.3 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 124.199 1.0 . . . . 0.0 109.282 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -74.86 125.3 28.52 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -136.95 149.63 47.68 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.159 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -110.91 132.17 54.43 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.892 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.51 ' HA ' HG22 ' A' ' 106' ' ' ILE . 68.1 mt -72.51 123.43 27.15 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.124 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 -98.02 -40.07 8.63 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.914 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -152.39 142.51 22.3 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -175.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 69.9 mt -119.21 131.99 70.33 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -123.92 90.55 3.29 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 174.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.41 ' O ' ' HB ' ' A' ' 67' ' ' THR . 10.5 pt-20 -67.17 -20.31 65.71 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.106 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -56.32 -42.86 78.33 Favored 'General case' 0 C--O 1.215 -0.741 0 O-C-N 123.991 0.807 . . . . 0.0 110.227 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.8 m-80 -101.81 -1.55 32.04 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.201 0.524 . . . . 0.0 110.215 175.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 65.63 39.29 95.34 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.597 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 37.0 p -128.28 155.69 44.19 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 122.382 0.273 . . . . 0.0 110.427 -175.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.93 147.19 46.24 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.77 122.04 34.76 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 176.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.51 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -126.01 153.35 34.09 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.737 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.497 -175.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.5 m -120.14 120.41 36.11 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 177.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -67.8 118.3 10.85 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.32 130.66 41.94 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 114.623 -1.172 . . . . 0.0 110.489 -174.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 100.02 -41.86 2.09 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -178.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -87.37 -43.21 12.29 Favored 'General case' 0 C--N 1.313 -1.006 0 O-C-N 122.515 -0.403 . . . . 0.0 110.955 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.41 1.48 68.95 Favored Glycine 0 N--CA 1.442 -0.96 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.623 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -76.06 148.09 38.2 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -135.32 140.84 45.41 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -178.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -152.01 158.16 42.7 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 178.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.8 t -93.66 115.46 32.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 175.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.2 t -129.49 141.21 41.04 Favored Pre-proline 0 C--N 1.281 -2.387 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -175.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.5 Cg_endo -61.5 145.03 98.27 Favored 'Trans proline' 0 N--CA 1.437 -1.833 0 C-N-CA 122.165 1.91 . . . . 0.0 110.671 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 55.2 mt -53.94 -26.15 24.07 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 123.887 0.875 . . . . 0.0 111.472 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 pp -64.37 -25.48 68.05 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.093 0.473 . . . . 0.0 110.855 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.425 HD22 ' HD2' ' A' ' 118' ' ' PRO . 73.5 m-20 -88.31 -12.84 42.34 Favored 'General case' 0 CA--C 1.486 -1.495 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.86 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 81.3 mt -86.7 125.88 34.18 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.153 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -114.91 155.76 46.0 Favored Pre-proline 0 C--N 1.288 -2.089 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.62 157.22 59.34 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 121.526 1.484 . . . . 0.0 110.46 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 58.5 t -80.13 79.45 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -98.74 100.17 11.35 Favored 'General case' 0 N--CA 1.42 -1.927 0 CA-C-N 114.199 -1.364 . . . . 0.0 109.783 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -92.06 59.74 3.64 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.423 -175.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.309 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.308 -179.724 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1129 ' ' DA2 . . . . . 0.465 HC21 ' HNE' ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.557 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.2 m -62.85 -37.48 86.98 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.691 0.758 . . . . 0.0 109.721 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 80.1 m -129.02 125.28 36.98 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 176.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.783 HE21 ' N ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -90.24 141.44 27.66 Favored Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -175.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -53.73 135.05 61.28 Favored 'Trans proline' 0 C--O 1.239 0.568 0 C-N-CA 123.16 2.573 . . . . 0.0 113.283 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.3 t -88.03 -18.03 29.84 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 177.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -140.99 143.24 34.35 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.9 t -85.48 104.67 15.48 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.413 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 95.2 m95 -110.06 151.52 27.1 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.637 179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -129.09 159.01 37.34 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 175.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.11 134.35 29.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 C-N-CA 123.385 0.674 . . . . 0.0 110.741 178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.1 35.97 25.87 Favored Glycine 0 N--CA 1.439 -1.164 0 N-CA-C 111.767 -0.533 . . . . 0.0 111.767 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -117.36 154.53 31.13 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -93.92 132.42 38.39 Favored 'General case' 0 C--N 1.275 -2.634 0 CA-C-O 121.68 0.752 . . . . 0.0 110.355 175.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.413 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 19.4 p -142.89 178.88 7.36 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.1 -178.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 33.5 mtp -118.99 130.54 55.74 Favored 'General case' 0 N--CA 1.408 -2.544 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.13 149.96 43.87 Favored 'General case' 0 C--N 1.28 -2.455 0 O-C-N 123.517 0.51 . . . . 0.0 109.964 -175.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 99.0 t -85.3 119.07 33.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.131 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.2 t90 -67.16 123.49 20.42 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 177.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.2 m -60.31 -28.23 67.95 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.607 0.718 . . . . 0.0 112.087 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -79.59 -41.87 26.21 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.628 -174.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -112.73 -15.74 12.91 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.804 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.39 3.92 89.95 Favored Glycine 0 C--N 1.313 -0.715 0 C-N-CA 120.03 -1.081 . . . . 0.0 113.561 177.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.451 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 33.0 mm-40 -90.14 161.22 15.87 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 122.362 -0.493 . . . . 0.0 109.701 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 71.2 m -95.14 135.54 36.58 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.461 ' CD2' HC11 ' A' 1129 ' ' DA2 . 97.7 m-85 -135.96 158.03 45.4 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.067 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -75.34 131.31 40.18 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.81 152.52 43.79 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.583 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -111.45 134.34 53.1 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.526 ' HA ' HG22 ' A' ' 106' ' ' ILE . 70.0 mt -72.15 125.07 30.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 C-N-CA 123.432 0.693 . . . . 0.0 111.659 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -96.28 -41.73 8.51 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.085 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -150.78 152.03 33.21 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 72.2 mt -124.77 136.04 62.02 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -112.67 91.61 3.72 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 105.615 -1.995 . . . . 0.0 105.615 174.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -65.64 -25.61 67.43 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.729 -176.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -64.6 -44.11 91.67 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.936 -176.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.4 m-80 -98.22 -5.53 33.11 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.97 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.422 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 68.19 40.94 87.68 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -175.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 40.3 p -125.41 155.93 39.62 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 122.641 -0.329 . . . . 0.0 110.143 -177.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -141.74 145.73 35.17 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-O 121.122 0.487 . . . . 0.0 111.105 176.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.99 125.03 35.67 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 175.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.526 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -128.12 154.59 38.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.546 -175.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 92.1 m -120.08 120.24 35.68 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.782 176.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -66.88 123.13 19.32 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 123.242 0.617 . . . . 0.0 110.38 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.75 137.9 55.81 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.275 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.28 -49.71 3.26 Favored Glycine 0 N--CA 1.439 -1.159 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.879 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -81.95 -35.48 29.01 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-O 120.758 0.313 . . . . 0.0 110.902 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 82.04 9.74 84.84 Favored Glycine 0 N--CA 1.441 -0.971 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.488 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -81.42 152.68 27.3 Favored 'General case' 0 CA--C 1.49 -1.332 0 O-C-N 122.634 -0.333 . . . . 0.0 110.109 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.09 138.79 40.74 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 120.645 0.26 . . . . 0.0 110.991 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -151.85 161.06 43.26 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.872 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 44.2 t -98.27 122.04 49.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.0 t -135.8 141.6 37.49 Favored Pre-proline 0 C--N 1.282 -2.348 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -174.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 36.8 Cg_endo -62.54 147.11 95.31 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 122.425 2.083 . . . . 0.0 111.207 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 55.6 mt -55.65 -26.05 42.49 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 123.668 0.787 . . . . 0.0 111.788 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 pp -63.92 -28.89 70.14 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 121.637 0.732 . . . . 0.0 110.511 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.8 m-20 -85.13 -17.62 36.71 Favored 'General case' 0 CA--C 1.484 -1.58 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.661 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 81.1 mt -82.98 125.79 31.8 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-O 121.64 0.733 . . . . 0.0 109.355 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -114.45 154.81 46.49 Favored Pre-proline 0 C--N 1.275 -2.658 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.214 178.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -67.38 155.38 70.65 Favored 'Trans proline' 0 C--O 1.255 1.367 0 C-N-CA 121.506 1.47 . . . . 0.0 110.003 175.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 99.3 t -74.33 95.67 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -86.65 115.39 24.07 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.322 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -96.86 13.81 27.45 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.498 0.666 . . . . 0.0 110.834 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.778 0 N-CA-C 110.786 -0.925 . . . . 0.0 110.786 178.762 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 1129 ' ' DA2 . . . . . 0.501 HC21 ' HNE' ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.492 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.6 m 64.21 18.98 11.59 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.091 0.957 . . . . 0.0 110.941 -178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.6 p -126.61 98.61 5.46 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.766 -174.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.582 ' OE1' ' HD2' ' A' ' 69' ' ' PRO . 6.2 tp-100 -112.15 126.15 28.93 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.582 ' HD2' ' OE1' ' A' ' 68' ' ' GLN . 34.8 Cg_exo -44.24 136.63 8.07 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 124.366 3.377 . . . . 0.0 113.8 175.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.6 t -97.4 -23.88 15.88 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.819 178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -135.23 135.49 41.0 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.07 -1.455 . . . . 0.0 107.07 -175.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.9 p -82.51 108.62 16.05 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 123.474 0.484 . . . . 0.0 110.476 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -115.81 151.95 34.25 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.219 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.409 ' HG2' ' OD2' ' A' ' 77' ' ' ASP . 21.6 pttm -127.79 162.65 26.13 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 173.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.2 t -64.49 135.57 27.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 122.943 0.497 . . . . 0.0 110.419 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.56 18.46 48.51 Favored Glycine 0 C--O 1.239 0.449 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.323 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.409 ' OD2' ' HG2' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -108.01 151.18 26.17 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -91.41 140.82 29.4 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-O 121.604 0.716 . . . . 0.0 109.844 173.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.42 ' SG ' HD22 ' A' ' 122' ' ' LEU . 16.5 p -146.8 173.01 12.77 Favored 'General case' 0 C--N 1.261 -3.248 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.3 mtp -114.12 130.22 56.59 Favored 'General case' 0 C--N 1.274 -2.695 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -121.19 150.67 40.96 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.38 -175.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.1 t -85.31 117.22 30.0 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.434 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.3 t90 -64.76 123.08 18.44 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.4 m -61.19 -22.8 65.08 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.434 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 28.0 mm-40 -83.28 -42.04 17.62 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -177.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -116.21 -15.47 11.05 Favored 'General case' 0 CA--C 1.509 -0.609 0 C-N-CA 118.849 -1.14 . . . . 0.0 112.124 -174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.09 6.37 89.2 Favored Glycine 0 C--N 1.315 -0.612 0 C-N-CA 120.394 -0.908 . . . . 0.0 114.098 176.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.453 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 28.3 mm-40 -91.28 161.81 14.88 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 176.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 59.4 m -91.33 135.64 33.67 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.453 ' CE1' ' HB2' ' A' ' 88' ' ' GLN . 96.4 m-85 -136.71 157.63 46.31 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 123.202 0.601 . . . . 0.0 109.481 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -76.43 123.8 26.56 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.43 151.89 49.0 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.845 -178.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -108.54 135.94 48.97 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.576 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.493 ' HA ' HG22 ' A' ' 106' ' ' ILE . 67.4 mt -73.46 118.51 18.93 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.937 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.819 177.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -94.71 -36.49 11.71 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.044 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -152.82 151.09 30.04 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.496 -177.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 68.4 mt -127.15 141.43 46.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -120.77 98.3 5.95 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 173.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -65.75 -25.01 67.08 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -177.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -63.08 -46.54 86.94 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.931 0.396 . . . . 0.0 110.957 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -93.82 -13.6 27.1 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.408 178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.506 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 68.87 40.8 84.46 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -175.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.596 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 40.6 p -122.93 155.59 36.42 Favored 'General case' 0 N--CA 1.424 -1.748 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -137.02 145.0 43.55 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 121.216 0.531 . . . . 0.0 111.108 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -91.9 121.58 33.63 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.493 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.4 152.84 30.55 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.691 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.818 -175.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.9 m -122.65 120.41 33.63 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.548 178.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -66.7 118.77 10.72 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.871 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.48 134.53 55.78 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.967 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 93.43 -54.61 2.41 Favored Glycine 0 N--CA 1.424 -2.136 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.554 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -74.77 -43.47 54.68 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.072 0.463 . . . . 0.0 111.059 -178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.79 4.81 69.26 Favored Glycine 0 N--CA 1.433 -1.525 0 C-N-CA 120.435 -0.888 . . . . 0.0 112.142 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -76.98 151.27 35.73 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 177.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -138.44 140.19 39.18 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -177.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -151.75 161.53 42.51 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 74.8 t -98.71 120.57 48.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.5 t -135.06 141.14 37.08 Favored Pre-proline 0 C--N 1.289 -2.053 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -176.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.596 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.3 Cg_endo -62.51 147.88 94.16 Favored 'Trans proline' 0 N--CA 1.446 -1.294 0 C-N-CA 122.552 2.168 . . . . 0.0 111.698 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 50.0 mt -55.51 -26.32 42.2 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 123.834 0.854 . . . . 0.0 111.515 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 pp -65.2 -26.78 68.29 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.968 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.426 HD22 ' HD2' ' A' ' 118' ' ' PRO . 75.4 m-20 -87.91 -17.42 31.41 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.784 -178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.42 HD22 ' SG ' ' A' ' 79' ' ' CYS . 83.8 mt -81.8 125.87 31.18 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.483 0.659 . . . . 0.0 109.276 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -114.75 151.19 45.14 Favored Pre-proline 0 C--N 1.284 -2.255 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.83 147.53 69.01 Favored 'Trans proline' 0 C--N 1.323 -0.771 0 C-N-CA 121.966 1.778 . . . . 0.0 111.378 178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 44.5 t -80.48 91.35 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.745 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -88.35 138.24 31.61 Favored 'General case' 0 N--CA 1.405 -2.719 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 173.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 72.6 30.4 1.87 Allowed 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 125.358 1.463 . . . . 0.0 110.686 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.423 -2.187 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 177.808 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1129 ' ' DA2 . . . . . 0.515 HC21 ' HNE' ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.3 m -127.94 29.69 5.38 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.6 m -83.89 102.9 12.72 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 113.698 -1.592 . . . . 0.0 109.612 -174.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -101.06 107.85 51.89 Favored Pre-proline 0 C--N 1.301 -1.525 0 N-CA-C 107.767 -1.198 . . . . 0.0 107.767 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -50.24 134.93 38.3 Favored 'Trans proline' 0 C--O 1.244 0.792 0 C-N-CA 123.802 3.001 . . . . 0.0 113.206 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.7 t -78.54 -22.56 47.09 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.565 0.698 . . . . 0.0 110.284 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -141.05 140.43 34.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.0 m -83.36 105.04 13.99 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.401 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 91.9 m95 -107.72 150.81 26.5 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.199 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -129.9 151.88 49.98 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.4 t -64.4 134.93 28.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.49 30.85 23.44 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.364 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -120.87 157.65 29.36 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -91.81 141.94 28.11 Favored 'General case' 0 N--CA 1.409 -2.508 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.285 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.42 ' SG ' HD22 ' A' ' 122' ' ' LEU . 22.5 p -148.26 177.37 9.47 Favored 'General case' 0 C--N 1.265 -3.089 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 36.6 mtp -118.51 130.66 56.05 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 106.66 -1.608 . . . . 0.0 106.66 173.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -120.23 150.17 41.1 Favored 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -176.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.1 t -86.0 113.91 24.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.7 t90 -64.46 122.64 17.22 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.5 t -65.23 -19.99 66.22 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 120.778 0.323 . . . . 0.0 111.285 -175.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -84.98 -42.65 14.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.497 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 9.2 t70 -108.33 -15.63 14.43 Favored 'General case' 0 C--N 1.308 -1.227 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.086 -175.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.72 2.27 89.84 Favored Glycine 0 C--N 1.316 -0.558 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.512 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.497 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 24.2 mm-40 -95.14 163.28 13.36 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 17.5 p -93.23 136.42 33.51 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.135 0.493 . . . . 0.0 110.74 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -134.07 158.68 42.96 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 124.145 0.978 . . . . 0.0 109.426 -178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -75.26 128.41 35.37 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.94 151.82 42.94 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.84 0.352 . . . . 0.0 110.905 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -113.75 135.29 54.11 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.433 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.521 ' HA ' HG22 ' A' ' 106' ' ' ILE . 64.3 mt -72.87 122.03 24.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.473 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -99.29 -33.5 10.7 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.462 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -153.66 150.78 28.95 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 77.1 mt -126.53 133.7 68.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -118.27 94.18 4.4 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.74 -20.69 66.01 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -61.4 -46.81 88.59 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -97.49 -13.88 21.45 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.047 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.485 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.05 36.59 51.29 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -177.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 43.9 p -124.52 155.35 39.14 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -176.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.36 147.88 50.6 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-O 121.011 0.434 . . . . 0.0 110.392 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.48 120.15 34.28 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.521 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.76 149.9 29.43 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.989 -174.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 94.0 m -118.02 120.56 38.17 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.078 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -68.48 125.4 26.36 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.576 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -64.09 136.95 57.72 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.407 -176.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 86.28 -46.83 3.66 Favored Glycine 0 C--N 1.311 -0.813 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.567 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -79.87 -43.01 23.05 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 121.155 0.502 . . . . 0.0 110.739 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 88.34 1.33 81.46 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.878 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -70.44 148.71 48.02 Favored 'General case' 0 CA--C 1.484 -1.583 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -136.64 133.96 36.81 Favored 'General case' 0 C--N 1.28 -2.445 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -177.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -146.86 156.32 43.01 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.0 t -91.1 122.05 42.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 176.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.7 t -135.84 141.19 35.86 Favored Pre-proline 0 C--N 1.283 -2.303 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -176.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.58 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 40.8 Cg_endo -62.38 146.6 95.67 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.423 2.082 . . . . 0.0 110.923 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.485 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 55.4 mt -54.66 -26.48 33.57 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 123.504 0.722 . . . . 0.0 111.497 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 pp -63.37 -27.87 69.61 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.897 0.38 . . . . 0.0 110.703 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -87.39 -14.71 39.89 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.518 -177.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.42 HD22 ' SG ' ' A' ' 79' ' ' CYS . 82.1 mt -84.27 126.28 33.03 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.198 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -114.34 151.54 45.19 Favored Pre-proline 0 C--N 1.285 -2.218 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -69.78 150.98 68.83 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.747 1.631 . . . . 0.0 111.607 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 64.0 t -79.74 96.26 2.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -85.2 109.51 18.36 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.263 0.554 . . . . 0.0 109.896 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -127.14 21.89 6.7 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.046 -179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.409 0 N-CA-C 107.644 -2.182 . . . . 0.0 107.644 179.287 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 1129 ' ' DA2 . . . . . 0.54 HC21 ' HNE' ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.471 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.3 m -69.21 104.82 2.3 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 123.286 0.366 . . . . 0.0 111.146 -177.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.2 t -175.42 -179.05 1.22 Allowed 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -115.56 151.39 46.06 Favored Pre-proline 0 C--N 1.286 -2.181 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -63.87 146.47 91.67 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 122.18 1.92 . . . . 0.0 111.537 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.8 t -74.45 -28.72 61.17 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.375 0.607 . . . . 0.0 110.027 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -141.84 144.95 34.14 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 11.1 m -87.95 105.62 17.57 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -111.25 151.88 27.79 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 122.754 0.421 . . . . 0.0 111.692 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.412 ' HB2' ' NZ ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -129.1 152.16 49.0 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 175.386 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.4 t -63.98 139.84 20.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 C-N-CA 123.325 0.65 . . . . 0.0 110.188 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.19 35.34 34.33 Favored Glycine 0 CA--C 1.497 -1.079 0 N-CA-C 111.646 -0.582 . . . . 0.0 111.646 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.2 153.74 38.42 Favored 'General case' 0 CA--C 1.481 -1.684 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -91.86 135.34 34.0 Favored 'General case' 0 N--CA 1.412 -2.375 0 O-C-N 123.872 0.732 . . . . 0.0 110.801 175.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 20.5 p -145.99 179.51 7.42 Favored 'General case' 0 C--N 1.27 -2.871 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.412 ' HG3' ' HA ' ' A' ' 125' ' ' VAL . 56.5 mtp -119.97 130.69 54.88 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 173.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.25 151.49 39.09 Favored 'General case' 0 C--N 1.276 -2.617 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.034 -174.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 88.6 t -85.28 115.8 27.57 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 176.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 12.3 t90 -64.15 121.39 14.1 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 26.1 t -63.19 -19.84 64.87 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 123.438 0.461 . . . . 0.0 111.431 -175.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -84.73 -43.2 14.5 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.982 -0.687 . . . . 0.0 112.417 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.421 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 11.2 t70 -111.87 -16.41 13.15 Favored 'General case' 0 CA--C 1.508 -0.652 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.765 -174.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.59 6.0 89.48 Favored Glycine 0 C--N 1.308 -0.99 0 C-N-CA 119.798 -1.191 . . . . 0.0 113.855 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.421 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 28.9 mm-40 -93.78 163.07 13.67 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 13.0 p -92.12 136.59 33.06 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 120.544 0.212 . . . . 0.0 110.77 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -137.69 157.96 45.37 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 124.052 0.941 . . . . 0.0 109.449 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -75.2 127.29 32.86 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -139.93 153.07 46.85 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.072 0.463 . . . . 0.0 110.964 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -113.01 134.59 54.44 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.45 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.532 ' HA ' HG22 ' A' ' 106' ' ' ILE . 67.4 mt -73.29 123.01 27.35 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 123.314 0.646 . . . . 0.0 112.2 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -95.13 -43.06 8.28 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.952 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -148.11 149.98 33.02 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.8 mt -129.17 138.33 54.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 O-C-N 123.382 0.426 . . . . 0.0 109.873 177.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -122.96 94.86 4.4 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 174.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.87 -25.95 66.65 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -177.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -61.28 -46.48 90.17 Favored 'General case' 0 C--O 1.221 -0.443 0 O-C-N 123.433 0.458 . . . . 0.0 109.938 -177.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -93.94 -12.6 28.43 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-O 121.29 0.567 . . . . 0.0 110.393 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.18 42.02 51.91 Favored Glycine 0 N--CA 1.436 -1.342 0 N-CA-C 110.598 -1.001 . . . . 0.0 110.598 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 60.4 p -126.88 157.45 39.33 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 -177.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.44 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -141.56 144.61 34.36 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.887 175.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.27 125.06 36.78 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 175.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.532 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -126.81 154.35 36.69 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.629 0 O-C-N 123.41 0.444 . . . . 0.0 110.659 -175.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.4 m -121.26 120.57 35.54 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.769 176.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -66.78 120.76 14.08 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 123.735 0.814 . . . . 0.0 110.738 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.62 123.81 21.9 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.765 -175.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.93 -34.14 6.02 Favored Glycine 0 N--CA 1.425 -2.059 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.009 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -96.23 -40.45 9.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.815 0.341 . . . . 0.0 111.432 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.06 6.02 65.42 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.256 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -81.28 151.1 28.24 Favored 'General case' 0 CA--C 1.488 -1.441 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -140.03 139.15 35.9 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.397 -176.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -147.35 160.55 42.4 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 123.716 0.635 . . . . 0.0 109.471 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 58.7 t -97.48 114.7 35.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 174.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.5 t -130.14 141.52 42.18 Favored Pre-proline 0 C--N 1.28 -2.455 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -175.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 38.3 Cg_endo -62.97 146.9 95.0 Favored 'Trans proline' 0 N--CA 1.445 -1.334 0 C-N-CA 122.04 1.827 . . . . 0.0 111.164 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 60.7 mt -53.0 -26.65 16.01 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.019 0.928 . . . . 0.0 111.918 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.4 pp -66.28 -24.48 66.57 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.066 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -91.42 -9.82 43.27 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 121.331 0.586 . . . . 0.0 110.561 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.44 HD11 ' HB3' ' A' ' 104' ' ' ALA . 80.1 mt -88.71 127.29 35.59 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.991 175.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -113.86 156.53 43.68 Favored Pre-proline 0 C--N 1.282 -2.345 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -65.56 160.38 43.41 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.086 1.858 . . . . 0.0 109.135 172.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.412 ' HA ' ' HG3' ' A' ' 80' ' ' MET . 89.2 t -70.43 89.01 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 122.153 0.978 . . . . 0.0 109.918 177.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -79.1 114.04 17.72 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 113.907 -1.497 . . . . 0.0 108.719 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -111.29 10.81 21.67 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.412 -2.937 0 N-CA-C 106.721 -2.551 . . . . 0.0 106.721 179.041 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1129 ' ' DA2 . . . . . 0.405 HC21 ' HNE' ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.201 0 CA-C-O 119.531 -0.271 . . . . 0.0 111.23 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.7 m 61.38 84.96 0.12 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-O 121.753 0.787 . . . . 0.0 111.309 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 p -123.77 134.6 53.63 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.8 -177.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -73.81 127.27 88.65 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.446 ' HB3' ' CD1' ' A' ' 119' ' ' LEU . 74.9 Cg_exo -48.5 153.22 3.43 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 124.099 3.2 . . . . 0.0 114.332 178.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.8 t -74.11 -25.53 59.84 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 121.328 0.585 . . . . 0.0 110.078 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -141.33 142.53 33.81 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 177.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.7 m -78.82 104.79 9.68 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 121.087 0.47 . . . . 0.0 110.398 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.424 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 91.4 m95 -115.92 151.19 35.84 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.584 179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -126.59 152.75 46.21 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.6 t -64.12 131.24 29.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 85.84 32.23 18.71 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 121.196 -0.526 . . . . 0.0 112.381 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 2.9 t70 -113.55 158.69 20.45 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -97.53 131.58 44.01 Favored 'General case' 0 N--CA 1.409 -2.486 0 CA-C-O 121.913 0.863 . . . . 0.0 110.862 174.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.424 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 17.4 p -144.04 179.62 7.08 Favored 'General case' 0 C--N 1.265 -3.074 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.197 -178.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.428 ' HG3' ' HA ' ' A' ' 125' ' ' VAL . 40.0 mtp -118.37 130.27 55.9 Favored 'General case' 0 N--CA 1.41 -2.449 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 172.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.94 149.98 41.24 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -176.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 78.5 t -85.36 116.18 28.25 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 115.498 -0.773 . . . . 0.0 109.052 177.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.492 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.7 t90 -64.31 121.6 14.7 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.7 t -65.08 -18.76 65.57 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 120.926 0.393 . . . . 0.0 111.339 -176.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.492 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 43.6 mt-10 -83.75 -41.84 17.19 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -176.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.53 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 15.9 t70 -114.79 -16.57 11.75 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 118.897 -1.121 . . . . 0.0 111.812 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 87.26 -0.89 86.0 Favored Glycine 0 C--N 1.3 -1.423 0 C-N-CA 119.832 -1.175 . . . . 0.0 113.47 178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.53 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 28.0 mm-40 -85.89 159.13 19.76 Favored 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.077 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 8.9 p -93.01 136.2 33.48 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.44 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 88' ' ' GLN . 97.5 m-85 -137.39 158.81 43.6 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 124.36 1.064 . . . . 0.0 108.957 -178.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -74.68 127.11 32.32 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.42 150.35 47.57 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.854 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 77' ' ' ASP . 42.9 tt0 -111.37 132.29 54.54 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.712 178.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.528 ' HA ' HG22 ' A' ' 106' ' ' ILE . 69.8 mt -71.99 124.39 28.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.079 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -96.14 -39.85 9.5 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.241 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -152.68 152.18 31.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -177.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 71.1 mt -125.55 140.48 48.27 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -123.87 91.35 3.45 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -65.92 -22.92 66.53 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 -175.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -71.5 -34.59 70.25 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.848 -178.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -98.51 -10.13 23.98 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.727 174.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.432 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 67.55 38.79 90.81 Favored Glycine 0 CA--C 1.5 -0.891 0 N-CA-C 110.597 -1.001 . . . . 0.0 110.597 -178.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.605 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 65.0 p -128.61 155.86 44.3 Favored 'General case' 0 N--CA 1.421 -1.898 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 -175.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.406 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -137.62 148.5 45.86 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 121.161 0.505 . . . . 0.0 110.566 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.68 122.02 38.01 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.528 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.94 154.83 33.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.538 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.317 -174.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 94.6 m -118.76 121.07 39.22 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -66.79 118.35 10.19 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.69 117.1 8.37 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.253 -173.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 110.39 -45.92 1.25 Allowed Glycine 0 N--CA 1.423 -2.193 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.847 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -81.83 -36.58 28.18 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.218 0.532 . . . . 0.0 110.975 -178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.81 2.58 86.45 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 120.081 -1.056 . . . . 0.0 112.01 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -73.52 147.8 43.68 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.31 129.39 25.15 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.473 -176.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -145.91 155.98 43.23 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.8 t -92.04 120.86 41.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 177.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.4 t -135.02 140.76 35.9 Favored Pre-proline 0 C--N 1.284 -2.256 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.0 Cg_endo -62.84 148.45 93.42 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.42 2.08 . . . . 0.0 111.463 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.446 ' CD1' ' HB3' ' A' ' 69' ' ' PRO . 56.2 mt -55.69 -26.34 44.5 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 123.883 0.873 . . . . 0.0 111.839 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.6 -25.43 67.39 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.085 0.554 . . . . 0.0 110.957 177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.413 HD22 ' HD2' ' A' ' 118' ' ' PRO . 73.9 m-20 -89.61 -13.31 37.43 Favored 'General case' 0 CA--C 1.482 -1.638 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.448 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 104' ' ' ALA . 80.6 mt -86.34 127.23 34.77 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.517 176.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -113.67 154.55 45.68 Favored Pre-proline 0 C--N 1.274 -2.69 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.48 ' O ' ' HG3' ' A' ' 126' ' ' GLU . 45.1 Cg_endo -66.58 160.43 46.09 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 122.045 1.83 . . . . 0.0 108.284 172.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.428 ' HA ' ' HG3' ' A' ' 80' ' ' MET . 76.7 t -67.74 94.1 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 122.438 1.113 . . . . 0.0 110.824 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 124' ' ' PRO . 41.9 mt-10 -86.86 103.3 15.13 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 113.909 -1.496 . . . . 0.0 108.57 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -96.69 9.27 42.13 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.628 0.728 . . . . 0.0 110.701 -178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.411 -2.977 0 N-CA-C 108.691 -1.763 . . . . 0.0 108.691 -179.908 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1129 ' ' DA2 . . . . . 0.417 HC21 ' HNE' ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 120.78 0.324 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.7 t -68.91 -37.76 79.16 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.266 0.555 . . . . 0.0 109.941 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.9 m -129.23 123.38 31.82 Favored 'General case' 0 N--CA 1.416 -2.167 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 177.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -95.25 123.95 55.28 Favored Pre-proline 0 C--N 1.292 -1.926 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -48.06 134.1 23.92 Favored 'Trans proline' 0 CA--C 1.51 -0.719 0 C-N-CA 123.54 2.826 . . . . 0.0 113.081 -176.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.0 t -87.4 -21.63 25.5 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -142.12 137.18 30.75 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 105.572 -2.01 . . . . 0.0 105.572 177.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 27.5 t -83.81 112.67 20.32 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -113.05 152.21 29.78 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -122.53 150.24 42.84 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 122.652 0.381 . . . . 0.0 110.136 175.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.5 t -64.3 138.53 22.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 81.36 25.71 53.74 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 121.393 -0.432 . . . . 0.0 112.708 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 13.0 t0 -105.57 165.43 11.16 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.609 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.0 mmpt? -94.34 130.87 40.47 Favored 'General case' 0 N--CA 1.41 -2.472 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 24.2 p -144.44 174.24 11.1 Favored 'General case' 0 C--N 1.258 -3.404 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.9 mtp -117.22 130.72 56.76 Favored 'General case' 0 C--N 1.271 -2.815 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.46 148.35 42.67 Favored 'General case' 0 C--N 1.264 -3.115 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -175.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 72.3 t -85.33 115.12 26.47 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.586 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 177.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.7 t90 -63.17 121.48 13.75 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.2 t -62.89 -20.07 64.8 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 122.813 0.445 . . . . 0.0 111.208 -175.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -82.11 -43.08 18.29 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.514 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 14.1 t70 -115.6 -16.13 11.34 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 118.657 -1.217 . . . . 0.0 112.276 -174.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.3 5.18 89.08 Favored Glycine 0 C--N 1.307 -1.053 0 C-N-CA 119.62 -1.276 . . . . 0.0 113.273 177.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.514 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 29.4 mm-40 -90.7 162.96 14.69 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 176.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 5.5 p -95.99 136.02 36.99 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.516 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.421 ' CD2' HC11 ' A' 1129 ' ' DA2 . 97.2 m-85 -137.88 158.03 45.19 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 124.007 0.923 . . . . 0.0 109.422 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -74.8 132.1 41.31 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.27 155.92 44.6 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.627 -177.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 77' ' ' ASP . 36.5 tt0 -114.61 132.67 56.28 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.542 176.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.593 ' HA ' HG22 ' A' ' 106' ' ' ILE . 71.6 mt -71.48 123.37 25.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 O-C-N 123.67 0.606 . . . . 0.0 112.081 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -96.97 -42.55 7.86 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.09 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 105' ' ' ALA . 26.3 tt0 -144.35 145.03 31.73 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.459 -174.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 80.1 mt -121.74 126.1 74.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 173.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -111.51 94.85 5.17 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 175.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -65.4 -25.32 67.5 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.949 -1.023 . . . . 0.0 113.401 -174.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -70.75 -44.59 66.45 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 121.436 0.636 . . . . 0.0 109.967 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -91.24 -7.77 50.31 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.987 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.525 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 64.63 39.26 96.6 Favored Glycine 0 N--CA 1.443 -0.86 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -177.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 53.7 p -123.01 155.93 35.85 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -177.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.529 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -138.58 138.8 38.26 Favored 'General case' 0 C--N 1.284 -2.275 0 CA-C-O 121.279 0.562 . . . . 0.0 110.208 176.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.576 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . . . -87.74 128.36 35.31 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 175.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.593 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -130.37 157.75 42.81 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.53 0 CA-C-O 120.669 0.271 . . . . 0.0 110.721 -175.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 65.2 m -121.68 120.6 35.18 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -67.89 120.67 14.57 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.334 179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.67 140.89 58.52 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.179 -176.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.65 -53.92 3.75 Favored Glycine 0 N--CA 1.43 -1.72 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -75.36 -43.16 51.97 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 120.924 0.392 . . . . 0.0 111.155 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.74 18.28 61.97 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.021 -1.085 . . . . 0.0 111.442 -177.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -87.61 156.12 19.64 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.95 143.52 32.0 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -151.78 162.19 41.42 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.465 ' HA ' ' HA ' ' A' ' 105' ' ' ALA . 57.5 t -100.91 113.83 38.14 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 174.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.1 t -126.44 141.13 39.1 Favored Pre-proline 0 C--N 1.278 -2.534 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -174.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.567 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 33.2 Cg_endo -62.38 149.99 88.84 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.255 1.97 . . . . 0.0 111.728 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 51.7 mt -56.62 -25.7 53.81 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 123.37 0.668 . . . . 0.0 110.71 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.7 pp -65.0 -23.94 67.36 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.536 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -93.71 -14.87 25.84 Favored 'General case' 0 CA--C 1.49 -1.35 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.571 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.529 HD11 ' HB3' ' A' ' 104' ' ' ALA . 71.6 mt -83.17 126.67 32.87 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -114.61 150.62 44.24 Favored Pre-proline 0 C--N 1.285 -2.228 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -71.59 148.02 52.67 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.436 1.424 . . . . 0.0 110.187 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 59.8 t -74.7 104.06 2.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -77.47 95.8 4.56 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.76 -177.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -128.81 13.38 6.35 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.625 177.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.497 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 -176.351 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 1129 ' ' DA2 . . . . . 0.519 ' HNE' HC21 ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.609 ' HA ' ' O ' ' A' ' 100' ' ' GLU . . . . . . . . 0 CA--C 1.513 -0.479 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.4 p -78.61 -19.79 51.89 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.163 0.506 . . . . 0.0 111.204 -178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.4 t -156.04 163.74 39.3 Favored 'General case' 0 N--CA 1.409 -2.497 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 175.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -102.3 135.21 19.64 Favored Pre-proline 0 C--N 1.281 -2.385 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -61.91 134.56 50.59 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.003 1.802 . . . . 0.0 111.409 -177.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.2 t -95.27 -7.4 38.95 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -140.75 133.18 28.43 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 31.4 p -88.36 105.71 17.76 Favored 'General case' 0 N--CA 1.422 -1.862 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.456 179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.489 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 94.2 m95 -99.28 150.89 21.64 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.392 179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -134.58 161.59 34.66 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 120.639 -0.425 . . . . 0.0 110.009 176.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.0 t -65.09 131.95 30.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 123.583 0.753 . . . . 0.0 110.008 178.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.21 38.02 10.53 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.228 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.75 153.32 41.1 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -92.27 133.87 35.42 Favored 'General case' 0 N--CA 1.417 -2.1 0 CA-C-O 121.65 0.738 . . . . 0.0 110.433 174.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.489 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 23.7 p -145.68 179.4 7.46 Favored 'General case' 0 C--N 1.267 -3.004 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.502 ' HG3' ' HA ' ' A' ' 125' ' ' VAL . 61.1 mtp -118.08 131.4 56.44 Favored 'General case' 0 N--CA 1.404 -2.772 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 172.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -118.26 148.89 41.97 Favored 'General case' 0 C--N 1.264 -3.11 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -175.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 76.9 t -84.63 113.67 23.67 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.482 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 13.5 t90 -63.29 122.67 16.76 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -177.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.1 t -63.5 -19.66 64.95 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 123.535 0.522 . . . . 0.0 111.583 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.482 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 21.9 mm-40 -84.73 -42.48 15.21 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -111.31 -15.62 13.57 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 118.62 -1.232 . . . . 0.0 111.791 -175.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.29 8.77 87.28 Favored Glycine 0 C--N 1.311 -0.81 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.16 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 26.8 mm-40 -101.69 162.31 13.0 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 26.5 p -92.48 136.4 33.24 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 121.415 0.626 . . . . 0.0 111.828 -178.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -135.8 158.4 44.5 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 124.284 1.033 . . . . 0.0 109.195 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -74.72 126.74 31.53 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -177.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.0 150.48 47.02 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.801 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -109.62 132.5 54.08 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.638 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.551 ' HA ' HG22 ' A' ' 106' ' ' ILE . 60.3 mt -72.52 123.2 26.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 123.165 0.586 . . . . 0.0 111.459 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -96.21 -40.3 9.25 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.982 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -154.71 152.64 30.16 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -177.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 57.1 mt -129.56 138.44 54.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.867 0.365 . . . . 0.0 110.076 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -122.34 91.29 3.47 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 173.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -66.9 -19.56 65.75 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -177.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.609 ' O ' ' HA ' ' A' ' 65' ' ' ALA . 12.8 tp10 -64.63 -46.31 83.12 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.556 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -90.45 -16.22 29.38 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.586 0.708 . . . . 0.0 109.834 176.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 75.85 37.91 37.76 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 61.4 p -123.92 155.42 38.17 Favored 'General case' 0 N--CA 1.413 -2.3 0 O-C-N 122.601 -0.352 . . . . 0.0 110.201 -176.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.429 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -138.31 140.53 39.59 Favored 'General case' 0 C--N 1.28 -2.425 0 CA-C-O 121.178 0.514 . . . . 0.0 109.874 176.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -89.33 121.9 32.04 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 107.13 -1.434 . . . . 0.0 107.13 177.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.551 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -126.74 154.83 37.04 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.512 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.99 -175.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 97.6 m -121.86 120.75 35.43 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.521 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -66.86 119.09 11.29 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.554 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -72.44 130.28 40.31 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.841 -176.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.49 -39.68 2.71 Favored Glycine 0 N--CA 1.427 -1.96 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -96.56 -39.97 9.27 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.244 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.31 -2.68 71.46 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.933 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -71.62 152.0 43.27 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-N 115.687 -0.256 . . . . 0.0 110.356 -179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -139.68 141.28 36.98 Favored 'General case' 0 C--N 1.285 -2.229 0 C-N-CA 121.023 -0.271 . . . . 0.0 110.568 -176.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -151.25 159.18 44.5 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.4 t -98.35 113.52 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.616 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 175.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.8 t -125.13 141.41 38.47 Favored Pre-proline 0 C--N 1.274 -2.675 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 46.0 Cg_endo -63.7 146.94 92.76 Favored 'Trans proline' 0 N--CA 1.443 -1.455 0 C-N-CA 121.777 1.651 . . . . 0.0 110.763 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 42.3 mt -55.51 -26.27 41.94 Favored 'General case' 0 C--N 1.317 -0.817 0 C-N-CA 123.537 0.735 . . . . 0.0 110.828 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 pp -63.86 -23.24 67.28 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 121.214 0.53 . . . . 0.0 110.849 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -93.54 -10.38 35.01 Favored 'General case' 0 CA--C 1.491 -1.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.465 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.429 HD11 ' HB3' ' A' ' 104' ' ' ALA . 80.2 mt -84.44 127.43 34.01 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 121.856 0.836 . . . . 0.0 109.962 176.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.0 mtpp -114.26 150.23 43.37 Favored Pre-proline 0 C--N 1.277 -2.574 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.135 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.82 153.79 70.47 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.597 1.531 . . . . 0.0 108.557 170.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.502 ' HA ' ' HG3' ' A' ' 80' ' ' MET . 45.1 t -73.44 97.77 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.246 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -77.28 73.56 3.86 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 122.197 0.999 . . . . 0.0 113.609 -176.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.411 ' HG2' HG12 ' A' ' 125' ' ' VAL . 9.6 pt-20 -122.79 14.67 10.07 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 122.928 1.347 . . . . 0.0 107.813 173.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.407 -3.299 0 N-CA-C 106.252 -2.739 . . . . 0.0 106.252 -179.412 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 1129 ' ' DA2 . . . . . 0.407 ' HNE' HC21 ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.295 0 N-CA-C 111.609 0.226 . . . . 0.0 111.609 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.2 m -91.72 -46.74 7.74 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.318 0.58 . . . . 0.0 111.179 -175.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.7 t -106.46 102.39 11.79 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.572 0.701 . . . . 0.0 109.45 -177.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -94.86 145.4 29.5 Favored Pre-proline 0 C--N 1.298 -1.666 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.369 -176.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -60.74 133.84 50.5 Favored 'Trans proline' 0 CA--C 1.515 -0.453 0 C-N-CA 122.596 2.197 . . . . 0.0 111.335 176.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.3 t -91.08 -16.54 27.67 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.05 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -142.22 139.16 31.91 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.2 p -85.78 104.85 15.84 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.451 0.643 . . . . 0.0 110.767 178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -105.69 152.11 23.57 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.647 -178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.9 pttm -127.14 158.9 35.84 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.667 -0.413 . . . . 0.0 109.911 175.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.7 t -65.14 138.0 23.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.863 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.35 38.64 28.53 Favored Glycine 0 N--CA 1.434 -1.453 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.55 154.14 37.08 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -95.22 135.44 36.8 Favored 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.97 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 18.7 p -147.17 176.86 9.63 Favored 'General case' 0 C--N 1.263 -3.173 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 34.2 mtp -115.67 130.53 56.89 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -119.74 151.67 38.41 Favored 'General case' 0 C--N 1.277 -2.553 0 O-C-N 123.44 0.462 . . . . 0.0 109.818 -175.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.4 t -85.19 114.27 25.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.504 ' CE3' ' HB2' ' A' ' 86' ' ' ASP . 12.4 t90 -67.03 125.52 26.25 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 58.6 m -57.75 -33.02 68.04 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.376 0.608 . . . . 0.0 111.844 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.402 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 30.4 mt-10 -79.07 -41.66 28.25 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -172.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.504 ' HB2' ' CE3' ' A' ' 83' ' ' TRP . 42.6 t0 -105.75 -16.3 14.71 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.681 0.753 . . . . 0.0 110.194 -176.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.88 8.13 77.08 Favored Glycine 0 C--N 1.316 -0.529 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.88 178.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -101.49 163.76 12.1 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 15.2 p -93.7 135.58 34.85 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.227 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -134.66 158.18 44.72 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 124.364 1.066 . . . . 0.0 109.185 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -75.26 125.64 29.38 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.26 0.552 . . . . 0.0 109.738 -176.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -140.42 154.36 46.65 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.652 -177.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -112.09 133.87 53.98 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.286 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.522 ' HA ' HG22 ' A' ' 106' ' ' ILE . 70.7 mt -71.94 122.31 23.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 C-N-CA 123.528 0.731 . . . . 0.0 111.453 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -96.96 -40.54 8.83 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.284 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -151.02 146.97 26.57 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -175.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 72.5 mt -122.45 135.88 61.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -120.03 93.97 4.23 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 174.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.13 -19.87 65.97 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -63.87 -46.47 84.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -93.01 -15.39 26.24 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.136 0.493 . . . . 0.0 110.244 178.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.441 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 74.3 37.02 48.97 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -176.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 41.2 p -125.6 155.81 40.14 Favored 'General case' 0 N--CA 1.416 -2.131 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -176.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.51 148.6 47.73 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-O 121.233 0.539 . . . . 0.0 110.28 177.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.07 124.79 39.3 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 176.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.522 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -126.75 154.7 36.93 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.693 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.644 -175.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 98.4 m -122.08 120.1 33.31 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -67.19 118.72 10.98 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 123.201 0.6 . . . . 0.0 110.494 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.78 129.41 39.69 Favored 'General case' 0 N--CA 1.436 -1.126 0 O-C-N 124.509 1.131 . . . . 0.0 110.883 -175.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.77 -44.99 1.76 Allowed Glycine 0 N--CA 1.425 -2.088 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.736 178.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -82.47 -43.14 17.6 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 120.729 0.299 . . . . 0.0 111.11 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.25 10.42 60.91 Favored Glycine 0 N--CA 1.438 -1.175 0 C-N-CA 120.457 -0.877 . . . . 0.0 112.642 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -85.02 156.92 20.9 Favored 'General case' 0 CA--C 1.488 -1.41 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.03 140.73 32.71 Favored 'General case' 0 C--N 1.29 -2.015 0 O-C-N 123.033 0.208 . . . . 0.0 110.789 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -151.75 158.9 43.98 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 123.371 0.419 . . . . 0.0 109.985 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 67.1 t -95.79 116.34 37.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 176.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.0 t -130.28 141.61 42.52 Favored Pre-proline 0 C--N 1.288 -2.099 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -174.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.566 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 42.1 Cg_endo -63.92 146.52 91.55 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.212 1.941 . . . . 0.0 111.108 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 61.6 mt -55.04 -26.15 35.38 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 123.906 0.882 . . . . 0.0 111.952 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.65 -27.05 68.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.057 178.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -88.9 -12.88 40.49 Favored 'General case' 0 CA--C 1.484 -1.584 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.803 -177.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 84.3 mt -82.64 126.15 32.01 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -114.11 148.43 40.02 Favored Pre-proline 0 C--N 1.28 -2.414 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.35 146.66 57.15 Favored 'Trans proline' 0 N--CA 1.443 -1.443 0 C-N-CA 121.31 1.34 . . . . 0.0 111.16 177.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 65.8 t -73.69 98.79 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.045 0 N-CA-C 104.919 -2.252 . . . . 0.0 104.919 173.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -73.6 101.17 3.53 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 -171.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -120.36 12.85 11.78 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 172.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.77 0 N-CA-C 106.988 -2.445 . . . . 0.0 106.988 -177.196 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 1129 ' ' DA2 . . . . . 0.507 ' HNE' HC21 ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.65 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.4 m -62.49 119.06 8.42 Favored 'General case' 0 N--CA 1.445 -0.685 0 O-C-N 123.359 0.412 . . . . 0.0 110.521 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 19.0 m -80.08 124.47 28.77 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.21 -178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -116.46 124.65 29.25 Favored Pre-proline 0 C--N 1.298 -1.636 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 171.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -52.57 137.95 58.07 Favored 'Trans proline' 0 C--O 1.242 0.689 0 C-N-CA 122.949 2.433 . . . . 0.0 113.076 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.9 t -74.0 -27.21 60.85 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 122.062 0.934 . . . . 0.0 108.541 175.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -140.55 130.63 24.8 Favored 'General case' 0 N--CA 1.408 -2.539 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 175.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.3 p -78.26 110.11 12.99 Favored 'General case' 0 C--N 1.289 -2.058 0 O-C-N 123.461 0.475 . . . . 0.0 111.112 -178.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -114.25 150.89 33.68 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.34 -179.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -131.01 157.18 43.69 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.464 177.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.8 t -63.76 141.61 17.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 C-N-CA 123.225 0.61 . . . . 0.0 111.05 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.73 31.23 40.94 Favored Glycine 0 N--CA 1.44 -1.05 0 C-N-CA 121.444 -0.407 . . . . 0.0 112.139 177.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -122.13 150.16 42.58 Favored 'General case' 0 CA--C 1.481 -1.678 0 CA-C-O 120.533 0.206 . . . . 0.0 111.04 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -90.84 138.64 31.43 Favored 'General case' 0 N--CA 1.406 -2.669 0 CA-C-O 121.858 0.837 . . . . 0.0 110.507 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 18.6 p -147.42 176.39 10.06 Favored 'General case' 0 C--N 1.271 -2.813 0 CA-C-N 113.952 -1.476 . . . . 0.0 107.5 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 41.1 mtp -116.4 130.85 56.98 Favored 'General case' 0 C--N 1.28 -2.447 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 173.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.99 151.9 38.28 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.529 -175.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 72.2 t -88.01 117.55 31.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.406 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.7 t90 -66.5 126.04 27.63 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.3 m -60.08 -30.85 69.5 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-O 121.232 0.539 . . . . 0.0 112.383 -178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.406 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 46.6 mt-10 -80.15 -42.55 23.25 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -173.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.436 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 10.0 t70 -109.27 -14.08 14.53 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 118.813 -1.155 . . . . 0.0 111.136 -178.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.95 3.65 89.41 Favored Glycine 0 C--N 1.305 -1.19 0 C-N-CA 120.544 -0.836 . . . . 0.0 113.604 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.436 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 28.4 mm-40 -93.28 162.72 13.89 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 117.559 0.68 . . . . 0.0 110.255 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 25.0 p -89.94 136.63 32.92 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.23 0.538 . . . . 0.0 110.367 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.412 ' CD2' HC11 ' A' 1129 ' ' DA2 . 96.9 m-85 -137.79 158.05 45.16 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 123.725 0.81 . . . . 0.0 108.955 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -75.21 128.98 36.7 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -142.35 150.12 40.31 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.304 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -110.41 134.56 52.21 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.53 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.455 ' HA ' HG22 ' A' ' 106' ' ' ILE . 66.0 mt -73.03 120.84 22.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.258 179.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -96.03 -39.07 9.93 Favored 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.425 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -151.39 147.79 27.32 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -176.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.7 mt -123.07 143.19 36.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -116.67 91.23 3.52 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 171.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -65.69 -20.29 66.23 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.984 -1.007 . . . . 0.0 113.091 -174.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -65.97 -46.65 77.34 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -91.92 -13.27 31.48 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.688 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.504 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 70.43 41.09 67.82 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 -175.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 41.3 p -123.58 155.75 37.06 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -138.33 146.72 42.72 Favored 'General case' 0 C--N 1.289 -2.061 0 CA-C-O 121.267 0.556 . . . . 0.0 111.134 177.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.89 122.05 37.12 Favored 'General case' 0 N--CA 1.417 -2.106 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 176.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.455 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.7 152.12 30.61 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.683 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.218 -174.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 90.9 m -117.01 122.99 45.78 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.051 177.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -72.62 124.43 25.24 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.752 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.32 134.42 55.76 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 114.706 -1.133 . . . . 0.0 111.044 -176.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.8 -48.25 3.26 Favored Glycine 0 N--CA 1.432 -1.591 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.249 178.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -78.51 -43.4 27.0 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 120.796 0.332 . . . . 0.0 111.003 -178.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 88.71 11.9 65.13 Favored Glycine 0 N--CA 1.442 -0.95 0 C-N-CA 120.262 -0.97 . . . . 0.0 111.911 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 107' ' ' THR . 4.3 m-20 -81.58 155.98 25.42 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -141.06 138.75 33.83 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.44 162.79 40.32 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 123.358 0.411 . . . . 0.0 109.982 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 76.6 t -97.56 121.87 48.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.8 t -136.55 141.09 34.24 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -177.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.585 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.4 Cg_endo -63.02 147.46 94.45 Favored 'Trans proline' 0 N--CA 1.446 -1.305 0 C-N-CA 122.432 2.088 . . . . 0.0 111.346 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 43.4 mt -54.24 -26.79 30.61 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 123.73 0.812 . . . . 0.0 111.501 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 pp -63.97 -27.26 69.01 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.953 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.44 HD22 ' HD2' ' A' ' 118' ' ' PRO . 67.2 m-20 -83.89 -27.27 28.75 Favored 'General case' 0 CA--C 1.487 -1.45 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.661 -178.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 81.5 mt -73.67 127.09 31.82 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.485 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.424 ' HE3' ' HA ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -112.76 153.96 44.95 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 178.127 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.96 151.79 56.72 Favored 'Trans proline' 0 C--O 1.246 0.904 0 C-N-CA 121.607 1.538 . . . . 0.0 111.048 175.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.9 t -84.91 94.49 3.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 176.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -78.2 107.6 10.92 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.966 -174.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -125.7 13.26 8.03 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.824 0.821 . . . . 0.0 109.4 178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.412 -2.912 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 -179.803 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 1129 ' ' DA2 . . . . . 0.477 ' HNE' HC21 ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.473 0 CA-C-O 120.617 0.246 . . . . 0.0 110.568 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.5 p -77.06 -45.54 26.76 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 95.9 m -88.15 119.93 29.01 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 174.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.461 HE21 ' HA ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -72.92 117.92 63.87 Favored Pre-proline 0 C--N 1.3 -1.544 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -179.365 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -57.58 134.4 62.95 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.141 1.894 . . . . 0.0 111.291 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.0 t -83.98 -23.27 31.11 Favored 'General case' 0 C--N 1.29 -2.0 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.102 178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -141.28 136.44 31.61 Favored 'General case' 0 N--CA 1.424 -1.742 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.8 m -82.52 105.6 13.7 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 123.391 0.432 . . . . 0.0 110.088 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -111.45 151.39 28.62 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.636 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -128.38 158.93 36.91 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 69.8 t -65.35 133.04 31.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 123.076 0.55 . . . . 0.0 110.066 176.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.85 31.4 23.83 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 121.199 -0.524 . . . . 0.0 112.786 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 1.3 t0 -115.32 164.06 14.8 Favored 'General case' 0 C--N 1.314 -0.941 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.836 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.424 ' HB3' HG21 ' A' ' 125' ' ' VAL . 6.4 mmpt? -94.46 131.9 39.67 Favored 'General case' 0 N--CA 1.422 -1.856 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.403 ' SG ' HD22 ' A' ' 122' ' ' LEU . 21.0 p -147.0 172.74 13.25 Favored 'General case' 0 C--N 1.267 -3.016 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.1 mtp -117.08 129.91 56.3 Favored 'General case' 0 N--CA 1.411 -2.377 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 174.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.0 154.82 37.95 Favored 'General case' 0 C--N 1.273 -2.72 0 CA-C-N 114.988 -1.005 . . . . 0.0 109.451 -173.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.0 t -87.51 122.15 38.94 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.18 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.437 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 10.8 t90 -71.44 122.17 19.91 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 177.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.9 m -61.34 -25.23 67.01 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.437 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 13.8 mm-40 -78.4 -42.11 31.14 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 115.552 -0.749 . . . . 0.0 112.783 -177.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.414 ' OD1' ' HG2' ' A' ' 88' ' ' GLN . 8.2 t70 -114.61 -15.52 11.97 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.271 -174.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 81.76 0.58 89.54 Favored Glycine 0 C--N 1.31 -0.881 0 C-N-CA 120.75 -0.738 . . . . 0.0 113.688 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.414 ' HG2' ' OD1' ' A' ' 86' ' ' ASP . 27.1 mm-40 -90.97 164.67 13.9 Favored 'General case' 0 C--N 1.31 -1.111 0 C-N-CA 120.237 -0.585 . . . . 0.0 110.189 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 22.0 p -90.37 136.18 33.21 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 120.787 0.327 . . . . 0.0 110.445 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -136.59 157.75 46.03 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 123.131 0.573 . . . . 0.0 109.777 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -75.41 130.97 39.84 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -143.52 154.55 43.74 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.746 -177.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 77' ' ' ASP . 36.0 tt0 -112.6 132.24 55.24 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.847 177.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.52 ' HA ' HG22 ' A' ' 106' ' ' ILE . 74.5 mt -69.54 124.4 25.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 O-C-N 123.673 0.608 . . . . 0.0 111.639 178.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -99.07 -40.65 7.91 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.265 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.667 ' HB3' ' HB3' ' A' ' 105' ' ' ALA . 27.7 tt0 -143.3 143.35 31.66 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -173.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 79.1 mt -125.76 129.65 72.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 175.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -119.01 93.62 4.16 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 174.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -66.16 -20.0 66.01 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.457 -178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -61.13 -46.95 88.48 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.273 0.558 . . . . 0.0 110.232 178.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -99.39 -8.92 24.12 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.012 0.434 . . . . 0.0 110.716 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.423 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 71.17 41.5 59.86 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 -177.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 75.5 p -123.07 157.33 33.04 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.509 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -139.43 140.26 37.3 Favored 'General case' 0 C--N 1.279 -2.492 0 CA-C-O 121.167 0.508 . . . . 0.0 109.937 175.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.667 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . . . -89.67 124.55 34.7 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 175.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.52 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -125.1 156.03 33.9 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 CA-C-O 120.855 0.36 . . . . 0.0 110.884 -174.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.425 ' HA ' ' O ' ' A' ' 113' ' ' ASN . 97.3 m -121.98 119.89 32.79 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.398 176.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -66.16 125.73 26.44 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.375 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.72 129.53 41.47 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.975 -174.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 90.28 -50.85 3.36 Favored Glycine 0 N--CA 1.437 -1.258 0 N-CA-C 111.616 -0.593 . . . . 0.0 111.616 177.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -70.15 -41.69 73.52 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.078 0.466 . . . . 0.0 110.071 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 85.36 5.5 85.05 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.615 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 107' ' ' THR . 4.0 m-20 -77.17 150.38 35.52 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.56 138.86 36.61 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.806 -176.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -151.69 162.73 40.52 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.209 179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.4 t -99.45 119.99 48.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.3 t -132.72 141.17 40.13 Favored Pre-proline 0 C--N 1.281 -2.374 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 30.4 Cg_endo -62.48 148.86 92.65 Favored 'Trans proline' 0 N--CA 1.441 -1.574 0 C-N-CA 122.217 1.944 . . . . 0.0 111.48 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 50.6 mt -54.93 -26.54 36.91 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.793 0.837 . . . . 0.0 111.168 178.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.9 pp -66.88 -24.2 66.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.957 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.426 HD22 ' HD2' ' A' ' 118' ' ' PRO . 74.4 m-20 -89.96 -17.92 27.03 Favored 'General case' 0 CA--C 1.49 -1.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.416 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.509 HD11 ' HB3' ' A' ' 104' ' ' ALA . 82.5 mt -82.2 125.37 30.84 Favored 'General case' 0 N--CA 1.426 -1.664 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.314 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -115.81 153.97 48.12 Favored Pre-proline 0 C--N 1.281 -2.386 0 CA-C-N 114.498 -1.228 . . . . 0.0 108.648 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -73.18 145.4 39.02 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 C-N-CA 121.347 1.365 . . . . 0.0 110.535 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.424 HG21 ' HB3' ' A' ' 78' ' ' LYS . 48.4 t -77.45 105.56 6.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -67.16 94.26 0.34 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.46 0.648 . . . . 0.0 109.417 174.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -107.13 -6.64 17.24 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.756 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.279 -2.638 0 CA-C-N 113.887 -1.506 . . . . 0.0 109.47 -179.197 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 1129 ' ' DA2 . . . . . 0.472 HC21 ' HNE' ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.431 0 CA-C-O 121.062 0.458 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.7 m -76.42 -36.4 58.04 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 176.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.654 ' HB ' ' O ' ' A' ' 99' ' ' GLU . 24.5 m -97.36 108.61 21.38 Favored 'General case' 0 N--CA 1.412 -2.34 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 176.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.442 ' HA ' ' OE1' ' A' ' 68' ' ' GLN . 13.6 mm-40 -86.75 119.45 71.25 Favored Pre-proline 0 C--N 1.288 -2.083 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.952 -176.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.32 134.8 31.72 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 124.069 3.179 . . . . 0.0 112.955 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.5 t -79.04 -19.5 51.26 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 122.153 0.978 . . . . 0.0 108.889 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -140.95 136.17 31.94 Favored 'General case' 0 N--CA 1.424 -1.753 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.9 t -78.94 105.18 10.08 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.427 0.632 . . . . 0.0 109.489 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 92.0 m95 -112.85 151.12 30.78 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.711 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -133.37 160.69 36.62 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 175.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.9 t -64.87 133.46 30.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.528 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 86.12 30.89 21.57 Favored Glycine 0 N--CA 1.438 -1.229 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.779 179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.03 152.17 35.21 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -92.12 132.4 36.63 Favored 'General case' 0 N--CA 1.404 -2.743 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.91 175.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 18.0 p -142.53 174.72 10.38 Favored 'General case' 0 C--N 1.259 -3.327 0 CA-C-N 114.403 -1.271 . . . . 0.0 107.78 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 38.4 mtp -115.52 130.19 56.79 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 173.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -121.27 149.55 42.72 Favored 'General case' 0 C--N 1.277 -2.551 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.488 -176.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 54.8 t -85.04 116.5 28.63 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 176.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -63.74 120.64 12.24 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.9 t -63.65 -18.6 64.12 Favored 'General case' 0 C--N 1.3 -1.579 0 C-N-CA 122.854 0.462 . . . . 0.0 111.298 -175.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -85.1 -42.51 14.72 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.439 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 11.0 t70 -115.91 -15.82 11.19 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 119.123 -1.031 . . . . 0.0 112.118 -173.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 86.32 -5.78 83.55 Favored Glycine 0 C--N 1.31 -0.861 0 C-N-CA 119.853 -1.165 . . . . 0.0 114.293 176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.476 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 25.8 mm-40 -83.61 158.4 21.91 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 22.2 p -90.37 136.04 33.31 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 120.936 0.398 . . . . 0.0 109.977 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.476 ' CE2' ' HB2' ' A' ' 88' ' ' GLN . 97.4 m-85 -136.91 158.53 44.24 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.612 0.765 . . . . 0.0 109.681 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -75.33 123.36 25.22 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -135.74 149.87 49.33 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.89 -178.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -112.05 132.35 54.87 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.986 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.494 ' HA ' HG22 ' A' ' 106' ' ' ILE . 64.5 mt -71.52 123.08 25.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.948 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -96.77 -41.34 8.52 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.09 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -151.7 142.09 22.49 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.574 -176.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 69.0 mt -113.44 138.35 43.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -120.8 92.06 3.67 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 176.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.654 ' O ' ' HB ' ' A' ' 67' ' ' THR . 8.9 pt-20 -65.76 -18.05 65.05 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.65 -46.91 80.51 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-O 121.412 0.625 . . . . 0.0 109.659 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -93.8 -15.66 24.89 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.566 178.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.42 37.4 47.36 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -175.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 42.8 p -125.36 155.79 39.74 Favored 'General case' 0 N--CA 1.427 -1.602 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -176.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -134.58 144.64 48.06 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-O 121.238 0.542 . . . . 0.0 110.412 177.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.62 121.79 32.85 Favored 'General case' 0 N--CA 1.414 -2.238 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.494 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.57 151.9 30.22 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.705 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.477 -175.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.8 m -119.71 121.26 38.82 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -67.73 118.24 10.72 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.46 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -71.28 126.27 29.16 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.569 -1.196 . . . . 0.0 111.171 -173.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 104.81 -37.69 3.66 Favored Glycine 0 N--CA 1.425 -2.065 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.097 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -89.9 -43.61 10.48 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.921 0.391 . . . . 0.0 110.172 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.43 4.91 62.17 Favored Glycine 0 N--CA 1.436 -1.313 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.044 -178.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -79.84 156.64 27.28 Favored 'General case' 0 CA--C 1.494 -1.185 0 CA-C-N 117.039 0.42 . . . . 0.0 109.934 178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -143.1 143.56 31.89 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 120.564 0.221 . . . . 0.0 110.622 -177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -151.67 162.48 40.93 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.8 t -103.73 115.37 45.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.9 t -128.72 141.5 41.81 Favored Pre-proline 0 C--N 1.279 -2.498 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.08 -173.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.2 Cg_endo -62.18 146.46 95.99 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 122.456 2.104 . . . . 0.0 111.457 -178.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 60.1 mt -55.15 -26.39 38.35 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 123.623 0.769 . . . . 0.0 111.469 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 pp -66.22 -24.37 66.6 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.958 178.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -90.26 -16.38 29.46 Favored 'General case' 0 CA--C 1.479 -1.763 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 84.7 mt -80.98 126.24 31.14 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.448 -0.796 . . . . 0.0 108.86 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -114.8 147.43 38.2 Favored Pre-proline 0 C--N 1.288 -2.084 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -67.36 150.64 81.02 Favored 'Trans proline' 0 C--N 1.317 -1.098 0 C-N-CA 122.006 1.804 . . . . 0.0 110.837 177.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 41.1 t -82.92 83.48 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.59 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -90.94 76.7 6.23 Favored 'General case' 0 N--CA 1.419 -2.019 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 61.82 20.55 11.53 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.777 -1.556 . . . . 0.0 113.606 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.042 0 CA-C-O 118.406 -1.219 . . . . 0.0 111.027 177.305 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A 1129 ' ' DA2 . . . . . 0.502 HC21 ' HNE' ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.217 -0.619 0 CA-C-O 120.731 0.301 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.4 m -74.24 -40.06 62.64 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 122.224 1.011 . . . . 0.0 108.353 176.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 58.5 m -138.8 148.42 43.78 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 174.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -105.82 133.15 20.33 Favored Pre-proline 0 C--N 1.302 -1.492 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -58.02 134.01 59.43 Favored 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.637 2.224 . . . . 0.0 112.594 178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.6 t -88.94 -18.95 26.44 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.345 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -141.54 149.03 40.3 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 -177.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.4 m -88.79 104.8 17.25 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -110.81 151.15 28.15 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.819 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -126.87 153.21 46.02 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.67 133.13 30.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 175.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.11 39.42 9.28 Favored Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.484 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -117.79 161.17 20.16 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -98.75 131.24 45.05 Favored 'General case' 0 N--CA 1.394 -3.258 0 CA-C-O 122.1 0.953 . . . . 0.0 110.818 175.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 15.5 p -143.63 168.09 20.71 Favored 'General case' 0 C--N 1.262 -3.227 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.129 -177.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 31.3 mtp -111.83 130.2 55.89 Favored 'General case' 0 C--N 1.272 -2.764 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 172.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -121.42 149.47 42.97 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -176.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.4 t -85.42 117.01 29.66 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 178.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.465 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.5 t90 -66.76 123.05 19.06 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 51.5 m -60.24 -26.36 66.36 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.465 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 45.4 mt-10 -82.09 -41.98 19.8 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.005 -174.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -110.99 -15.48 13.74 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.762 -178.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.28 10.51 86.16 Favored Glycine 0 C--N 1.307 -1.056 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.643 177.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -98.94 160.09 14.5 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 23.0 p -90.34 136.33 33.12 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 120.879 0.371 . . . . 0.0 110.916 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.4 ' CD2' HC11 ' A' 1129 ' ' DA2 . 96.7 m-85 -136.46 158.14 45.14 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 123.725 0.81 . . . . 0.0 110.085 -179.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -76.66 125.89 30.03 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.415 0.626 . . . . 0.0 109.887 -177.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -139.25 155.06 48.02 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.688 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -114.49 132.47 56.28 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.138 179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.545 ' HA ' HG22 ' A' ' 106' ' ' ILE . 69.4 mt -70.88 123.85 25.84 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.311 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -98.34 -40.53 8.27 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.545 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.435 ' HB3' ' HB3' ' A' ' 105' ' ' ALA . 29.1 tt0 -148.43 146.35 28.4 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -174.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 72.1 mt -124.72 137.61 56.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -116.98 95.48 5.02 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 174.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -65.99 -22.1 66.44 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -175.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -67.86 -46.78 70.77 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-O 121.277 0.561 . . . . 0.0 110.354 -178.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -92.39 -9.47 41.61 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.784 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.545 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 64.56 41.98 97.62 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -176.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 41.6 p -126.23 155.9 41.12 Favored 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -139.73 149.01 43.11 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 121.207 0.527 . . . . 0.0 111.313 178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.435 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . . . -95.41 124.05 39.24 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 176.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.545 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -126.41 155.07 36.53 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.046 -175.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.7 m -121.79 120.34 34.32 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 177.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -68.91 121.63 16.99 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.381 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.1 135.34 57.15 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.167 -174.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 88.74 -46.13 3.29 Favored Glycine 0 C--N 1.309 -0.934 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.743 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 45.4 m-85 -77.23 -40.24 45.58 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.985 0.421 . . . . 0.0 110.698 -178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.97 7.89 76.85 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.526 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -82.07 149.25 28.15 Favored 'General case' 0 CA--C 1.485 -1.519 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -144.05 137.57 27.71 Favored 'General case' 0 C--N 1.28 -2.436 0 C-N-CA 120.865 -0.334 . . . . 0.0 110.803 -176.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -151.83 160.55 43.51 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 123.521 0.513 . . . . 0.0 110.031 -179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.0 t -93.34 122.07 44.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 14.4 t -135.75 141.21 36.12 Favored Pre-proline 0 C--N 1.282 -2.328 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -177.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.2 Cg_endo -63.21 148.55 92.99 Favored 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 122.273 1.982 . . . . 0.0 111.497 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 50.6 mt -55.54 -26.32 42.6 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 123.858 0.863 . . . . 0.0 111.412 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 pp -63.97 -26.97 68.82 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 121.434 0.635 . . . . 0.0 110.497 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.453 HD22 ' HD2' ' A' ' 118' ' ' PRO . 67.5 m-20 -84.17 -26.03 29.13 Favored 'General case' 0 CA--C 1.476 -1.902 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.576 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.2 mt -78.3 126.23 30.49 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.272 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -114.67 150.32 43.77 Favored Pre-proline 0 C--N 1.288 -2.086 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 175.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.85 146.91 48.93 Favored 'Trans proline' 0 C--N 1.325 -0.663 0 C-N-CA 121.493 1.462 . . . . 0.0 110.871 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 96.4 t -79.83 100.71 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -85.67 118.7 25.34 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -102.57 4.61 38.62 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-O 121.763 0.792 . . . . 0.0 110.338 -178.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.415 -2.738 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 -178.04 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 1129 ' ' DA2 . . . . . 0.406 ' HNE' HC21 ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.207 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.5 t -71.9 -30.65 65.59 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.1 m -119.95 134.85 55.12 Favored 'General case' 0 N--CA 1.4 -2.933 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 175.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -116.92 132.72 23.28 Favored Pre-proline 0 C--N 1.297 -1.698 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.8 136.49 42.03 Favored 'Trans proline' 0 C--O 1.25 1.081 0 C-N-CA 122.069 1.846 . . . . 0.0 110.804 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.8 t -74.14 -23.56 59.29 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.736 -176.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -140.95 140.18 34.39 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 105.695 -1.965 . . . . 0.0 105.695 -179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.7 m -81.24 104.93 12.05 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.139 0.495 . . . . 0.0 110.002 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.419 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 92.0 m95 -112.79 151.25 30.56 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.252 177.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -133.71 155.24 50.09 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.355 176.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.9 t -63.5 141.42 18.17 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.15 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.13 27.92 51.1 Favored Glycine 0 CA--C 1.498 -0.975 0 C-N-CA 121.401 -0.428 . . . . 0.0 112.527 177.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.46 153.81 41.43 Favored 'General case' 0 CA--C 1.488 -1.438 0 CA-C-O 120.927 0.394 . . . . 0.0 111.774 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -90.71 141.28 28.95 Favored 'General case' 0 N--CA 1.413 -2.321 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.76 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.419 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 14.2 p -147.99 175.2 11.18 Favored 'General case' 0 C--N 1.265 -3.097 0 CA-C-N 113.573 -1.649 . . . . 0.0 107.158 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.404 ' HB2' ' HB2' ' A' ' 123' ' ' LYS . 82.0 mmm -112.13 129.38 56.25 Favored 'General case' 0 C--N 1.271 -2.811 0 N-CA-C 105.142 -2.17 . . . . 0.0 105.142 175.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 89' ' ' CYS . . . -122.39 147.52 46.19 Favored 'General case' 0 C--N 1.266 -3.063 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.089 -176.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 92.8 t -85.09 115.01 26.17 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.473 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 12.7 t90 -64.44 121.22 13.86 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.6 t -63.12 -20.25 65.2 Favored 'General case' 0 C--N 1.295 -1.775 0 O-C-N 123.434 0.459 . . . . 0.0 111.658 -176.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.473 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 37.6 mm-40 -84.82 -42.22 15.34 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -177.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -109.74 -15.98 14.01 Favored 'General case' 0 CA--C 1.507 -0.708 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.239 -175.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 79.59 9.33 86.97 Favored Glycine 0 C--O 1.221 -0.66 0 C-N-CA 120.396 -0.907 . . . . 0.0 113.076 177.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -102.85 162.03 13.26 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 7.1 p -89.87 136.6 32.94 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.085 0.469 . . . . 0.0 111.91 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -136.06 158.52 44.21 Favored 'General case' 0 C--N 1.311 -1.071 0 C-N-CA 124.866 1.266 . . . . 0.0 109.134 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -75.03 127.95 34.43 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -178.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -141.41 151.98 43.92 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.71 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -111.33 133.35 53.71 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.394 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.438 ' HA ' HG22 ' A' ' 106' ' ' ILE . 67.8 mt -72.67 123.94 28.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 123.745 0.818 . . . . 0.0 111.92 179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -99.69 -38.21 8.8 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.638 -1.164 . . . . 0.0 110.989 179.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -151.79 143.91 23.92 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 116.231 -0.441 . . . . 0.0 109.879 -175.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 64.5 mt -124.29 140.23 48.24 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -124.39 94.39 4.19 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 171.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -66.28 -23.11 66.33 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -66.76 -44.14 82.22 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.397 0.617 . . . . 0.0 109.821 -179.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -92.67 -9.51 40.57 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.357 0.599 . . . . 0.0 110.367 177.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 68.13 39.19 88.61 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.527 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 73.8 p -125.28 155.42 40.19 Favored 'General case' 0 N--CA 1.425 -1.71 0 O-C-N 122.265 -0.55 . . . . 0.0 110.405 -176.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.449 ' HB3' HD11 ' A' ' 122' ' ' LEU . . . -138.48 146.15 41.7 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-O 121.461 0.648 . . . . 0.0 110.601 176.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -94.62 121.59 36.34 Favored 'General case' 0 N--CA 1.416 -2.16 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 176.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.438 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.97 153.19 31.93 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.679 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.862 -175.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 87.8 m -120.38 120.37 35.78 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.779 177.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -67.33 124.85 24.29 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 123.543 0.737 . . . . 0.0 110.72 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.24 129.28 39.43 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.023 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 95.28 -39.59 2.83 Favored Glycine 0 N--CA 1.441 -0.979 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.919 178.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -87.06 -40.24 14.87 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.286 0.565 . . . . 0.0 110.157 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 86.21 11.29 72.87 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.823 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -80.51 154.07 27.76 Favored 'General case' 0 CA--C 1.487 -1.468 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.91 139.1 30.62 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.729 -176.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -149.2 160.58 43.24 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 56.8 t -98.06 114.82 36.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 176.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.3 t -130.67 141.4 41.82 Favored Pre-proline 0 C--N 1.281 -2.408 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -175.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.591 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 40.9 Cg_endo -63.05 148.36 93.48 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.371 2.047 . . . . 0.0 111.682 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 54.3 mt -55.2 -26.78 41.39 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 123.595 0.758 . . . . 0.0 111.539 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.63 -23.5 66.82 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.248 0.547 . . . . 0.0 111.057 178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -92.13 -13.24 31.01 Favored 'General case' 0 CA--C 1.485 -1.551 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.026 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.449 HD11 ' HB3' ' A' ' 104' ' ' ALA . 82.1 mt -85.28 125.95 33.32 Favored 'General case' 0 N--CA 1.425 -1.691 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 80' ' ' MET . 71.0 mmtt -114.75 153.19 46.89 Favored Pre-proline 0 C--N 1.284 -2.276 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.84 154.02 53.49 Favored 'Trans proline' 0 C--O 1.248 1.021 0 C-N-CA 121.475 1.45 . . . . 0.0 111.869 177.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 46.1 t -81.76 80.12 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-O 121.962 0.887 . . . . 0.0 108.885 179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -97.56 99.26 10.65 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.511 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.86 10.8 9.59 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.155 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.415 -2.745 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 -178.675 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 1129 ' ' DA2 . . . . . 0.493 ' HNE' HC21 ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.605 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.8 t -154.79 145.11 22.02 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 87.6 m -129.52 118.12 21.56 Favored 'General case' 0 N--CA 1.412 -2.347 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -67.45 125.76 91.6 Favored Pre-proline 0 C--N 1.298 -1.652 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.37 134.75 37.12 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 122.444 2.096 . . . . 0.0 112.233 -176.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 15.3 t -78.69 -24.49 45.02 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -141.2 137.42 32.62 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 105.232 -2.136 . . . . 0.0 105.232 177.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.1 m -83.72 112.01 19.68 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.649 0.737 . . . . 0.0 110.916 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.462 ' CZ3' ' HB3' ' A' ' 79' ' ' CYS . 97.5 m95 -116.3 151.8 35.13 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.872 -179.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 21.2 pttm -132.97 160.0 38.37 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 175.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.61 136.41 26.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 C-N-CA 123.687 0.795 . . . . 0.0 111.362 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 87.21 21.99 46.74 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 116.246 -0.434 . . . . 0.0 112.33 177.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.66 153.55 28.73 Favored 'General case' 0 CA--C 1.482 -1.655 0 CA-C-O 120.598 0.237 . . . . 0.0 110.453 -177.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -91.81 135.29 34.03 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-O 121.93 0.872 . . . . 0.0 110.809 175.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.462 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . 19.4 p -146.03 176.38 9.76 Favored 'General case' 0 C--N 1.265 -3.085 0 CA-C-N 114.023 -1.444 . . . . 0.0 107.181 179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 59.9 mtp -115.82 130.84 57.0 Favored 'General case' 0 C--N 1.27 -2.891 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 173.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.79 150.54 39.62 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -175.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 82.7 t -85.39 115.29 26.77 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.473 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.528 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 11.0 t90 -63.74 123.25 18.4 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.1 t -62.36 -25.06 67.7 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.229 0.538 . . . . 0.0 110.997 -177.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.528 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 21.5 mm-40 -79.05 -41.73 28.13 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -176.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -115.33 -16.31 11.48 Favored 'General case' 0 CA--C 1.502 -0.891 0 C-N-CA 117.654 -1.618 . . . . 0.0 112.367 -178.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 83.59 5.75 88.04 Favored Glycine 0 C--N 1.306 -1.116 0 C-N-CA 119.795 -1.193 . . . . 0.0 113.596 177.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 27.5 mm-40 -93.19 161.6 14.35 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 177.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 23.4 p -94.25 135.74 35.31 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-O 120.957 0.408 . . . . 0.0 110.56 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.432 ' CD2' HC11 ' A' 1129 ' ' DA2 . 97.5 m-85 -137.9 157.6 46.08 Favored 'General case' 0 C--N 1.31 -1.149 0 C-N-CA 123.741 0.817 . . . . 0.0 109.203 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -75.5 126.02 30.19 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -177.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -138.25 151.15 47.37 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -112.08 133.37 54.28 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.115 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.49 ' HA ' HG22 ' A' ' 106' ' ' ILE . 66.4 mt -71.72 123.34 25.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 123.558 0.743 . . . . 0.0 111.756 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -97.39 -38.61 9.56 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.513 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -154.97 151.57 28.65 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 71.6 mt -123.33 137.27 57.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -117.68 95.82 5.11 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -65.54 -22.6 66.73 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.768 -1.106 . . . . 0.0 113.022 -177.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -65.08 -46.3 81.7 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 120.603 0.24 . . . . 0.0 110.78 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -95.36 -5.86 42.37 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.84 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.422 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 64.75 43.15 96.67 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -176.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 39.9 p -127.27 156.0 42.61 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -175.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.32 141.7 43.8 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-O 121.09 0.471 . . . . 0.0 110.086 176.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -88.04 120.76 29.69 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.49 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.89 154.22 32.57 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.679 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.082 -174.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.7 m -121.82 120.41 34.49 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.469 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -67.11 123.35 20.02 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 123.387 0.675 . . . . 0.0 110.359 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -65.48 135.67 55.48 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.266 -176.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.92 -55.81 3.7 Favored Glycine 0 N--CA 1.429 -1.784 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.948 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -72.99 -41.94 63.79 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.137 0.494 . . . . 0.0 110.806 -179.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 89.95 2.03 75.54 Favored Glycine 0 N--CA 1.436 -1.353 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.836 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -72.81 158.05 36.29 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -145.14 135.86 24.48 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.591 -176.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -146.97 157.9 43.76 Favored 'General case' 0 N--CA 1.432 -1.336 0 O-C-N 123.715 0.634 . . . . 0.0 109.67 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 69.4 t -91.96 114.32 28.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 174.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.1 t -128.0 141.67 41.97 Favored Pre-proline 0 C--N 1.29 -2.017 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -175.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.57 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 43.5 Cg_endo -64.28 147.13 91.0 Favored 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 122.126 1.884 . . . . 0.0 111.192 -178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 48.0 mt -55.38 -26.07 39.12 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 123.494 0.717 . . . . 0.0 111.138 178.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.39 -19.47 65.41 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.18 178.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -95.78 -13.27 24.24 Favored 'General case' 0 CA--C 1.486 -1.504 0 CA-C-O 120.951 0.405 . . . . 0.0 111.357 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.414 HD22 ' SG ' ' A' ' 79' ' ' CYS . 83.5 mt -81.94 126.29 31.76 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.257 177.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -114.09 154.3 46.16 Favored Pre-proline 0 C--N 1.288 -2.09 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.42 153.11 70.93 Favored 'Trans proline' 0 C--O 1.243 0.763 0 C-N-CA 121.616 1.544 . . . . 0.0 110.428 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 43.6 t -84.54 98.34 5.88 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -87.05 116.47 25.13 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.011 178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -88.94 1.34 55.6 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.513 0.673 . . . . 0.0 110.621 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.281 -2.494 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 -177.662 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 1129 ' ' DA2 . . . . . 0.432 HC11 ' CD2' ' A' ' 90' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.31 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.3 t -68.86 -43.45 75.36 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 106.05 -1.833 . . . . 0.0 106.05 174.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.6 m -120.97 141.94 50.23 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 170.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 22.4 tm0? -113.33 123.43 33.35 Favored Pre-proline 0 N--CA 1.428 -1.571 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 176.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -49.99 133.26 34.24 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.277 2.651 . . . . 0.0 114.538 -175.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 t -83.79 -22.01 31.97 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.49 -179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -141.0 140.45 34.33 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 105.769 -1.938 . . . . 0.0 105.769 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.2 t -87.51 109.92 19.95 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-O 121.605 0.717 . . . . 0.0 109.425 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -112.06 152.21 28.47 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.469 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -131.19 160.95 33.32 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 175.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 99.0 t -66.0 139.31 21.45 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.771 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 76.8 32.82 48.63 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 111.595 -0.602 . . . . 0.0 111.595 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 93' ' ' GLU . 1.4 t70 -110.49 159.18 17.74 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -95.26 131.19 41.59 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 17.9 p -144.65 173.94 11.39 Favored 'General case' 0 C--N 1.263 -3.181 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 43.8 mtp -117.28 130.55 56.62 Favored 'General case' 0 C--N 1.28 -2.451 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 173.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.04 149.97 40.76 Favored 'General case' 0 C--N 1.27 -2.883 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 69.9 t -87.41 113.54 24.96 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 176.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.454 ' CE2' ' HB2' ' A' ' 85' ' ' GLU . 12.7 t90 -63.46 120.45 11.69 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -179.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.7 t -67.06 -16.58 64.44 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 121.224 0.535 . . . . 0.0 110.946 -174.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.454 ' HB2' ' CE2' ' A' ' 83' ' ' TRP . 38.4 mt-10 -85.1 -42.29 14.93 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -178.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.521 ' OD2' ' HG2' ' A' ' 88' ' ' GLN . 13.9 t70 -110.31 -15.72 13.89 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.289 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.82 4.39 90.07 Favored Glycine 0 C--N 1.305 -1.17 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.374 176.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.521 ' HG2' ' OD2' ' A' ' 86' ' ' ASP . 28.1 mm-40 -94.68 161.26 14.26 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.913 178.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 7.9 p -92.65 136.08 33.54 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-O 121.311 0.577 . . . . 0.0 111.623 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -136.87 157.72 46.09 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 123.797 0.839 . . . . 0.0 109.441 -178.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -75.34 132.98 41.33 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -144.47 158.09 43.92 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.896 -177.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 77' ' ' ASP . 43.9 tt0 -120.6 134.08 55.31 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.819 179.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.492 ' HA ' HG22 ' A' ' 106' ' ' ILE . 70.9 mt -71.78 125.33 30.14 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 O-C-N 123.759 0.662 . . . . 0.0 112.733 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -98.43 -42.54 7.29 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.601 -1.182 . . . . 0.0 111.306 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -148.8 143.44 26.34 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 -174.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 67.0 mt -121.81 138.46 52.03 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -123.05 92.6 3.74 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 171.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -65.49 -24.79 67.24 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -177.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -63.04 -45.32 92.8 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.537 -177.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -95.2 -4.71 45.42 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.26 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 64.61 43.04 97.04 Favored Glycine 0 N--CA 1.438 -1.214 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -177.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 41.6 p -128.44 155.7 44.36 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 122.69 -0.3 . . . . 0.0 110.491 -177.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -140.39 144.52 36.26 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-O 121.058 0.456 . . . . 0.0 110.009 175.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -90.03 124.77 35.05 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.492 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -127.85 152.08 35.47 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.488 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.977 -175.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 86.3 m -116.23 120.47 39.07 Favored 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.988 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -69.12 125.93 28.2 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.915 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.45 128.4 35.86 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.44 -1.255 . . . . 0.0 111.57 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 91.13 -46.65 2.87 Favored Glycine 0 N--CA 1.437 -1.27 0 C-N-CA 121.293 -0.48 . . . . 0.0 112.798 177.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -78.75 -33.94 46.11 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 120.621 0.248 . . . . 0.0 110.981 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 83.88 -0.92 89.34 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.548 178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -71.6 150.19 44.92 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 106' ' ' ILE . . . -139.51 132.08 28.78 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.714 -176.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -144.48 160.76 40.56 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.564 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.8 t -96.09 116.21 37.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 15.2 t -130.69 141.42 41.89 Favored Pre-proline 0 C--N 1.278 -2.533 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -176.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 40.0 Cg_endo -62.92 146.36 94.85 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 C-N-CA 122.057 1.838 . . . . 0.0 110.889 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 56.3 mt -54.27 -26.49 29.33 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 123.966 0.906 . . . . 0.0 111.672 179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.5 pp -65.65 -23.84 66.89 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.289 0.566 . . . . 0.0 110.92 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -90.0 -13.72 35.49 Favored 'General case' 0 CA--C 1.49 -1.347 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.994 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 80.2 mt -85.58 126.34 33.81 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.193 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -114.61 152.75 46.54 Favored Pre-proline 0 C--N 1.281 -2.402 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.9 151.31 50.6 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 121.48 1.453 . . . . 0.0 110.31 176.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 60.2 t -76.53 101.53 2.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.302 0.572 . . . . 0.0 110.333 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -74.73 103.99 5.21 Favored 'General case' 0 N--CA 1.433 -1.317 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.887 176.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -98.64 6.85 46.74 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.99 -174.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.282 -2.424 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -178.429 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 1129 ' ' DA2 . . . . . 0.503 HC21 ' HNE' ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.052 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.5 t -78.97 86.42 4.84 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.3 t -164.71 141.6 6.16 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -117.65 114.48 37.82 Favored Pre-proline 0 C--N 1.298 -1.66 0 C-N-CA 120.781 -0.367 . . . . 0.0 110.748 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -58.89 148.31 84.93 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 123.029 2.486 . . . . 0.0 112.44 177.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.7 t -109.95 -15.28 14.1 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.196 0.522 . . . . 0.0 110.682 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -141.66 141.65 33.38 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 -177.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.2 m -93.35 119.85 32.96 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 122.69 0.396 . . . . 0.0 110.378 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -121.54 152.23 39.43 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 123.028 0.531 . . . . 0.0 111.332 -178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -133.35 154.46 50.71 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.221 177.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.5 t -63.82 141.91 17.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 C-N-CA 123.914 0.886 . . . . 0.0 110.51 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 83.1 19.39 62.92 Favored Glycine 0 CA--C 1.499 -0.959 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 178.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.51 151.88 34.02 Favored 'General case' 0 CA--C 1.477 -1.858 0 CA-C-O 120.502 0.191 . . . . 0.0 110.754 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -90.97 142.03 28.21 Favored 'General case' 0 N--CA 1.399 -2.978 0 O-C-N 123.907 0.755 . . . . 0.0 110.25 176.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 21.0 p -148.99 176.59 10.31 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 114.028 -1.442 . . . . 0.0 107.207 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 47.5 mtp -116.67 131.23 57.0 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.91 149.05 42.24 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -176.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 88.9 t -85.87 118.77 33.08 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -67.03 120.58 13.89 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.3 m -57.63 -28.89 64.1 Favored 'General case' 0 C--N 1.288 -2.065 0 C-N-CA 123.205 0.602 . . . . 0.0 112.26 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -77.64 -41.98 36.46 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.953 -176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.481 ' OD1' ' HG2' ' A' ' 88' ' ' GLN . 9.0 t70 -113.49 -16.26 12.44 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 118.58 -1.248 . . . . 0.0 111.748 -175.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 82.83 3.18 90.61 Favored Glycine 0 C--N 1.31 -0.914 0 C-N-CA 120.27 -0.967 . . . . 0.0 113.021 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.481 ' HG2' ' OD1' ' A' ' 86' ' ' ASP . 30.0 mm-40 -94.01 160.85 14.53 Favored 'General case' 0 C--N 1.314 -0.949 0 O-C-N 122.619 -0.342 . . . . 0.0 110.08 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 11.1 p -90.43 136.8 32.83 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-O 120.991 0.424 . . . . 0.0 110.528 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.431 ' CD2' HC11 ' A' 1129 ' ' DA2 . 96.8 m-85 -136.46 157.16 47.44 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -78.66 123.96 27.68 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.106 0.479 . . . . 0.0 110.012 -176.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -137.62 152.32 49.23 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.34 -176.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -108.41 134.25 51.46 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.165 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.546 ' HA ' HG22 ' A' ' 106' ' ' ILE . 63.6 mt -73.25 118.6 18.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.161 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -94.38 -38.72 10.83 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.442 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -153.81 150.4 28.41 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 -176.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 68.4 mt -124.7 141.2 45.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -120.6 90.97 3.43 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -66.35 -21.71 66.25 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.427 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -60.09 -46.22 90.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.061 178.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -94.61 -15.61 23.89 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.393 0.616 . . . . 0.0 110.648 176.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.504 ' O ' ' HG ' ' A' ' 119' ' ' LEU . . . 76.73 37.41 34.41 Favored Glycine 0 N--CA 1.44 -1.098 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -177.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.603 ' HA ' ' HA ' ' A' ' 118' ' ' PRO . 50.8 p -124.44 158.02 33.79 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -176.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -136.29 147.65 47.58 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-O 121.075 0.464 . . . . 0.0 110.501 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -95.66 121.8 37.76 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 176.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.546 HG22 ' HA ' ' A' ' 94' ' ' ILE . 2.9 pp -124.83 153.72 32.06 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.72 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.751 -174.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 95.1 m -121.45 121.29 37.21 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -68.7 119.71 13.53 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.995 -178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -67.38 130.65 43.75 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 124.262 0.976 . . . . 0.0 110.284 -175.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.09 -51.26 1.29 Allowed Glycine 0 N--CA 1.429 -1.819 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.456 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -76.79 -43.62 36.06 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.762 0.315 . . . . 0.0 110.76 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.22 2.27 66.19 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.339 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -75.99 154.53 35.74 Favored 'General case' 0 CA--C 1.492 -1.252 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.23 138.79 31.69 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -152.34 162.81 40.64 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 123.178 0.299 . . . . 0.0 110.642 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.2 t -97.82 120.37 47.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 13.3 t -133.96 141.02 38.13 Favored Pre-proline 0 C--N 1.284 -2.256 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -176.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 37.4 Cg_endo -64.21 146.97 91.2 Favored 'Trans proline' 0 N--CA 1.438 -1.765 0 C-N-CA 122.071 1.847 . . . . 0.0 111.436 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 102' ' ' GLY . 45.2 mt -53.93 -26.41 25.27 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 123.864 0.865 . . . . 0.0 111.317 178.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 pp -68.09 -21.61 64.95 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.119 179.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.419 HD22 ' HD2' ' A' ' 118' ' ' PRO . 73.4 m-20 -93.09 -17.88 23.28 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.064 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 85.9 mt -77.74 126.83 31.47 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-O 121.435 0.636 . . . . 0.0 109.856 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -114.4 155.47 45.79 Favored Pre-proline 0 C--N 1.291 -1.965 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.55 148.7 48.26 Favored 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 121.735 1.623 . . . . 0.0 111.356 176.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 48.9 t -76.9 96.88 1.58 Allowed 'Isoleucine or valine' 0 CA--C 1.509 -0.626 0 CA-C-O 121.226 0.536 . . . . 0.0 110.376 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -92.92 116.03 28.67 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.294 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -107.03 13.31 27.64 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 121.669 0.747 . . . . 0.0 110.256 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.422 -2.272 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.628 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A 1129 ' ' DA2 . . . . . 0.487 HC21 ' HNE' ' A' 1129 ' ' DA2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_